id	sid	tid	token	lemma	pos
biomedich-267	1	1	biology	biology	NOUN
biomedich-267	1	2	,	,	PUNCT
biomedich-267	1	3	medicine	medicine	NOUN
biomedich-267	1	4	,	,	PUNCT
biomedich-267	1	5	&	&	CCONJ
biomedich-267	1	6	natural	natural	ADJ
biomedich-267	1	7	product	product	NOUN
biomedich-267	1	8	chemistry	chemistry	NOUN
biomedich-267	1	9	issn	issn	VERB
biomedich-267	1	10	2089	2089	NUM
biomedich-267	1	11	-	-	SYM
biomedich-267	1	12	6514	6514	NUM
biomedich-267	1	13	(	(	PUNCT
biomedich-267	1	14	paper	paper	NOUN
biomedich-267	1	15	)	)	PUNCT
biomedich-267	1	16	volume	volume	NOUN
biomedich-267	1	17	12	12	NUM
biomedich-267	1	18	,	,	PUNCT
biomedich-267	1	19	number	number	NOUN
biomedich-267	1	20	1	1	NUM
biomedich-267	1	21	,	,	PUNCT
biomedich-267	1	22	april	april	PROPN
biomedich-267	1	23	2023	2023	NUM
biomedich-267	2	1	|	|	ADV
biomedich-267	2	2	pages	page	NOUN
biomedich-267	2	3	:	:	PUNCT
biomedich-267	2	4	45	45	NUM
biomedich-267	2	5	-	-	SYM
biomedich-267	2	6	53	53	NUM
biomedich-267	2	7	|	|	ADV
biomedich-267	2	8	doi	doi	NOUN
biomedich-267	2	9	:	:	PUNCT
biomedich-267	2	10	10.14421	10.14421	NUM
biomedich-267	2	11	/	/	SYM
biomedich-267	2	12	biomedich.2023.121.45	biomedich.2023.121.45	NOUN
biomedich-267	2	13	-	-	SYM
biomedich-267	2	14	53	53	NUM
biomedich-267	2	15	issn	issn	PROPN
biomedich-267	2	16	2540	2540	NUM
biomedich-267	2	17	-	-	SYM
biomedich-267	2	18	9328	9328	NUM
biomedich-267	2	19	(	(	PUNCT
biomedich-267	2	20	online	online	ADV
biomedich-267	2	21	)	)	PUNCT
biomedich-267	2	22	the	the	DET
biomedich-267	2	23	association	association	NOUN
biomedich-267	2	24	between	between	ADP
biomedich-267	2	25	some	some	DET
biomedich-267	2	26	endocrine	endocrine	NOUN
biomedich-267	2	27	conditions	condition	NOUN
biomedich-267	2	28	and	and	CCONJ
biomedich-267	2	29	covid-19	covid-19	PROPN
biomedich-267	2	30	:	:	PUNCT
biomedich-267	2	31	a	a	DET
biomedich-267	2	32	review	review	NOUN
biomedich-267	2	33	harem	harem	VERB
biomedich-267	2	34	othman	othman	PROPN
biomedich-267	2	35	smail	smail	PROPN
biomedich-267	2	36	department	department	PROPN
biomedich-267	2	37	of	of	ADP
biomedich-267	2	38	biology	biology	NOUN
biomedich-267	2	39	,	,	PUNCT
biomedich-267	2	40	faculty	faculty	NOUN
biomedich-267	2	41	of	of	ADP
biomedich-267	2	42	science	science	NOUN
biomedich-267	2	43	and	and	CCONJ
biomedich-267	2	44	health	health	NOUN
biomedich-267	2	45	,	,	PUNCT
biomedich-267	2	46	koya	koya	PROPN
biomedich-267	2	47	university	university	PROPN
biomedich-267	2	48	,	,	PUNCT
biomedich-267	2	49	koya	koya	PROPN
biomedich-267	2	50	koy45	koy45	PROPN
biomedich-267	2	51	,	,	PUNCT
biomedich-267	2	52	kurdistan	kurdistan	PROPN
biomedich-267	2	53	region	region	NOUN
biomedich-267	2	54	-	-	PUNCT
biomedich-267	2	55	f.r	f.r	PROPN
biomedich-267	2	56	.	.	PUNCT
biomedich-267	2	57	iraq	iraq	PROPN
biomedich-267	2	58	.	.	PUNCT
biomedich-267	3	1	corresponding	correspond	VERB
biomedich-267	3	2	author	author	NOUN
biomedich-267	3	3	harem.othman@koyauniversity.org	harem.othman@koyauniversity.org	PROPN
biomedich-267	3	4	manuscript	manuscript	NOUN
biomedich-267	3	5	received	receive	VERB
biomedich-267	3	6	:	:	PUNCT
biomedich-267	3	7	22	22	NUM
biomedich-267	3	8	september	september	PROPN
biomedich-267	3	9	,	,	PUNCT
biomedich-267	3	10	2022	2022	NUM
biomedich-267	3	11	.	.	PUNCT
biomedich-267	4	1	revision	revision	NOUN
biomedich-267	4	2	accepted	accept	VERB
biomedich-267	4	3	:	:	PUNCT
biomedich-267	4	4	03	03	NUM
biomedich-267	4	5	october	october	PROPN
biomedich-267	4	6	,	,	PUNCT
biomedich-267	4	7	2022	2022	NUM
biomedich-267	4	8	.	.	PUNCT
biomedich-267	5	1	published	publish	VERB
biomedich-267	5	2	:	:	PUNCT
biomedich-267	5	3	11	11	NUM
biomedich-267	5	4	october	october	PROPN
biomedich-267	5	5	,	,	PUNCT
biomedich-267	5	6	2022	2022	NUM
biomedich-267	5	7	.	.	PUNCT
biomedich-267	6	1	abstract	abstract	ADJ
biomedich-267	6	2	the	the	DET
biomedich-267	6	3	review	review	NOUN
biomedich-267	6	4	aimed	aim	VERB
biomedich-267	6	5	to	to	PART
biomedich-267	6	6	understand	understand	VERB
biomedich-267	6	7	and	and	CCONJ
biomedich-267	6	8	explain	explain	VERB
biomedich-267	6	9	the	the	DET
biomedich-267	6	10	association	association	NOUN
biomedich-267	6	11	between	between	ADP
biomedich-267	6	12	some	some	DET
biomedich-267	6	13	major	major	ADJ
biomedich-267	6	14	endocrine	endocrine	NOUN
biomedich-267	6	15	conditions	condition	NOUN
biomedich-267	6	16	and	and	CCONJ
biomedich-267	6	17	covid-19	covid-19	PROPN
biomedich-267	6	18	.	.	PUNCT
biomedich-267	7	1	since	since	SCONJ
biomedich-267	7	2	march	march	PROPN
biomedich-267	7	3	2019	2019	NUM
biomedich-267	7	4	,	,	PUNCT
biomedich-267	7	5	covid-19	covid-19	PROPN
biomedich-267	7	6	has	have	AUX
biomedich-267	7	7	been	be	AUX
biomedich-267	7	8	identified	identify	VERB
biomedich-267	7	9	as	as	ADP
biomedich-267	7	10	a	a	DET
biomedich-267	7	11	pandemic	pandemic	NOUN
biomedich-267	7	12	by	by	ADP
biomedich-267	7	13	the	the	DET
biomedich-267	7	14	world	world	PROPN
biomedich-267	7	15	health	health	PROPN
biomedich-267	7	16	organization	organization	NOUN
biomedich-267	7	17	(	(	PUNCT
biomedich-267	7	18	who	who	PRON
biomedich-267	7	19	)	)	PUNCT
biomedich-267	7	20	and	and	CCONJ
biomedich-267	7	21	has	have	AUX
biomedich-267	7	22	infected	infect	VERB
biomedich-267	7	23	millions	million	NOUN
biomedich-267	7	24	of	of	ADP
biomedich-267	7	25	individuals	individual	NOUN
biomedich-267	7	26	worldwide	worldwide	ADV
biomedich-267	7	27	.	.	PUNCT
biomedich-267	8	1	according	accord	VERB
biomedich-267	8	2	to	to	ADP
biomedich-267	8	3	the	the	DET
biomedich-267	8	4	literature	literature	PROPN
biomedich-267	8	5	review	review	PROPN
biomedich-267	8	6	,	,	PUNCT
biomedich-267	8	7	endocrine	endocrine	ADJ
biomedich-267	8	8	disorders	disorder	NOUN
biomedich-267	8	9	include	include	VERB
biomedich-267	8	10	diabetes	diabete	NOUN
biomedich-267	8	11	,	,	PUNCT
biomedich-267	8	12	obesity	obesity	NOUN
biomedich-267	8	13	,	,	PUNCT
biomedich-267	8	14	hypertension	hypertension	NOUN
biomedich-267	8	15	,	,	PUNCT
biomedich-267	8	16	and	and	CCONJ
biomedich-267	8	17	thyroid	thyroid	NOUN
biomedich-267	8	18	.	.	PUNCT
biomedich-267	9	1	the	the	DET
biomedich-267	9	2	development	development	NOUN
biomedich-267	9	3	and	and	CCONJ
biomedich-267	9	4	progress	progress	NOUN
biomedich-267	9	5	of	of	ADP
biomedich-267	9	6	covid-19	covid-19	PROPN
biomedich-267	9	7	patients	patient	NOUN
biomedich-267	9	8	could	could	AUX
biomedich-267	9	9	be	be	AUX
biomedich-267	9	10	affected	affect	VERB
biomedich-267	9	11	but	but	CCONJ
biomedich-267	9	12	not	not	PART
biomedich-267	9	13	yet	yet	ADV
biomedich-267	9	14	approved	approve	VERB
biomedich-267	9	15	by	by	ADP
biomedich-267	9	16	all	all	DET
biomedich-267	9	17	the	the	DET
biomedich-267	9	18	studies	study	NOUN
biomedich-267	9	19	.	.	PUNCT
biomedich-267	10	1	in	in	ADP
biomedich-267	10	2	diabetes	diabetes	NOUN
biomedich-267	10	3	mellitus	mellitus	NOUN
biomedich-267	10	4	,	,	PUNCT
biomedich-267	10	5	covid-19	covid-19	PROPN
biomedich-267	10	6	may	may	AUX
biomedich-267	10	7	affect	affect	VERB
biomedich-267	10	8	cytokines	cytokine	NOUN
biomedich-267	10	9	and	and	CCONJ
biomedich-267	10	10	increase	increase	VERB
biomedich-267	10	11	releases	release	NOUN
biomedich-267	10	12	of	of	ADP
biomedich-267	10	13	il-1	il-1	PRON
biomedich-267	10	14	,	,	PUNCT
biomedich-267	10	15	il-6	il-6	NUM
biomedich-267	10	16	,	,	PUNCT
biomedich-267	10	17	and	and	CCONJ
biomedich-267	10	18	complications	complication	NOUN
biomedich-267	10	19	caused	cause	VERB
biomedich-267	10	20	by	by	ADP
biomedich-267	10	21	diabetes	diabete	NOUN
biomedich-267	10	22	.	.	PUNCT
biomedich-267	11	1	in	in	ADP
biomedich-267	11	2	obese	obese	ADJ
biomedich-267	11	3	patients	patient	NOUN
biomedich-267	11	4	,	,	PUNCT
biomedich-267	11	5	there	there	PRON
biomedich-267	11	6	was	be	VERB
biomedich-267	11	7	an	an	DET
biomedich-267	11	8	increased	increase	VERB
biomedich-267	11	9	risk	risk	NOUN
biomedich-267	11	10	of	of	ADP
biomedich-267	11	11	progressing	progress	VERB
biomedich-267	11	12	to	to	PART
biomedich-267	11	13	severe	severe	VERB
biomedich-267	11	14	covid-19	covid-19	PROPN
biomedich-267	11	15	.	.	PUNCT
biomedich-267	12	1	because	because	SCONJ
biomedich-267	12	2	of	of	ADP
biomedich-267	12	3	the	the	DET
biomedich-267	12	4	international	international	ADJ
biomedich-267	12	5	spread	spread	NOUN
biomedich-267	12	6	of	of	ADP
biomedich-267	12	7	severe	severe	ADJ
biomedich-267	12	8	acute	acute	ADJ
biomedich-267	12	9	respiratory	respiratory	ADJ
biomedich-267	12	10	syndrome	syndrome	NOUN
biomedich-267	12	11	coronavirus	coronavirus	NOUN
biomedich-267	12	12	,	,	PUNCT
biomedich-267	12	13	clinicians	clinician	NOUN
biomedich-267	12	14	should	should	AUX
biomedich-267	12	15	pay	pay	VERB
biomedich-267	12	16	special	special	ADJ
biomedich-267	12	17	attention	attention	NOUN
biomedich-267	12	18	to	to	ADP
biomedich-267	12	19	obese	obese	ADJ
biomedich-267	12	20	patients	patient	NOUN
biomedich-267	12	21	who	who	PRON
biomedich-267	12	22	should	should	AUX
biomedich-267	12	23	be	be	AUX
biomedich-267	12	24	monitored	monitor	VERB
biomedich-267	12	25	closely	closely	ADV
biomedich-267	12	26	with	with	ADP
biomedich-267	12	27	timely	timely	ADJ
biomedich-267	12	28	and	and	CCONJ
biomedich-267	12	29	aggressive	aggressive	ADJ
biomedich-267	12	30	care	care	NOUN
biomedich-267	12	31	.	.	PUNCT
biomedich-267	13	1	covid-19	covid-19	PROPN
biomedich-267	13	2	pathophysiology	pathophysiology	NOUN
biomedich-267	13	3	and	and	CCONJ
biomedich-267	13	4	risk	risk	NOUN
biomedich-267	13	5	in	in	ADP
biomedich-267	13	6	a	a	DET
biomedich-267	13	7	high	high	ADJ
biomedich-267	13	8	incidence	incidence	NOUN
biomedich-267	13	9	of	of	ADP
biomedich-267	13	10	hypertension	hypertension	NOUN
biomedich-267	13	11	has	have	AUX
biomedich-267	13	12	been	be	AUX
biomedich-267	13	13	found	find	VERB
biomedich-267	13	14	in	in	ADP
biomedich-267	13	15	patients	patient	NOUN
biomedich-267	13	16	with	with	ADP
biomedich-267	13	17	covid-19	covid-19	PROPN
biomedich-267	13	18	and	and	CCONJ
biomedich-267	13	19	can	can	AUX
biomedich-267	13	20	be	be	AUX
biomedich-267	13	21	studied	study	VERB
biomedich-267	13	22	in	in	ADP
biomedich-267	13	23	many	many	ADJ
biomedich-267	13	24	kinds	kind	NOUN
biomedich-267	13	25	of	of	ADP
biomedich-267	13	26	studies	study	NOUN
biomedich-267	13	27	,	,	PUNCT
biomedich-267	13	28	such	such	ADJ
biomedich-267	13	29	as	as	ADP
biomedich-267	13	30	in	in	ADP
biomedich-267	13	31	china	china	PROPN
biomedich-267	13	32	.	.	PUNCT
biomedich-267	14	1	however	however	ADV
biomedich-267	14	2	,	,	PUNCT
biomedich-267	14	3	hypertension	hypertension	NOUN
biomedich-267	14	4	is	be	AUX
biomedich-267	14	5	considered	consider	VERB
biomedich-267	14	6	one	one	NUM
biomedich-267	14	7	of	of	ADP
biomedich-267	14	8	the	the	DET
biomedich-267	14	9	most	most	ADV
biomedich-267	14	10	significant	significant	ADJ
biomedich-267	14	11	risk	risk	NOUN
biomedich-267	14	12	factors	factor	NOUN
biomedich-267	14	13	for	for	ADP
biomedich-267	14	14	covid-19	covid-19	PROPN
biomedich-267	14	15	.	.	PUNCT
biomedich-267	15	1	in	in	ADP
biomedich-267	15	2	addition	addition	NOUN
biomedich-267	15	3	to	to	ADP
biomedich-267	15	4	the	the	DET
biomedich-267	15	5	above	above	ADJ
biomedich-267	15	6	data	datum	NOUN
biomedich-267	15	7	on	on	ADP
biomedich-267	15	8	associations	association	NOUN
biomedich-267	15	9	between	between	ADP
biomedich-267	15	10	covid-19	covid-19	PROPN
biomedich-267	15	11	and	and	CCONJ
biomedich-267	15	12	endocrine	endocrine	NOUN
biomedich-267	15	13	disorders	disorder	NOUN
biomedich-267	15	14	,	,	PUNCT
biomedich-267	15	15	data	datum	NOUN
biomedich-267	15	16	on	on	ADP
biomedich-267	15	17	thyroid	thyroid	NOUN
biomedich-267	15	18	function	function	NOUN
biomedich-267	15	19	or	or	CCONJ
biomedich-267	15	20	thyroid	thyroid	NOUN
biomedich-267	15	21	disease	disease	NOUN
biomedich-267	15	22	in	in	ADP
biomedich-267	15	23	covid-19	covid-19	PROPN
biomedich-267	15	24	is	be	AUX
biomedich-267	15	25	not	not	PART
biomedich-267	15	26	yet	yet	ADV
biomedich-267	15	27	available	available	ADJ
biomedich-267	15	28	and	and	CCONJ
biomedich-267	15	29	can	can	AUX
biomedich-267	15	30	not	not	PART
biomedich-267	15	31	be	be	AUX
biomedich-267	15	32	commonly	commonly	ADV
biomedich-267	15	33	reported	report	VERB
biomedich-267	15	34	.	.	PUNCT
biomedich-267	16	1	keywords	keyword	NOUN
biomedich-267	16	2	:	:	PUNCT
biomedich-267	16	3	covid-19	covid-19	PROPN
biomedich-267	16	4	;	;	PUNCT
biomedich-267	16	5	diabetes	diabetes	NOUN
biomedich-267	16	6	mellitus	mellitus	NOUN
biomedich-267	16	7	;	;	PUNCT
biomedich-267	16	8	bidirectional	bidirectional	NOUN
biomedich-267	16	9	;	;	PUNCT
biomedich-267	16	10	obesity	obesity	NOUN
biomedich-267	16	11	;	;	PUNCT
biomedich-267	16	12	pathophysiology	pathophysiology	NOUN
biomedich-267	16	13	;	;	PUNCT
biomedich-267	16	14	blood	blood	NOUN
biomedich-267	16	15	pressure	pressure	NOUN
biomedich-267	16	16	;	;	PUNCT
biomedich-267	16	17	hypothyroidism	hypothyroidism	NOUN
biomedich-267	16	18	.	.	PUNCT
biomedich-267	17	1	introduction	introduction	NOUN
biomedich-267	17	2	coronavirus	coronavirus	NOUN
biomedich-267	17	3	disease	disease	NOUN
biomedich-267	17	4	has	have	AUX
biomedich-267	17	5	affected	affect	VERB
biomedich-267	17	6	millions	million	NOUN
biomedich-267	17	7	of	of	ADP
biomedich-267	17	8	individuals	individual	NOUN
biomedich-267	17	9	worldwide	worldwide	ADV
biomedich-267	17	10	(	(	PUNCT
biomedich-267	17	11	covid-199	covid-199	NOUN
biomedich-267	17	12	)	)	PUNCT
biomedich-267	17	13	(	(	PUNCT
biomedich-267	17	14	mathew	mathew	PROPN
biomedich-267	17	15	et	et	PROPN
biomedich-267	17	16	al	al	PROPN
biomedich-267	17	17	.	.	PROPN
biomedich-267	17	18	,	,	PUNCT
biomedich-267	17	19	2020	2020	NUM
biomedich-267	17	20	;	;	PUNCT
biomedich-267	17	21	rostam	rostam	NOUN
biomedich-267	17	22	et	et	NOUN
biomedich-267	17	23	al	al	PROPN
biomedich-267	17	24	.	.	PROPN
biomedich-267	17	25	,	,	PUNCT
biomedich-267	17	26	2020	2020	NUM
biomedich-267	17	27	)	)	PUNCT
biomedich-267	17	28	.	.	PUNCT
biomedich-267	18	1	this	this	DET
biomedich-267	18	2	latest	late	ADJ
biomedich-267	18	3	coronavirus	coronavirus	NOUN
biomedich-267	18	4	,	,	PUNCT
biomedich-267	18	5	which	which	PRON
biomedich-267	18	6	also	also	ADV
biomedich-267	18	7	includes	include	VERB
biomedich-267	18	8	middle	middle	PROPN
biomedich-267	18	9	east	east	ADJ
biomedich-267	18	10	respiratory	respiratory	ADJ
biomedich-267	18	11	syndrome	syndrome	NOUN
biomedich-267	18	12	(	(	PUNCT
biomedich-267	18	13	mers)-cov	mers)-cov	NOUN
biomedich-267	18	14	and	and	CCONJ
biomedich-267	18	15	sars	sar	NOUN
biomedich-267	18	16	-	-	PUNCT
biomedich-267	18	17	cov-1	cov-1	NUM
biomedich-267	18	18	,	,	PUNCT
biomedich-267	18	19	is	be	AUX
biomedich-267	18	20	a	a	DET
biomedich-267	18	21	human	human	ADJ
biomedich-267	18	22	β	β	NOUN
biomedich-267	18	23	-	-	NOUN
biomedich-267	18	24	coronavirus	coronavirus	NOUN
biomedich-267	18	25	.	.	PUNCT
biomedich-267	19	1	these	these	DET
biomedich-267	19	2	viruses	virus	NOUN
biomedich-267	19	3	are	be	AUX
biomedich-267	19	4	predominantly	predominantly	ADV
biomedich-267	19	5	connected	connect	VERB
biomedich-267	19	6	to	to	ADP
biomedich-267	19	7	respiratory	respiratory	ADJ
biomedich-267	19	8	illnesses	illness	NOUN
biomedich-267	19	9	,	,	PUNCT
biomedich-267	19	10	such	such	ADJ
biomedich-267	19	11	as	as	ADP
biomedich-267	19	12	pneumonia	pneumonia	NOUN
biomedich-267	19	13	,	,	PUNCT
biomedich-267	19	14	ards	ard	NOUN
biomedich-267	19	15	,	,	PUNCT
biomedich-267	19	16	and	and	CCONJ
biomedich-267	19	17	pulmonary	pulmonary	ADJ
biomedich-267	19	18	oedema	oedema	NOUN
biomedich-267	19	19	(	(	PUNCT
biomedich-267	19	20	di	di	X
biomedich-267	19	21	et	et	PROPN
biomedich-267	19	22	al	al	PROPN
biomedich-267	19	23	.	.	PROPN
biomedich-267	19	24	,2020	,2020	PROPN
biomedich-267	19	25	)	)	PUNCT
biomedich-267	19	26	.	.	PUNCT
biomedich-267	20	1	endocrine	endocrine	ADJ
biomedich-267	20	2	disorders	disorder	NOUN
biomedich-267	20	3	are	be	AUX
biomedich-267	20	4	no	no	DET
biomedich-267	20	5	exception	exception	NOUN
biomedich-267	20	6	,	,	PUNCT
biomedich-267	20	7	and	and	CCONJ
biomedich-267	20	8	some	some	DET
biomedich-267	20	9	endocrine	endocrine	ADJ
biomedich-267	20	10	organs	organ	NOUN
biomedich-267	20	11	are	be	AUX
biomedich-267	20	12	at	at	ADP
biomedich-267	20	13	risk	risk	NOUN
biomedich-267	20	14	of	of	ADP
biomedich-267	20	15	direct	direct	ADJ
biomedich-267	20	16	or	or	CCONJ
biomedich-267	20	17	indirect	indirect	ADJ
biomedich-267	20	18	covid-19	covid-19	PROPN
biomedich-267	20	19	damage	damage	NOUN
biomedich-267	20	20	.	.	PUNCT
biomedich-267	21	1	although	although	SCONJ
biomedich-267	21	2	there	there	PRON
biomedich-267	21	3	is	be	VERB
biomedich-267	21	4	still	still	ADV
biomedich-267	21	5	no	no	DET
biomedich-267	21	6	proof	proof	NOUN
biomedich-267	21	7	of	of	ADP
biomedich-267	21	8	a	a	DET
biomedich-267	21	9	greater	great	ADJ
biomedich-267	21	10	predisposition	predisposition	NOUN
biomedich-267	21	11	in	in	ADP
biomedich-267	21	12	patients	patient	NOUN
biomedich-267	21	13	with	with	ADP
biomedich-267	21	14	diabetes	diabetes	NOUN
biomedich-267	21	15	and	and	CCONJ
biomedich-267	21	16	obesity	obesity	NOUN
biomedich-267	21	17	to	to	PART
biomedich-267	21	18	contract	contract	VERB
biomedich-267	21	19	the	the	DET
biomedich-267	21	20	infection	infection	NOUN
biomedich-267	21	21	,	,	PUNCT
biomedich-267	21	22	the	the	DET
biomedich-267	21	23	coexistence	coexistence	NOUN
biomedich-267	21	24	of	of	ADP
biomedich-267	21	25	both	both	DET
biomedich-267	21	26	conditions	condition	NOUN
biomedich-267	21	27	leads	lead	VERB
biomedich-267	21	28	to	to	ADP
biomedich-267	21	29	a	a	DET
biomedich-267	21	30	worse	bad	ADJ
biomedich-267	21	31	prognosis	prognosis	NOUN
biomedich-267	21	32	since	since	SCONJ
biomedich-267	21	33	both	both	DET
biomedich-267	21	34	conditions	condition	NOUN
biomedich-267	21	35	impart	impart	VERB
biomedich-267	21	36	an	an	DET
biomedich-267	21	37	impaired	impaired	ADJ
biomedich-267	21	38	immune	immune	ADJ
biomedich-267	21	39	system	system	NOUN
biomedich-267	21	40	(	(	PUNCT
biomedich-267	21	41	marazuela	marazuela	PROPN
biomedich-267	21	42	et	et	PROPN
biomedich-267	21	43	al	al	PROPN
biomedich-267	21	44	.	.	PROPN
biomedich-267	21	45	,	,	PUNCT
biomedich-267	21	46	2020	2020	NUM
biomedich-267	21	47	)	)	PUNCT
biomedich-267	21	48	.	.	PUNCT
biomedich-267	22	1	evidence	evidence	NOUN
biomedich-267	22	2	is	be	AUX
biomedich-267	22	3	growing	grow	VERB
biomedich-267	22	4	to	to	PART
biomedich-267	22	5	indicate	indicate	VERB
biomedich-267	22	6	that	that	SCONJ
biomedich-267	22	7	patients	patient	NOUN
biomedich-267	22	8	with	with	ADP
biomedich-267	22	9	endocrinopathies	endocrinopathie	NOUN
biomedich-267	22	10	such	such	ADJ
biomedich-267	22	11	as	as	ADP
biomedich-267	22	12	diabetes	diabetes	NOUN
biomedich-267	22	13	mellitus	mellitus	NOUN
biomedich-267	22	14	(	(	PUNCT
biomedich-267	22	15	dm	dm	PROPN
biomedich-267	22	16	)	)	PUNCT
biomedich-267	22	17	,	,	PUNCT
biomedich-267	22	18	hypertension	hypertension	NOUN
biomedich-267	22	19	(	(	PUNCT
biomedich-267	22	20	htn	htn	PROPN
biomedich-267	22	21	)	)	PUNCT
biomedich-267	22	22	,	,	PUNCT
biomedich-267	22	23	obesity	obesity	NOUN
biomedich-267	22	24	,	,	PUNCT
biomedich-267	22	25	and	and	CCONJ
biomedich-267	22	26	cardiovascular	cardiovascular	ADJ
biomedich-267	22	27	disease	disease	NOUN
biomedich-267	22	28	are	be	AUX
biomedich-267	22	29	at	at	ADP
biomedich-267	22	30	greater	great	ADJ
biomedich-267	22	31	risk	risk	NOUN
biomedich-267	22	32	of	of	ADP
biomedich-267	22	33	complications	complication	NOUN
biomedich-267	22	34	associated	associate	VERB
biomedich-267	22	35	with	with	ADP
biomedich-267	22	36	covid-19	covid-19	PROPN
biomedich-267	22	37	.	.	PUNCT
biomedich-267	23	1	in	in	ADP
biomedich-267	23	2	covid19	covid19	NOUN
biomedich-267	23	3	non	non	NOUN
biomedich-267	23	4	-	-	NOUN
biomedich-267	23	5	survivors	survivor	NOUN
biomedich-267	23	6	and	and	CCONJ
biomedich-267	23	7	serious	serious	ADJ
biomedich-267	23	8	cases	case	NOUN
biomedich-267	23	9	,	,	PUNCT
biomedich-267	23	10	studies	study	NOUN
biomedich-267	23	11	from	from	ADP
biomedich-267	23	12	the	the	DET
biomedich-267	23	13	uk	uk	PROPN
biomedich-267	23	14	and	and	CCONJ
biomedich-267	23	15	us	we	PRON
biomedich-267	23	16	suggested	suggest	VERB
biomedich-267	23	17	a	a	DET
biomedich-267	23	18	high	high	ADJ
biomedich-267	23	19	prevalence	prevalence	NOUN
biomedich-267	23	20	of	of	ADP
biomedich-267	23	21	dm	dm	NOUN
biomedich-267	23	22	and	and	CCONJ
biomedich-267	23	23	obesity	obesity	NOUN
biomedich-267	23	24	.	.	PUNCT
biomedich-267	24	1	htn	htn	PROPN
biomedich-267	24	2	(	(	PUNCT
biomedich-267	24	3	49.7	49.7	NUM
biomedich-267	24	4	%	%	NOUN
biomedich-267	24	5	)	)	PUNCT
biomedich-267	24	6	,	,	PUNCT
biomedich-267	24	7	obesity	obesity	NOUN
biomedich-267	24	8	(	(	PUNCT
biomedich-267	24	9	48.3	48.3	NUM
biomedich-267	24	10	%	%	NOUN
biomedich-267	24	11	)	)	PUNCT
biomedich-267	24	12	,	,	PUNCT
biomedich-267	24	13	dm	dm	INTJ
biomedich-267	24	14	(	(	PUNCT
biomedich-267	24	15	28.3	28.3	NUM
biomedich-267	24	16	%	%	NOUN
biomedich-267	24	17	)	)	PUNCT
biomedich-267	24	18	,	,	PUNCT
biomedich-267	24	19	and	and	CCONJ
biomedich-267	24	20	cardiovascular	cardiovascular	ADJ
biomedich-267	24	21	disease	disease	NOUN
biomedich-267	24	22	(	(	PUNCT
biomedich-267	24	23	27.8	27.8	NUM
biomedich-267	24	24	%	%	NOUN
biomedich-267	24	25	)	)	PUNCT
biomedich-267	24	26	are	be	AUX
biomedich-267	24	27	the	the	DET
biomedich-267	24	28	most	most	ADV
biomedich-267	24	29	widely	widely	ADV
biomedich-267	24	30	identified	identify	VERB
biomedich-267	24	31	cardiometabolic	cardiometabolic	NOUN
biomedich-267	24	32	comorbidities	comorbiditie	NOUN
biomedich-267	24	33	related	relate	VERB
biomedich-267	24	34	to	to	ADP
biomedich-267	24	35	covid-19	covid-19	PROPN
biomedich-267	24	36	in	in	ADP
biomedich-267	24	37	the	the	DET
biomedich-267	24	38	us	us	PROPN
biomedich-267	24	39	(	(	PUNCT
biomedich-267	24	40	shekhar	shekhar	PROPN
biomedich-267	24	41	et	et	PROPN
biomedich-267	24	42	al	al	PROPN
biomedich-267	24	43	.	.	PROPN
biomedich-267	24	44	,	,	PUNCT
biomedich-267	24	45	2020	2020	NUM
biomedich-267	24	46	)	)	PUNCT
biomedich-267	24	47	.	.	PUNCT
biomedich-267	25	1	metabolic	metabolic	NOUN
biomedich-267	25	2	syndrome	syndrome	NOUN
biomedich-267	25	3	is	be	AUX
biomedich-267	25	4	a	a	DET
biomedich-267	25	5	constellation	constellation	NOUN
biomedich-267	25	6	of	of	ADP
biomedich-267	25	7	cardiovascular	cardiovascular	ADJ
biomedich-267	25	8	risk	risk	NOUN
biomedich-267	25	9	factors	factor	NOUN
biomedich-267	25	10	,	,	PUNCT
biomedich-267	25	11	including	include	VERB
biomedich-267	25	12	abdominal	abdominal	ADJ
biomedich-267	25	13	obesity	obesity	NOUN
biomedich-267	25	14	,	,	PUNCT
biomedich-267	25	15	high	high	ADJ
biomedich-267	25	16	blood	blood	NOUN
biomedich-267	25	17	pressure	pressure	NOUN
biomedich-267	25	18	,	,	PUNCT
biomedich-267	25	19	dysglycemia	dysglycemia	NOUN
biomedich-267	25	20	,	,	PUNCT
biomedich-267	25	21	atherogenic	atherogenic	ADJ
biomedich-267	25	22	dyslipidemia	dyslipidemia	NOUN
biomedich-267	25	23	,	,	PUNCT
biomedich-267	25	24	and	and	CCONJ
biomedich-267	25	25	pro	pro	ADJ
biomedich-267	25	26	-	-	ADJ
biomedich-267	25	27	thrombotic	thrombotic	ADJ
biomedich-267	25	28	and	and	CCONJ
biomedich-267	25	29	pro	pro	ADJ
biomedich-267	25	30	-	-	ADJ
biomedich-267	25	31	inflammatory	inflammatory	ADJ
biomedich-267	25	32	states	state	NOUN
biomedich-267	25	33	.	.	PUNCT
biomedich-267	26	1	metabolic	metabolic	NOUN
biomedich-267	26	2	syndrome	syndrome	NOUN
biomedich-267	26	3	is	be	AUX
biomedich-267	26	4	clinically	clinically	ADV
biomedich-267	26	5	characterized	characterize	VERB
biomedich-267	26	6	as	as	ADP
biomedich-267	26	7	the	the	DET
biomedich-267	26	8	occurrence	occurrence	NOUN
biomedich-267	26	9	of	of	ADP
biomedich-267	26	10	three	three	NUM
biomedich-267	26	11	or	or	CCONJ
biomedich-267	26	12	more	more	ADJ
biomedich-267	26	13	of	of	ADP
biomedich-267	26	14	the	the	DET
biomedich-267	26	15	following	follow	VERB
biomedich-267	26	16	factors	factor	NOUN
biomedich-267	26	17	:	:	PUNCT
biomedich-267	26	18	increased	increase	VERB
biomedich-267	26	19	waist	waist	NOUN
biomedich-267	26	20	circumference	circumference	NOUN
biomedich-267	26	21	(	(	PUNCT
biomedich-267	26	22	population	population	NOUN
biomedich-267	26	23	and	and	CCONJ
biomedich-267	26	24	countryspecific	countryspecific	NOUN
biomedich-267	26	25	cutoff	cutoff	NOUN
biomedich-267	26	26	)	)	PUNCT
biomedich-267	26	27	,	,	PUNCT
biomedich-267	26	28	hypertriglyceridemia	hypertriglyceridemia	NOUN
biomedich-267	26	29	(	(	PUNCT
biomedich-267	26	30	>	>	SYM
biomedich-267	26	31	150	150	NUM
biomedich-267	26	32	mg	mg	PROPN
biomedich-267	26	33	/	/	SYM
biomedich-267	26	34	dl	dl	PROPN
biomedich-267	26	35	or	or	CCONJ
biomedich-267	26	36	hypertriglyceridemia	hypertriglyceridemia	VERB
biomedich-267	26	37	treatment	treatment	NOUN
biomedich-267	26	38	)	)	PUNCT
biomedich-267	26	39	,	,	PUNCT
biomedich-267	26	40	elevated	elevate	VERB
biomedich-267	26	41	blood	blood	NOUN
biomedich-267	26	42	pressure	pressure	NOUN
biomedich-267	26	43	(	(	PUNCT
biomedich-267	26	44	systolic	systolic	ADJ
biomedich-267	26	45	130	130	NUM
biomedich-267	26	46	and	and	CCONJ
biomedich-267	26	47	diastolic	diastolic	ADJ
biomedich-267	26	48	85	85	NUM
biomedich-267	26	49	mm	mm	NUM
biomedich-267	26	50	hg	hg	NOUN
biomedich-267	26	51	or	or	CCONJ
biomedich-267	26	52	hypertension	hypertension	NOUN
biomedich-267	26	53	treatment	treatment	NOUN
biomedich-267	26	54	history	history	NOUN
biomedich-267	26	55	)	)	PUNCT
biomedich-267	26	56	,	,	PUNCT
biomedich-267	26	57	elevated	elevate	VERB
biomedich-267	26	58	blood	blood	NOUN
biomedich-267	26	59	pressure	pressure	NOUN
biomedich-267	26	60	(	(	PUNCT
biomedich-267	26	61	systolic	systolic	ADJ
biomedich-267	26	62	130	130	NUM
biomedich-267	26	63	and	and	CCONJ
biomedich-267	26	64	diastolic	diastolic	ADJ
biomedich-267	26	65	85	85	NUM
biomedich-267	26	66	mm	mm	NUM
biomedich-267	26	67	hg	hg	NOUN
biomedich-267	26	68	or	or	CCONJ
biomedich-267	26	69	hypertension	hypertension	NOUN
biomedich-267	26	70	treatment	treatment	NOUN
biomedich-267	26	71	history	history	NOUN
biomedich-267	26	72	)	)	PUNCT
biomedich-267	26	73	,	,	PUNCT
biomedich-267	26	74	high	high	ADJ
biomedich-267	26	75	-	-	PUNCT
biomedich-267	26	76	density	density	NOUN
biomedich-267	26	77	lipoprotein	lipoprotein	ADJ
biomedich-267	26	78	cholesterol	cholesterol	NOUN
biomedich-267	26	79	reduction	reduction	NOUN
biomedich-267	26	80	(	(	PUNCT
biomedich-267	26	81	<	<	X
biomedich-267	26	82	40	40	NUM
biomedich-267	26	83	mg	mg	PROPN
biomedich-267	26	84	/	/	SYM
biomedich-267	26	85	dl	dl	PROPN
biomedich-267	26	86	in	in	ADP
biomedich-267	26	87	males	male	NOUN
biomedich-267	26	88	;	;	PUNCT
biomedich-267	26	89	<	<	X
biomedich-267	26	90	50	50	NUM
biomedich-267	26	91	mg	mg	PROPN
biomedich-267	26	92	/	/	SYM
biomedich-267	26	93	dl	dl	PROPN
biomedich-267	26	94	in	in	ADP
biomedich-267	26	95	females	female	NOUN
biomedich-267	26	96	)	)	PUNCT
biomedich-267	26	97	and	and	CCONJ
biomedich-267	26	98	dysglycemia	dysglycemia	X
biomedich-267	26	99	(	(	PUNCT
biomedich-267	26	100	<	<	X
biomedich-267	26	101	100	100	NUM
biomedich-267	26	102	mg	mg	PROPN
biomedich-267	26	103	/	/	SYM
biomedich-267	26	104	dl	dl	PROPN
biomedich-267	26	105	or	or	CCONJ
biomedich-267	26	106	hyperglycemia	hyperglycemia	NOUN
biomedich-267	26	107	treatment	treatment	NOUN
biomedich-267	26	108	)	)	PUNCT
biomedich-267	26	109	(	(	PUNCT
biomedich-267	26	110	bonora	bonora	NOUN
biomedich-267	26	111	et	et	PROPN
biomedich-267	26	112	al	al	PROPN
biomedich-267	26	113	.	.	PROPN
biomedich-267	26	114	,	,	PUNCT
biomedich-267	26	115	2018	2018	NUM
biomedich-267	26	116	;	;	PUNCT
biomedich-267	26	117	bansal	bansal	NOUN
biomedich-267	26	118	et	et	PROPN
biomedich-267	26	119	al	al	PROPN
biomedich-267	26	120	.	.	PROPN
biomedich-267	26	121	,	,	PUNCT
biomedich-267	26	122	2020	2020	NUM
biomedich-267	26	123	)	)	PUNCT
biomedich-267	26	124	.	.	PUNCT
biomedich-267	27	1	the	the	DET
biomedich-267	27	2	severity	severity	NOUN
biomedich-267	27	3	of	of	ADP
biomedich-267	27	4	covid-19	covid-19	PROPN
biomedich-267	27	5	can	can	AUX
biomedich-267	27	6	be	be	AUX
biomedich-267	27	7	impaired	impair	VERB
biomedich-267	27	8	by	by	ADP
biomedich-267	27	9	hypertension	hypertension	NOUN
biomedich-267	27	10	,	,	PUNCT
biomedich-267	27	11	diabetes	diabetes	NOUN
biomedich-267	27	12	,	,	PUNCT
biomedich-267	27	13	and	and	CCONJ
biomedich-267	27	14	coronary	coronary	ADJ
biomedich-267	27	15	heart	heart	NOUN
biomedich-267	27	16	disease	disease	NOUN
biomedich-267	27	17	.	.	PUNCT
biomedich-267	28	1	in	in	ADP
biomedich-267	28	2	addition	addition	NOUN
biomedich-267	28	3	,	,	PUNCT
biomedich-267	28	4	it	it	PRON
biomedich-267	28	5	may	may	AUX
biomedich-267	28	6	be	be	AUX
biomedich-267	28	7	associated	associate	VERB
biomedich-267	28	8	with	with	ADP
biomedich-267	28	9	an	an	DET
biomedich-267	28	10	angiotensin	angiotensin	NOUN
biomedich-267	28	11	-	-	PUNCT
biomedich-267	28	12	converting	convert	VERB
biomedich-267	28	13	enzyme	enzyme	NOUN
biomedich-267	28	14	2	2	NUM
biomedich-267	28	15	(	(	PUNCT
biomedich-267	28	16	ace2	ace2	NOUN
biomedich-267	28	17	)	)	PUNCT
biomedich-267	28	18	deficiency	deficiency	NOUN
biomedich-267	28	19	,	,	PUNCT
biomedich-267	28	20	and	and	CCONJ
biomedich-267	28	21	a	a	DET
biomedich-267	28	22	glucolipid	glucolipid	ADJ
biomedich-267	28	23	metabolic	metabolic	NOUN
biomedich-267	28	24	disorder	disorder	NOUN
biomedich-267	28	25	(	(	PUNCT
biomedich-267	28	26	glmd	glmd	NOUN
biomedich-267	28	27	)	)	PUNCT
biomedich-267	28	28	mediated	mediate	VERB
biomedich-267	28	29	cytokine	cytokine	NOUN
biomedich-267	28	30	storm	storm	NOUN
biomedich-267	28	31	(	(	PUNCT
biomedich-267	28	32	chen	chen	PROPN
biomedich-267	28	33	et	et	PROPN
biomedich-267	28	34	al	al	PROPN
biomedich-267	28	35	.	.	PROPN
biomedich-267	28	36	,	,	PUNCT
biomedich-267	28	37	2020	2020	NUM
biomedich-267	28	38	)	)	PUNCT
biomedich-267	28	39	.	.	PUNCT
biomedich-267	29	1	several	several	ADJ
biomedich-267	29	2	research	research	NOUN
biomedich-267	29	3	studies	study	NOUN
biomedich-267	29	4	have	have	AUX
biomedich-267	29	5	targeted	target	VERB
biomedich-267	29	6	the	the	DET
biomedich-267	29	7	epidemiological	epidemiological	ADJ
biomedich-267	29	8	and	and	CCONJ
biomedich-267	29	9	clinical	clinical	ADJ
biomedich-267	29	10	features	feature	NOUN
biomedich-267	29	11	of	of	ADP
biomedich-267	29	12	patients	patient	NOUN
biomedich-267	29	13	infected	infect	VERB
biomedich-267	29	14	with	with	ADP
biomedich-267	29	15	covid-19	covid-19	PROPN
biomedich-267	29	16	,	,	PUNCT
biomedich-267	29	17	but	but	CCONJ
biomedich-267	29	18	the	the	DET
biomedich-267	29	19	risk	risk	NOUN
biomedich-267	29	20	factors	factor	NOUN
biomedich-267	29	21	for	for	ADP
biomedich-267	29	22	severity	severity	NOUN
biomedich-267	29	23	and	and	CCONJ
biomedich-267	29	24	mortality	mortality	NOUN
biomedich-267	29	25	have	have	AUX
biomedich-267	29	26	not	not	PART
biomedich-267	29	27	been	be	AUX
biomedich-267	29	28	thoroughly	thoroughly	ADV
biomedich-267	29	29	investigated	investigate	VERB
biomedich-267	29	30	.	.	PUNCT
biomedich-267	30	1	identifying	identify	VERB
biomedich-267	30	2	major	major	ADJ
biomedich-267	30	3	risk	risk	NOUN
biomedich-267	30	4	factors	factor	NOUN
biomedich-267	30	5	and	and	CCONJ
biomedich-267	30	6	taking	take	VERB
biomedich-267	30	7	effective	effective	ADJ
biomedich-267	30	8	https://doi.org/10.14421/biomedich.2023.121.45-53	https://doi.org/10.14421/biomedich.2023.121.45-53	NOUN
biomedich-267	30	9	46	46	NUM
biomedich-267	30	10	biology	biology	NOUN
biomedich-267	30	11	,	,	PUNCT
biomedich-267	30	12	medicine	medicine	NOUN
biomedich-267	30	13	,	,	PUNCT
biomedich-267	30	14	&	&	CCONJ
biomedich-267	30	15	natural	natural	ADJ
biomedich-267	30	16	product	product	NOUN
biomedich-267	30	17	chemistry	chemistry	NOUN
biomedich-267	30	18	12	12	NUM
biomedich-267	30	19	(	(	PUNCT
biomedich-267	30	20	1	1	NUM
biomedich-267	30	21	)	)	PUNCT
biomedich-267	30	22	,	,	PUNCT
biomedich-267	30	23	2023	2023	NUM
biomedich-267	30	24	:	:	PUNCT
biomedich-267	30	25	45	45	NUM
biomedich-267	30	26	-	-	SYM
biomedich-267	30	27	53	53	NUM
biomedich-267	30	28	clinical	clinical	ADJ
biomedich-267	30	29	steps	step	NOUN
biomedich-267	30	30	will	will	AUX
biomedich-267	30	31	greatly	greatly	ADV
biomedich-267	30	32	contribute	contribute	VERB
biomedich-267	30	33	to	to	ADP
biomedich-267	30	34	saving	save	VERB
biomedich-267	30	35	lives	life	NOUN
biomedich-267	30	36	(	(	PUNCT
biomedich-267	30	37	zhou	zhou	X
biomedich-267	30	38	et	et	PROPN
biomedich-267	30	39	al	al	PROPN
biomedich-267	30	40	.	.	PROPN
biomedich-267	30	41	,	,	PUNCT
biomedich-267	30	42	2020	2020	NUM
biomedich-267	30	43	;	;	PUNCT
biomedich-267	30	44	zaki	zaki	PROPN
biomedich-267	30	45	et	et	PROPN
biomedich-267	30	46	al	al	PROPN
biomedich-267	30	47	.	.	PROPN
biomedich-267	30	48	,	,	PUNCT
biomedich-267	30	49	2020	2020	NUM
biomedich-267	30	50	)	)	PUNCT
biomedich-267	30	51	.	.	PUNCT
biomedich-267	31	1	covid-19	covid-19	PROPN
biomedich-267	31	2	and	and	CCONJ
biomedich-267	31	3	diabetes	diabetes	NOUN
biomedich-267	31	4	mellitus	mellitus	NOUN
biomedich-267	31	5	diabetes	diabete	VERB
biomedich-267	31	6	mellitus	mellitus	NOUN
biomedich-267	31	7	(	(	PUNCT
biomedich-267	31	8	dm	dm	NOUN
biomedich-267	31	9	)	)	PUNCT
biomedich-267	31	10	is	be	AUX
biomedich-267	31	11	chronic	chronic	ADJ
biomedich-267	31	12	with	with	ADP
biomedich-267	31	13	catastrophic	catastrophic	ADJ
biomedich-267	31	14	multi	multi	ADJ
biomedich-267	31	15	-	-	ADJ
biomedich-267	31	16	systemic	systemic	ADJ
biomedich-267	31	17	complications	complication	NOUN
biomedich-267	31	18	and	and	CCONJ
biomedich-267	31	19	may	may	AUX
biomedich-267	31	20	be	be	AUX
biomedich-267	31	21	associated	associate	VERB
biomedich-267	31	22	with	with	ADP
biomedich-267	31	23	extreme	extreme	ADJ
biomedich-267	31	24	coronavirus	coronavirus	NOUN
biomedich-267	31	25	disease	disease	NOUN
biomedich-267	31	26	2019	2019	NUM
biomedich-267	31	27	(	(	PUNCT
biomedich-267	31	28	covid-19	covid-19	PROPN
biomedich-267	31	29	)	)	PUNCT
biomedich-267	31	30	(	(	PUNCT
biomedich-267	31	31	huang	huang	PROPN
biomedich-267	31	32	et	et	PROPN
biomedich-267	31	33	al	al	PROPN
biomedich-267	31	34	.	.	PROPN
biomedich-267	31	35	,	,	PUNCT
biomedich-267	31	36	2020	2020	NUM
biomedich-267	31	37	)	)	PUNCT
biomedich-267	31	38	larger	large	ADJ
biomedich-267	31	39	studies	study	NOUN
biomedich-267	31	40	from	from	ADP
biomedich-267	31	41	china	china	PROPN
biomedich-267	31	42	gave	give	VERB
biomedich-267	31	43	more	more	ADV
biomedich-267	31	44	consistent	consistent	ADJ
biomedich-267	31	45	prevalence	prevalence	NOUN
biomedich-267	31	46	rates	rate	NOUN
biomedich-267	31	47	.	.	PUNCT
biomedich-267	32	1	diabetes	diabetes	NOUN
biomedich-267	32	2	was	be	AUX
biomedich-267	32	3	present	present	ADJ
biomedich-267	32	4	in	in	ADP
biomedich-267	32	5	7.4	7.4	NUM
biomedich-267	32	6	per	per	NOUN
biomedich-267	32	7	cent	cent	NOUN
biomedich-267	32	8	of	of	ADP
biomedich-267	32	9	1099	1099	NUM
biomedich-267	32	10	(	(	PUNCT
biomedich-267	32	11	median	median	ADJ
biomedich-267	32	12	age	age	NOUN
biomedich-267	32	13	of	of	ADP
biomedich-267	32	14	47	47	NUM
biomedich-267	32	15	years	year	NOUN
biomedich-267	32	16	)	)	PUNCT
biomedich-267	32	17	(	(	PUNCT
biomedich-267	32	18	guan	guan	PROPN
biomedich-267	32	19	et	et	PROPN
biomedich-267	32	20	al	al	PROPN
biomedich-267	32	21	.	.	PROPN
biomedich-267	32	22	,2020	,2020	PROPN
biomedich-267	32	23	)	)	PUNCT
biomedich-267	32	24	.	.	PUNCT
biomedich-267	33	1	and	and	CCONJ
biomedich-267	33	2	8.2	8.2	NUM
biomedich-267	33	3	per	per	ADP
biomedich-267	33	4	cent	cent	NOUN
biomedich-267	33	5	of	of	ADP
biomedich-267	33	6	1	1	NUM
biomedich-267	33	7	590	590	NUM
biomedich-267	33	8	(	(	PUNCT
biomedich-267	33	9	median	median	ADJ
biomedich-267	33	10	age	age	NOUN
biomedich-267	33	11	48.9	48.9	NUM
biomedich-267	33	12	years	year	NOUN
biomedich-267	33	13	)	)	PUNCT
biomedich-267	33	14	hospitalized	hospitalize	VERB
biomedich-267	33	15	individuals	individual	NOUN
biomedich-267	33	16	in	in	ADP
biomedich-267	33	17	two	two	NUM
biomedich-267	33	18	multicenter	multicenter	ADJ
biomedich-267	33	19	national	national	ADJ
biomedich-267	33	20	studies	study	NOUN
biomedich-267	33	21	.	.	PUNCT
biomedich-267	34	1	also	also	ADV
biomedich-267	34	2	,	,	PUNCT
biomedich-267	34	3	of	of	ADP
biomedich-267	34	4	7337	7337	NUM
biomedich-267	34	5	people	people	NOUN
biomedich-267	34	6	admitted	admit	VERB
biomedich-267	34	7	to	to	ADP
biomedich-267	34	8	nineteen	nineteen	NUM
biomedich-267	34	9	hospitals	hospital	NOUN
biomedich-267	34	10	in	in	ADP
biomedich-267	34	11	the	the	DET
biomedich-267	34	12	province	province	NOUN
biomedich-267	34	13	of	of	ADP
biomedich-267	34	14	hubei	hubei	PROPN
biomedich-267	34	15	(	(	PUNCT
biomedich-267	34	16	median	median	ADJ
biomedich-267	34	17	age	age	NOUN
biomedich-267	34	18	54	54	NUM
biomedich-267	34	19	years	year	NOUN
biomedich-267	34	20	)	)	PUNCT
biomedich-267	34	21	,	,	PUNCT
biomedich-267	34	22	952	952	NUM
biomedich-267	34	23	(	(	PUNCT
biomedich-267	34	24	13.0	13.0	NUM
biomedich-267	34	25	%	%	NOUN
biomedich-267	34	26	)	)	PUNCT
biomedich-267	34	27	had	have	VERB
biomedich-267	34	28	type	type	NOUN
biomedich-267	34	29	2	2	NUM
biomedich-267	34	30	diabetes	diabete	NOUN
biomedich-267	34	31	,	,	PUNCT
biomedich-267	34	32	while	while	SCONJ
biomedich-267	34	33	a	a	DET
biomedich-267	34	34	survey	survey	NOUN
biomedich-267	34	35	by	by	ADP
biomedich-267	34	36	the	the	DET
biomedich-267	34	37	chinese	chinese	ADJ
biomedich-267	34	38	center	center	NOUN
biomedich-267	34	39	for	for	ADP
biomedich-267	34	40	disease	disease	NOUN
biomedich-267	34	41	control	control	NOUN
biomedich-267	34	42	and	and	CCONJ
biomedich-267	34	43	prevention	prevention	NOUN
biomedich-267	34	44	(	(	PUNCT
biomedich-267	34	45	china	china	PROPN
biomedich-267	34	46	cdc	cdc	PROPN
biomedich-267	34	47	)	)	PUNCT
biomedich-267	34	48	,	,	PUNCT
biomedich-267	34	49	which	which	PRON
biomedich-267	34	50	also	also	ADV
biomedich-267	34	51	included	include	VERB
biomedich-267	34	52	nonhospitalized	nonhospitalize	VERB
biomedich-267	34	53	people	people	NOUN
biomedich-267	34	54	,	,	PUNCT
biomedich-267	34	55	showed	show	VERB
biomedich-267	34	56	a	a	DET
biomedich-267	34	57	lower	low	ADJ
biomedich-267	34	58	prevalence	prevalence	NOUN
biomedich-267	34	59	of	of	ADP
biomedich-267	34	60	diabetes	diabetes	NOUN
biomedich-267	34	61	(	(	PUNCT
biomedich-267	34	62	5.3	5.3	NUM
biomedich-267	34	63	%	%	NOUN
biomedich-267	34	64	)	)	PUNCT
biomedich-267	34	65	among	among	ADP
biomedich-267	34	66	44,672	44,672	NUM
biomedich-267	34	67	reported	report	VERB
biomedich-267	34	68	cases	case	NOUN
biomedich-267	34	69	of	of	ADP
biomedich-267	34	70	covid-19	covid-19	PROPN
biomedich-267	34	71	through	through	ADP
biomedich-267	34	72	february	february	PROPN
biomedich-267	34	73	(	(	PUNCT
biomedich-267	34	74	pugliese	pugliese	PROPN
biomedich-267	34	75	et	et	PROPN
biomedich-267	34	76	al	al	PROPN
biomedich-267	34	77	.	.	PROPN
biomedich-267	34	78	,2020	,2020	PROPN
biomedich-267	34	79	)	)	PUNCT
biomedich-267	34	80	.	.	PUNCT
biomedich-267	35	1	notably	notably	ADV
biomedich-267	35	2	,	,	PUNCT
biomedich-267	35	3	guo	guo	PROPN
biomedich-267	35	4	et	et	PROPN
biomedich-267	35	5	al	al	PROPN
biomedich-267	35	6	.	.	PROPN
biomedich-267	35	7	data	datum	NOUN
biomedich-267	35	8	indicate	indicate	VERB
biomedich-267	35	9	that	that	SCONJ
biomedich-267	35	10	an	an	DET
biomedich-267	35	11	initial	initial	ADJ
biomedich-267	35	12	milder	mild	ADJ
biomedich-267	35	13	appearance	appearance	NOUN
biomedich-267	35	14	of	of	ADP
biomedich-267	35	15	sars	sar	NOUN
biomedich-267	35	16	-	-	PUNCT
biomedich-267	35	17	cov-2	cov-2	PART
biomedich-267	35	18	infection	infection	NOUN
biomedich-267	35	19	may	may	AUX
biomedich-267	35	20	mask	mask	VERB
biomedich-267	35	21	the	the	DET
biomedich-267	35	22	seriousness	seriousness	NOUN
biomedich-267	35	23	of	of	ADP
biomedich-267	35	24	covid-19	covid-19	PROPN
biomedich-267	35	25	in	in	ADP
biomedich-267	35	26	diabetes	diabetes	NOUN
biomedich-267	35	27	,	,	PUNCT
biomedich-267	35	28	with	with	ADP
biomedich-267	35	29	fewer	few	ADJ
biomedich-267	35	30	patients	patient	NOUN
biomedich-267	35	31	reporting	report	VERB
biomedich-267	35	32	fever	fever	NOUN
biomedich-267	35	33	,	,	PUNCT
biomedich-267	35	34	chill	chill	NOUN
biomedich-267	35	35	,	,	PUNCT
biomedich-267	35	36	chest	chest	NOUN
biomedich-267	35	37	tightness	tightness	NOUN
biomedich-267	35	38	,	,	PUNCT
biomedich-267	35	39	and	and	CCONJ
biomedich-267	35	40	shortness	shortness	NOUN
biomedich-267	35	41	of	of	ADP
biomedich-267	35	42	breath	breath	NOUN
biomedich-267	35	43	(	(	PUNCT
biomedich-267	35	44	maddaloni	maddaloni	NOUN
biomedich-267	35	45	et	et	PROPN
biomedich-267	35	46	al	al	PROPN
biomedich-267	35	47	.	.	PROPN
biomedich-267	35	48	,	,	PUNCT
biomedich-267	35	49	2020	2020	NUM
biomedich-267	35	50	)	)	PUNCT
biomedich-267	35	51	.	.	PUNCT
biomedich-267	36	1	in	in	ADP
biomedich-267	36	2	addition	addition	NOUN
biomedich-267	36	3	,	,	PUNCT
biomedich-267	36	4	the	the	DET
biomedich-267	36	5	fundamental	fundamental	ADJ
biomedich-267	36	6	and	and	CCONJ
biomedich-267	36	7	clinical	clinical	ADJ
biomedich-267	36	8	science	science	NOUN
biomedich-267	36	9	of	of	ADP
biomedich-267	36	10	the	the	DET
biomedich-267	36	11	possible	possible	ADJ
biomedich-267	36	12	interrelationships	interrelationship	NOUN
biomedich-267	36	13	between	between	ADP
biomedich-267	36	14	diabetes	diabetes	NOUN
biomedich-267	36	15	mellitus	mellitus	NOUN
biomedich-267	36	16	and	and	CCONJ
biomedich-267	36	17	covid-19	covid-19	PROPN
biomedich-267	36	18	was	be	AUX
biomedich-267	36	19	investigated	investigate	VERB
biomedich-267	36	20	(	(	PUNCT
biomedich-267	36	21	drucker	drucker	NOUN
biomedich-267	36	22	2020	2020	NUM
biomedich-267	36	23	)	)	PUNCT
biomedich-267	36	24	.	.	PUNCT
biomedich-267	37	1	however	however	ADV
biomedich-267	37	2	,	,	PUNCT
biomedich-267	37	3	knowledge	knowledge	NOUN
biomedich-267	37	4	in	in	ADP
biomedich-267	37	5	this	this	DET
biomedich-267	37	6	area	area	NOUN
biomedich-267	37	7	is	be	AUX
biomedich-267	37	8	quickly	quickly	ADV
biomedich-267	37	9	emerging	emerge	VERB
biomedich-267	37	10	,	,	PUNCT
biomedich-267	37	11	with	with	ADP
biomedich-267	37	12	numerous	numerous	ADJ
biomedich-267	37	13	publications	publication	NOUN
biomedich-267	37	14	appearing	appear	VERB
biomedich-267	37	15	frequently	frequently	ADV
biomedich-267	37	16	.	.	PUNCT
biomedich-267	38	1	this	this	DET
biomedich-267	38	2	review	review	NOUN
biomedich-267	38	3	summarizes	summarize	VERB
biomedich-267	38	4	recent	recent	ADJ
biomedich-267	38	5	developments	development	NOUN
biomedich-267	38	6	in	in	ADP
biomedich-267	38	7	diabetes	diabetes	NOUN
biomedich-267	38	8	mellitus	mellitus	NOUN
biomedich-267	38	9	and	and	CCONJ
biomedich-267	38	10	covid-19	covid-19	PROPN
biomedich-267	38	11	and	and	CCONJ
biomedich-267	38	12	emphasizes	emphasize	VERB
biomedich-267	38	13	clinical	clinical	ADJ
biomedich-267	38	14	guidelines	guideline	NOUN
biomedich-267	38	15	for	for	ADP
biomedich-267	38	16	patients	patient	NOUN
biomedich-267	38	17	at	at	ADP
biomedich-267	38	18	risk	risk	NOUN
biomedich-267	38	19	of	of	ADP
biomedich-267	38	20	or	or	CCONJ
biomedich-267	38	21	affected	affect	VERB
biomedich-267	38	22	by	by	ADP
biomedich-267	38	23	covid19	covid19	NOUN
biomedich-267	38	24	with	with	ADP
biomedich-267	38	25	diabetes	diabetes	NOUN
biomedich-267	38	26	mellitus	mellitus	NOUN
biomedich-267	38	27	.	.	PUNCT
biomedich-267	39	1	unfortunately	unfortunately	ADV
biomedich-267	39	2	,	,	PUNCT
biomedich-267	39	3	most	most	ADV
biomedich-267	39	4	accessible	accessible	ADJ
biomedich-267	39	5	research	research	NOUN
biomedich-267	39	6	does	do	AUX
biomedich-267	39	7	not	not	PART
biomedich-267	39	8	differentiate	differentiate	VERB
biomedich-267	39	9	between	between	ADP
biomedich-267	39	10	diabetes	diabetes	NOUN
biomedich-267	39	11	mellitus	mellitus	NOUN
biomedich-267	39	12	and	and	CCONJ
biomedich-267	39	13	,	,	PUNCT
biomedich-267	39	14	due	due	ADP
biomedich-267	39	15	to	to	ADP
biomedich-267	39	16	its	its	PRON
biomedich-267	39	17	high	high	ADJ
biomedich-267	39	18	prevalence	prevalence	NOUN
biomedich-267	39	19	,	,	PUNCT
biomedich-267	39	20	focuses	focus	VERB
biomedich-267	39	21	mostly	mostly	ADV
biomedich-267	39	22	on	on	ADP
biomedich-267	39	23	t2	t2	PROPN
biomedich-267	39	24	dm	dm	PROPN
biomedich-267	39	25	(	(	PUNCT
biomedich-267	39	26	kumar	kumar	PROPN
biomedich-267	39	27	et	et	PROPN
biomedich-267	39	28	al	al	PROPN
biomedich-267	39	29	.	.	PROPN
biomedich-267	39	30	,	,	PUNCT
biomedich-267	39	31	2020	2020	NUM
biomedich-267	39	32	)	)	PUNCT
biomedich-267	39	33	compared	compare	VERB
biomedich-267	39	34	to	to	ADP
biomedich-267	39	35	non	non	NOUN
biomedich-267	39	36	-	-	NOUN
biomedich-267	39	37	diabetics	diabetic	NOUN
biomedich-267	39	38	,	,	PUNCT
biomedich-267	39	39	diabetes	diabetes	NOUN
biomedich-267	39	40	in	in	ADP
biomedich-267	39	41	patients	patient	NOUN
biomedich-267	39	42	with	with	ADP
biomedich-267	39	43	covid-19	covid-19	PROPN
biomedich-267	39	44	is	be	AUX
biomedich-267	39	45	associated	associate	VERB
biomedich-267	39	46	with	with	ADP
biomedich-267	39	47	a	a	DET
biomedich-267	39	48	two	two	NUM
biomedich-267	39	49	-	-	PUNCT
biomedich-267	39	50	fold	fold	ADJ
biomedich-267	39	51	rise	rise	NOUN
biomedich-267	39	52	in	in	ADP
biomedich-267	39	53	mortality	mortality	NOUN
biomedich-267	39	54	and	and	CCONJ
biomedich-267	39	55	covid-19	covid-19	PROPN
biomedich-267	39	56	severity	severity	NOUN
biomedich-267	39	57	.	.	PUNCT
biomedich-267	40	1	more	more	ADJ
biomedich-267	40	2	research	research	NOUN
biomedich-267	40	3	is	be	AUX
biomedich-267	40	4	needed	need	VERB
biomedich-267	40	5	on	on	ADP
biomedich-267	40	6	pathogenic	pathogenic	ADJ
biomedich-267	40	7	pathways	pathway	NOUN
biomedich-267	40	8	and	and	CCONJ
biomedich-267	40	9	therapeutic	therapeutic	ADJ
biomedich-267	40	10	effects	effect	NOUN
biomedich-267	40	11	(	(	PUNCT
biomedich-267	40	12	kumar	kumar	PROPN
biomedich-267	40	13	et	et	PROPN
biomedich-267	40	14	al	al	PROPN
biomedich-267	40	15	.	.	PROPN
biomedich-267	40	16	,	,	PUNCT
biomedich-267	40	17	2020	2020	NUM
biomedich-267	40	18	)	)	PUNCT
biomedich-267	40	19	.	.	PUNCT
biomedich-267	41	1	several	several	ADJ
biomedich-267	41	2	data	datum	NOUN
biomedich-267	41	3	sets	set	NOUN
biomedich-267	41	4	from	from	ADP
biomedich-267	41	5	china	china	PROPN
biomedich-267	41	6	,	,	PUNCT
biomedich-267	41	7	italy	italy	PROPN
biomedich-267	41	8	,	,	PUNCT
biomedich-267	41	9	and	and	CCONJ
biomedich-267	41	10	the	the	DET
biomedich-267	41	11	usa	usa	PROPN
biomedich-267	41	12	have	have	AUX
biomedich-267	41	13	consistently	consistently	ADV
biomedich-267	41	14	recorded	record	VERB
biomedich-267	41	15	that	that	SCONJ
biomedich-267	41	16	in	in	ADP
biomedich-267	41	17	patients	patient	NOUN
biomedich-267	41	18	with	with	ADP
biomedich-267	41	19	advanced	advanced	ADJ
biomedich-267	41	20	age	age	NOUN
biomedich-267	41	21	(	(	PUNCT
biomedich-267	41	22	>	>	SYM
biomedich-267	41	23	70	70	NUM
biomedich-267	41	24	years	year	NOUN
biomedich-267	41	25	of	of	ADP
biomedich-267	41	26	age	age	NOUN
biomedich-267	41	27	)	)	PUNCT
biomedich-267	41	28	and	and	CCONJ
biomedich-267	41	29	pre	pre	ADJ
biomedich-267	41	30	-	-	ADJ
biomedich-267	41	31	existing	existing	ADJ
biomedich-267	41	32	comorbidities	comorbiditie	NOUN
biomedich-267	41	33	,	,	PUNCT
biomedich-267	41	34	primarily	primarily	ADV
biomedich-267	41	35	diabetes	diabete	VERB
biomedich-267	41	36	mellitus	mellitus	NOUN
biomedich-267	41	37	(	(	PUNCT
biomedich-267	41	38	dm	dm	PROPN
biomedich-267	41	39	)	)	PUNCT
biomedich-267	41	40	,	,	PUNCT
biomedich-267	41	41	hypertension	hypertension	NOUN
biomedich-267	41	42	,	,	PUNCT
biomedich-267	41	43	and	and	CCONJ
biomedich-267	41	44	cardiovascular	cardiovascular	ADJ
biomedich-267	41	45	disease	disease	NOUN
biomedich-267	41	46	,	,	PUNCT
biomedich-267	41	47	the	the	DET
biomedich-267	41	48	clinical	clinical	ADJ
biomedich-267	41	49	course	course	NOUN
biomedich-267	41	50	of	of	ADP
biomedich-267	41	51	covid-19	covid-19	PROPN
biomedich-267	41	52	is	be	AUX
biomedich-267	41	53	more	more	ADV
biomedich-267	41	54	serious	serious	ADJ
biomedich-267	41	55	(	(	PUNCT
biomedich-267	41	56	yang	yang	PROPN
biomedich-267	41	57	2020	2020	NUM
biomedich-267	41	58	)	)	PUNCT
biomedich-267	41	59	.	.	PUNCT
biomedich-267	42	1	the	the	DET
biomedich-267	42	2	dm	dm	PROPN
biomedich-267	42	3	and	and	CCONJ
biomedich-267	42	4	covid-19	covid-19	PROPN
biomedich-267	42	5	relationship	relationship	NOUN
biomedich-267	42	6	are	be	AUX
biomedich-267	42	7	bidirectional	bidirectional	ADJ
biomedich-267	42	8	.	.	PUNCT
biomedich-267	43	1	on	on	ADP
biomedich-267	43	2	the	the	DET
biomedich-267	43	3	one	one	NUM
biomedich-267	43	4	hand	hand	NOUN
biomedich-267	43	5	,	,	PUNCT
biomedich-267	43	6	dm	dm	PROPN
biomedich-267	43	7	will	will	AUX
biomedich-267	43	8	increase	increase	VERB
biomedich-267	43	9	the	the	DET
biomedich-267	43	10	risk	risk	NOUN
biomedich-267	43	11	of	of	ADP
biomedich-267	43	12	sars	sar	NOUN
biomedich-267	43	13	-	-	PUNCT
biomedich-267	43	14	cov2	cov2	PROPN
biomedich-267	43	15	contraction	contraction	NOUN
biomedich-267	43	16	and	and	CCONJ
biomedich-267	43	17	further	far	ADV
biomedich-267	43	18	complicate	complicate	VERB
biomedich-267	43	19	the	the	DET
biomedich-267	43	20	clinical	clinical	ADJ
biomedich-267	43	21	path	path	NOUN
biomedich-267	43	22	of	of	ADP
biomedich-267	43	23	covid-19	covid-19	PROPN
biomedich-267	43	24	,	,	PUNCT
biomedich-267	43	25	resulting	result	VERB
biomedich-267	43	26	in	in	ADP
biomedich-267	43	27	increased	increase	VERB
biomedich-267	43	28	severity	severity	NOUN
biomedich-267	43	29	and	and	CCONJ
biomedich-267	43	30	mortality	mortality	NOUN
biomedich-267	43	31	(	(	PUNCT
biomedich-267	43	32	onder	onder	PROPN
biomedich-267	43	33	2020	2020	NUM
biomedich-267	43	34	)	)	PUNCT
biomedich-267	43	35	.	.	PUNCT
biomedich-267	44	1	certain	certain	ADJ
biomedich-267	44	2	clinical	clinical	ADJ
biomedich-267	44	3	and	and	CCONJ
biomedich-267	44	4	biological	biological	ADJ
biomedich-267	44	5	features	feature	NOUN
biomedich-267	44	6	determine	determine	VERB
biomedich-267	44	7	high	high	ADJ
biomedich-267	44	8	-	-	PUNCT
biomedich-267	44	9	risk	risk	NOUN
biomedich-267	44	10	phenotypes	phenotype	NOUN
biomedich-267	44	11	within	within	ADP
biomedich-267	44	12	the	the	DET
biomedich-267	44	13	dm	dm	PROPN
biomedich-267	44	14	population	population	NOUN
biomedich-267	44	15	,	,	PUNCT
biomedich-267	44	16	and	and	CCONJ
biomedich-267	44	17	such	such	ADJ
biomedich-267	44	18	prognostic	prognostic	ADJ
biomedich-267	44	19	markers	marker	NOUN
biomedich-267	44	20	need	need	VERB
biomedich-267	44	21	to	to	PART
biomedich-267	44	22	be	be	AUX
biomedich-267	44	23	characterized	characterize	VERB
biomedich-267	44	24	in	in	ADP
biomedich-267	44	25	future	future	ADJ
biomedich-267	44	26	studies	study	NOUN
biomedich-267	44	27	(	(	PUNCT
biomedich-267	44	28	smail	smail	NOUN
biomedich-267	44	29	et	et	PROPN
biomedich-267	44	30	al	al	PROPN
biomedich-267	44	31	.	.	PROPN
biomedich-267	44	32	,	,	PUNCT
biomedich-267	44	33	2022	2022	NUM
biomedich-267	44	34	)	)	PUNCT
biomedich-267	44	35	.	.	PUNCT
biomedich-267	45	1	in	in	ADP
biomedich-267	45	2	the	the	DET
biomedich-267	45	3	sense	sense	NOUN
biomedich-267	45	4	of	of	ADP
biomedich-267	45	5	patient	patient	NOUN
biomedich-267	45	6	-	-	PUNCT
biomedich-267	45	7	tailored	tailor	VERB
biomedich-267	45	8	precision	precision	NOUN
biomedich-267	45	9	medicine	medicine	NOUN
biomedich-267	45	10	,	,	PUNCT
biomedich-267	45	11	which	which	PRON
biomedich-267	45	12	emerges	emerge	VERB
biomedich-267	45	13	as	as	ADP
biomedich-267	45	14	an	an	DET
biomedich-267	45	15	urgent	urgent	ADJ
biomedich-267	45	16	priority	priority	NOUN
biomedich-267	45	17	in	in	ADP
biomedich-267	45	18	the	the	DET
biomedich-267	45	19	era	era	NOUN
biomedich-267	45	20	of	of	ADP
biomedich-267	45	21	covid-19	covid-19	PROPN
biomedich-267	45	22	,	,	PUNCT
biomedich-267	45	23	more	more	ADJ
biomedich-267	45	24	research	research	NOUN
biomedich-267	45	25	is	be	AUX
biomedich-267	45	26	required	require	VERB
biomedich-267	45	27	to	to	PART
biomedich-267	45	28	explore	explore	VERB
biomedich-267	45	29	which	which	PRON
biomedich-267	45	30	subgroups	subgroup	NOUN
biomedich-267	45	31	of	of	ADP
biomedich-267	45	32	dm	dm	PROPN
biomedich-267	45	33	patients	patient	NOUN
biomedich-267	45	34	are	be	AUX
biomedich-267	45	35	anticipated	anticipate	VERB
biomedich-267	45	36	to	to	PART
biomedich-267	45	37	benefit	benefit	VERB
biomedich-267	45	38	most	most	ADV
biomedich-267	45	39	from	from	ADP
biomedich-267	45	40	particular	particular	ADJ
biomedich-267	45	41	antiviral	antiviral	NOUN
biomedich-267	45	42	,	,	PUNCT
biomedich-267	45	43	immunomodulatory	immunomodulatory	ADJ
biomedich-267	45	44	and	and	CCONJ
biomedich-267	45	45	other	other	ADJ
biomedich-267	45	46	treatment	treatment	NOUN
biomedich-267	45	47	strategies	strategy	NOUN
biomedich-267	45	48	(	(	PUNCT
biomedich-267	45	49	koliaki	koliaki	ADV
biomedich-267	45	50	et	et	PROPN
biomedich-267	45	51	al	al	PROPN
biomedich-267	45	52	.	.	PROPN
biomedich-267	45	53	,	,	PUNCT
biomedich-267	45	54	2020	2020	NUM
biomedich-267	45	55	)	)	PUNCT
biomedich-267	45	56	.	.	PUNCT
biomedich-267	46	1	given	give	VERB
biomedich-267	46	2	the	the	DET
biomedich-267	46	3	high	high	ADJ
biomedich-267	46	4	risk	risk	NOUN
biomedich-267	46	5	,	,	PUNCT
biomedich-267	46	6	people	people	NOUN
biomedich-267	46	7	with	with	ADP
biomedich-267	46	8	dm	dm	PROPN
biomedich-267	46	9	should	should	AUX
biomedich-267	46	10	take	take	VERB
biomedich-267	46	11	special	special	ADJ
biomedich-267	46	12	precautions	precaution	NOUN
biomedich-267	46	13	during	during	ADP
biomedich-267	46	14	the	the	DET
biomedich-267	46	15	covid19	covid19	NOUN
biomedich-267	46	16	pandemic	pandemic	ADJ
biomedich-267	46	17	.	.	PUNCT
biomedich-267	47	1	the	the	DET
biomedich-267	47	2	norm	norm	NOUN
biomedich-267	47	3	should	should	AUX
biomedich-267	47	4	be	be	AUX
biomedich-267	47	5	strict	strict	ADJ
biomedich-267	47	6	social	social	ADJ
biomedich-267	47	7	distancing	distancing	NOUN
biomedich-267	47	8	and	and	CCONJ
biomedich-267	47	9	proper	proper	ADJ
biomedich-267	47	10	hanging	hang	VERB
biomedich-267	47	11	hygiene	hygiene	NOUN
biomedich-267	47	12	.	.	PUNCT
biomedich-267	48	1	good	good	ADJ
biomedich-267	48	2	glycemic	glycemic	ADJ
biomedich-267	48	3	regulation	regulation	NOUN
biomedich-267	48	4	should	should	AUX
biomedich-267	48	5	be	be	AUX
biomedich-267	48	6	of	of	ADP
biomedich-267	48	7	utmost	utmost	ADJ
biomedich-267	48	8	significance	significance	NOUN
biomedich-267	48	9	as	as	SCONJ
biomedich-267	48	10	it	it	PRON
biomedich-267	48	11	has	have	AUX
biomedich-267	48	12	been	be	AUX
biomedich-267	48	13	shown	show	VERB
biomedich-267	48	14	to	to	PART
biomedich-267	48	15	improve	improve	VERB
biomedich-267	48	16	the	the	DET
biomedich-267	48	17	innate	innate	ADJ
biomedich-267	48	18	immune	immune	ADJ
biomedich-267	48	19	system	system	NOUN
biomedich-267	48	20	.	.	PUNCT
biomedich-267	49	1	although	although	SCONJ
biomedich-267	49	2	it	it	PRON
biomedich-267	49	3	would	would	AUX
biomedich-267	49	4	be	be	AUX
biomedich-267	49	5	prudent	prudent	ADJ
biomedich-267	49	6	to	to	PART
biomedich-267	49	7	adhere	adhere	VERB
biomedich-267	49	8	to	to	ADP
biomedich-267	49	9	or	or	CCONJ
biomedich-267	49	10	intensify	intensify	VERB
biomedich-267	49	11	the	the	DET
biomedich-267	49	12	ongoing	ongoing	ADJ
biomedich-267	49	13	treatment	treatment	NOUN
biomedich-267	49	14	,	,	PUNCT
biomedich-267	49	15	doctors	doctor	NOUN
biomedich-267	49	16	may	may	AUX
biomedich-267	49	17	consider	consider	VERB
biomedich-267	49	18	reviewing	review	VERB
biomedich-267	49	19	the	the	DET
biomedich-267	49	20	prescription	prescription	NOUN
biomedich-267	49	21	(	(	PUNCT
biomedich-267	49	22	pal	pal	NOUN
biomedich-267	49	23	et	et	PROPN
biomedich-267	49	24	al	al	PROPN
biomedich-267	49	25	.	.	PROPN
biomedich-267	49	26	,	,	PUNCT
biomedich-267	49	27	2020	2020	NUM
biomedich-267	49	28	)	)	PUNCT
biomedich-267	49	29	.	.	PUNCT
biomedich-267	50	1	compromised	compromise	VERB
biomedich-267	50	2	innate	innate	ADJ
biomedich-267	50	3	immunity	immunity	NOUN
biomedich-267	50	4	,	,	PUNCT
biomedich-267	50	5	pro	pro	ADJ
biomedich-267	50	6	-	-	ADJ
biomedich-267	50	7	inflammatory	inflammatory	ADJ
biomedich-267	50	8	cytokine	cytokine	NOUN
biomedich-267	50	9	environment	environment	NOUN
biomedich-267	50	10	,	,	PUNCT
biomedich-267	50	11	decreased	decrease	VERB
biomedich-267	50	12	ace2	ace2	NOUN
biomedich-267	50	13	expression	expression	NOUN
biomedich-267	50	14	,	,	PUNCT
biomedich-267	50	15	and	and	CCONJ
biomedich-267	50	16	the	the	DET
biomedich-267	50	17	use	use	NOUN
biomedich-267	50	18	of	of	ADP
biomedich-267	50	19	antagonists	antagonist	NOUN
biomedich-267	50	20	of	of	ADP
biomedich-267	50	21	the	the	DET
biomedich-267	50	22	renin	renin	ADJ
biomedich-267	50	23	-	-	PUNCT
biomedich-267	50	24	angiotensin	angiotensin	NOUN
biomedich-267	50	25	-	-	PUNCT
biomedich-267	50	26	aldosterone	aldosterone	NOUN
biomedich-267	50	27	system	system	NOUN
biomedich-267	50	28	in	in	ADP
biomedich-267	50	29	people	people	NOUN
biomedich-267	50	30	with	with	ADP
biomedich-267	50	31	diabetes	diabetes	NOUN
biomedich-267	50	32	mellitus	mellitus	NOUN
biomedich-267	50	33	lead	lead	VERB
biomedich-267	50	34	to	to	ADP
biomedich-267	50	35	a	a	DET
biomedich-267	50	36	weak	weak	ADJ
biomedich-267	50	37	covid-19	covid-19	PROPN
biomedich-267	50	38	prognosis	prognosis	NOUN
biomedich-267	50	39	.	.	PUNCT
biomedich-267	51	1	direct	direct	ADJ
biomedich-267	51	2	β	β	NOUN
biomedich-267	51	3	-	-	NOUN
biomedich-267	51	4	cell	cell	NOUN
biomedich-267	51	5	injury	injury	NOUN
biomedich-267	51	6	,	,	PUNCT
biomedich-267	51	7	cytokine	cytokine	NOUN
biomedich-267	51	8	-	-	PUNCT
biomedich-267	51	9	induced	induce	VERB
biomedich-267	51	10	insulin	insulin	NOUN
biomedich-267	51	11	resistance	resistance	NOUN
biomedich-267	51	12	,	,	PUNCT
biomedich-267	51	13	hypokalemia	hypokalemia	NOUN
biomedich-267	51	14	,	,	PUNCT
biomedich-267	51	15	and	and	CCONJ
biomedich-267	51	16	drugs	drug	NOUN
biomedich-267	51	17	used	use	VERB
biomedich-267	51	18	to	to	PART
biomedich-267	51	19	treat	treat	VERB
biomedich-267	51	20	covid-19	covid-19	PROPN
biomedich-267	51	21	(	(	PUNCT
biomedich-267	51	22	such	such	ADJ
biomedich-267	51	23	as	as	ADP
biomedich-267	51	24	corticosteroids	corticosteroid	NOUN
biomedich-267	51	25	,	,	PUNCT
biomedich-267	51	26	lopinavir	lopinavir	PROPN
biomedich-267	51	27	/	/	SYM
biomedich-267	51	28	ritonavir	ritonavir	PROPN
biomedich-267	51	29	)	)	PUNCT
biomedich-267	51	30	can	can	AUX
biomedich-267	51	31	,	,	PUNCT
biomedich-267	51	32	on	on	ADP
biomedich-267	51	33	the	the	DET
biomedich-267	51	34	other	other	ADJ
biomedich-267	51	35	hand	hand	NOUN
biomedich-267	51	36	,	,	PUNCT
biomedich-267	51	37	lead	lead	VERB
biomedich-267	51	38	to	to	ADP
biomedich-267	51	39	a	a	DET
biomedich-267	51	40	worsening	worsening	NOUN
biomedich-267	51	41	of	of	ADP
biomedich-267	51	42	glucose	glucose	NOUN
biomedich-267	51	43	control	control	NOUN
biomedich-267	51	44	in	in	ADP
biomedich-267	51	45	individuals	individual	NOUN
biomedich-267	51	46	with	with	ADP
biomedich-267	51	47	diabetes	diabetes	NOUN
biomedich-267	51	48	mellitus	mellitus	NOUN
biomedich-267	51	49	(	(	PUNCT
biomedich-267	51	50	pal	pal	NOUN
biomedich-267	51	51	et	et	PROPN
biomedich-267	51	52	al	al	PROPN
biomedich-267	51	53	.	.	PROPN
biomedich-267	51	54	,	,	PUNCT
biomedich-267	51	55	2020	2020	NUM
biomedich-267	51	56	)	)	PUNCT
biomedich-267	51	57	.	.	PUNCT
biomedich-267	52	1	several	several	ADJ
biomedich-267	52	2	studies	study	NOUN
biomedich-267	52	3	have	have	AUX
biomedich-267	52	4	attempted	attempt	VERB
biomedich-267	52	5	to	to	PART
biomedich-267	52	6	understand	understand	VERB
biomedich-267	52	7	the	the	DET
biomedich-267	52	8	potentially	potentially	ADV
biomedich-267	52	9	increased	increase	VERB
biomedich-267	52	10	vulnerability	vulnerability	NOUN
biomedich-267	52	11	of	of	ADP
biomedich-267	52	12	diabetes	diabetes	NOUN
biomedich-267	52	13	patients	patient	NOUN
biomedich-267	52	14	to	to	ADP
biomedich-267	52	15	sars	sar	NOUN
biomedich-267	52	16	-	-	PUNCT
biomedich-267	52	17	cov-2	cov-2	PART
biomedich-267	52	18	infection	infection	NOUN
biomedich-267	52	19	.	.	PUNCT
biomedich-267	53	1	however	however	ADV
biomedich-267	53	2	,	,	PUNCT
biomedich-267	53	3	no	no	DET
biomedich-267	53	4	data	datum	NOUN
biomedich-267	53	5	have	have	AUX
biomedich-267	53	6	shown	show	VERB
biomedich-267	53	7	that	that	SCONJ
biomedich-267	53	8	these	these	DET
biomedich-267	53	9	patients	patient	NOUN
biomedich-267	53	10	are	be	AUX
biomedich-267	53	11	at	at	ADP
biomedich-267	53	12	higher	high	ADJ
biomedich-267	53	13	risk	risk	NOUN
biomedich-267	53	14	of	of	ADP
biomedich-267	53	15	contracting	contract	VERB
biomedich-267	53	16	covid-19	covid-19	PROPN
biomedich-267	53	17	.	.	PROPN
biomedich-267	53	18	via	via	ADP
biomedich-267	53	19	the	the	DET
biomedich-267	53	20	ace2	ace2	PROPN
biomedich-267	53	21	receptor	receptor	NOUN
biomedich-267	53	22	,	,	PUNCT
biomedich-267	53	23	sars	sar	NOUN
biomedich-267	53	24	-	-	PUNCT
biomedich-267	53	25	cov-2	cov-2	PART
biomedich-267	53	26	reaches	reach	VERB
biomedich-267	53	27	the	the	DET
biomedich-267	53	28	host	host	NOUN
biomedich-267	53	29	cell	cell	NOUN
biomedich-267	53	30	.	.	PUNCT
biomedich-267	54	1	while	while	SCONJ
biomedich-267	54	2	consensus	consensus	NOUN
biomedich-267	54	3	on	on	ADP
biomedich-267	54	4	the	the	DET
biomedich-267	54	5	role	role	NOUN
biomedich-267	54	6	of	of	ADP
biomedich-267	54	7	ace2	ace2	NOUN
biomedich-267	54	8	in	in	ADP
biomedich-267	54	9	the	the	DET
biomedich-267	54	10	crosstalk	crosstalk	NOUN
biomedich-267	54	11	between	between	ADP
biomedich-267	54	12	diabetes	diabete	NOUN
biomedich-267	54	13	and	and	CCONJ
biomedich-267	54	14	covid-19	covid-19	PROPN
biomedich-267	54	15	has	have	AUX
biomedich-267	54	16	not	not	PART
biomedich-267	54	17	yet	yet	ADV
biomedich-267	54	18	been	be	AUX
biomedich-267	54	19	achieved	achieve	VERB
biomedich-267	54	20	,	,	PUNCT
biomedich-267	54	21	some	some	PRON
biomedich-267	54	22	argue	argue	VERB
biomedich-267	54	23	that	that	SCONJ
biomedich-267	54	24	diabetes	diabetes	NOUN
biomedich-267	54	25	patients	patient	NOUN
biomedich-267	54	26	have	have	VERB
biomedich-267	54	27	elevated	elevate	VERB
biomedich-267	54	28	ace2	ace2	NOUN
biomedich-267	54	29	expression	expression	NOUN
biomedich-267	54	30	,	,	PUNCT
biomedich-267	54	31	thus	thus	ADV
biomedich-267	54	32	facilitating	facilitate	VERB
biomedich-267	54	33	viral	viral	ADJ
biomedich-267	54	34	entry	entry	NOUN
biomedich-267	54	35	and	and	CCONJ
biomedich-267	54	36	subsequent	subsequent	ADJ
biomedich-267	54	37	replication	replication	NOUN
biomedich-267	54	38	.	.	PUNCT
biomedich-267	55	1	others	other	NOUN
biomedich-267	55	2	show	show	VERB
biomedich-267	55	3	that	that	SCONJ
biomedich-267	55	4	patients	patient	NOUN
biomedich-267	55	5	with	with	ADP
biomedich-267	55	6	diabetes	diabetes	NOUN
biomedich-267	55	7	have	have	VERB
biomedich-267	55	8	low	low	ADJ
biomedich-267	55	9	levels	level	NOUN
biomedich-267	55	10	of	of	ADP
biomedich-267	55	11	ace2	ace2	NOUN
biomedich-267	55	12	and	and	CCONJ
biomedich-267	55	13	that	that	SCONJ
biomedich-267	55	14	other	other	ADJ
biomedich-267	55	15	causes	cause	NOUN
biomedich-267	55	16	,	,	PUNCT
biomedich-267	55	17	such	such	ADJ
biomedich-267	55	18	as	as	ADP
biomedich-267	55	19	treatment	treatment	NOUN
biomedich-267	55	20	with	with	ADP
biomedich-267	55	21	ace	ace	NOUN
biomedich-267	55	22	/	/	SYM
biomedich-267	55	23	arbs	arb	NOUN
biomedich-267	55	24	,	,	PUNCT
biomedich-267	55	25	hypoglycemic	hypoglycemic	ADJ
biomedich-267	55	26	agents	agent	NOUN
biomedich-267	55	27	,	,	PUNCT
biomedich-267	55	28	and	and	CCONJ
biomedich-267	55	29	statins	statin	NOUN
biomedich-267	55	30	,	,	PUNCT
biomedich-267	55	31	are	be	AUX
biomedich-267	55	32	responsible	responsible	ADJ
biomedich-267	55	33	for	for	ADP
biomedich-267	55	34	the	the	DET
biomedich-267	55	35	observed	observed	ADJ
biomedich-267	55	36	rise	rise	NOUN
biomedich-267	55	37	in	in	ADP
biomedich-267	55	38	ace2	ace2	PROPN
biomedich-267	55	39	(	(	PUNCT
biomedich-267	55	40	azar	azar	PROPN
biomedich-267	55	41	et	et	PROPN
biomedich-267	55	42	al	al	PROPN
biomedich-267	55	43	.	.	PROPN
biomedich-267	55	44	,	,	PUNCT
biomedich-267	55	45	2020	2020	NUM
biomedich-267	55	46	)	)	PUNCT
biomedich-267	55	47	.	.	PUNCT
biomedich-267	56	1	the	the	DET
biomedich-267	56	2	degree	degree	NOUN
biomedich-267	56	3	to	to	PART
biomedich-267	56	4	which	which	PRON
biomedich-267	56	5	clinical	clinical	ADJ
biomedich-267	56	6	and	and	CCONJ
biomedich-267	56	7	demographic	demographic	ADJ
biomedich-267	56	8	variables	variable	NOUN
biomedich-267	56	9	moderate	moderate	VERB
biomedich-267	56	10	this	this	DET
biomedich-267	56	11	relationship	relationship	NOUN
biomedich-267	56	12	is	be	AUX
biomedich-267	56	13	uncertain	uncertain	ADJ
biomedich-267	56	14	,	,	PUNCT
biomedich-267	56	15	although	although	SCONJ
biomedich-267	56	16	signs	sign	NOUN
biomedich-267	56	17	link	link	VERB
biomedich-267	56	18	higher	high	ADJ
biomedich-267	56	19	bmi	bmi	NOUN
biomedich-267	56	20	and	and	CCONJ
biomedich-267	56	21	higher	high	ADJ
biomedich-267	56	22	hba1c	hba1c	NOUN
biomedich-267	56	23	to	to	PART
biomedich-267	56	24	worse	bad	ADJ
biomedich-267	56	25	outcomes	outcome	NOUN
biomedich-267	56	26	in	in	ADP
biomedich-267	56	27	people	people	NOUN
biomedich-267	56	28	with	with	ADP
biomedich-267	56	29	covid-19	covid-19	PROPN
biomedich-267	56	30	diabetes	diabetes	NOUN
biomedich-267	56	31	.	.	PUNCT
biomedich-267	57	1	covid-19	covid-19	PROPN
biomedich-267	57	2	also	also	ADV
biomedich-267	57	3	risks	risk	VERB
biomedich-267	57	4	leading	lead	VERB
biomedich-267	57	5	to	to	ADP
biomedich-267	57	6	worse	bad	ADJ
biomedich-267	57	7	diabetes	diabetes	NOUN
biomedich-267	57	8	outcomes	outcome	NOUN
biomedich-267	57	9	due	due	ADP
biomedich-267	57	10	to	to	ADP
biomedich-267	57	11	disturbances	disturbance	NOUN
biomedich-267	57	12	caused	cause	VERB
biomedich-267	57	13	by	by	ADP
biomedich-267	57	14	the	the	DET
biomedich-267	57	15	pandemic	pandemic	NOUN
biomedich-267	57	16	,	,	PUNCT
biomedich-267	57	17	including	include	VERB
biomedich-267	57	18	stress	stress	NOUN
biomedich-267	57	19	and	and	CCONJ
biomedich-267	57	20	changes	change	NOUN
biomedich-267	57	21	in	in	ADP
biomedich-267	57	22	routine	routine	ADJ
biomedich-267	57	23	treatment	treatment	NOUN
biomedich-267	57	24	,	,	PUNCT
biomedich-267	57	25	diet	diet	NOUN
biomedich-267	57	26	,	,	PUNCT
biomedich-267	57	27	and	and	CCONJ
biomedich-267	57	28	physical	physical	ADJ
biomedich-267	57	29	activity	activity	NOUN
biomedich-267	57	30	,	,	PUNCT
biomedich-267	57	31	and	and	CCONJ
biomedich-267	57	32	posing	pose	VERB
biomedich-267	57	33	immediate	immediate	ADJ
biomedich-267	57	34	risks	risk	NOUN
biomedich-267	57	35	to	to	ADP
biomedich-267	57	36	people	people	NOUN
biomedich-267	57	37	with	with	ADP
biomedich-267	57	38	diabetes	diabetes	NOUN
biomedich-267	57	39	(	(	PUNCT
biomedich-267	57	40	hartmann	hartmann	PROPN
biomedich-267	57	41	et	et	PROPN
biomedich-267	57	42	al	al	PROPN
biomedich-267	57	43	.	.	PROPN
biomedich-267	57	44	,	,	PUNCT
biomedich-267	57	45	2020	2020	NUM
biomedich-267	57	46	)	)	PUNCT
biomedich-267	57	47	dysregulated	dysregulate	VERB
biomedich-267	57	48	post	post	ADJ
biomedich-267	57	49	-	-	ADJ
biomedich-267	57	50	infection	infection	ADJ
biomedich-267	57	51	immune	immune	ADJ
biomedich-267	57	52	response	response	NOUN
biomedich-267	57	53	is	be	AUX
biomedich-267	57	54	characterized	characterize	VERB
biomedich-267	57	55	by	by	ADP
biomedich-267	57	56	delayed	delay	VERB
biomedich-267	57	57	and	and	CCONJ
biomedich-267	57	58	reduced	reduce	VERB
biomedich-267	57	59	recruitment	recruitment	NOUN
biomedich-267	57	60	in	in	ADP
biomedich-267	57	61	lung	lung	NOUN
biomedich-267	57	62	tissue	tissue	NOUN
biomedich-267	57	63	of	of	ADP
biomedich-267	57	64	cd4	cd4	PROPN
biomedich-267	57	65	+	+	PROPN
biomedich-267	57	66	t	t	NOUN
biomedich-267	57	67	cells	cell	NOUN
biomedich-267	57	68	,	,	PUNCT
biomedich-267	57	69	inflammatory	inflammatory	ADJ
biomedich-267	57	70	monocytes	monocyte	NOUN
biomedich-267	57	71	,	,	PUNCT
biomedich-267	57	72	and	and	CCONJ
biomedich-267	57	73	macrophages	macrophage	NOUN
biomedich-267	57	74	.	.	PUNCT
biomedich-267	58	1	in	in	ADP
biomedich-267	58	2	addition	addition	NOUN
biomedich-267	58	3	to	to	ADP
biomedich-267	58	4	the	the	DET
biomedich-267	58	5	reduced	reduced	ADJ
biomedich-267	58	6	overall	overall	ADJ
biomedich-267	58	7	cd4	cd4	PROPN
biomedich-267	58	8	+	+	PROPN
biomedich-267	58	9	t	t	NOUN
biomedich-267	58	10	cell	cell	NOUN
biomedich-267	58	11	response	response	NOUN
biomedich-267	58	12	,	,	PUNCT
biomedich-267	58	13	infected	infect	VERB
biomedich-267	58	14	diabetic	diabetic	ADJ
biomedich-267	58	15	mice	mouse	NOUN
biomedich-267	58	16	also	also	ADV
biomedich-267	58	17	showed	show	VERB
biomedich-267	58	18	a	a	DET
biomedich-267	58	19	more	more	ADV
biomedich-267	58	20	prominent	prominent	ADJ
biomedich-267	58	21	th17	th17	NOUN
biomedich-267	58	22	response	response	NOUN
biomedich-267	58	23	with	with	ADP
biomedich-267	58	24	increased	increase	VERB
biomedich-267	58	25	il-17a	il-17a	PROPN
biomedich-267	58	26	levels	level	NOUN
biomedich-267	58	27	,	,	PUNCT
biomedich-267	58	28	implying	imply	VERB
biomedich-267	58	29	that	that	SCONJ
biomedich-267	58	30	a	a	DET
biomedich-267	58	31	shift	shift	NOUN
biomedich-267	58	32	in	in	ADP
biomedich-267	58	33	cytokine	cytokine	ADJ
biomedich-267	58	34	profiles	profile	NOUN
biomedich-267	58	35	could	could	AUX
biomedich-267	58	36	be	be	AUX
biomedich-267	58	37	partially	partially	ADV
biomedich-267	58	38	responsible	responsible	ADJ
biomedich-267	58	39	for	for	ADP
biomedich-267	58	40	the	the	DET
biomedich-267	58	41	severity	severity	NOUN
biomedich-267	58	42	of	of	ADP
biomedich-267	58	43	the	the	DET
biomedich-267	58	44	disease	disease	NOUN
biomedich-267	58	45	(	(	PUNCT
biomedich-267	58	46	angelidi	angelidi	VERB
biomedich-267	58	47	et	et	PROPN
biomedich-267	58	48	al	al	PROPN
biomedich-267	58	49	.	.	PROPN
biomedich-267	58	50	,	,	PUNCT
biomedich-267	58	51	2020	2020	NUM
biomedich-267	58	52	)	)	PUNCT
biomedich-267	58	53	an	an	DET
biomedich-267	58	54	independent	independent	ADJ
biomedich-267	58	55	risk	risk	NOUN
biomedich-267	58	56	factor	factor	NOUN
biomedich-267	58	57	for	for	ADP
biomedich-267	58	58	the	the	DET
biomedich-267	58	59	prognosis	prognosis	NOUN
biomedich-267	58	60	of	of	ADP
biomedich-267	58	61	covid-19	covid-19	PROPN
biomedich-267	58	62	is	be	AUX
biomedich-267	58	63	diabetes	diabete	NOUN
biomedich-267	58	64	.	.	PUNCT
biomedich-267	59	1	smail	smail	NOUN
biomedich-267	59	2	–	–	PUNCT
biomedich-267	59	3	the	the	DET
biomedich-267	59	4	association	association	NOUN
biomedich-267	59	5	between	between	ADP
biomedich-267	59	6	some	some	DET
biomedich-267	59	7	endocrine	endocrine	NOUN
biomedich-267	59	8	conditions	condition	NOUN
biomedich-267	59	9	and	and	CCONJ
biomedich-267	59	10	covid-19	covid-19	PROPN
biomedich-267	59	11	:	:	PUNCT
biomedich-267	59	12	a	a	DET
biomedich-267	59	13	review	review	NOUN
biomedich-267	59	14	47	47	NUM
biomedich-267	59	15	therefore	therefore	ADV
biomedich-267	59	16	,	,	PUNCT
biomedich-267	59	17	the	the	DET
biomedich-267	59	18	prevention	prevention	NOUN
biomedich-267	59	19	and	and	CCONJ
biomedich-267	59	20	treatment	treatment	NOUN
biomedich-267	59	21	of	of	ADP
biomedich-267	59	22	diabetic	diabetic	ADJ
biomedich-267	59	23	patients	patient	NOUN
biomedich-267	59	24	,	,	PUNCT
biomedich-267	59	25	especially	especially	ADV
biomedich-267	59	26	those	those	PRON
biomedich-267	59	27	needing	need	VERB
biomedich-267	59	28	insulin	insulin	NOUN
biomedich-267	59	29	therapy	therapy	NOUN
biomedich-267	59	30	,	,	PUNCT
biomedich-267	59	31	should	should	AUX
biomedich-267	59	32	be	be	AUX
biomedich-267	59	33	given	give	VERB
biomedich-267	59	34	greater	great	ADJ
biomedich-267	59	35	attention	attention	NOUN
biomedich-267	59	36	(	(	PUNCT
biomedich-267	59	37	shang	shang	PROPN
biomedich-267	59	38	et	et	PROPN
biomedich-267	59	39	al	al	PROPN
biomedich-267	59	40	.	.	PROPN
biomedich-267	59	41	,	,	PUNCT
biomedich-267	59	42	2020	2020	NUM
biomedich-267	59	43	)	)	PUNCT
biomedich-267	59	44	.	.	PUNCT
biomedich-267	60	1	from	from	ADP
biomedich-267	60	2	43	43	NUM
biomedich-267	60	3	reports	report	NOUN
biomedich-267	60	4	,	,	PUNCT
biomedich-267	60	5	the	the	DET
biomedich-267	60	6	meta	meta	NOUN
biomedich-267	60	7	-	-	PUNCT
biomedich-267	60	8	analysis	analysis	NOUN
biomedich-267	60	9	was	be	AUX
biomedich-267	60	10	based	base	VERB
biomedich-267	60	11	on	on	ADP
biomedich-267	60	12	23007	23007	NUM
biomedich-267	60	13	patients	patient	NOUN
biomedich-267	60	14	.	.	PUNCT
biomedich-267	61	1	the	the	DET
biomedich-267	61	2	pooled	pooled	ADJ
biomedich-267	61	3	prevalence	prevalence	NOUN
biomedich-267	61	4	of	of	ADP
biomedich-267	61	5	diabetes	diabetes	NOUN
biomedich-267	61	6	in	in	ADP
biomedich-267	61	7	patients	patient	NOUN
biomedich-267	61	8	infected	infect	VERB
biomedich-267	61	9	with	with	ADP
biomedich-267	61	10	covid-19	covid-19	PROPN
biomedich-267	61	11	was	be	AUX
biomedich-267	61	12	15	15	NUM
biomedich-267	61	13	%	%	NOUN
biomedich-267	61	14	(	(	PUNCT
biomedich-267	61	15	95	95	NUM
biomedich-267	61	16	%	%	NOUN
biomedich-267	61	17	ci	ci	NOUN
biomedich-267	61	18	:	:	PUNCT
biomedich-267	61	19	12%–18	12%–18	NUM
biomedich-267	61	20	%	%	NOUN
biomedich-267	61	21	)	)	PUNCT
biomedich-267	61	22	,	,	PUNCT
biomedich-267	61	23	p	p	X
biomedich-267	61	24	=	=	PUNCT
biomedich-267	61	25	<	<	X
biomedich-267	61	26	0.0001	0.0001	NUM
biomedich-267	61	27	.	.	PUNCT
biomedich-267	62	1	furthermore	furthermore	ADV
biomedich-267	62	2	,	,	PUNCT
biomedich-267	62	3	in	in	ADP
biomedich-267	62	4	covid-19	covid-19	PROPN
biomedich-267	62	5	patients	patient	NOUN
biomedich-267	62	6	with	with	ADP
biomedich-267	62	7	diabetes	diabetes	NOUN
biomedich-267	62	8	,	,	PUNCT
biomedich-267	62	9	the	the	DET
biomedich-267	62	10	risk	risk	NOUN
biomedich-267	62	11	of	of	ADP
biomedich-267	62	12	mortality	mortality	NOUN
biomedich-267	62	13	was	be	AUX
biomedich-267	62	14	found	find	VERB
biomedich-267	62	15	to	to	PART
biomedich-267	62	16	be	be	AUX
biomedich-267	62	17	substantially	substantially	ADV
biomedich-267	62	18	higher	high	ADJ
biomedich-267	62	19	relative	relative	ADJ
biomedich-267	62	20	to	to	ADP
biomedich-267	62	21	covid-19	covid-19	PROPN
biomedich-267	62	22	patients	patient	NOUN
biomedich-267	62	23	without	without	ADP
biomedich-267	62	24	diabetes	diabetes	NOUN
biomedich-267	62	25	,	,	PUNCT
biomedich-267	62	26	with	with	ADP
biomedich-267	62	27	a	a	DET
biomedich-267	62	28	pooled	pooled	ADJ
biomedich-267	62	29	risk	risk	NOUN
biomedich-267	62	30	ratio	ratio	NOUN
biomedich-267	62	31	of	of	ADP
biomedich-267	62	32	1.61	1.61	NUM
biomedich-267	62	33	(	(	PUNCT
biomedich-267	62	34	95	95	NUM
biomedich-267	62	35	%	%	NOUN
biomedich-267	62	36	ci	ci	NOUN
biomedich-267	62	37	:	:	PUNCT
biomedich-267	62	38	1.16–2.25	1.16–2.25	NUM
biomedich-267	62	39	%	%	NOUN
biomedich-267	62	40	)	)	PUNCT
biomedich-267	62	41	,	,	PUNCT
biomedich-267	62	42	p	p	X
biomedich-267	62	43	=	=	NOUN
biomedich-267	62	44	0.005	0.005	NUM
biomedich-267	62	45	(	(	PUNCT
biomedich-267	62	46	hussain	hussain	PROPN
biomedich-267	62	47	et	et	PROPN
biomedich-267	62	48	al	al	PROPN
biomedich-267	62	49	.	.	PROPN
biomedich-267	62	50	,	,	PUNCT
biomedich-267	62	51	2020	2020	NUM
biomedich-267	62	52	)	)	PUNCT
biomedich-267	62	53	.	.	PUNCT
biomedich-267	63	1	the	the	DET
biomedich-267	63	2	pandemic	pandemic	NOUN
biomedich-267	63	3	of	of	ADP
biomedich-267	63	4	covid-19	covid-19	PROPN
biomedich-267	63	5	has	have	AUX
biomedich-267	63	6	questioned	question	VERB
biomedich-267	63	7	both	both	CCONJ
biomedich-267	63	8	institutional	institutional	ADJ
biomedich-267	63	9	and	and	CCONJ
biomedich-267	63	10	diabetes	diabetes	NOUN
biomedich-267	63	11	self	self	NOUN
biomedich-267	63	12	-	-	PUNCT
biomedich-267	63	13	management	management	NOUN
biomedich-267	63	14	.	.	PUNCT
biomedich-267	64	1	continuing	continue	VERB
biomedich-267	64	2	social	social	ADJ
biomedich-267	64	3	distancing	distancing	NOUN
biomedich-267	64	4	and	and	CCONJ
biomedich-267	64	5	lockdowns	lockdown	NOUN
biomedich-267	64	6	have	have	AUX
biomedich-267	64	7	adversely	adversely	ADV
biomedich-267	64	8	influenced	influence	VERB
biomedich-267	64	9	access	access	NOUN
biomedich-267	64	10	to	to	ADP
biomedich-267	64	11	care	care	NOUN
biomedich-267	64	12	and	and	CCONJ
biomedich-267	64	13	self	self	NOUN
biomedich-267	64	14	-	-	PUNCT
biomedich-267	64	15	management	management	NOUN
biomedich-267	64	16	(	(	PUNCT
biomedich-267	64	17	mukona	mukona	PROPN
biomedich-267	64	18	et	et	PROPN
biomedich-267	64	19	al	al	PROPN
biomedich-267	64	20	.	.	PROPN
biomedich-267	64	21	,	,	PUNCT
biomedich-267	64	22	2020	2020	NUM
biomedich-267	64	23	)	)	PUNCT
biomedich-267	64	24	sars	sar	NOUN
biomedich-267	64	25	-	-	PUNCT
biomedich-267	64	26	cov-2	cov-2	NOUN
biomedich-267	64	27	infected	infected	ADJ
biomedich-267	64	28	t2	t2	NOUN
biomedich-267	64	29	dm	dm	PROPN
biomedich-267	64	30	patients	patient	NOUN
biomedich-267	64	31	reported	report	VERB
biomedich-267	64	32	decreased	decrease	VERB
biomedich-267	64	33	body	body	NOUN
biomedich-267	64	34	mass	mass	NOUN
biomedich-267	64	35	index	index	NOUN
biomedich-267	64	36	(	(	PUNCT
biomedich-267	64	37	bmi	bmi	PROPN
biomedich-267	64	38	)	)	PUNCT
biomedich-267	64	39	,	,	PUNCT
biomedich-267	64	40	lymphocytes	lymphocyte	VERB
biomedich-267	64	41	,	,	PUNCT
biomedich-267	64	42	ua	ua	PROPN
biomedich-267	64	43	,	,	PUNCT
biomedich-267	64	44	albumin	albumin	ADJ
biomedich-267	64	45	levels	level	NOUN
biomedich-267	64	46	,	,	PUNCT
biomedich-267	64	47	and	and	CCONJ
biomedich-267	64	48	increased	increase	VERB
biomedich-267	64	49	crp	crp	PROPN
biomedich-267	64	50	levels	level	NOUN
biomedich-267	64	51	.	.	PUNCT
biomedich-267	65	1	oxidative	oxidative	ADJ
biomedich-267	65	2	stress	stress	NOUN
biomedich-267	65	3	response	response	NOUN
biomedich-267	65	4	and	and	CCONJ
biomedich-267	65	5	nutritional	nutritional	ADJ
biomedich-267	65	6	intake	intake	NOUN
biomedich-267	65	7	may	may	AUX
biomedich-267	65	8	be	be	AUX
biomedich-267	65	9	associated	associate	VERB
biomedich-267	65	10	with	with	ADP
biomedich-267	65	11	reduced	reduced	ADJ
biomedich-267	65	12	bmi	bmi	PROPN
biomedich-267	65	13	,	,	PUNCT
biomedich-267	65	14	ua	ua	PROPN
biomedich-267	65	15	,	,	PUNCT
biomedich-267	65	16	and	and	CCONJ
biomedich-267	65	17	albumin	albumin	ADJ
biomedich-267	65	18	levels	level	NOUN
biomedich-267	65	19	.	.	PUNCT
biomedich-267	66	1	in	in	ADP
biomedich-267	66	2	addition	addition	NOUN
biomedich-267	66	3	,	,	PUNCT
biomedich-267	66	4	the	the	DET
biomedich-267	66	5	infection	infection	NOUN
biomedich-267	66	6	may	may	AUX
biomedich-267	66	7	be	be	AUX
biomedich-267	66	8	associated	associate	VERB
biomedich-267	66	9	with	with	ADP
biomedich-267	66	10	reduced	reduced	ADJ
biomedich-267	66	11	lymphocyte	lymphocyte	ADJ
biomedich-267	66	12	counts	count	NOUN
biomedich-267	66	13	and	and	CCONJ
biomedich-267	66	14	elevated	elevated	ADJ
biomedich-267	66	15	crp	crp	NOUN
biomedich-267	66	16	levels	level	NOUN
biomedich-267	66	17	(	(	PUNCT
biomedich-267	66	18	liang	liang	PROPN
biomedich-267	66	19	et	et	PROPN
biomedich-267	66	20	al	al	PROPN
biomedich-267	66	21	.	.	PROPN
biomedich-267	66	22	,	,	PUNCT
biomedich-267	66	23	2020	2020	NUM
biomedich-267	66	24	)	)	PUNCT
biomedich-267	66	25	.	.	PUNCT
biomedich-267	67	1	there	there	PRON
biomedich-267	67	2	are	be	VERB
biomedich-267	67	3	major	major	ADJ
biomedich-267	67	4	concerns	concern	NOUN
biomedich-267	67	5	about	about	ADP
biomedich-267	67	6	worsening	worsen	VERB
biomedich-267	67	7	glycemic	glycemic	ADJ
biomedich-267	67	8	regulation	regulation	NOUN
biomedich-267	67	9	,	,	PUNCT
biomedich-267	67	10	inaccessibility	inaccessibility	NOUN
biomedich-267	67	11	of	of	ADP
biomedich-267	67	12	suitable	suitable	ADJ
biomedich-267	67	13	drugs	drug	NOUN
biomedich-267	67	14	,	,	PUNCT
biomedich-267	67	15	inaccessibility	inaccessibility	NOUN
biomedich-267	67	16	of	of	ADP
biomedich-267	67	17	health	health	NOUN
biomedich-267	67	18	care	care	NOUN
biomedich-267	67	19	or	or	CCONJ
biomedich-267	67	20	infection	infection	NOUN
biomedich-267	67	21	with	with	ADP
biomedich-267	67	22	sars	sar	NOUN
biomedich-267	67	23	-	-	PUNCT
biomedich-267	67	24	cov-2	cov-2	NOUN
biomedich-267	67	25	,	,	PUNCT
biomedich-267	67	26	and	and	CCONJ
biomedich-267	67	27	worse	bad	ADJ
biomedich-267	67	28	results	result	NOUN
biomedich-267	67	29	during	during	ADP
biomedich-267	67	30	the	the	DET
biomedich-267	67	31	covid-19	covid-19	PROPN
biomedich-267	67	32	pandemic	pandemic	NOUN
biomedich-267	67	33	.	.	PUNCT
biomedich-267	68	1	although	although	SCONJ
biomedich-267	68	2	there	there	PRON
biomedich-267	68	3	are	be	VERB
biomedich-267	68	4	some	some	DET
biomedich-267	68	5	recommendations	recommendation	NOUN
biomedich-267	68	6	for	for	ADP
biomedich-267	68	7	diabetes	diabetes	NOUN
biomedich-267	68	8	treatment	treatment	NOUN
biomedich-267	68	9	and	and	CCONJ
biomedich-267	68	10	related	related	ADJ
biomedich-267	68	11	complications	complication	NOUN
biomedich-267	68	12	during	during	ADP
biomedich-267	68	13	the	the	DET
biomedich-267	68	14	covid-19	covid-19	PROPN
biomedich-267	68	15	pandemic	pandemic	NOUN
biomedich-267	68	16	,	,	PUNCT
biomedich-267	68	17	very	very	ADV
biomedich-267	68	18	few	few	ADJ
biomedich-267	68	19	discuss	discuss	VERB
biomedich-267	68	20	the	the	DET
biomedich-267	68	21	psychological	psychological	ADJ
biomedich-267	68	22	problems	problem	NOUN
biomedich-267	68	23	of	of	ADP
biomedich-267	68	24	people	people	NOUN
biomedich-267	68	25	with	with	ADP
biomedich-267	68	26	diabetes	diabetes	NOUN
biomedich-267	68	27	(	(	PUNCT
biomedich-267	68	28	singhai	singhai	VERB
biomedich-267	68	29	et	et	PROPN
biomedich-267	68	30	al	al	PROPN
biomedich-267	68	31	.	.	PROPN
biomedich-267	68	32	,	,	PUNCT
biomedich-267	68	33	2020	2020	NUM
biomedich-267	68	34	)	)	PUNCT
biomedich-267	68	35	.	.	PUNCT
biomedich-267	69	1	several	several	ADJ
biomedich-267	69	2	specialist	specialist	ADJ
biomedich-267	69	3	bodies	body	NOUN
biomedich-267	69	4	have	have	AUX
biomedich-267	69	5	temporarily	temporarily	ADV
biomedich-267	69	6	updated	update	VERB
biomedich-267	69	7	gestational	gestational	ADJ
biomedich-267	69	8	diabetes	diabetes	NOUN
biomedich-267	69	9	mellitus	mellitus	NOUN
biomedich-267	69	10	(	(	PUNCT
biomedich-267	69	11	gdm	gdm	NOUN
biomedich-267	69	12	)	)	PUNCT
biomedich-267	69	13	testing	testing	NOUN
biomedich-267	69	14	guidelines	guideline	NOUN
biomedich-267	69	15	during	during	ADP
biomedich-267	69	16	the	the	DET
biomedich-267	69	17	covid-19	covid-19	PROPN
biomedich-267	69	18	pandemic	pandemic	NOUN
biomedich-267	69	19	to	to	PART
biomedich-267	69	20	minimize	minimize	VERB
biomedich-267	69	21	person	person	NOUN
biomedich-267	69	22	-	-	PUNCT
biomedich-267	69	23	toperson	toperson	NOUN
biomedich-267	69	24	contact	contact	NOUN
biomedich-267	69	25	.	.	PUNCT
biomedich-267	70	1	the	the	DET
biomedich-267	70	2	current	current	ADJ
biomedich-267	70	3	temporary	temporary	ADJ
biomedich-267	70	4	australian	australian	ADJ
biomedich-267	70	5	guidelines	guideline	NOUN
biomedich-267	70	6	indicate	indicate	VERB
biomedich-267	70	7	that	that	SCONJ
biomedich-267	70	8	no	no	DET
biomedich-267	70	9	glucose	glucose	NOUN
biomedich-267	70	10	tolerance	tolerance	NOUN
biomedich-267	70	11	test	test	NOUN
biomedich-267	70	12	(	(	PUNCT
biomedich-267	70	13	gtt	gtt	PROPN
biomedich-267	70	14	)	)	PUNCT
biomedich-267	70	15	is	be	AUX
biomedich-267	70	16	needed	need	VERB
biomedich-267	70	17	if	if	SCONJ
biomedich-267	70	18	the	the	DET
biomedich-267	70	19	fasting	fasting	NOUN
biomedich-267	70	20	glucose	glucose	NOUN
biomedich-267	70	21	is	be	AUX
biomedich-267	70	22	around	around	ADV
biomedich-267	70	23	4.6	4.6	NUM
biomedich-267	70	24	mmol	mmol	NOUN
biomedich-267	70	25	/	/	SYM
biomedich-267	70	26	l	l	NOUN
biomedich-267	70	27	(	(	PUNCT
biomedich-267	70	28	van	van	PROPN
biomedich-267	70	29	et	et	PROPN
biomedich-267	70	30	al	al	PROPN
biomedich-267	70	31	.	.	PROPN
biomedich-267	70	32	,	,	PUNCT
biomedich-267	70	33	2020	2020	NUM
biomedich-267	70	34	)	)	PUNCT
biomedich-267	70	35	.	.	PUNCT
biomedich-267	71	1	a	a	DET
biomedich-267	71	2	common	common	ADJ
biomedich-267	71	3	medical	medical	ADJ
biomedich-267	71	4	condition	condition	NOUN
biomedich-267	71	5	in	in	ADP
biomedich-267	71	6	pregnancy	pregnancy	NOUN
biomedich-267	71	7	is	be	AUX
biomedich-267	71	8	gestational	gestational	ADJ
biomedich-267	71	9	diabetes	diabetes	NOUN
biomedich-267	71	10	mellitus	mellitus	NOUN
biomedich-267	71	11	(	(	PUNCT
biomedich-267	71	12	gdm	gdm	NOUN
biomedich-267	71	13	)	)	PUNCT
biomedich-267	71	14	.	.	PUNCT
biomedich-267	72	1	the	the	DET
biomedich-267	72	2	australasian	australasian	ADJ
biomedich-267	72	3	pregnancy	pregnancy	NOUN
biomedich-267	72	4	diabetes	diabetes	NOUN
biomedich-267	72	5	society	society	NOUN
biomedich-267	72	6	(	(	PUNCT
biomedich-267	72	7	adips	adip	NOUN
biomedich-267	72	8	)	)	PUNCT
biomedich-267	72	9	suggests	suggest	VERB
biomedich-267	72	10	monitoring	monitor	VERB
biomedich-267	72	11	all	all	DET
biomedich-267	72	12	women	woman	NOUN
biomedich-267	72	13	in	in	ADP
biomedich-267	72	14	each	each	DET
biomedich-267	72	15	pregnancy	pregnancy	NOUN
biomedich-267	72	16	,	,	PUNCT
biomedich-267	72	17	preferably	preferably	ADV
biomedich-267	72	18	using	use	VERB
biomedich-267	72	19	a	a	DET
biomedich-267	72	20	two	two	NUM
biomedich-267	72	21	-	-	PUNCT
biomedich-267	72	22	hour	hour	NOUN
biomedich-267	72	23	glucose	glucose	NOUN
biomedich-267	72	24	tolerance	tolerance	NOUN
biomedich-267	72	25	test	test	NOUN
biomedich-267	72	26	(	(	PUNCT
biomedich-267	72	27	gtt	gtt	PROPN
biomedich-267	72	28	)	)	PUNCT
biomedich-267	72	29	.	.	PUNCT
biomedich-267	73	1	the	the	DET
biomedich-267	73	2	diagnostic	diagnostic	ADJ
biomedich-267	73	3	criteria	criterion	NOUN
biomedich-267	73	4	derive	derive	VERB
biomedich-267	73	5	from	from	ADP
biomedich-267	73	6	world	world	PROPN
biomedich-267	73	7	health	health	NOUN
biomedich-267	73	8	organization	organization	NOUN
biomedich-267	73	9	(	(	PUNCT
biomedich-267	73	10	who	who	PRON
biomedich-267	73	11	)	)	PUNCT
biomedich-267	73	12	guidelines	guideline	NOUN
biomedich-267	73	13	based	base	VERB
biomedich-267	73	14	on	on	ADP
biomedich-267	73	15	the	the	DET
biomedich-267	73	16	findings	finding	NOUN
biomedich-267	73	17	of	of	ADP
biomedich-267	73	18	the	the	DET
biomedich-267	73	19	hyperglycaemia	hyperglycaemia	NOUN
biomedich-267	73	20	and	and	CCONJ
biomedich-267	73	21	pregnancy	pregnancy	NOUN
biomedich-267	73	22	outcomes	outcome	NOUN
biomedich-267	73	23	(	(	PUNCT
biomedich-267	73	24	hapo	hapo	PROPN
biomedich-267	73	25	)	)	PUNCT
biomedich-267	73	26	report	report	NOUN
biomedich-267	73	27	(	(	PUNCT
biomedich-267	73	28	metzger	metzger	NOUN
biomedich-267	73	29	et	et	PROPN
biomedich-267	73	30	al	al	PROPN
biomedich-267	73	31	.	.	PROPN
biomedich-267	73	32	,	,	PUNCT
biomedich-267	73	33	2008	2008	NUM
biomedich-267	73	34	)	)	PUNCT
biomedich-267	73	35	.	.	PUNCT
biomedich-267	74	1	in	in	ADP
biomedich-267	74	2	patients	patient	NOUN
biomedich-267	74	3	with	with	ADP
biomedich-267	74	4	diabetes	diabetes	NOUN
biomedich-267	74	5	,	,	PUNCT
biomedich-267	74	6	there	there	PRON
biomedich-267	74	7	is	be	VERB
biomedich-267	74	8	evidence	evidence	NOUN
biomedich-267	74	9	of	of	ADP
biomedich-267	74	10	an	an	DET
biomedich-267	74	11	increased	increase	VERB
biomedich-267	74	12	incidence	incidence	NOUN
biomedich-267	74	13	and	and	CCONJ
biomedich-267	74	14	severity	severity	NOUN
biomedich-267	74	15	of	of	ADP
biomedich-267	74	16	covid-19	covid-19	PROPN
biomedich-267	74	17	.	.	PUNCT
biomedich-267	75	1	the	the	DET
biomedich-267	75	2	pathophysiology	pathophysiology	NOUN
biomedich-267	75	3	of	of	ADP
biomedich-267	75	4	diabetes	diabetes	NOUN
biomedich-267	75	5	could	could	AUX
biomedich-267	75	6	be	be	AUX
biomedich-267	75	7	influenced	influence	VERB
biomedich-267	75	8	by	by	ADP
biomedich-267	75	9	covid-19	covid-19	PROPN
biomedich-267	75	10	.	.	PUNCT
biomedich-267	76	1	therefore	therefore	ADV
biomedich-267	76	2	,	,	PUNCT
biomedich-267	76	3	it	it	PRON
biomedich-267	76	4	is	be	AUX
biomedich-267	76	5	critical	critical	ADJ
biomedich-267	76	6	for	for	SCONJ
biomedich-267	76	7	patients	patient	NOUN
biomedich-267	76	8	infected	infect	VERB
biomedich-267	76	9	with	with	ADP
biomedich-267	76	10	covid-19	covid-19	PROPN
biomedich-267	76	11	to	to	PART
biomedich-267	76	12	regulate	regulate	VERB
biomedich-267	76	13	blood	blood	NOUN
biomedich-267	76	14	glucose	glucose	NOUN
biomedich-267	76	15	and	and	CCONJ
biomedich-267	76	16	those	those	PRON
biomedich-267	76	17	without	without	ADP
biomedich-267	76	18	the	the	DET
biomedich-267	76	19	disease	disease	NOUN
biomedich-267	76	20	.	.	PUNCT
biomedich-267	77	1	innovations	innovation	NOUN
biomedich-267	77	2	such	such	ADJ
biomedich-267	77	3	as	as	ADP
biomedich-267	77	4	telemedicine	telemedicine	NOUN
biomedich-267	77	5	effectively	effectively	ADV
biomedich-267	77	6	treat	treat	VERB
biomedich-267	77	7	diabetes	diabetes	NOUN
biomedich-267	77	8	patients	patient	NOUN
biomedich-267	77	9	today	today	NOUN
biomedich-267	77	10	(	(	PUNCT
biomedich-267	77	11	singh	singh	PROPN
biomedich-267	77	12	et	et	PROPN
biomedich-267	77	13	al	al	PROPN
biomedich-267	77	14	.	.	PROPN
biomedich-267	77	15	,	,	PUNCT
biomedich-267	77	16	2020	2020	NUM
biomedich-267	77	17	)	)	PUNCT
biomedich-267	77	18	.	.	PUNCT
biomedich-267	78	1	in	in	ADP
biomedich-267	78	2	patients	patient	NOUN
biomedich-267	78	3	infected	infect	VERB
biomedich-267	78	4	with	with	ADP
biomedich-267	78	5	various	various	ADJ
biomedich-267	78	6	viruses	virus	NOUN
biomedich-267	78	7	,	,	PUNCT
biomedich-267	78	8	including	include	VERB
biomedich-267	78	9	the	the	DET
biomedich-267	78	10	2009	2009	NUM
biomedich-267	78	11	pandemic	pandemic	ADJ
biomedich-267	78	12	influenza	influenza	NOUN
biomedich-267	78	13	a	a	DET
biomedich-267	78	14	(	(	PUNCT
biomedich-267	78	15	h1n1	h1n1	NOUN
biomedich-267	78	16	)	)	PUNCT
biomedich-267	78	17	,	,	PUNCT
biomedich-267	78	18	sars	sars	PROPN
biomedich-267	78	19	-	-	PUNCT
biomedich-267	78	20	cov	cov	NOUN
biomedich-267	78	21	,	,	PUNCT
biomedich-267	78	22	and	and	CCONJ
biomedich-267	78	23	mers	mer	NOUN
biomedich-267	78	24	-	-	PUNCT
biomedich-267	78	25	cov	cov	NOUN
biomedich-267	78	26	,	,	PUNCT
biomedich-267	78	27	diabetes	diabetes	NOUN
biomedich-267	78	28	and	and	CCONJ
biomedich-267	78	29	uncontrolled	uncontrolled	ADJ
biomedich-267	78	30	glycemia	glycemia	NOUN
biomedich-267	78	31	have	have	AUX
biomedich-267	78	32	been	be	AUX
biomedich-267	78	33	identified	identify	VERB
biomedich-267	78	34	as	as	ADP
biomedich-267	78	35	important	important	ADJ
biomedich-267	78	36	predictors	predictor	NOUN
biomedich-267	78	37	of	of	ADP
biomedich-267	78	38	severity	severity	NOUN
biomedich-267	78	39	and	and	CCONJ
biomedich-267	78	40	deaths	death	NOUN
biomedich-267	78	41	.	.	PUNCT
biomedich-267	79	1	some	some	DET
biomedich-267	79	2	studies	study	NOUN
biomedich-267	79	3	have	have	AUX
biomedich-267	79	4	not	not	PART
biomedich-267	79	5	found	find	VERB
biomedich-267	79	6	a	a	DET
biomedich-267	79	7	strong	strong	ADJ
biomedich-267	79	8	link	link	NOUN
biomedich-267	79	9	between	between	ADP
biomedich-267	79	10	diabetes	diabetes	NOUN
biomedich-267	79	11	and	and	CCONJ
biomedich-267	79	12	serious	serious	ADJ
biomedich-267	79	13	disease	disease	NOUN
biomedich-267	79	14	in	in	ADP
biomedich-267	79	15	the	the	DET
biomedich-267	79	16	emerging	emerge	VERB
biomedich-267	79	17	sars	sar	NOUN
biomedich-267	79	18	-	-	PUNCT
biomedich-267	79	19	cov-2	cov-2	NOUN
biomedich-267	79	20	pandemic	pandemic	NOUN
biomedich-267	79	21	.	.	PUNCT
biomedich-267	80	1	however	however	ADV
biomedich-267	80	2	,	,	PUNCT
biomedich-267	80	3	other	other	ADJ
biomedich-267	80	4	studies	study	NOUN
biomedich-267	80	5	from	from	ADP
biomedich-267	80	6	china	china	PROPN
biomedich-267	80	7	and	and	CCONJ
biomedich-267	80	8	italy	italy	PROPN
biomedich-267	80	9	have	have	AUX
biomedich-267	80	10	shown	show	VERB
biomedich-267	80	11	that	that	SCONJ
biomedich-267	80	12	elderly	elderly	ADJ
biomedich-267	80	13	patients	patient	NOUN
biomedich-267	80	14	with	with	ADP
biomedich-267	80	15	chronic	chronic	ADJ
biomedich-267	80	16	diseases	disease	NOUN
biomedich-267	80	17	,	,	PUNCT
biomedich-267	80	18	including	include	VERB
biomedich-267	80	19	diabetes	diabetes	NOUN
biomedich-267	80	20	,	,	PUNCT
biomedich-267	80	21	are	be	AUX
biomedich-267	80	22	at	at	ADP
biomedich-267	80	23	higher	high	ADJ
biomedich-267	80	24	risk	risk	NOUN
biomedich-267	80	25	of	of	ADP
biomedich-267	80	26	significant	significant	ADJ
biomedich-267	80	27	covid-19	covid-19	PROPN
biomedich-267	80	28	and	and	CCONJ
biomedich-267	80	29	mortality	mortality	NOUN
biomedich-267	80	30	,	,	PUNCT
biomedich-267	80	31	respectively	respectively	ADV
biomedich-267	80	32	(	(	PUNCT
biomedich-267	80	33	hussain	hussain	PROPN
biomedich-267	80	34	et	et	PROPN
biomedich-267	80	35	al	al	PROPN
biomedich-267	80	36	.	.	PROPN
biomedich-267	80	37	,	,	PUNCT
biomedich-267	80	38	2020	2020	NUM
biomedich-267	80	39	)	)	PUNCT
biomedich-267	80	40	.	.	PUNCT
biomedich-267	81	1	the	the	DET
biomedich-267	81	2	mortality	mortality	NOUN
biomedich-267	81	3	rate	rate	NOUN
biomedich-267	81	4	was	be	AUX
biomedich-267	81	5	9.9	9.9	NUM
biomedich-267	81	6	%	%	NOUN
biomedich-267	81	7	in	in	ADP
biomedich-267	81	8	a	a	DET
biomedich-267	81	9	meta	meta	ADJ
biomedich-267	81	10	-	-	PUNCT
biomedich-267	81	11	analysis	analysis	NOUN
biomedich-267	81	12	of	of	ADP
biomedich-267	81	13	hospitalized	hospitalize	VERB
biomedich-267	81	14	patients	patient	NOUN
biomedich-267	81	15	in	in	ADP
biomedich-267	81	16	china	china	PROPN
biomedich-267	81	17	with	with	ADP
biomedich-267	81	18	a	a	DET
biomedich-267	81	19	diagnosis	diagnosis	NOUN
biomedich-267	81	20	of	of	ADP
biomedich-267	81	21	covid19	covid19	NOUN
biomedich-267	81	22	.	.	PUNCT
biomedich-267	82	1	a	a	DET
biomedich-267	82	2	higher	high	ADJ
biomedich-267	82	3	incidence	incidence	NOUN
biomedich-267	82	4	of	of	ADP
biomedich-267	82	5	diabetes	diabetes	NOUN
biomedich-267	82	6	mellitus	mellitus	NOUN
biomedich-267	82	7	was	be	AUX
biomedich-267	82	8	separately	separately	ADV
biomedich-267	82	9	associated	associate	VERB
biomedich-267	82	10	with	with	ADP
biomedich-267	82	11	a	a	DET
biomedich-267	82	12	worse	bad	ADJ
biomedich-267	82	13	prognosis	prognosis	NOUN
biomedich-267	82	14	.	.	PUNCT
biomedich-267	83	1	the	the	DET
biomedich-267	83	2	independent	independent	ADJ
biomedich-267	83	3	impact	impact	NOUN
biomedich-267	83	4	of	of	ADP
biomedich-267	83	5	covid-19	covid-19	PROPN
biomedich-267	83	6	mortality	mortality	NOUN
biomedich-267	83	7	on	on	ADP
biomedich-267	83	8	diabetes	diabetes	NOUN
biomedich-267	83	9	mellitus	mellitus	NOUN
biomedich-267	83	10	should	should	AUX
biomedich-267	83	11	be	be	AUX
biomedich-267	83	12	seen	see	VERB
biomedich-267	83	13	as	as	ADP
biomedich-267	83	14	hypothesis	hypothesis	NOUN
biomedich-267	83	15	-	-	PUNCT
biomedich-267	83	16	generating	generate	VERB
biomedich-267	83	17	and	and	CCONJ
biomedich-267	83	18	needs	need	VERB
biomedich-267	83	19	further	further	ADJ
biomedich-267	83	20	research	research	NOUN
biomedich-267	83	21	(	(	PUNCT
biomedich-267	83	22	miller	miller	PROPN
biomedich-267	83	23	et	et	PROPN
biomedich-267	83	24	al	al	PROPN
biomedich-267	83	25	.	.	PROPN
biomedich-267	83	26	,	,	PUNCT
biomedich-267	83	27	2020	2020	NUM
biomedich-267	83	28	)	)	PUNCT
biomedich-267	83	29	.	.	PUNCT
biomedich-267	84	1	figure	figure	NOUN
biomedich-267	84	2	1	1	NUM
biomedich-267	84	3	.	.	PUNCT
biomedich-267	85	1	covid-19	covid-19	PROPN
biomedich-267	85	2	,	,	PUNCT
biomedich-267	85	3	cytokine	cytokine	ADJ
biomedich-267	85	4	storm	storm	NOUN
biomedich-267	85	5	,	,	PUNCT
biomedich-267	85	6	diabetes	diabetes	NOUN
biomedich-267	85	7	mellitus	mellitus	NOUN
biomedich-267	85	8	:	:	PUNCT
biomedich-267	85	9	a	a	DET
biomedich-267	85	10	vicious	vicious	ADJ
biomedich-267	85	11	cycle	cycle	NOUN
biomedich-267	85	12	(	(	PUNCT
biomedich-267	85	13	azar	azar	PROPN
biomedich-267	85	14	et	et	PROPN
biomedich-267	85	15	al	al	PROPN
biomedich-267	85	16	.	.	PROPN
biomedich-267	85	17	,2020	,2020	PROPN
biomedich-267	85	18	)	)	PUNCT
biomedich-267	85	19	.	.	PUNCT
biomedich-267	86	1	covid-19	covid-19	PROPN
biomedich-267	86	2	and	and	CCONJ
biomedich-267	86	3	obesity	obesity	NOUN
biomedich-267	86	4	according	accord	VERB
biomedich-267	86	5	to	to	ADP
biomedich-267	86	6	estimates	estimate	NOUN
biomedich-267	86	7	from	from	ADP
biomedich-267	86	8	the	the	DET
biomedich-267	86	9	world	world	PROPN
biomedich-267	86	10	health	health	PROPN
biomedich-267	86	11	organization	organization	NOUN
biomedich-267	86	12	,	,	PUNCT
biomedich-267	86	13	obesity	obesity	NOUN
biomedich-267	86	14	is	be	AUX
biomedich-267	86	15	a	a	DET
biomedich-267	86	16	global	global	ADJ
biomedich-267	86	17	epidemic	epidemic	NOUN
biomedich-267	86	18	,	,	PUNCT
biomedich-267	86	19	with	with	ADP
biomedich-267	86	20	at	at	ADV
biomedich-267	86	21	least	least	ADV
biomedich-267	86	22	2.8	2.8	NUM
biomedich-267	86	23	million	million	NUM
biomedich-267	86	24	people	people	NOUN
biomedich-267	86	25	dying	die	VERB
biomedich-267	86	26	each	each	DET
biomedich-267	86	27	year	year	NOUN
biomedich-267	86	28	due	due	ADP
biomedich-267	86	29	to	to	ADP
biomedich-267	86	30	becoming	become	VERB
biomedich-267	86	31	overweight	overweight	ADJ
biomedich-267	86	32	or	or	CCONJ
biomedich-267	86	33	obese	obese	ADJ
biomedich-267	86	34	(	(	PUNCT
biomedich-267	86	35	hussain	hussain	PROPN
biomedich-267	86	36	et	et	PROPN
biomedich-267	86	37	al	al	PROPN
biomedich-267	86	38	.	.	PROPN
biomedich-267	86	39	,	,	PUNCT
biomedich-267	86	40	2020	2020	NUM
biomedich-267	86	41	)	)	PUNCT
biomedich-267	86	42	.	.	PUNCT
biomedich-267	87	1	obesity	obesity	NOUN
biomedich-267	87	2	is	be	AUX
biomedich-267	87	3	a	a	DET
biomedich-267	87	4	condition	condition	NOUN
biomedich-267	87	5	characterized	characterize	VERB
biomedich-267	87	6	by	by	ADP
biomedich-267	87	7	the	the	DET
biomedich-267	87	8	assistance	assistance	NOUN
biomedich-267	87	9	of	of	ADP
biomedich-267	87	10	extra	extra	ADJ
biomedich-267	87	11	adiposity	adiposity	NOUN
biomedich-267	87	12	tissue	tissue	NOUN
biomedich-267	87	13	that	that	PRON
biomedich-267	87	14	provides	provide	VERB
biomedich-267	87	15	substantial	substantial	ADJ
biomedich-267	87	16	morbidity	morbidity	NOUN
biomedich-267	87	17	and	and	CCONJ
biomedich-267	87	18	mortality	mortality	NOUN
biomedich-267	87	19	due	due	ADP
biomedich-267	87	20	to	to	ADP
biomedich-267	87	21	its	its	PRON
biomedich-267	87	22	complications	complication	NOUN
biomedich-267	87	23	linked	link	VERB
biomedich-267	87	24	to	to	ADP
biomedich-267	87	25	several	several	ADJ
biomedich-267	87	26	weights	weight	NOUN
biomedich-267	87	27	.	.	PUNCT
biomedich-267	88	1	therefore	therefore	ADV
biomedich-267	88	2	,	,	PUNCT
biomedich-267	88	3	the	the	DET
biomedich-267	88	4	diagnostic	diagnostic	ADJ
biomedich-267	88	5	comparison	comparison	NOUN
biomedich-267	88	6	should	should	AUX
biomedich-267	88	7	consist	consist	VERB
biomedich-267	88	8	of	of	ADP
biomedich-267	88	9	an	an	DET
biomedich-267	88	10	anthropometric	anthropometric	ADJ
biomedich-267	88	11	test	test	NOUN
biomedich-267	88	12	that	that	PRON
biomedich-267	88	13	indicates	indicate	VERB
biomedich-267	88	14	elevated	elevated	ADJ
biomedich-267	88	15	fat	fat	ADJ
biomedich-267	88	16	mass	mass	NOUN
biomedich-267	88	17	and	and	CCONJ
biomedich-267	88	18	the	the	DET
biomedich-267	88	19	extent	extent	NOUN
biomedich-267	88	20	to	to	PART
biomedich-267	88	21	which	which	PRON
biomedich-267	88	22	the	the	DET
biomedich-267	88	23	well	well	ADV
biomedich-267	88	24	-	-	PUNCT
biomedich-267	88	25	being	being	NOUN
biomedich-267	88	26	of	of	ADP
biomedich-267	88	27	individual	individual	ADJ
biomedich-267	88	28	patients	patient	NOUN
biomedich-267	88	29	is	be	AUX
biomedich-267	88	30	adversely	adversely	ADV
biomedich-267	88	31	affected	affect	VERB
biomedich-267	88	32	by	by	ADP
biomedich-267	88	33	excess	excess	ADJ
biomedich-267	88	34	adiposity	adiposity	NOUN
biomedich-267	88	35	(	(	PUNCT
biomedich-267	88	36	smail	smail	NOUN
biomedich-267	88	37	2019	2019	NUM
biomedich-267	88	38	and	and	CCONJ
biomedich-267	88	39	smail	smail	VERB
biomedich-267	88	40	et	et	PROPN
biomedich-267	88	41	al	al	PROPN
biomedich-267	88	42	.	.	PROPN
biomedich-267	88	43	,	,	PUNCT
biomedich-267	88	44	2021	2021	NUM
biomedich-267	88	45	)	)	PUNCT
biomedich-267	88	46	.	.	PUNCT
biomedich-267	89	1	although	although	SCONJ
biomedich-267	89	2	the	the	DET
biomedich-267	89	3	effects	effect	NOUN
biomedich-267	89	4	of	of	ADP
biomedich-267	89	5	covid-19	covid-19	PROPN
biomedich-267	89	6	on	on	ADP
biomedich-267	89	7	obese	obese	ADJ
biomedich-267	89	8	patients	patient	NOUN
biomedich-267	89	9	have	have	AUX
biomedich-267	89	10	not	not	PART
biomedich-267	89	11	yet	yet	ADV
biomedich-267	89	12	been	be	AUX
biomedich-267	89	13	well	well	ADV
biomedich-267	89	14	established	establish	VERB
biomedich-267	89	15	,	,	PUNCT
biomedich-267	89	16	the	the	DET
biomedich-267	89	17	experience	experience	NOUN
biomedich-267	89	18	of	of	ADP
biomedich-267	89	19	h1n1	h1n1	NOUN
biomedich-267	89	20	influenza	influenza	NOUN
biomedich-267	89	21	can	can	AUX
biomedich-267	89	22	serve	serve	VERB
biomedich-267	89	23	as	as	ADP
biomedich-267	89	24	a	a	DET
biomedich-267	89	25	warning	warning	NOUN
biomedich-267	89	26	for	for	ADP
biomedich-267	89	27	treating	treat	VERB
biomedich-267	89	28	obese	obese	ADJ
biomedich-267	89	29	patients	patient	NOUN
biomedich-267	89	30	,	,	PUNCT
biomedich-267	89	31	particularly	particularly	ADV
biomedich-267	89	32	patients	patient	NOUN
biomedich-267	89	33	with	with	ADP
biomedich-267	89	34	extreme	extreme	ADJ
biomedich-267	89	35	obesity	obesity	NOUN
biomedich-267	89	36	.	.	PUNCT
biomedich-267	90	1	from	from	ADP
biomedich-267	90	2	2009	2009	NUM
biomedich-267	90	3	to	to	ADP
biomedich-267	90	4	2010	2010	NUM
biomedich-267	90	5	,	,	PUNCT
biomedich-267	90	6	adult	adult	NOUN
biomedich-267	90	7	obesity	obesity	NOUN
biomedich-267	90	8	and	and	CCONJ
biomedich-267	90	9	extreme	extreme	ADJ
biomedich-267	90	10	obesity	obesity	NOUN
biomedich-267	90	11	rates	rate	NOUN
biomedich-267	90	12	rose	rise	VERB
biomedich-267	90	13	between	between	ADP
biomedich-267	90	14	2017	2017	NUM
biomedich-267	90	15	and	and	CCONJ
biomedich-267	90	16	2018	2018	NUM
biomedich-267	90	17	and	and	CCONJ
biomedich-267	90	18	now	now	ADV
biomedich-267	90	19	stand	stand	VERB
biomedich-267	90	20	at	at	ADP
biomedich-267	90	21	42	42	NUM
biomedich-267	90	22	%	%	NOUN
biomedich-267	90	23	and	and	CCONJ
biomedich-267	90	24	9	9	NUM
biomedich-267	90	25	%	%	NOUN
biomedich-267	90	26	,	,	PUNCT
biomedich-267	90	27	respectively	respectively	ADV
biomedich-267	90	28	(	(	PUNCT
biomedich-267	90	29	hales	hales	PROPN
biomedich-267	90	30	et	et	PROPN
biomedich-267	90	31	al	al	PROPN
biomedich-267	90	32	.	.	PROPN
biomedich-267	90	33	,	,	PUNCT
biomedich-267	90	34	2020	2020	NUM
biomedich-267	90	35	)	)	PUNCT
biomedich-267	90	36	.	.	PUNCT
biomedich-267	91	1	the	the	DET
biomedich-267	91	2	findings	finding	NOUN
biomedich-267	91	3	indicate	indicate	VERB
biomedich-267	91	4	that	that	PRON
biomedich-267	91	5	relative	relative	ADJ
biomedich-267	91	6	to	to	ADP
biomedich-267	91	7	the	the	DET
biomedich-267	91	8	h1n1	h1n1	NOUN
biomedich-267	91	9	experience	experience	NOUN
biomedich-267	91	10	,	,	PUNCT
biomedich-267	91	11	the	the	DET
biomedich-267	91	12	proportion	proportion	NOUN
biomedich-267	91	13	of	of	ADP
biomedich-267	91	14	patients	patient	NOUN
biomedich-267	91	15	with	with	ADP
biomedich-267	91	16	obesity	obesity	NOUN
biomedich-267	91	17	,	,	PUNCT
biomedich-267	91	18	extreme	extreme	ADJ
biomedich-267	91	19	obesity	obesity	NOUN
biomedich-267	91	20	,	,	PUNCT
biomedich-267	91	21	and	and	CCONJ
biomedich-267	91	22	covid-19	covid-19	PROPN
biomedich-267	91	23	infections	infection	NOUN
biomedich-267	91	24	will	will	AUX
biomedich-267	91	25	increase	increase	VERB
biomedich-267	91	26	,	,	PUNCT
biomedich-267	91	27	and	and	CCONJ
biomedich-267	91	28	the	the	DET
biomedich-267	91	29	disease	disease	NOUN
biomedich-267	91	30	will	will	AUX
biomedich-267	91	31	likely	likely	ADV
biomedich-267	91	32	have	have	VERB
biomedich-267	91	33	a	a	DET
biomedich-267	91	34	more	more	ADV
biomedich-267	91	35	severe	severe	ADJ
biomedich-267	91	36	48	48	NUM
biomedich-267	91	37	biology	biology	NOUN
biomedich-267	91	38	,	,	PUNCT
biomedich-267	91	39	medicine	medicine	NOUN
biomedich-267	91	40	,	,	PUNCT
biomedich-267	91	41	&	&	CCONJ
biomedich-267	91	42	natural	natural	ADJ
biomedich-267	91	43	product	product	NOUN
biomedich-267	91	44	chemistry	chemistry	NOUN
biomedich-267	91	45	12	12	NUM
biomedich-267	91	46	(	(	PUNCT
biomedich-267	91	47	1	1	NUM
biomedich-267	91	48	)	)	PUNCT
biomedich-267	91	49	,	,	PUNCT
biomedich-267	91	50	2023	2023	NUM
biomedich-267	91	51	:	:	PUNCT
biomedich-267	91	52	45	45	NUM
biomedich-267	91	53	-	-	SYM
biomedich-267	91	54	53	53	NUM
biomedich-267	91	55	path	path	NOUN
biomedich-267	91	56	in	in	ADP
biomedich-267	91	57	such	such	ADJ
biomedich-267	91	58	patients	patient	NOUN
biomedich-267	91	59	.	.	PUNCT
biomedich-267	92	1	these	these	DET
biomedich-267	92	2	results	result	NOUN
biomedich-267	92	3	further	far	ADV
biomedich-267	92	4	highlight	highlight	VERB
biomedich-267	92	5	the	the	DET
biomedich-267	92	6	need	need	NOUN
biomedich-267	92	7	for	for	ADP
biomedich-267	92	8	improved	improved	ADJ
biomedich-267	92	9	attention	attention	NOUN
biomedich-267	92	10	,	,	PUNCT
biomedich-267	92	11	diagnosis	diagnosis	NOUN
biomedich-267	92	12	and	and	CCONJ
biomedich-267	92	13	testing	testing	NOUN
biomedich-267	92	14	priority	priority	NOUN
biomedich-267	92	15	,	,	PUNCT
biomedich-267	92	16	and	and	CCONJ
biomedich-267	92	17	aggressive	aggressive	ADJ
biomedich-267	92	18	care	care	NOUN
biomedich-267	92	19	for	for	ADP
biomedich-267	92	20	obesity	obesity	NOUN
biomedich-267	92	21	patients	patient	NOUN
biomedich-267	92	22	and	and	CCONJ
biomedich-267	92	23	covid-19	covid-19	PROPN
biomedich-267	92	24	infections	infection	NOUN
biomedich-267	92	25	(	(	PUNCT
biomedich-267	92	26	dietz	dietz	PROPN
biomedich-267	92	27	et	et	PROPN
biomedich-267	92	28	al	al	PROPN
biomedich-267	92	29	.	.	PROPN
biomedich-267	92	30	,	,	PUNCT
biomedich-267	92	31	2020	2020	NUM
biomedich-267	92	32	)	)	PUNCT
biomedich-267	92	33	.	.	PUNCT
biomedich-267	93	1	although	although	SCONJ
biomedich-267	93	2	the	the	DET
biomedich-267	93	3	data	datum	NOUN
biomedich-267	93	4	on	on	ADP
biomedich-267	93	5	the	the	DET
biomedich-267	93	6	effect	effect	NOUN
biomedich-267	93	7	of	of	ADP
biomedich-267	93	8	sars	sar	NOUN
biomedich-267	93	9	-	-	PUNCT
biomedich-267	93	10	cov-2	cov-2	NOUN
biomedich-267	93	11	in	in	ADP
biomedich-267	93	12	people	people	NOUN
biomedich-267	93	13	with	with	ADP
biomedich-267	93	14	obesity	obesity	NOUN
biomedich-267	93	15	are	be	AUX
biomedich-267	93	16	minimal	minimal	ADJ
biomedich-267	93	17	,	,	PUNCT
biomedich-267	93	18	and	and	CCONJ
biomedich-267	93	19	their	their	PRON
biomedich-267	93	20	relationship	relationship	NOUN
biomedich-267	93	21	has	have	AUX
biomedich-267	93	22	not	not	PART
biomedich-267	93	23	yet	yet	ADV
biomedich-267	93	24	been	be	AUX
biomedich-267	93	25	fully	fully	ADV
biomedich-267	93	26	established	establish	VERB
biomedich-267	93	27	,	,	PUNCT
biomedich-267	93	28	it	it	PRON
biomedich-267	93	29	has	have	AUX
biomedich-267	93	30	been	be	AUX
biomedich-267	93	31	found	find	VERB
biomedich-267	93	32	that	that	SCONJ
biomedich-267	93	33	people	people	NOUN
biomedich-267	93	34	with	with	ADP
biomedich-267	93	35	excessive	excessive	ADJ
biomedich-267	93	36	body	body	NOUN
biomedich-267	93	37	weight	weight	NOUN
biomedich-267	93	38	may	may	AUX
biomedich-267	93	39	experience	experience	VERB
biomedich-267	93	40	a	a	DET
biomedich-267	93	41	more	more	ADV
biomedich-267	93	42	severe	severe	ADJ
biomedich-267	93	43	covid-19	covid-19	PROPN
biomedich-267	93	44	infection	infection	NOUN
biomedich-267	93	45	(	(	PUNCT
biomedich-267	93	46	puig	puig	X
biomedich-267	93	47	et	et	NOUN
biomedich-267	93	48	al	al	PROPN
biomedich-267	93	49	.	.	PROPN
biomedich-267	93	50	,	,	PUNCT
biomedich-267	93	51	2020	2020	NUM
biomedich-267	93	52	)	)	PUNCT
biomedich-267	93	53	.	.	PUNCT
biomedich-267	94	1	as	as	SCONJ
biomedich-267	94	2	stated	state	VERB
biomedich-267	94	3	earlier	early	ADV
biomedich-267	94	4	,	,	PUNCT
biomedich-267	94	5	it	it	PRON
biomedich-267	94	6	is	be	AUX
biomedich-267	94	7	especially	especially	ADV
biomedich-267	94	8	noticeable	noticeable	ADJ
biomedich-267	94	9	in	in	ADP
biomedich-267	94	10	people	people	NOUN
biomedich-267	94	11	affected	affect	VERB
biomedich-267	94	12	by	by	ADP
biomedich-267	94	13	other	other	ADJ
biomedich-267	94	14	risk	risk	NOUN
biomedich-267	94	15	factors	factor	NOUN
biomedich-267	94	16	associated	associate	VERB
biomedich-267	94	17	with	with	ADP
biomedich-267	94	18	a	a	DET
biomedich-267	94	19	more	more	ADV
biomedich-267	94	20	serious	serious	ADJ
biomedich-267	94	21	disease	disease	NOUN
biomedich-267	94	22	course	course	NOUN
biomedich-267	94	23	.	.	PUNCT
biomedich-267	95	1	this	this	DET
biomedich-267	95	2	correlation	correlation	NOUN
biomedich-267	95	3	was	be	AUX
biomedich-267	95	4	also	also	ADV
biomedich-267	95	5	noted	note	VERB
biomedich-267	95	6	during	during	ADP
biomedich-267	95	7	the	the	DET
biomedich-267	95	8	2009	2009	NUM
biomedich-267	95	9	influenza	influenza	NOUN
biomedich-267	95	10	a	a	DET
biomedich-267	95	11	pandemic	pandemic	NOUN
biomedich-267	95	12	,	,	PUNCT
biomedich-267	95	13	which	which	PRON
biomedich-267	95	14	identified	identify	VERB
biomedich-267	95	15	obesity	obesity	NOUN
biomedich-267	95	16	as	as	ADP
biomedich-267	95	17	an	an	DET
biomedich-267	95	18	independent	independent	ADJ
biomedich-267	95	19	risk	risk	NOUN
biomedich-267	95	20	factor	factor	NOUN
biomedich-267	95	21	for	for	ADP
biomedich-267	95	22	complications	complication	NOUN
biomedich-267	95	23	.	.	PUNCT
biomedich-267	96	1	obesity	obesity	NOUN
biomedich-267	96	2	patients	patient	NOUN
biomedich-267	96	3	suffered	suffer	VERB
biomedich-267	96	4	more	more	ADJ
biomedich-267	96	5	than	than	ADP
biomedich-267	96	6	40	40	NUM
biomedich-267	96	7	per	per	ADP
biomedich-267	96	8	cent	cent	NOUN
biomedich-267	96	9	longer	long	ADV
biomedich-267	96	10	after	after	ADP
biomedich-267	96	11	a	a	DET
biomedich-267	96	12	high	high	ADJ
biomedich-267	96	13	-	-	PUNCT
biomedich-267	96	14	fat	fat	NOUN
biomedich-267	96	15	diet	diet	NOUN
biomedich-267	96	16	than	than	ADP
biomedich-267	96	17	people	people	NOUN
biomedich-267	96	18	without	without	ADP
biomedich-267	96	19	excessive	excessive	ADJ
biomedich-267	96	20	body	body	NOUN
biomedich-267	96	21	weight	weight	NOUN
biomedich-267	96	22	(	(	PUNCT
biomedich-267	96	23	kassir	kassir	NOUN
biomedich-267	96	24	2020	2020	NUM
biomedich-267	96	25	)	)	PUNCT
biomedich-267	96	26	.	.	PUNCT
biomedich-267	97	1	therefore	therefore	ADV
biomedich-267	97	2	,	,	PUNCT
biomedich-267	97	3	obesity	obesity	NOUN
biomedich-267	97	4	during	during	ADP
biomedich-267	97	5	the	the	DET
biomedich-267	97	6	covid-19	covid-19	PROPN
biomedich-267	97	7	outbreak	outbreak	NOUN
biomedich-267	97	8	seems	seem	VERB
biomedich-267	97	9	to	to	PART
biomedich-267	97	10	require	require	VERB
biomedich-267	97	11	more	more	ADJ
biomedich-267	97	12	attention	attention	NOUN
biomedich-267	97	13	,	,	PUNCT
biomedich-267	97	14	especially	especially	ADV
biomedich-267	97	15	in	in	ADP
biomedich-267	97	16	western	western	ADJ
biomedich-267	97	17	countries	country	NOUN
biomedich-267	97	18	where	where	SCONJ
biomedich-267	97	19	obesity	obesity	NOUN
biomedich-267	97	20	prevalence	prevalence	NOUN
biomedich-267	97	21	is	be	AUX
biomedich-267	97	22	high	high	ADJ
biomedich-267	97	23	(	(	PUNCT
biomedich-267	97	24	rychter	rychter	NOUN
biomedich-267	97	25	et	et	PROPN
biomedich-267	97	26	al	al	PROPN
biomedich-267	97	27	.	.	PROPN
biomedich-267	97	28	,	,	PUNCT
biomedich-267	97	29	2020	2020	NUM
biomedich-267	97	30	)	)	PUNCT
biomedich-267	97	31	.	.	PUNCT
biomedich-267	98	1	there	there	PRON
biomedich-267	98	2	was	be	VERB
biomedich-267	98	3	an	an	DET
biomedich-267	98	4	increased	increase	VERB
biomedich-267	98	5	risk	risk	NOUN
biomedich-267	98	6	of	of	ADP
biomedich-267	98	7	progressing	progress	VERB
biomedich-267	98	8	to	to	PART
biomedich-267	98	9	extreme	extreme	VERB
biomedich-267	98	10	covid-19	covid-19	PROPN
biomedich-267	98	11	in	in	ADP
biomedich-267	98	12	obese	obese	ADJ
biomedich-267	98	13	patients	patient	NOUN
biomedich-267	98	14	.	.	PUNCT
biomedich-267	99	1	since	since	SCONJ
biomedich-267	99	2	severe	severe	ADJ
biomedich-267	99	3	acute	acute	ADJ
biomedich-267	99	4	respiratory	respiratory	ADJ
biomedich-267	99	5	syndrome	syndrome	NOUN
biomedich-267	99	6	coronavirus	coronavirus	NOUN
biomedich-267	99	7	two	two	NUM
biomedich-267	99	8	will	will	AUX
biomedich-267	99	9	continue	continue	VERB
biomedich-267	99	10	to	to	PART
biomedich-267	99	11	spread	spread	VERB
biomedich-267	99	12	internationally	internationally	ADV
biomedich-267	99	13	,	,	PUNCT
biomedich-267	99	14	clinicians	clinician	NOUN
biomedich-267	99	15	should	should	AUX
biomedich-267	99	16	pay	pay	VERB
biomedich-267	99	17	particular	particular	ADJ
biomedich-267	99	18	attention	attention	NOUN
biomedich-267	99	19	to	to	ADP
biomedich-267	99	20	obese	obese	ADJ
biomedich-267	99	21	patients	patient	NOUN
biomedich-267	99	22	who	who	PRON
biomedich-267	99	23	should	should	AUX
biomedich-267	99	24	be	be	AUX
biomedich-267	99	25	handled	handle	VERB
biomedich-267	99	26	closely	closely	ADV
biomedich-267	99	27	with	with	ADP
biomedich-267	99	28	prompt	prompt	ADJ
biomedich-267	99	29	and	and	CCONJ
biomedich-267	99	30	aggressive	aggressive	ADJ
biomedich-267	99	31	treatment	treatment	NOUN
biomedich-267	99	32	(	(	PUNCT
biomedich-267	99	33	cai	cai	X
biomedich-267	99	34	et	et	PROPN
biomedich-267	99	35	al	al	PROPN
biomedich-267	99	36	.	.	PROPN
biomedich-267	99	37	,	,	PUNCT
biomedich-267	99	38	2020	2020	NUM
biomedich-267	99	39	)	)	PUNCT
biomedich-267	99	40	.	.	PUNCT
biomedich-267	100	1	for	for	ADP
biomedich-267	100	2	variables	variable	NOUN
biomedich-267	100	3	associated	associate	VERB
biomedich-267	100	4	with	with	ADP
biomedich-267	100	5	covid-19	covid-19	PROPN
biomedich-267	100	6	risk	risk	NOUN
biomedich-267	100	7	,	,	PUNCT
biomedich-267	100	8	severity	severity	NOUN
biomedich-267	100	9	,	,	PUNCT
biomedich-267	100	10	and	and	CCONJ
biomedich-267	100	11	their	their	PRON
biomedich-267	100	12	potential	potential	NOUN
biomedich-267	100	13	for	for	ADP
biomedich-267	100	14	decreased	decrease	VERB
biomedich-267	100	15	therapeutic	therapeutic	ADJ
biomedich-267	100	16	and	and	CCONJ
biomedich-267	100	17	prophylactic	prophylactic	ADJ
biomedich-267	100	18	treatments	treatment	NOUN
biomedich-267	100	19	among	among	ADP
biomedich-267	100	20	these	these	DET
biomedich-267	100	21	individuals	individual	NOUN
biomedich-267	100	22	,	,	PUNCT
biomedich-267	100	23	mechanistic	mechanistic	ADJ
biomedich-267	100	24	mechanisms	mechanism	NOUN
biomedich-267	100	25	for	for	ADP
biomedich-267	100	26	obesity	obesity	NOUN
biomedich-267	100	27	are	be	AUX
biomedich-267	100	28	presented	present	VERB
biomedich-267	100	29	in	in	ADP
biomedich-267	100	30	detail	detail	NOUN
biomedich-267	100	31	.	.	PUNCT
biomedich-267	101	1	the	the	DET
biomedich-267	101	2	substantial	substantial	ADJ
biomedich-267	101	3	main	main	ADJ
biomedich-267	101	4	changes	change	NOUN
biomedich-267	101	5	in	in	ADP
biomedich-267	101	6	morbidity	morbidity	NOUN
biomedich-267	101	7	and	and	CCONJ
biomedich-267	101	8	mortality	mortality	NOUN
biomedich-267	101	9	from	from	ADP
biomedich-267	101	10	covid-19	covid-19	PROPN
biomedich-267	101	11	are	be	AUX
biomedich-267	101	12	correlated	correlate	VERB
biomedich-267	101	13	with	with	ADP
biomedich-267	101	14	individuals	individual	NOUN
biomedich-267	101	15	with	with	ADP
biomedich-267	101	16	obesity	obesity	NOUN
biomedich-267	101	17	.	.	PUNCT
biomedich-267	102	1	several	several	ADJ
biomedich-267	102	2	mechanisms	mechanism	NOUN
biomedich-267	102	3	explain	explain	VERB
biomedich-267	102	4	this	this	DET
biomedich-267	102	5	impact	impact	NOUN
biomedich-267	102	6	jointly	jointly	ADV
biomedich-267	102	7	.	.	PUNCT
biomedich-267	103	1	a	a	DET
biomedich-267	103	2	major	major	ADJ
biomedich-267	103	3	concern	concern	NOUN
biomedich-267	103	4	is	be	AUX
biomedich-267	103	5	that	that	SCONJ
biomedich-267	103	6	vaccinations	vaccination	NOUN
biomedich-267	103	7	for	for	ADP
biomedich-267	103	8	obesity	obesity	NOUN
biomedich-267	103	9	may	may	AUX
biomedich-267	103	10	be	be	AUX
biomedich-267	103	11	less	less	ADV
biomedich-267	103	12	successful	successful	ADJ
biomedich-267	103	13	(	(	PUNCT
biomedich-267	103	14	popkin	popkin	PROPN
biomedich-267	103	15	et	et	PROPN
biomedich-267	103	16	al	al	PROPN
biomedich-267	103	17	.	.	PROPN
biomedich-267	103	18	,	,	PUNCT
biomedich-267	103	19	2020	2020	NUM
biomedich-267	103	20	)	)	PUNCT
biomedich-267	103	21	.	.	PUNCT
biomedich-267	104	1	in	in	ADP
biomedich-267	104	2	theory	theory	NOUN
biomedich-267	104	3	,	,	PUNCT
biomedich-267	104	4	early	early	ADJ
biomedich-267	104	5	intubation	intubation	NOUN
biomedich-267	104	6	benefits	benefit	NOUN
biomedich-267	104	7	identified	identify	VERB
biomedich-267	104	8	in	in	ADP
biomedich-267	104	9	patients	patient	NOUN
biomedich-267	104	10	with	with	ADP
biomedich-267	104	11	covid-19	covid-19	PROPN
biomedich-267	104	12	can	can	AUX
biomedich-267	104	13	indicate	indicate	VERB
biomedich-267	104	14	osa	osa	PROPN
biomedich-267	104	15	alleviation	alleviation	NOUN
biomedich-267	104	16	in	in	ADP
biomedich-267	104	17	some	some	DET
biomedich-267	104	18	patients	patient	NOUN
biomedich-267	104	19	.	.	PUNCT
biomedich-267	105	1	similarly	similarly	ADV
biomedich-267	105	2	,	,	PUNCT
biomedich-267	105	3	concerns	concern	NOUN
biomedich-267	105	4	of	of	ADP
biomedich-267	105	5	contamination	contamination	NOUN
biomedich-267	105	6	from	from	ADP
biomedich-267	105	7	using	use	VERB
biomedich-267	105	8	nasal	nasal	PROPN
biomedich-267	105	9	pap	pap	NOUN
biomedich-267	105	10	in	in	ADP
biomedich-267	105	11	some	some	DET
biomedich-267	105	12	patients	patient	NOUN
biomedich-267	105	13	with	with	ADP
biomedich-267	105	14	obstructive	obstructive	ADJ
biomedich-267	105	15	sleep	sleep	NOUN
biomedich-267	105	16	apnea	apnea	NOUN
biomedich-267	105	17	could	could	AUX
biomedich-267	105	18	lead	lead	VERB
biomedich-267	105	19	to	to	ADP
biomedich-267	105	20	deterioration	deterioration	NOUN
biomedich-267	105	21	.	.	PUNCT
biomedich-267	106	1	mechanistic	mechanistic	ADJ
biomedich-267	106	2	research	research	NOUN
biomedich-267	106	3	is	be	AUX
biomedich-267	106	4	encouraged	encourage	VERB
biomedich-267	106	5	,	,	PUNCT
biomedich-267	106	6	given	give	VERB
biomedich-267	106	7	the	the	DET
biomedich-267	106	8	possible	possible	ADJ
biomedich-267	106	9	connection	connection	NOUN
biomedich-267	106	10	between	between	ADP
biomedich-267	106	11	osa	osa	PROPN
biomedich-267	106	12	,	,	PUNCT
biomedich-267	106	13	obesity	obesity	NOUN
biomedich-267	106	14	,	,	PUNCT
biomedich-267	106	15	and	and	CCONJ
biomedich-267	106	16	covid-19	covid-19	PROPN
biomedich-267	106	17	(	(	PUNCT
biomedich-267	106	18	mcsharry	mcsharry	VERB
biomedich-267	106	19	et	et	PROPN
biomedich-267	106	20	al	al	PROPN
biomedich-267	106	21	.	.	PROPN
biomedich-267	106	22	,	,	PUNCT
biomedich-267	106	23	2020	2020	NUM
biomedich-267	106	24	)	)	PUNCT
biomedich-267	106	25	.	.	PUNCT
biomedich-267	107	1	in	in	ADP
biomedich-267	107	2	young	young	ADJ
biomedich-267	107	3	patients	patient	NOUN
biomedich-267	107	4	,	,	PUNCT
biomedich-267	107	5	obesity	obesity	NOUN
biomedich-267	107	6	is	be	AUX
biomedich-267	107	7	a	a	DET
biomedich-267	107	8	significant	significant	ADJ
biomedich-267	107	9	predictor	predictor	NOUN
biomedich-267	107	10	of	of	ADP
biomedich-267	107	11	covid-19	covid-19	PROPN
biomedich-267	107	12	severity	severity	NOUN
biomedich-267	107	13	.	.	PUNCT
biomedich-267	108	1	the	the	DET
biomedich-267	108	2	key	key	ADJ
biomedich-267	108	3	mechanism	mechanism	NOUN
biomedich-267	108	4	is	be	AUX
biomedich-267	108	5	connected	connect	VERB
biomedich-267	108	6	to	to	PART
biomedich-267	108	7	liver	liver	NOUN
biomedich-267	108	8	and	and	CCONJ
biomedich-267	108	9	kidney	kidney	NOUN
biomedich-267	108	10	damage	damage	NOUN
biomedich-267	108	11	(	(	PUNCT
biomedich-267	108	12	deng	deng	PROPN
biomedich-267	108	13	et	et	PROPN
biomedich-267	108	14	al	al	PROPN
biomedich-267	108	15	.	.	PROPN
biomedich-267	108	16	,	,	PUNCT
biomedich-267	108	17	2020	2020	NUM
biomedich-267	108	18	)	)	PUNCT
biomedich-267	108	19	study	study	NOUN
biomedich-267	108	20	shows	show	VERB
biomedich-267	108	21	that	that	SCONJ
biomedich-267	108	22	patients	patient	NOUN
biomedich-267	108	23	with	with	ADP
biomedich-267	108	24	overweight	overweight	NOUN
biomedich-267	108	25	and	and	CCONJ
biomedich-267	108	26	obese	obese	NOUN
biomedich-267	108	27	who	who	PRON
biomedich-267	108	28	have	have	VERB
biomedich-267	108	29	covid-19	covid-19	PROPN
biomedich-267	108	30	are	be	AUX
biomedich-267	108	31	at	at	ADP
biomedich-267	108	32	higher	high	ADJ
biomedich-267	108	33	risk	risk	NOUN
biomedich-267	108	34	for	for	ADP
biomedich-267	108	35	mortality	mortality	NOUN
biomedich-267	108	36	and	and	CCONJ
biomedich-267	108	37	intubation	intubation	NOUN
biomedich-267	108	38	than	than	ADP
biomedich-267	108	39	those	those	PRON
biomedich-267	108	40	with	with	ADP
biomedich-267	108	41	typical	typical	ADJ
biomedich-267	108	42	bmi	bmi	NOUN
biomedich-267	108	43	.	.	PUNCT
biomedich-267	109	1	these	these	DET
biomedich-267	109	2	results	result	NOUN
biomedich-267	109	3	support	support	VERB
biomedich-267	109	4	the	the	DET
biomedich-267	109	5	hypothesis	hypothesis	NOUN
biomedich-267	109	6	that	that	SCONJ
biomedich-267	109	7	obesity	obesity	NOUN
biomedich-267	109	8	is	be	AUX
biomedich-267	109	9	a	a	DET
biomedich-267	109	10	risk	risk	NOUN
biomedich-267	109	11	factor	factor	NOUN
biomedich-267	109	12	for	for	ADP
biomedich-267	109	13	complications	complication	NOUN
biomedich-267	109	14	of	of	ADP
biomedich-267	109	15	covid-19	covid-19	PROPN
biomedich-267	109	16	and	and	CCONJ
biomedich-267	109	17	should	should	AUX
biomedich-267	109	18	be	be	AUX
biomedich-267	109	19	considered	consider	VERB
biomedich-267	109	20	for	for	ADP
biomedich-267	109	21	covid-19	covid-19	PROPN
biomedich-267	109	22	management	management	NOUN
biomedich-267	109	23	(	(	PUNCT
biomedich-267	109	24	nakeshbandi	nakeshbandi	PROPN
biomedich-267	109	25	et	et	PROPN
biomedich-267	109	26	al	al	PROPN
biomedich-267	109	27	.	.	PROPN
biomedich-267	109	28	,	,	PUNCT
biomedich-267	109	29	2020	2020	NUM
biomedich-267	109	30	)	)	PUNCT
biomedich-267	109	31	.	.	PUNCT
biomedich-267	110	1	in	in	ADP
biomedich-267	110	2	addition	addition	NOUN
biomedich-267	110	3	,	,	PUNCT
biomedich-267	110	4	there	there	PRON
biomedich-267	110	5	was	be	VERB
biomedich-267	110	6	an	an	DET
biomedich-267	110	7	increased	increase	VERB
biomedich-267	110	8	risk	risk	NOUN
biomedich-267	110	9	of	of	ADP
biomedich-267	110	10	progressing	progress	VERB
biomedich-267	110	11	to	to	PART
biomedich-267	110	12	extreme	extreme	VERB
biomedich-267	110	13	covid-19	covid-19	PROPN
biomedich-267	110	14	in	in	ADP
biomedich-267	110	15	obese	obese	ADJ
biomedich-267	110	16	patients	patient	NOUN
biomedich-267	110	17	.	.	PUNCT
biomedich-267	111	1	since	since	SCONJ
biomedich-267	111	2	severe	severe	ADJ
biomedich-267	111	3	acute	acute	ADJ
biomedich-267	111	4	respiratory	respiratory	ADJ
biomedich-267	111	5	syndrome	syndrome	NOUN
biomedich-267	111	6	coronavirus	coronavirus	NOUN
biomedich-267	111	7	two	two	NUM
biomedich-267	111	8	will	will	AUX
biomedich-267	111	9	continue	continue	VERB
biomedich-267	111	10	to	to	PART
biomedich-267	111	11	spread	spread	VERB
biomedich-267	111	12	internationally	internationally	ADV
biomedich-267	111	13	,	,	PUNCT
biomedich-267	111	14	clinicians	clinician	NOUN
biomedich-267	111	15	should	should	AUX
biomedich-267	111	16	pay	pay	VERB
biomedich-267	111	17	particular	particular	ADJ
biomedich-267	111	18	attention	attention	NOUN
biomedich-267	111	19	to	to	ADP
biomedich-267	111	20	obese	obese	ADJ
biomedich-267	111	21	patients	patient	NOUN
biomedich-267	111	22	who	who	PRON
biomedich-267	111	23	should	should	AUX
biomedich-267	111	24	be	be	AUX
biomedich-267	111	25	handled	handle	VERB
biomedich-267	111	26	closely	closely	ADV
biomedich-267	111	27	with	with	ADP
biomedich-267	111	28	prompt	prompt	ADJ
biomedich-267	111	29	and	and	CCONJ
biomedich-267	111	30	aggressive	aggressive	ADJ
biomedich-267	111	31	treatment	treatment	NOUN
biomedich-267	111	32	(	(	PUNCT
biomedich-267	111	33	cai	cai	X
biomedich-267	111	34	et	et	PROPN
biomedich-267	111	35	al	al	PROPN
biomedich-267	111	36	.	.	PROPN
biomedich-267	111	37	,	,	PUNCT
biomedich-267	111	38	2020	2020	NUM
biomedich-267	111	39	)	)	PUNCT
biomedich-267	111	40	.	.	PUNCT
biomedich-267	112	1	obesity	obesity	NOUN
biomedich-267	112	2	,	,	PUNCT
biomedich-267	112	3	especially	especially	ADV
biomedich-267	112	4	in	in	ADP
biomedich-267	112	5	male	male	ADJ
biomedich-267	112	6	and	and	CCONJ
biomedich-267	112	7	younger	young	ADJ
biomedich-267	112	8	populations	population	NOUN
biomedich-267	112	9	,	,	PUNCT
biomedich-267	112	10	plays	play	VERB
biomedich-267	112	11	a	a	DET
biomedich-267	112	12	significant	significant	ADJ
biomedich-267	112	13	role	role	NOUN
biomedich-267	112	14	in	in	ADP
biomedich-267	112	15	the	the	DET
biomedich-267	112	16	risk	risk	NOUN
biomedich-267	112	17	of	of	ADP
biomedich-267	112	18	death	death	NOUN
biomedich-267	112	19	from	from	ADP
biomedich-267	112	20	covid19	covid19	NOUN
biomedich-267	112	21	.	.	PUNCT
biomedich-267	113	1	the	the	DET
biomedich-267	113	2	lack	lack	NOUN
biomedich-267	113	3	of	of	ADP
biomedich-267	113	4	impact	impact	NOUN
biomedich-267	113	5	of	of	ADP
biomedich-267	113	6	racial	racial	ADJ
biomedich-267	113	7	/	/	SYM
biomedich-267	113	8	ethnic	ethnic	ADJ
biomedich-267	113	9	and	and	CCONJ
biomedich-267	113	10	socioeconomic	socioeconomic	ADJ
biomedich-267	113	11	inequalities	inequality	NOUN
biomedich-267	113	12	on	on	ADP
biomedich-267	113	13	mortality	mortality	NOUN
biomedich-267	113	14	can	can	AUX
biomedich-267	113	15	be	be	AUX
biomedich-267	113	16	explained	explain	VERB
biomedich-267	113	17	by	by	ADP
biomedich-267	113	18	the	the	DET
biomedich-267	113	19	capitated	capitate	VERB
biomedich-267	113	20	system	system	NOUN
biomedich-267	113	21	with	with	ADP
biomedich-267	113	22	more	more	ADV
biomedich-267	113	23	equalized	equalized	ADJ
biomedich-267	113	24	access	access	NOUN
biomedich-267	113	25	to	to	ADP
biomedich-267	113	26	health	health	NOUN
biomedich-267	113	27	care	care	NOUN
biomedich-267	113	28	.	.	PUNCT
biomedich-267	114	1	the	the	DET
biomedich-267	114	2	data	datum	NOUN
biomedich-267	114	3	highlight	highlight	VERB
biomedich-267	114	4	the	the	DET
biomedich-267	114	5	leading	lead	VERB
biomedich-267	114	6	role	role	NOUN
biomedich-267	114	7	of	of	ADP
biomedich-267	114	8	extreme	extreme	ADJ
biomedich-267	114	9	obesity	obesity	NOUN
biomedich-267	114	10	over	over	ADP
biomedich-267	114	11	correlated	correlate	VERB
biomedich-267	114	12	risk	risk	NOUN
biomedich-267	114	13	factors	factor	NOUN
biomedich-267	114	14	,	,	PUNCT
biomedich-267	114	15	which	which	PRON
biomedich-267	114	16	offers	offer	VERB
biomedich-267	114	17	an	an	DET
biomedich-267	114	18	early	early	ADJ
biomedich-267	114	19	intervention	intervention	NOUN
biomedich-267	114	20	target	target	NOUN
biomedich-267	114	21	(	(	PUNCT
biomedich-267	114	22	tartof	tartof	PROPN
biomedich-267	114	23	et	et	PROPN
biomedich-267	114	24	al	al	PROPN
biomedich-267	114	25	.	.	PROPN
biomedich-267	114	26	,	,	PUNCT
biomedich-267	114	27	2020	2020	NUM
biomedich-267	114	28	)	)	PUNCT
biomedich-267	114	29	the	the	DET
biomedich-267	114	30	position	position	NOUN
biomedich-267	114	31	of	of	ADP
biomedich-267	114	32	obesity	obesity	NOUN
biomedich-267	114	33	,	,	PUNCT
biomedich-267	114	34	particularly	particularly	ADV
biomedich-267	114	35	given	give	VERB
biomedich-267	114	36	its	its	PRON
biomedich-267	114	37	high	high	ADJ
biomedich-267	114	38	prevalence	prevalence	NOUN
biomedich-267	114	39	worldwide	worldwide	ADV
biomedich-267	114	40	,	,	PUNCT
biomedich-267	114	41	is	be	AUX
biomedich-267	114	42	of	of	ADP
biomedich-267	114	43	great	great	ADJ
biomedich-267	114	44	relevance	relevance	NOUN
biomedich-267	114	45	.	.	PUNCT
biomedich-267	115	1	however	however	ADV
biomedich-267	115	2	,	,	PUNCT
biomedich-267	115	3	it	it	PRON
biomedich-267	115	4	is	be	AUX
biomedich-267	115	5	important	important	ADJ
biomedich-267	115	6	to	to	PART
biomedich-267	115	7	bear	bear	VERB
biomedich-267	115	8	in	in	ADP
biomedich-267	115	9	mind	mind	NOUN
biomedich-267	115	10	that	that	SCONJ
biomedich-267	115	11	the	the	DET
biomedich-267	115	12	assessment	assessment	NOUN
biomedich-267	115	13	of	of	ADP
biomedich-267	115	14	obesity	obesity	NOUN
biomedich-267	115	15	through	through	ADP
biomedich-267	115	16	bmi	bmi	NOUN
biomedich-267	115	17	is	be	AUX
biomedich-267	115	18	highly	highly	ADV
biomedich-267	115	19	arguable	arguable	ADJ
biomedich-267	115	20	,	,	PUNCT
biomedich-267	115	21	particularly	particularly	ADV
biomedich-267	115	22	in	in	ADP
biomedich-267	115	23	older	old	ADJ
biomedich-267	115	24	people	people	NOUN
biomedich-267	115	25	.	.	PUNCT
biomedich-267	116	1	first	first	ADV
biomedich-267	116	2	,	,	PUNCT
biomedich-267	116	3	since	since	SCONJ
biomedich-267	116	4	its	its	PRON
biomedich-267	116	5	numerator	numerator	NOUN
biomedich-267	116	6	(	(	PUNCT
biomedich-267	116	7	i.e.	i.e.	X
biomedich-267	116	8	bodyweight	bodyweight	NOUN
biomedich-267	116	9	)	)	PUNCT
biomedich-267	116	10	comes	come	VERB
biomedich-267	116	11	from	from	ADP
biomedich-267	116	12	the	the	DET
biomedich-267	116	13	fat	fat	ADJ
biomedich-267	116	14	and	and	CCONJ
biomedich-267	116	15	fat	fat	ADJ
biomedich-267	116	16	-	-	PUNCT
biomedich-267	116	17	free	free	ADJ
biomedich-267	116	18	mass	mass	NOUN
biomedich-267	116	19	amount	amount	NOUN
biomedich-267	116	20	,	,	PUNCT
biomedich-267	116	21	it	it	PRON
biomedich-267	116	22	should	should	AUX
biomedich-267	116	23	be	be	AUX
biomedich-267	116	24	noted	note	VERB
biomedich-267	116	25	that	that	SCONJ
biomedich-267	116	26	bmi	bmi	NOUN
biomedich-267	116	27	does	do	AUX
biomedich-267	116	28	not	not	PART
biomedich-267	116	29	strictly	strictly	ADV
biomedich-267	116	30	reflect	reflect	VERB
biomedich-267	116	31	adiposity	adiposity	NOUN
biomedich-267	116	32	.	.	PUNCT
biomedich-267	117	1	second	second	ADJ
biomedich-267	117	2	,	,	PUNCT
biomedich-267	117	3	the	the	DET
biomedich-267	117	4	cut	cut	NOUN
biomedich-267	117	5	points	point	NOUN
biomedich-267	117	6	that	that	PRON
biomedich-267	117	7	categorize	categorize	VERB
biomedich-267	117	8	overweight	overweight	NOUN
biomedich-267	117	9	and	and	CCONJ
biomedich-267	117	10	obese	obese	NOUN
biomedich-267	117	11	are	be	AUX
biomedich-267	117	12	subjective	subjective	ADJ
biomedich-267	117	13	and	and	CCONJ
biomedich-267	117	14	cohort	cohort	NOUN
biomedich-267	117	15	-	-	PUNCT
biomedich-267	117	16	based	base	VERB
biomedich-267	117	17	for	for	ADP
biomedich-267	117	18	young	young	ADJ
biomedich-267	117	19	and	and	CCONJ
biomedich-267	117	20	middle	middle	ADJ
biomedich-267	117	21	-	-	PUNCT
biomedich-267	117	22	aged	aged	ADJ
biomedich-267	117	23	people	people	NOUN
biomedich-267	117	24	and	and	CCONJ
biomedich-267	117	25	insufficient	insufficient	ADJ
biomedich-267	117	26	for	for	ADP
biomedich-267	117	27	older	old	ADJ
biomedich-267	117	28	people	people	NOUN
biomedich-267	117	29	(	(	PUNCT
biomedich-267	117	30	sattar	sattar	PROPN
biomedich-267	117	31	et	et	PROPN
biomedich-267	117	32	al	al	PROPN
biomedich-267	117	33	.	.	PROPN
biomedich-267	117	34	,	,	PUNCT
biomedich-267	117	35	2020	2020	NUM
biomedich-267	117	36	)	)	PUNCT
biomedich-267	117	37	.	.	PUNCT
biomedich-267	118	1	third	third	ADV
biomedich-267	118	2	,	,	PUNCT
biomedich-267	118	3	with	with	ADP
biomedich-267	118	4	age	age	NOUN
biomedich-267	118	5	,	,	PUNCT
biomedich-267	118	6	body	body	NOUN
biomedich-267	118	7	fat	fat	NOUN
biomedich-267	118	8	accumulates	accumulate	VERB
biomedich-267	118	9	with	with	ADP
biomedich-267	118	10	a	a	DET
biomedich-267	118	11	decrease	decrease	NOUN
biomedich-267	118	12	in	in	ADP
biomedich-267	118	13	muscle	muscle	NOUN
biomedich-267	118	14	mass	mass	PROPN
biomedich-267	118	15	.	.	PUNCT
biomedich-267	119	1	obesity	obesity	NOUN
biomedich-267	119	2	is	be	AUX
biomedich-267	119	3	often	often	ADV
biomedich-267	119	4	underestimated	underestimate	VERB
biomedich-267	119	5	in	in	ADP
biomedich-267	119	6	older	old	ADJ
biomedich-267	119	7	people	people	NOUN
biomedich-267	119	8	,	,	PUNCT
biomedich-267	119	9	who	who	PRON
biomedich-267	119	10	may	may	AUX
biomedich-267	119	11	have	have	VERB
biomedich-267	119	12	excess	excess	ADJ
biomedich-267	119	13	adiposity	adiposity	NOUN
biomedich-267	119	14	within	within	ADP
biomedich-267	119	15	the	the	DET
biomedich-267	119	16	normal	normal	ADJ
biomedich-267	119	17	/	/	SYM
biomedich-267	119	18	overweight	overweight	ADJ
biomedich-267	119	19	body	body	NOUN
biomedich-267	119	20	size	size	NOUN
biomedich-267	119	21	(	(	PUNCT
biomedich-267	119	22	so	so	ADV
biomedich-267	119	23	-	-	PUNCT
biomedich-267	119	24	called	call	VERB
biomedich-267	119	25	sarcopenic	sarcopenic	ADJ
biomedich-267	119	26	obesity	obesity	NOUN
biomedich-267	119	27	)	)	PUNCT
biomedich-267	119	28	.	.	PUNCT
biomedich-267	120	1	finally	finally	ADV
biomedich-267	120	2	,	,	PUNCT
biomedich-267	120	3	ethnic	ethnic	ADJ
biomedich-267	120	4	differences	difference	NOUN
biomedich-267	120	5	can	can	AUX
biomedich-267	120	6	determine	determine	VERB
biomedich-267	120	7	significant	significant	ADJ
biomedich-267	120	8	variability	variability	NOUN
biomedich-267	120	9	in	in	ADP
biomedich-267	120	10	body	body	NOUN
biomedich-267	120	11	fat	fat	ADJ
biomedich-267	120	12	distribution	distribution	NOUN
biomedich-267	120	13	,	,	PUNCT
biomedich-267	120	14	especially	especially	ADV
biomedich-267	120	15	regarding	regard	VERB
biomedich-267	120	16	ectopic	ectopic	NOUN
biomedich-267	120	17	and	and	CCONJ
biomedich-267	120	18	visceral	visceral	ADJ
biomedich-267	120	19	fat	fat	NOUN
biomedich-267	120	20	(	(	PUNCT
biomedich-267	120	21	azzolino	azzolino	NOUN
biomedich-267	120	22	et	et	PROPN
biomedich-267	120	23	al	al	PROPN
biomedich-267	120	24	.	.	PROPN
biomedich-267	120	25	,	,	PUNCT
biomedich-267	120	26	2020	2020	NUM
biomedich-267	120	27	)	)	PUNCT
biomedich-267	120	28	.	.	PUNCT
biomedich-267	121	1	this	this	DET
biomedich-267	121	2	relative	relative	ADJ
biomedich-267	121	3	inefficiency	inefficiency	NOUN
biomedich-267	121	4	reveals	reveal	VERB
biomedich-267	121	5	a	a	DET
biomedich-267	121	6	reduced	reduced	ADJ
biomedich-267	121	7	ventilatory	ventilatory	ADJ
biomedich-267	121	8	reserve	reserve	NOUN
biomedich-267	121	9	and	and	CCONJ
biomedich-267	121	10	a	a	DET
biomedich-267	121	11	risk	risk	NOUN
biomedich-267	121	12	for	for	ADP
biomedich-267	121	13	respiratory	respiratory	ADJ
biomedich-267	121	14	failure	failure	NOUN
biomedich-267	121	15	,	,	PUNCT
biomedich-267	121	16	even	even	ADV
biomedich-267	121	17	in	in	ADP
biomedich-267	121	18	mild	mild	ADJ
biomedich-267	121	19	systemic	systemic	ADJ
biomedich-267	121	20	or	or	CCONJ
biomedich-267	121	21	pulmonary	pulmonary	ADJ
biomedich-267	121	22	conditions	condition	NOUN
biomedich-267	121	23	.	.	PUNCT
biomedich-267	122	1	taken	take	VERB
biomedich-267	122	2	together	together	ADV
biomedich-267	122	3	,	,	PUNCT
biomedich-267	122	4	any	any	DET
biomedich-267	122	5	respiratory	respiratory	ADJ
biomedich-267	122	6	insults	insult	NOUN
biomedich-267	122	7	will	will	AUX
biomedich-267	122	8	seriously	seriously	ADV
biomedich-267	122	9	compromise	compromise	VERB
biomedich-267	122	10	the	the	DET
biomedich-267	122	11	already	already	ADV
biomedich-267	122	12	attenuated	attenuate	VERB
biomedich-267	122	13	respiratory	respiratory	ADJ
biomedich-267	122	14	system	system	NOUN
biomedich-267	122	15	of	of	ADP
biomedich-267	122	16	obese	obese	ADJ
biomedich-267	122	17	subjects	subject	NOUN
biomedich-267	122	18	,	,	PUNCT
biomedich-267	122	19	ensuring	ensure	VERB
biomedich-267	122	20	that	that	SCONJ
biomedich-267	122	21	these	these	DET
biomedich-267	122	22	patients	patient	NOUN
biomedich-267	122	23	will	will	AUX
biomedich-267	122	24	fail	fail	VERB
biomedich-267	122	25	to	to	PART
biomedich-267	122	26	recover	recover	VERB
biomedich-267	122	27	if	if	SCONJ
biomedich-267	122	28	they	they	PRON
biomedich-267	122	29	have	have	AUX
biomedich-267	122	30	acquired	acquire	VERB
biomedich-267	122	31	any	any	DET
biomedich-267	122	32	serious	serious	ADJ
biomedich-267	122	33	diseases	disease	NOUN
biomedich-267	122	34	that	that	PRON
biomedich-267	122	35	can	can	AUX
biomedich-267	122	36	deleteriously	deleteriously	ADV
biomedich-267	122	37	impact	impact	VERB
biomedich-267	122	38	respiratory	respiratory	ADJ
biomedich-267	122	39	function	function	NOUN
biomedich-267	122	40	,	,	PUNCT
biomedich-267	122	41	such	such	ADJ
biomedich-267	122	42	as	as	ADP
biomedich-267	122	43	covid-19	covid-19	PROPN
biomedich-267	122	44	(	(	PUNCT
biomedich-267	122	45	albashir	albashir	PROPN
biomedich-267	122	46	et	et	PROPN
biomedich-267	122	47	al	al	PROPN
biomedich-267	122	48	.	.	PROPN
biomedich-267	122	49	,	,	PUNCT
biomedich-267	122	50	2020	2020	NUM
biomedich-267	122	51	)	)	PUNCT
biomedich-267	122	52	the	the	DET
biomedich-267	122	53	results	result	NOUN
biomedich-267	122	54	indicate	indicate	VERB
biomedich-267	122	55	an	an	DET
biomedich-267	122	56	interplay	interplay	NOUN
biomedich-267	122	57	and	and	CCONJ
biomedich-267	122	58	dynamic	dynamic	ADJ
biomedich-267	122	59	pathophysiology	pathophysiology	NOUN
biomedich-267	122	60	between	between	ADP
biomedich-267	122	61	covid-19	covid-19	PROPN
biomedich-267	122	62	and	and	CCONJ
biomedich-267	122	63	diabetes	diabetes	NOUN
biomedich-267	122	64	.	.	PUNCT
biomedich-267	123	1	for	for	ADP
biomedich-267	123	2	clinical	clinical	ADJ
biomedich-267	123	3	practice	practice	NOUN
biomedich-267	123	4	and	and	CCONJ
biomedich-267	123	5	public	public	ADJ
biomedich-267	123	6	health	health	NOUN
biomedich-267	123	7	,	,	PUNCT
biomedich-267	123	8	it	it	PRON
biomedich-267	123	9	is	be	AUX
biomedich-267	123	10	a	a	DET
biomedich-267	123	11	significant	significant	ADJ
biomedich-267	123	12	priority	priority	NOUN
biomedich-267	123	13	to	to	PART
biomedich-267	123	14	understand	understand	VERB
biomedich-267	123	15	how	how	SCONJ
biomedich-267	123	16	diabetes	diabetes	NOUN
biomedich-267	123	17	can	can	AUX
biomedich-267	123	18	lead	lead	VERB
biomedich-267	123	19	to	to	ADP
biomedich-267	123	20	extreme	extreme	ADJ
biomedich-267	123	21	covid-19	covid-19	PROPN
biomedich-267	123	22	and	and	CCONJ
biomedich-267	123	23	how	how	SCONJ
biomedich-267	123	24	covid-19	covid-19	PROPN
biomedich-267	123	25	can	can	AUX
biomedich-267	123	26	worsen	worsen	VERB
biomedich-267	123	27	diabetes	diabetes	NOUN
biomedich-267	123	28	pathophysiology	pathophysiology	NOUN
biomedich-267	123	29	or	or	CCONJ
biomedich-267	123	30	its	its	PRON
biomedich-267	123	31	effects	effect	NOUN
biomedich-267	123	32	.	.	PUNCT
biomedich-267	124	1	to	to	PART
biomedich-267	124	2	counter	counter	VERB
biomedich-267	124	3	this	this	PRON
biomedich-267	124	4	,	,	PUNCT
biomedich-267	124	5	a	a	DET
biomedich-267	124	6	global	global	ADJ
biomedich-267	124	7	registry	registry	NOUN
biomedich-267	124	8	(	(	PUNCT
biomedich-267	124	9	covid	covid	PROPN
biomedich-267	124	10	)	)	PUNCT
biomedich-267	124	11	was	be	AUX
biomedich-267	124	12	introduced	introduce	VERB
biomedich-267	124	13	to	to	PART
biomedich-267	124	14	promote	promote	VERB
biomedich-267	124	15	the	the	DET
biomedich-267	124	16	study	study	NOUN
biomedich-267	124	17	of	of	ADP
biomedich-267	124	18	covid-19	covid-19	PROPN
biomedich-267	124	19	-	-	PUNCT
biomedich-267	124	20	related	relate	VERB
biomedich-267	124	21	diabetes	diabetes	NOUN
biomedich-267	124	22	manifestations	manifestation	NOUN
biomedich-267	124	23	,	,	PUNCT
biomedich-267	124	24	their	their	PRON
biomedich-267	124	25	effects	effect	NOUN
biomedich-267	124	26	,	,	PUNCT
biomedich-267	124	27	and	and	CCONJ
biomedich-267	124	28	best	good	ADJ
biomedich-267	124	29	care	care	NOUN
biomedich-267	124	30	(	(	PUNCT
biomedich-267	124	31	rubino	rubino	NOUN
biomedich-267	124	32	et	et	PROPN
biomedich-267	124	33	al	al	PROPN
biomedich-267	124	34	.	.	PROPN
biomedich-267	124	35	,	,	PUNCT
biomedich-267	124	36	2020	2020	NUM
biomedich-267	124	37	)	)	PUNCT
biomedich-267	124	38	.	.	PUNCT
biomedich-267	125	1	a	a	DET
biomedich-267	125	2	wealth	wealth	NOUN
biomedich-267	125	3	of	of	ADP
biomedich-267	125	4	data	datum	NOUN
biomedich-267	125	5	has	have	AUX
biomedich-267	125	6	emerged	emerge	VERB
biomedich-267	125	7	on	on	ADP
biomedich-267	125	8	this	this	DET
biomedich-267	125	9	subject	subject	NOUN
biomedich-267	125	10	over	over	ADP
biomedich-267	125	11	the	the	DET
biomedich-267	125	12	short	short	ADJ
biomedich-267	125	13	period	period	NOUN
biomedich-267	125	14	of	of	ADP
biomedich-267	125	15	the	the	DET
biomedich-267	125	16	covid-19	covid-19	PROPN
biomedich-267	125	17	pandemic	pandemic	NOUN
biomedich-267	125	18	,	,	PUNCT
biomedich-267	125	19	but	but	CCONJ
biomedich-267	125	20	important	important	ADJ
biomedich-267	125	21	questions	question	NOUN
biomedich-267	125	22	still	still	ADV
biomedich-267	125	23	need	need	VERB
biomedich-267	125	24	to	to	PART
biomedich-267	125	25	be	be	AUX
biomedich-267	125	26	addressed	address	VERB
biomedich-267	125	27	.	.	PUNCT
biomedich-267	126	1	here	here	ADV
biomedich-267	126	2	,	,	PUNCT
biomedich-267	126	3	the	the	DET
biomedich-267	126	4	current	current	ADJ
biomedich-267	126	5	literature	literature	NOUN
biomedich-267	126	6	on	on	ADP
biomedich-267	126	7	the	the	DET
biomedich-267	126	8	relationship	relationship	NOUN
biomedich-267	126	9	between	between	ADP
biomedich-267	126	10	covid-19	covid-19	PROPN
biomedich-267	126	11	and	and	CCONJ
biomedich-267	126	12	diabetes	diabetes	NOUN
biomedich-267	126	13	is	be	AUX
biomedich-267	126	14	reviewed	review	VERB
biomedich-267	126	15	,	,	PUNCT
biomedich-267	126	16	and	and	CCONJ
biomedich-267	126	17	future	future	ADJ
biomedich-267	126	18	studies	study	NOUN
biomedich-267	126	19	'	'	PART
biomedich-267	126	20	priorities	priority	NOUN
biomedich-267	126	21	are	be	AUX
biomedich-267	126	22	considered	consider	VERB
biomedich-267	126	23	(	(	PUNCT
biomedich-267	126	24	vas	vas	X
biomedich-267	126	25	et	et	PROPN
biomedich-267	126	26	al	al	PROPN
biomedich-267	126	27	.	.	PROPN
biomedich-267	126	28	,	,	PUNCT
biomedich-267	126	29	2020	2020	NUM
biomedich-267	126	30	)	)	PUNCT
biomedich-267	126	31	.	.	PUNCT
biomedich-267	127	1	the	the	DET
biomedich-267	127	2	role	role	NOUN
biomedich-267	127	3	of	of	ADP
biomedich-267	127	4	cytokines	cytokine	NOUN
biomedich-267	127	5	,	,	PUNCT
biomedich-267	127	6	rapamycin	rapamycin	ADJ
biomedich-267	127	7	mammalian	mammalian	ADJ
biomedich-267	127	8	target	target	NOUN
biomedich-267	127	9	(	(	PUNCT
biomedich-267	127	10	mtor	mtor	NOUN
biomedich-267	127	11	)	)	PUNCT
biomedich-267	127	12	,	,	PUNCT
biomedich-267	127	13	and	and	CCONJ
biomedich-267	127	14	altered	alter	VERB
biomedich-267	127	15	polarization	polarization	NOUN
biomedich-267	127	16	of	of	ADP
biomedich-267	127	17	natural	natural	ADJ
biomedich-267	127	18	killer	killer	NOUN
biomedich-267	127	19	cells	cell	NOUN
biomedich-267	127	20	in	in	ADP
biomedich-267	127	21	the	the	DET
biomedich-267	127	22	hazardous	hazardous	ADJ
biomedich-267	127	23	relation	relation	NOUN
biomedich-267	127	24	between	between	ADP
biomedich-267	127	25	covid-19	covid-19	PROPN
biomedich-267	127	26	and	and	CCONJ
biomedich-267	127	27	obesity	obesity	NOUN
biomedich-267	127	28	.	.	PUNCT
biomedich-267	128	1	these	these	DET
biomedich-267	128	2	pathways	pathway	NOUN
biomedich-267	128	3	encourage	encourage	VERB
biomedich-267	128	4	and	and	CCONJ
biomedich-267	128	5	accelerate	accelerate	VERB
biomedich-267	128	6	the	the	DET
biomedich-267	128	7	deleterious	deleterious	ADJ
biomedich-267	128	8	downstream	downstream	ADJ
biomedich-267	128	9	cellular	cellular	ADJ
biomedich-267	128	10	effects	effect	NOUN
biomedich-267	128	11	of	of	ADP
biomedich-267	128	12	sars	sar	NOUN
biomedich-267	128	13	-	-	PUNCT
biomedich-267	128	14	cov2	cov2	PROPN
biomedich-267	128	15	.	.	PUNCT
biomedich-267	129	1	also	also	ADV
biomedich-267	129	2	,	,	PUNCT
biomedich-267	129	3	it	it	PRON
biomedich-267	129	4	is	be	AUX
biomedich-267	129	5	well	well	ADV
biomedich-267	129	6	known	know	VERB
biomedich-267	129	7	that	that	SCONJ
biomedich-267	129	8	obesity	obesity	NOUN
biomedich-267	129	9	is	be	AUX
biomedich-267	129	10	associated	associate	VERB
biomedich-267	129	11	with	with	ADP
biomedich-267	129	12	smail	smail	NOUN
biomedich-267	129	13	–	–	PUNCT
biomedich-267	129	14	the	the	DET
biomedich-267	129	15	association	association	NOUN
biomedich-267	129	16	between	between	ADP
biomedich-267	129	17	some	some	DET
biomedich-267	129	18	endocrine	endocrine	NOUN
biomedich-267	129	19	conditions	condition	NOUN
biomedich-267	129	20	and	and	CCONJ
biomedich-267	129	21	covid-19	covid-19	PROPN
biomedich-267	129	22	:	:	PUNCT
biomedich-267	129	23	a	a	DET
biomedich-267	129	24	review	review	NOUN
biomedich-267	129	25	49	49	NUM
biomedich-267	129	26	decreased	decrease	VERB
biomedich-267	129	27	lung	lung	NOUN
biomedich-267	129	28	capacity	capacity	NOUN
biomedich-267	129	29	and	and	CCONJ
biomedich-267	129	30	poor	poor	ADJ
biomedich-267	129	31	response	response	NOUN
biomedich-267	129	32	to	to	ADP
biomedich-267	129	33	mechanical	mechanical	ADJ
biomedich-267	129	34	ventilation	ventilation	NOUN
biomedich-267	129	35	,	,	PUNCT
biomedich-267	129	36	putting	put	VERB
biomedich-267	129	37	these	these	DET
biomedich-267	129	38	individuals	individual	NOUN
biomedich-267	129	39	at	at	ADP
biomedich-267	129	40	high	high	ADJ
biomedich-267	129	41	risk	risk	NOUN
biomedich-267	129	42	of	of	ADP
biomedich-267	129	43	serious	serious	ADJ
biomedich-267	129	44	covid-19	covid-19	PROPN
biomedich-267	129	45	disease	disease	NOUN
biomedich-267	129	46	and	and	CCONJ
biomedich-267	129	47	mortality	mortality	NOUN
biomedich-267	129	48	.	.	PUNCT
biomedich-267	130	1	also	also	ADV
biomedich-267	130	2	,	,	PUNCT
biomedich-267	130	3	obesity	obesity	NOUN
biomedich-267	130	4	can	can	AUX
biomedich-267	130	5	lead	lead	VERB
biomedich-267	130	6	to	to	ADP
biomedich-267	130	7	other	other	ADJ
biomedich-267	130	8	complications	complication	NOUN
biomedich-267	130	9	,	,	PUNCT
biomedich-267	130	10	such	such	ADJ
biomedich-267	130	11	as	as	ADP
biomedich-267	130	12	renal	renal	ADJ
biomedich-267	130	13	failure	failure	NOUN
biomedich-267	130	14	,	,	PUNCT
biomedich-267	130	15	cardiovascular	cardiovascular	ADJ
biomedich-267	130	16	disease	disease	NOUN
biomedich-267	130	17	,	,	PUNCT
biomedich-267	130	18	hypertension	hypertension	NOUN
biomedich-267	130	19	,	,	PUNCT
biomedich-267	130	20	and	and	CCONJ
biomedich-267	130	21	vascular	vascular	ADJ
biomedich-267	130	22	injury	injury	NOUN
biomedich-267	130	23	,	,	PUNCT
biomedich-267	130	24	further	far	ADV
biomedich-267	130	25	speeding	speed	VERB
biomedich-267	130	26	up	up	ADP
biomedich-267	130	27	the	the	DET
biomedich-267	130	28	negative	negative	ADJ
biomedich-267	130	29	clinical	clinical	ADJ
biomedich-267	130	30	outcomes	outcome	NOUN
biomedich-267	130	31	of	of	ADP
biomedich-267	130	32	covid-19	covid-19	PROPN
biomedich-267	130	33	.	.	PUNCT
biomedich-267	131	1	obese	obese	ADJ
biomedich-267	131	2	individuals	individual	NOUN
biomedich-267	131	3	should	should	AUX
biomedich-267	131	4	be	be	AUX
biomedich-267	131	5	protected	protect	VERB
biomedich-267	131	6	from	from	ADP
biomedich-267	131	7	possible	possible	ADJ
biomedich-267	131	8	viral	viral	ADJ
biomedich-267	131	9	exposure	exposure	NOUN
biomedich-267	131	10	to	to	ADP
biomedich-267	131	11	sars	sar	NOUN
biomedich-267	131	12	-	-	PUNCT
biomedich-267	131	13	cov-2	cov-2	NOUN
biomedich-267	131	14	with	with	ADP
biomedich-267	131	15	compulsory	compulsory	ADJ
biomedich-267	131	16	safety	safety	NOUN
biomedich-267	131	17	devices	device	NOUN
biomedich-267	131	18	and	and	CCONJ
biomedich-267	131	19	social	social	ADJ
biomedich-267	131	20	distancing	distancing	NOUN
biomedich-267	131	21	considerations	consideration	NOUN
biomedich-267	131	22	(	(	PUNCT
biomedich-267	131	23	caci	caci	NOUN
biomedich-267	131	24	et	et	PROPN
biomedich-267	131	25	al	al	PROPN
biomedich-267	131	26	.	.	PROPN
biomedich-267	131	27	,	,	PUNCT
biomedich-267	131	28	2020	2020	NUM
biomedich-267	131	29	)	)	PUNCT
biomedich-267	131	30	.	.	PUNCT
biomedich-267	132	1	it	it	PRON
biomedich-267	132	2	is	be	AUX
biomedich-267	132	3	stated	state	VERB
biomedich-267	132	4	that	that	SCONJ
biomedich-267	132	5	people	people	NOUN
biomedich-267	132	6	with	with	ADP
biomedich-267	132	7	obesity	obesity	NOUN
biomedich-267	132	8	or	or	CCONJ
biomedich-267	132	9	overweight	overweight	NOUN
biomedich-267	132	10	are	be	AUX
biomedich-267	132	11	less	less	ADV
biomedich-267	132	12	involved	involve	VERB
biomedich-267	132	13	.	.	PUNCT
biomedich-267	133	1	moreover	moreover	ADV
biomedich-267	133	2	,	,	PUNCT
biomedich-267	133	3	community	community	NOUN
biomedich-267	133	4	health	health	NOUN
biomedich-267	133	5	centres	centre	NOUN
biomedich-267	133	6	,	,	PUNCT
biomedich-267	133	7	gyms	gym	NOUN
biomedich-267	133	8	,	,	PUNCT
biomedich-267	133	9	swimming	swimming	NOUN
biomedich-267	133	10	pools	pool	NOUN
biomedich-267	133	11	,	,	PUNCT
biomedich-267	133	12	and	and	CCONJ
biomedich-267	133	13	parks	park	NOUN
biomedich-267	133	14	have	have	AUX
biomedich-267	133	15	been	be	AUX
biomedich-267	133	16	closed	close	VERB
biomedich-267	133	17	by	by	ADP
biomedich-267	133	18	law	law	NOUN
biomedich-267	133	19	in	in	ADP
biomedich-267	133	20	many	many	ADJ
biomedich-267	133	21	countries	country	NOUN
biomedich-267	133	22	as	as	ADP
biomedich-267	133	23	part	part	NOUN
biomedich-267	133	24	of	of	ADP
biomedich-267	133	25	their	their	PRON
biomedich-267	133	26	quarantine	quarantine	NOUN
biomedich-267	133	27	policy	policy	NOUN
biomedich-267	133	28	during	during	ADP
biomedich-267	133	29	the	the	DET
biomedich-267	133	30	covid-19	covid-19	PROPN
biomedich-267	133	31	pandemic	pandemic	NOUN
biomedich-267	133	32	.	.	PUNCT
biomedich-267	134	1	such	such	ADJ
biomedich-267	134	2	diet	diet	NOUN
biomedich-267	134	3	and	and	CCONJ
biomedich-267	134	4	social	social	ADJ
biomedich-267	134	5	shifts	shift	NOUN
biomedich-267	134	6	may	may	AUX
biomedich-267	134	7	have	have	AUX
biomedich-267	134	8	led	lead	VERB
biomedich-267	134	9	to	to	ADP
biomedich-267	134	10	a	a	DET
biomedich-267	134	11	rise	rise	NOUN
biomedich-267	134	12	in	in	ADP
biomedich-267	134	13	body	body	NOUN
biomedich-267	134	14	weight	weight	NOUN
biomedich-267	134	15	in	in	ADP
biomedich-267	134	16	individuals	individual	NOUN
biomedich-267	134	17	with	with	ADP
biomedich-267	134	18	obesity	obesity	NOUN
biomedich-267	134	19	and	and	CCONJ
biomedich-267	134	20	the	the	DET
biomedich-267	134	21	general	general	ADJ
biomedich-267	134	22	population	population	NOUN
biomedich-267	134	23	(	(	PUNCT
biomedich-267	134	24	lim	lim	PROPN
biomedich-267	134	25	et	et	PROPN
biomedich-267	134	26	al	al	PROPN
biomedich-267	134	27	.	.	PROPN
biomedich-267	134	28	,	,	PUNCT
biomedich-267	134	29	2020	2020	NUM
biomedich-267	134	30	)	)	PUNCT
biomedich-267	134	31	.	.	PUNCT
biomedich-267	135	1	many	many	ADJ
biomedich-267	135	2	variables	variable	NOUN
biomedich-267	135	3	could	could	AUX
biomedich-267	135	4	be	be	AUX
biomedich-267	135	5	involved	involve	VERB
biomedich-267	135	6	in	in	ADP
biomedich-267	135	7	the	the	DET
biomedich-267	135	8	worsening	worsening	NOUN
biomedich-267	135	9	of	of	ADP
biomedich-267	135	10	covid-19	covid-19	PROPN
biomedich-267	135	11	obesity	obesity	NOUN
biomedich-267	135	12	.	.	PUNCT
biomedich-267	136	1	obesity	obesity	NOUN
biomedich-267	136	2	can	can	AUX
biomedich-267	136	3	increase	increase	VERB
biomedich-267	136	4	the	the	DET
biomedich-267	136	5	expression	expression	NOUN
biomedich-267	136	6	in	in	ADP
biomedich-267	136	7	the	the	DET
biomedich-267	136	8	bronchus	bronchus	NOUN
biomedich-267	136	9	and	and	CCONJ
biomedich-267	136	10	blood	blood	NOUN
biomedich-267	136	11	of	of	ADP
biomedich-267	136	12	ace2	ace2	PROPN
biomedich-267	136	13	and	and	CCONJ
biomedich-267	136	14	cd147	cd147	PROPN
biomedich-267	136	15	-	-	PUNCT
biomedich-267	136	16	related	relate	VERB
biomedich-267	136	17	genes	gene	NOUN
biomedich-267	136	18	,	,	PUNCT
biomedich-267	136	19	while	while	SCONJ
biomedich-267	136	20	the	the	DET
biomedich-267	136	21	latter	latter	ADJ
biomedich-267	136	22	are	be	AUX
biomedich-267	136	23	sars	sar	NOUN
biomedich-267	136	24	-	-	PUNCT
biomedich-267	136	25	cov-2	cov-2	PART
biomedich-267	136	26	receptors	receptor	NOUN
biomedich-267	136	27	that	that	PRON
biomedich-267	136	28	invade	invade	VERB
biomedich-267	136	29	(	(	PUNCT
biomedich-267	136	30	radzikowska	radzikowska	PROPN
biomedich-267	136	31	et	et	PROPN
biomedich-267	136	32	al	al	PROPN
biomedich-267	136	33	.	.	PROPN
biomedich-267	136	34	,	,	PUNCT
biomedich-267	136	35	2020	2020	NUM
biomedich-267	136	36	)	)	PUNCT
biomedich-267	136	37	.	.	PUNCT
biomedich-267	137	1	this	this	PRON
biomedich-267	137	2	would	would	AUX
biomedich-267	137	3	make	make	VERB
biomedich-267	137	4	obese	obese	ADJ
biomedich-267	137	5	subjects	subject	NOUN
biomedich-267	137	6	more	more	ADV
biomedich-267	137	7	vulnerable	vulnerable	ADJ
biomedich-267	137	8	to	to	ADP
biomedich-267	137	9	infection	infection	NOUN
biomedich-267	137	10	and	and	CCONJ
biomedich-267	137	11	could	could	AUX
biomedich-267	137	12	,	,	PUNCT
biomedich-267	137	13	to	to	ADP
biomedich-267	137	14	some	some	DET
biomedich-267	137	15	degree	degree	NOUN
biomedich-267	137	16	,	,	PUNCT
biomedich-267	137	17	explain	explain	VERB
biomedich-267	137	18	the	the	DET
biomedich-267	137	19	higher	high	ADJ
biomedich-267	137	20	positive	positive	ADJ
biomedich-267	137	21	sars	sar	NOUN
biomedich-267	137	22	-	-	PUNCT
biomedich-267	137	23	cov-2	cov-2	PART
biomedich-267	137	24	test	test	NOUN
biomedich-267	137	25	rate	rate	NOUN
biomedich-267	137	26	.	.	PUNCT
biomedich-267	138	1	obesity	obesity	NOUN
biomedich-267	138	2	and	and	CCONJ
biomedich-267	138	3	concomitant	concomitant	ADJ
biomedich-267	138	4	metabolic	metabolic	NOUN
biomedich-267	138	5	syndrome	syndrome	NOUN
biomedich-267	138	6	can	can	AUX
biomedich-267	138	7	cause	cause	VERB
biomedich-267	138	8	possible	possible	ADJ
biomedich-267	138	9	harm	harm	NOUN
biomedich-267	138	10	to	to	ADP
biomedich-267	138	11	the	the	DET
biomedich-267	138	12	function	function	NOUN
biomedich-267	138	13	of	of	ADP
biomedich-267	138	14	the	the	DET
biomedich-267	138	15	organ	organ	NOUN
biomedich-267	138	16	,	,	PUNCT
biomedich-267	138	17	making	make	VERB
biomedich-267	138	18	it	it	PRON
biomedich-267	138	19	more	more	ADV
biomedich-267	138	20	vulnerable	vulnerable	ADJ
biomedich-267	138	21	to	to	ADP
biomedich-267	138	22	failure	failure	NOUN
biomedich-267	138	23	in	in	ADP
biomedich-267	138	24	the	the	DET
biomedich-267	138	25	lungs	lung	NOUN
biomedich-267	138	26	,	,	PUNCT
biomedich-267	138	27	kidneys	kidney	NOUN
biomedich-267	138	28	,	,	PUNCT
biomedich-267	138	29	and	and	CCONJ
biomedich-267	138	30	other	other	ADJ
biomedich-267	138	31	organs	organ	NOUN
biomedich-267	138	32	(	(	PUNCT
biomedich-267	138	33	yang	yang	PROPN
biomedich-267	138	34	et	et	PROPN
biomedich-267	138	35	al	al	PROPN
biomedich-267	138	36	.	.	PROPN
biomedich-267	138	37	,	,	PUNCT
biomedich-267	138	38	2020	2020	NUM
biomedich-267	138	39	)	)	PUNCT
biomedich-267	138	40	.	.	PUNCT
biomedich-267	139	1	however	however	ADV
biomedich-267	139	2	,	,	PUNCT
biomedich-267	139	3	in	in	ADP
biomedich-267	139	4	some	some	DET
biomedich-267	139	5	acute	acute	ADJ
biomedich-267	139	6	diseases	disease	NOUN
biomedich-267	139	7	,	,	PUNCT
biomedich-267	139	8	including	include	VERB
biomedich-267	139	9	acute	acute	ADJ
biomedich-267	139	10	respiratory	respiratory	ADJ
biomedich-267	139	11	distress	distress	NOUN
biomedich-267	139	12	syndrome	syndrome	NOUN
biomedich-267	139	13	,	,	PUNCT
biomedich-267	139	14	where	where	SCONJ
biomedich-267	139	15	patients	patient	NOUN
biomedich-267	139	16	with	with	ADP
biomedich-267	139	17	obesity	obesity	NOUN
biomedich-267	139	18	may	may	AUX
biomedich-267	139	19	have	have	VERB
biomedich-267	139	20	better	well	ADJ
biomedich-267	139	21	outcomes	outcome	NOUN
biomedich-267	139	22	,	,	PUNCT
biomedich-267	139	23	some	some	PRON
biomedich-267	139	24	have	have	AUX
biomedich-267	139	25	proposed	propose	VERB
biomedich-267	139	26	an	an	DET
biomedich-267	139	27	obesity	obesity	NOUN
biomedich-267	139	28	paradox	paradox	NOUN
biomedich-267	139	29	;	;	PUNCT
biomedich-267	139	30	it	it	PRON
biomedich-267	139	31	is	be	AUX
biomedich-267	139	32	uncertain	uncertain	ADJ
biomedich-267	139	33	if	if	SCONJ
biomedich-267	139	34	this	this	DET
biomedich-267	139	35	phenomenon	phenomenon	NOUN
biomedich-267	139	36	exists	exist	VERB
biomedich-267	139	37	in	in	ADP
biomedich-267	139	38	patients	patient	NOUN
biomedich-267	139	39	with	with	ADP
biomedich-267	139	40	covid-19	covid-19	PROPN
biomedich-267	139	41	(	(	PUNCT
biomedich-267	139	42	goyal	goyal	PROPN
biomedich-267	139	43	et	et	PROPN
biomedich-267	139	44	al	al	PROPN
biomedich-267	139	45	.	.	PROPN
biomedich-267	139	46	,	,	PUNCT
biomedich-267	139	47	2020	2020	NUM
biomedich-267	139	48	)	)	PUNCT
biomedich-267	139	49	.	.	PUNCT
biomedich-267	140	1	on	on	ADP
biomedich-267	140	2	the	the	DET
biomedich-267	140	3	one	one	NUM
biomedich-267	140	4	hand	hand	NOUN
biomedich-267	140	5	,	,	PUNCT
biomedich-267	140	6	emerging	emerge	VERB
biomedich-267	140	7	evidence	evidence	NOUN
biomedich-267	140	8	indicates	indicate	VERB
biomedich-267	140	9	that	that	SCONJ
biomedich-267	140	10	obesity	obesity	NOUN
biomedich-267	140	11	is	be	AUX
biomedich-267	140	12	a	a	DET
biomedich-267	140	13	risk	risk	NOUN
biomedich-267	140	14	factor	factor	NOUN
biomedich-267	140	15	in	in	ADP
biomedich-267	140	16	adults	adult	NOUN
biomedich-267	140	17	for	for	ADP
biomedich-267	140	18	a	a	DET
biomedich-267	140	19	more	more	ADV
biomedich-267	140	20	extreme	extreme	ADJ
biomedich-267	140	21	and	and	CCONJ
biomedich-267	140	22	complicated	complicated	ADJ
biomedich-267	140	23	course	course	NOUN
biomedich-267	140	24	of	of	ADP
biomedich-267	140	25	covid-19	covid-19	PROPN
biomedich-267	140	26	.	.	PUNCT
biomedich-267	141	1	on	on	ADP
biomedich-267	141	2	the	the	DET
biomedich-267	141	3	other	other	ADJ
biomedich-267	141	4	hand	hand	NOUN
biomedich-267	141	5	,	,	PUNCT
biomedich-267	141	6	the	the	DET
biomedich-267	141	7	health	health	NOUN
biomedich-267	141	8	emergency	emergency	NOUN
biomedich-267	141	9	triggered	trigger	VERB
biomedich-267	141	10	by	by	ADP
biomedich-267	141	11	the	the	DET
biomedich-267	141	12	epidemic	epidemic	NOUN
biomedich-267	141	13	diverts	divert	VERB
biomedich-267	141	14	attention	attention	NOUN
biomedich-267	141	15	to	to	ADP
biomedich-267	141	16	infectious	infectious	ADJ
biomedich-267	141	17	diseases	disease	NOUN
biomedich-267	141	18	from	from	ADP
biomedich-267	141	19	preventing	prevent	VERB
biomedich-267	141	20	and	and	CCONJ
biomedich-267	141	21	treating	treat	VERB
biomedich-267	141	22	non	non	ADJ
biomedich-267	141	23	-	-	ADJ
biomedich-267	141	24	communicable	communicable	ADJ
biomedich-267	141	25	chronic	chronic	ADJ
biomedich-267	141	26	diseases	disease	NOUN
biomedich-267	141	27	(	(	PUNCT
biomedich-267	141	28	dicker	dicker	NOUN
biomedich-267	141	29	et	et	PROPN
biomedich-267	141	30	al	al	PROPN
biomedich-267	141	31	.	.	PROPN
biomedich-267	141	32	,	,	PUNCT
biomedich-267	141	33	2020	2020	NUM
biomedich-267	141	34	)	)	PUNCT
biomedich-267	141	35	.	.	PUNCT
biomedich-267	142	1	most	most	ADJ
biomedich-267	142	2	covid-19	covid-19	PROPN
biomedich-267	142	3	patients	patient	NOUN
biomedich-267	142	4	die	die	VERB
biomedich-267	142	5	due	due	ADP
biomedich-267	142	6	to	to	ADP
biomedich-267	142	7	covid-19	covid-19	PROPN
biomedich-267	142	8	pneumonia	pneumonia	NOUN
biomedich-267	142	9	after	after	ADP
biomedich-267	142	10	requiring	require	VERB
biomedich-267	142	11	artificial	artificial	ADJ
biomedich-267	142	12	ventilation	ventilation	NOUN
biomedich-267	142	13	for	for	ADP
biomedich-267	142	14	hypoxemic	hypoxemic	ADJ
biomedich-267	142	15	respiratory	respiratory	ADJ
biomedich-267	142	16	failure	failure	NOUN
biomedich-267	142	17	.	.	PUNCT
biomedich-267	143	1	emerging	emerge	VERB
biomedich-267	143	2	covid-19	covid-19	PROPN
biomedich-267	143	3	lung	lung	NOUN
biomedich-267	143	4	post	post	ADJ
biomedich-267	143	5	-	-	ADJ
biomedich-267	143	6	mortem	mortem	ADJ
biomedich-267	143	7	histopathology	histopathology	NOUN
biomedich-267	143	8	provides	provide	VERB
biomedich-267	143	9	insights	insight	NOUN
biomedich-267	143	10	into	into	ADP
biomedich-267	143	11	the	the	DET
biomedich-267	143	12	underlying	underlie	VERB
biomedich-267	143	13	pathophysiology	pathophysiology	NOUN
biomedich-267	143	14	.	.	PUNCT
biomedich-267	144	1	in	in	ADP
biomedich-267	144	2	short	short	ADJ
biomedich-267	144	3	,	,	PUNCT
biomedich-267	144	4	there	there	PRON
biomedich-267	144	5	is	be	VERB
biomedich-267	144	6	evidence	evidence	NOUN
biomedich-267	144	7	of	of	ADP
biomedich-267	144	8	diffuse	diffuse	ADJ
biomedich-267	144	9	alveolar	alveolar	ADJ
biomedich-267	144	10	injury	injury	NOUN
biomedich-267	144	11	,	,	PUNCT
biomedich-267	144	12	as	as	ADP
biomedich-267	144	13	in	in	ADP
biomedich-267	144	14	other	other	ADJ
biomedich-267	144	15	types	type	NOUN
biomedich-267	144	16	of	of	ADP
biomedich-267	144	17	viral	viral	ADJ
biomedich-267	144	18	pneumonia	pneumonia	NOUN
biomedich-267	144	19	,	,	PUNCT
biomedich-267	144	20	but	but	CCONJ
biomedich-267	144	21	sometimes	sometimes	ADV
biomedich-267	144	22	this	this	PRON
biomedich-267	144	23	is	be	AUX
biomedich-267	144	24	patchy	patchy	ADJ
biomedich-267	144	25	(	(	PUNCT
biomedich-267	144	26	lockhart	lockhart	PROPN
biomedich-267	144	27	et	et	PROPN
biomedich-267	144	28	al	al	PROPN
biomedich-267	144	29	.	.	PROPN
biomedich-267	144	30	,	,	PUNCT
biomedich-267	144	31	2020	2020	NUM
biomedich-267	144	32	)	)	PUNCT
biomedich-267	144	33	.	.	PUNCT
biomedich-267	145	1	therefore	therefore	ADV
biomedich-267	145	2	,	,	PUNCT
biomedich-267	145	3	it	it	PRON
biomedich-267	145	4	is	be	AUX
biomedich-267	145	5	important	important	ADJ
biomedich-267	145	6	to	to	PART
biomedich-267	145	7	collect	collect	VERB
biomedich-267	145	8	anthropometric	anthropometric	ADJ
biomedich-267	145	9	information	information	NOUN
biomedich-267	145	10	for	for	ADP
biomedich-267	145	11	patients	patient	NOUN
biomedich-267	145	12	with	with	ADP
biomedich-267	145	13	covid-19	covid-19	PROPN
biomedich-267	145	14	because	because	SCONJ
biomedich-267	145	15	of	of	ADP
biomedich-267	145	16	the	the	DET
biomedich-267	145	17	potentially	potentially	ADV
biomedich-267	145	18	critical	critical	ADJ
biomedich-267	145	19	role	role	NOUN
biomedich-267	145	20	of	of	ADP
biomedich-267	145	21	body	body	NOUN
biomedich-267	145	22	weight	weight	NOUN
biomedich-267	145	23	or	or	CCONJ
biomedich-267	145	24	adiposity	adiposity	NOUN
biomedich-267	145	25	in	in	ADP
biomedich-267	145	26	determining	determine	VERB
biomedich-267	145	27	the	the	DET
biomedich-267	145	28	incidence	incidence	NOUN
biomedich-267	145	29	and	and	CCONJ
biomedich-267	145	30	severity	severity	NOUN
biomedich-267	145	31	of	of	ADP
biomedich-267	145	32	pneumonia	pneumonia	NOUN
biomedich-267	145	33	(	(	PUNCT
biomedich-267	145	34	and	and	CCONJ
biomedich-267	145	35	probably	probably	ADV
biomedich-267	145	36	other	other	ADJ
biomedich-267	145	37	complications	complication	NOUN
biomedich-267	145	38	)	)	PUNCT
biomedich-267	145	39	(	(	PUNCT
biomedich-267	145	40	stefan	stefan	PROPN
biomedich-267	145	41	et	et	PROPN
biomedich-267	145	42	al	al	PROPN
biomedich-267	145	43	.	.	PROPN
biomedich-267	145	44	,	,	PUNCT
biomedich-267	145	45	2020	2020	NUM
biomedich-267	145	46	)	)	PUNCT
biomedich-267	145	47	.	.	PUNCT
biomedich-267	146	1	therefore	therefore	ADV
biomedich-267	146	2	,	,	PUNCT
biomedich-267	146	3	special	special	ADJ
biomedich-267	146	4	medical	medical	ADJ
biomedich-267	146	5	care	care	NOUN
biomedich-267	146	6	and	and	CCONJ
biomedich-267	146	7	effective	effective	ADJ
biomedich-267	146	8	intervention	intervention	NOUN
biomedich-267	146	9	should	should	AUX
biomedich-267	146	10	be	be	AUX
biomedich-267	146	11	undertaken	undertake	VERB
biomedich-267	146	12	during	during	ADP
biomedich-267	146	13	hospitalization	hospitalization	NOUN
biomedich-267	146	14	and	and	CCONJ
biomedich-267	146	15	later	later	ADV
biomedich-267	146	16	clinical	clinical	ADJ
biomedich-267	146	17	follow	follow	NOUN
biomedich-267	146	18	-	-	PUNCT
biomedich-267	146	19	up	up	NOUN
biomedich-267	146	20	in	in	ADP
biomedich-267	146	21	obesity	obesity	NOUN
biomedich-267	146	22	patients	patient	NOUN
biomedich-267	146	23	with	with	ADP
biomedich-267	146	24	covid-19	covid-19	PROPN
biomedich-267	146	25	,	,	PUNCT
biomedich-267	146	26	especially	especially	ADV
biomedich-267	146	27	those	those	PRON
biomedich-267	146	28	with	with	ADP
biomedich-267	146	29	additional	additional	ADJ
biomedich-267	146	30	comorbidities	comorbiditie	NOUN
biomedich-267	146	31	(	(	PUNCT
biomedich-267	146	32	kang	kang	PROPN
biomedich-267	146	33	et	et	PROPN
biomedich-267	146	34	al	al	PROPN
biomedich-267	146	35	.	.	PROPN
biomedich-267	146	36	,	,	PUNCT
biomedich-267	146	37	2020	2020	NUM
biomedich-267	146	38	)	)	PUNCT
biomedich-267	146	39	.	.	PUNCT
biomedich-267	147	1	it	it	PRON
biomedich-267	147	2	is	be	AUX
biomedich-267	147	3	unclear	unclear	ADJ
biomedich-267	147	4	if	if	SCONJ
biomedich-267	147	5	this	this	PRON
biomedich-267	147	6	is	be	AUX
biomedich-267	147	7	driven	drive	VERB
biomedich-267	147	8	by	by	ADP
biomedich-267	147	9	these	these	DET
biomedich-267	147	10	populations	population	NOUN
biomedich-267	147	11	'	'	PART
biomedich-267	147	12	higher	high	ADJ
biomedich-267	147	13	prevalence	prevalence	NOUN
biomedich-267	147	14	and	and	CCONJ
biomedich-267	147	15	risks	risk	NOUN
biomedich-267	147	16	of	of	ADP
biomedich-267	147	17	obesity	obesity	NOUN
biomedich-267	147	18	(	(	PUNCT
biomedich-267	147	19	driving	drive	VERB
biomedich-267	147	20	diabetes	diabetes	NOUN
biomedich-267	147	21	and	and	CCONJ
biomedich-267	147	22	hypertension	hypertension	NOUN
biomedich-267	147	23	)	)	PUNCT
biomedich-267	147	24	.	.	PUNCT
biomedich-267	148	1	regarding	regard	VERB
biomedich-267	148	2	progression	progression	NOUN
biomedich-267	148	3	to	to	ADP
biomedich-267	148	4	more	more	ADV
biomedich-267	148	5	extreme	extreme	ADJ
biomedich-267	148	6	severity	severity	NOUN
biomedich-267	148	7	requiring	require	VERB
biomedich-267	148	8	acute	acute	ADJ
biomedich-267	148	9	treatment	treatment	NOUN
biomedich-267	148	10	or	or	CCONJ
biomedich-267	148	11	death	death	NOUN
biomedich-267	148	12	,	,	PUNCT
biomedich-267	148	13	we	we	PRON
biomedich-267	148	14	do	do	AUX
biomedich-267	148	15	not	not	PART
biomedich-267	148	16	yet	yet	ADV
biomedich-267	148	17	have	have	VERB
biomedich-267	148	18	data	datum	NOUN
biomedich-267	148	19	on	on	ADP
biomedich-267	148	20	results	result	NOUN
biomedich-267	148	21	for	for	ADP
biomedich-267	148	22	those	those	PRON
biomedich-267	148	23	with	with	ADP
biomedich-267	148	24	obesity	obesity	NOUN
biomedich-267	148	25	and	and	CCONJ
biomedich-267	148	26	less	less	ADV
biomedich-267	148	27	severe	severe	ADJ
biomedich-267	148	28	covid-19	covid-19	PROPN
biomedich-267	148	29	disease	disease	NOUN
biomedich-267	148	30	.	.	PUNCT
biomedich-267	149	1	such	such	ADJ
biomedich-267	149	2	data	datum	NOUN
biomedich-267	149	3	would	would	AUX
biomedich-267	149	4	be	be	AUX
biomedich-267	149	5	necessary	necessary	ADJ
biomedich-267	149	6	to	to	PART
biomedich-267	149	7	fully	fully	ADV
biomedich-267	149	8	understand	understand	VERB
biomedich-267	149	9	the	the	DET
biomedich-267	149	10	risk	risk	NOUN
biomedich-267	149	11	of	of	ADP
biomedich-267	149	12	mortality	mortality	NOUN
biomedich-267	149	13	for	for	ADP
biomedich-267	149	14	those	those	PRON
biomedich-267	149	15	with	with	ADP
biomedich-267	149	16	obesity	obesity	NOUN
biomedich-267	149	17	,	,	PUNCT
biomedich-267	149	18	particularly	particularly	ADV
biomedich-267	149	19	with	with	ADP
biomedich-267	149	20	the	the	DET
biomedich-267	149	21	understanding	understanding	NOUN
biomedich-267	149	22	that	that	PRON
biomedich-267	149	23	survival	survival	NOUN
biomedich-267	149	24	of	of	ADP
biomedich-267	149	25	critical	critical	ADJ
biomedich-267	149	26	care	care	NOUN
biomedich-267	149	27	may	may	AUX
biomedich-267	149	28	be	be	AUX
biomedich-267	149	29	greater	great	ADJ
biomedich-267	149	30	for	for	ADP
biomedich-267	149	31	those	those	PRON
biomedich-267	149	32	with	with	ADP
biomedich-267	149	33	moderate	moderate	ADJ
biomedich-267	149	34	levels	level	NOUN
biomedich-267	149	35	of	of	ADP
biomedich-267	149	36	obesity	obesity	NOUN
biomedich-267	149	37	(	(	PUNCT
biomedich-267	149	38	fine	fine	INTJ
biomedich-267	149	39	et	et	PROPN
biomedich-267	149	40	al	al	PROPN
biomedich-267	149	41	.	.	PROPN
biomedich-267	149	42	,	,	PUNCT
biomedich-267	149	43	2020	2020	NUM
biomedich-267	149	44	)	)	PUNCT
biomedich-267	149	45	.	.	PUNCT
biomedich-267	150	1	absolute	absolute	ADJ
biomedich-267	150	2	and	and	CCONJ
biomedich-267	150	3	central	central	ADJ
biomedich-267	150	4	obesity	obesity	NOUN
biomedich-267	150	5	,	,	PUNCT
biomedich-267	150	6	in	in	ADP
biomedich-267	150	7	short	short	ADJ
biomedich-267	150	8	,	,	PUNCT
biomedich-267	150	9	are	be	AUX
biomedich-267	150	10	risk	risk	NOUN
biomedich-267	150	11	factors	factor	NOUN
biomedich-267	150	12	for	for	ADP
biomedich-267	150	13	hospital	hospital	NOUN
biomedich-267	150	14	admission	admission	NOUN
biomedich-267	150	15	to	to	ADP
biomedich-267	150	16	covid-19	covid-19	PROPN
biomedich-267	150	17	.	.	PUNCT
biomedich-267	151	1	even	even	ADV
biomedich-267	151	2	with	with	ADP
biomedich-267	151	3	a	a	DET
biomedich-267	151	4	moderate	moderate	ADJ
biomedich-267	151	5	weight	weight	NOUN
biomedich-267	151	6	gain	gain	NOUN
biomedich-267	151	7	,	,	PUNCT
biomedich-267	151	8	the	the	DET
biomedich-267	151	9	high	high	ADJ
biomedich-267	151	10	risk	risk	NOUN
biomedich-267	151	11	was	be	AUX
biomedich-267	151	12	evident	evident	ADJ
biomedich-267	151	13	.	.	PUNCT
biomedich-267	152	1	impaired	impair	VERB
biomedich-267	152	2	glucose	glucose	NOUN
biomedich-267	152	3	and	and	CCONJ
biomedich-267	152	4	lipid	lipid	NOUN
biomedich-267	152	5	metabolism	metabolism	NOUN
biomedich-267	152	6	may	may	AUX
biomedich-267	152	7	be	be	AUX
biomedich-267	152	8	involved	involve	VERB
biomedich-267	152	9	in	in	ADP
biomedich-267	152	10	the	the	DET
biomedich-267	152	11	mechanisms	mechanism	NOUN
biomedich-267	152	12	(	(	PUNCT
biomedich-267	152	13	hamer	hamer	NOUN
biomedich-267	152	14	et	et	PROPN
biomedich-267	152	15	al	al	PROPN
biomedich-267	152	16	.	.	PROPN
biomedich-267	152	17	,	,	PUNCT
biomedich-267	152	18	2020	2020	NUM
biomedich-267	152	19	)	)	PUNCT
biomedich-267	152	20	.	.	PUNCT
biomedich-267	153	1	figure	figure	NOUN
biomedich-267	153	2	2	2	NUM
biomedich-267	153	3	.	.	PUNCT
biomedich-267	153	4	potential	potential	ADJ
biomedich-267	153	5	pathways	pathway	NOUN
biomedich-267	153	6	that	that	PRON
biomedich-267	153	7	increase	increase	VERB
biomedich-267	153	8	the	the	DET
biomedich-267	153	9	risk	risk	NOUN
biomedich-267	153	10	of	of	ADP
biomedich-267	153	11	serious	serious	ADJ
biomedich-267	153	12	covid-19	covid-19	PROPN
biomedich-267	153	13	illness	illness	NOUN
biomedich-267	153	14	and	and	CCONJ
biomedich-267	153	15	death	death	NOUN
biomedich-267	153	16	in	in	ADP
biomedich-267	153	17	individuals	individual	NOUN
biomedich-267	153	18	with	with	ADP
biomedich-267	153	19	obesity	obesity	NOUN
biomedich-267	153	20	.	.	PUNCT
biomedich-267	154	1	there	there	PRON
biomedich-267	154	2	are	be	VERB
biomedich-267	154	3	a	a	DET
biomedich-267	154	4	variety	variety	NOUN
biomedich-267	154	5	of	of	ADP
biomedich-267	154	6	possible	possible	ADJ
biomedich-267	154	7	mechanisms	mechanism	NOUN
biomedich-267	154	8	by	by	ADP
biomedich-267	154	9	which	which	PRON
biomedich-267	154	10	obesity	obesity	NOUN
biomedich-267	154	11	can	can	AUX
biomedich-267	154	12	impact	impact	VERB
biomedich-267	154	13	adverse	adverse	ADJ
biomedich-267	154	14	covid-19	covid-19	PROPN
biomedich-267	154	15	outcomes	outcome	NOUN
biomedich-267	154	16	.	.	PUNCT
biomedich-267	155	1	these	these	PRON
biomedich-267	155	2	include	include	VERB
biomedich-267	155	3	chronic	chronic	ADJ
biomedich-267	155	4	inflammation	inflammation	NOUN
biomedich-267	155	5	,	,	PUNCT
biomedich-267	155	6	respiratory	respiratory	ADJ
biomedich-267	155	7	function	function	NOUN
biomedich-267	155	8	deficiency	deficiency	NOUN
biomedich-267	155	9	,	,	PUNCT
biomedich-267	155	10	pulmonary	pulmonary	ADJ
biomedich-267	155	11	perfusion	perfusion	NOUN
biomedich-267	155	12	,	,	PUNCT
biomedich-267	155	13	practical	practical	ADJ
biomedich-267	155	14	concerns	concern	NOUN
biomedich-267	155	15	in	in	ADP
biomedich-267	155	16	critical	critical	ADJ
biomedich-267	155	17	care	care	NOUN
biomedich-267	155	18	environments	environment	NOUN
biomedich-267	155	19	when	when	SCONJ
biomedich-267	155	20	treating	treat	VERB
biomedich-267	155	21	obese	obese	ADJ
biomedich-267	155	22	patients	patient	NOUN
biomedich-267	155	23	,	,	PUNCT
biomedich-267	155	24	immune	immune	ADJ
biomedich-267	155	25	dysregulation	dysregulation	NOUN
biomedich-267	155	26	,	,	PUNCT
biomedich-267	155	27	obesity	obesity	NOUN
biomedich-267	155	28	,	,	PUNCT
biomedich-267	155	29	metabolic	metabolic	NOUN
biomedich-267	155	30	and	and	CCONJ
biomedich-267	155	31	vascular	vascular	ADJ
biomedich-267	155	32	complications	complication	NOUN
biomedich-267	155	33	,	,	PUNCT
biomedich-267	155	34	and	and	CCONJ
biomedich-267	155	35	relative	relative	ADJ
biomedich-267	155	36	decreases	decrease	NOUN
biomedich-267	155	37	in	in	ADP
biomedich-267	155	38	main	main	ADJ
biomedich-267	155	39	hormones	hormone	NOUN
biomedich-267	155	40	.	.	PUNCT
biomedich-267	156	1	tnf	tnf	PROPN
biomedich-267	156	2	-	-	PUNCT
biomedich-267	156	3	alpha	alpha	PROPN
biomedich-267	156	4	,	,	PUNCT
biomedich-267	156	5	tumour	tumour	NOUN
biomedich-267	156	6	necrosis	necrosis	NOUN
biomedich-267	156	7	factor	factor	NOUN
biomedich-267	156	8	-	-	PUNCT
biomedich-267	156	9	alpha	alpha	NOUN
biomedich-267	156	10	;	;	PUNCT
biomedich-267	156	11	frc	frc	X
biomedich-267	156	12	,	,	PUNCT
biomedich-267	156	13	residual	residual	ADJ
biomedich-267	156	14	functional	functional	ADJ
biomedich-267	156	15	potential	potential	NOUN
biomedich-267	156	16	(	(	PUNCT
biomedich-267	156	17	kwok	kwok	PROPN
biomedich-267	156	18	et	et	PROPN
biomedich-267	156	19	al	al	PROPN
biomedich-267	156	20	.	.	PROPN
biomedich-267	156	21	,2020	,2020	PROPN
biomedich-267	156	22	)	)	PUNCT
biomedich-267	156	23	.	.	PUNCT
biomedich-267	157	1	hypertesion	hypertesion	NOUN
biomedich-267	157	2	and	and	CCONJ
biomedich-267	157	3	covid-19	covid-19	PROPN
biomedich-267	157	4	pathophysiology	pathophysiology	NOUN
biomedich-267	157	5	and	and	CCONJ
biomedich-267	157	6	risk	risk	NOUN
biomedich-267	157	7	in	in	ADP
biomedich-267	157	8	patients	patient	NOUN
biomedich-267	157	9	with	with	ADP
biomedich-267	157	10	covid-19	covid-19	PROPN
biomedich-267	157	11	,	,	PUNCT
biomedich-267	157	12	a	a	DET
biomedich-267	157	13	high	high	ADJ
biomedich-267	157	14	incidence	incidence	NOUN
biomedich-267	157	15	of	of	ADP
biomedich-267	157	16	hypertension	hypertension	NOUN
biomedich-267	157	17	have	have	AUX
biomedich-267	157	18	been	be	AUX
biomedich-267	157	19	observed	observe	VERB
biomedich-267	157	20	,	,	PUNCT
biomedich-267	157	21	with	with	ADP
biomedich-267	157	22	htn	htn	PROPN
biomedich-267	157	23	likely	likely	ADV
biomedich-267	157	24	predisposing	predispose	VERB
biomedich-267	157	25	them	they	PRON
biomedich-267	157	26	to	to	ADP
biomedich-267	157	27	an	an	DET
biomedich-267	157	28	increased	increase	VERB
biomedich-267	157	29	risk	risk	NOUN
biomedich-267	157	30	of	of	ADP
biomedich-267	157	31	more	more	ADV
biomedich-267	157	32	serious	serious	ADJ
biomedich-267	157	33	illness	illness	NOUN
biomedich-267	157	34	.	.	PUNCT
biomedich-267	158	1	the	the	DET
biomedich-267	158	2	danger	danger	NOUN
biomedich-267	158	3	may	may	AUX
biomedich-267	158	4	stem	stem	VERB
biomedich-267	158	5	from	from	ADP
biomedich-267	158	6	several	several	ADJ
biomedich-267	158	7	factors	factor	NOUN
biomedich-267	158	8	.	.	PUNCT
biomedich-267	159	1	first	first	ADV
biomedich-267	159	2	,	,	PUNCT
biomedich-267	159	3	hypertension	hypertension	NOUN
biomedich-267	159	4	is	be	AUX
biomedich-267	159	5	mainly	mainly	ADV
biomedich-267	159	6	associated	associate	VERB
biomedich-267	159	7	with	with	ADP
biomedich-267	159	8	immune	immune	ADJ
biomedich-267	159	9	dysregulation	dysregulation	NOUN
biomedich-267	159	10	,	,	PUNCT
biomedich-267	159	11	which	which	PRON
biomedich-267	159	12	occurs	occur	VERB
biomedich-267	159	13	as	as	ADP
biomedich-267	159	14	higher	high	ADJ
biomedich-267	159	15	levels	level	NOUN
biomedich-267	159	16	of	of	ADP
biomedich-267	159	17	il-17	il-17	X
biomedich-267	159	18	,	,	PUNCT
biomedich-267	159	19	the	the	DET
biomedich-267	159	20	irregular	irregular	ADJ
biomedich-267	159	21	activity	activity	NOUN
biomedich-267	159	22	of	of	ADP
biomedich-267	159	23	natural	natural	ADJ
biomedich-267	159	24	killer	killer	NOUN
biomedich-267	159	25	cells	cell	NOUN
biomedich-267	159	26	,	,	PUNCT
biomedich-267	159	27	and	and	CCONJ
biomedich-267	159	28	cytotoxic	cytotoxic	ADJ
biomedich-267	159	29	defects	defect	NOUN
biomedich-267	159	30	of	of	ADP
biomedich-267	159	31	t	t	NOUN
biomedich-267	159	32	cells	cell	NOUN
biomedich-267	159	33	partially	partially	ADV
biomedich-267	159	34	reversible	reversible	ADJ
biomedich-267	159	35	by	by	ADP
biomedich-267	159	36	mineralocorticoid	mineralocorticoid	ADJ
biomedich-267	159	37	receptor	receptor	NOUN
biomedich-267	159	38	antagonists	antagonist	NOUN
biomedich-267	159	39	(	(	PUNCT
biomedich-267	159	40	shekhar	shekhar	PROPN
biomedich-267	159	41	et	et	PROPN
biomedich-267	159	42	al	al	PROPN
biomedich-267	159	43	.	.	PROPN
biomedich-267	159	44	,	,	PUNCT
biomedich-267	159	45	2020	2020	NUM
biomedich-267	159	46	)	)	PUNCT
biomedich-267	159	47	.	.	PUNCT
biomedich-267	160	1	therefore	therefore	ADV
biomedich-267	160	2	,	,	PUNCT
biomedich-267	160	3	the	the	DET
biomedich-267	160	4	initially	initially	ADV
biomedich-267	160	5	reported	report	VERB
biomedich-267	160	6	correlation	correlation	NOUN
biomedich-267	160	7	between	between	ADP
biomedich-267	160	8	hypertension	hypertension	NOUN
biomedich-267	160	9	and	and	CCONJ
biomedich-267	160	10	hospitalization	hospitalization	NOUN
biomedich-267	160	11	rates	rate	NOUN
biomedich-267	160	12	for	for	ADP
biomedich-267	160	13	covid-19	covid-19	PROPN
biomedich-267	160	14	in	in	ADP
biomedich-267	160	15	china	china	PROPN
biomedich-267	160	16	is	be	AUX
biomedich-267	160	17	not	not	PART
biomedich-267	160	18	surprising.3	surprising.3	PROPN
biomedich-267	160	19	indeed	indeed	ADV
biomedich-267	160	20	,	,	PUNCT
biomedich-267	160	21	the	the	DET
biomedich-267	160	22	50	50	NUM
biomedich-267	160	23	biology	biology	NOUN
biomedich-267	160	24	,	,	PUNCT
biomedich-267	160	25	medicine	medicine	NOUN
biomedich-267	160	26	,	,	PUNCT
biomedich-267	160	27	&	&	CCONJ
biomedich-267	160	28	natural	natural	ADJ
biomedich-267	160	29	product	product	NOUN
biomedich-267	160	30	chemistry	chemistry	NOUN
biomedich-267	160	31	12	12	NUM
biomedich-267	160	32	(	(	PUNCT
biomedich-267	160	33	1	1	NUM
biomedich-267	160	34	)	)	PUNCT
biomedich-267	160	35	,	,	PUNCT
biomedich-267	160	36	2023	2023	NUM
biomedich-267	160	37	:	:	PUNCT
biomedich-267	160	38	45	45	NUM
biomedich-267	160	39	-	-	SYM
biomedich-267	160	40	53	53	NUM
biomedich-267	160	41	proportion	proportion	NOUN
biomedich-267	160	42	of	of	ADP
biomedich-267	160	43	self	self	NOUN
biomedich-267	160	44	-	-	PUNCT
biomedich-267	160	45	reported	report	VERB
biomedich-267	160	46	hypertension	hypertension	NOUN
biomedich-267	160	47	was	be	AUX
biomedich-267	160	48	12.6	12.6	NUM
biomedich-267	160	49	%	%	NOUN
biomedich-267	160	50	in	in	ADP
biomedich-267	160	51	a	a	DET
biomedich-267	160	52	wide	wide	ADJ
biomedich-267	160	53	database	database	NOUN
biomedich-267	160	54	of	of	ADP
biomedich-267	160	55	20,982	20,982	NUM
biomedich-267	160	56	patients	patient	NOUN
biomedich-267	160	57	with	with	ADP
biomedich-267	160	58	diagnosed	diagnose	VERB
biomedich-267	160	59	covid-19	covid-19	PROPN
biomedich-267	160	60	infections	infection	NOUN
biomedich-267	160	61	and	and	CCONJ
biomedich-267	160	62	information	information	NOUN
biomedich-267	160	63	on	on	ADP
biomedich-267	160	64	underlying	underlie	VERB
biomedich-267	160	65	diseases	disease	NOUN
biomedich-267	160	66	(	(	PUNCT
biomedich-267	160	67	kreutz	kreutz	PROPN
biomedich-267	160	68	et	et	PROPN
biomedich-267	160	69	al	al	PROPN
biomedich-267	160	70	.	.	PROPN
biomedich-267	160	71	,	,	PUNCT
biomedich-267	160	72	2020	2020	NUM
biomedich-267	160	73	)	)	PUNCT
biomedich-267	160	74	.	.	PUNCT
biomedich-267	161	1	it	it	PRON
biomedich-267	161	2	is	be	AUX
biomedich-267	161	3	unknown	unknown	ADJ
biomedich-267	161	4	whether	whether	SCONJ
biomedich-267	161	5	or	or	CCONJ
biomedich-267	161	6	not	not	PART
biomedich-267	161	7	uncontrolled	uncontrolled	ADJ
biomedich-267	161	8	blood	blood	NOUN
biomedich-267	161	9	pressure	pressure	NOUN
biomedich-267	161	10	is	be	AUX
biomedich-267	161	11	a	a	DET
biomedich-267	161	12	risk	risk	NOUN
biomedich-267	161	13	factor	factor	NOUN
biomedich-267	161	14	for	for	ADP
biomedich-267	161	15	covid-19	covid-19	PROPN
biomedich-267	161	16	acquisition	acquisition	NOUN
biomedich-267	161	17	or	or	CCONJ
biomedich-267	161	18	whether	whether	SCONJ
biomedich-267	161	19	or	or	CCONJ
biomedich-267	161	20	not	not	PART
biomedich-267	161	21	controlled	control	VERB
biomedich-267	161	22	blood	blood	NOUN
biomedich-267	161	23	pressure	pressure	NOUN
biomedich-267	161	24	is	be	AUX
biomedich-267	161	25	less	less	ADJ
biomedich-267	161	26	of	of	ADP
biomedich-267	161	27	a	a	DET
biomedich-267	161	28	risk	risk	NOUN
biomedich-267	161	29	factor	factor	NOUN
biomedich-267	161	30	for	for	ADP
biomedich-267	161	31	hypertension	hypertension	NOUN
biomedich-267	161	32	patients	patient	NOUN
biomedich-267	161	33	.	.	PUNCT
biomedich-267	162	1	however	however	ADV
biomedich-267	162	2	,	,	PUNCT
biomedich-267	162	3	some	some	DET
biomedich-267	162	4	organizations	organization	NOUN
biomedich-267	162	5	have	have	AUX
biomedich-267	162	6	also	also	ADV
biomedich-267	162	7	emphasized	emphasize	VERB
biomedich-267	162	8	that	that	SCONJ
biomedich-267	162	9	blood	blood	NOUN
biomedich-267	162	10	pressure	pressure	NOUN
biomedich-267	162	11	regulation	regulation	NOUN
biomedich-267	162	12	remains	remain	VERB
biomedich-267	162	13	a	a	DET
biomedich-267	162	14	significant	significant	ADJ
biomedich-267	162	15	factor	factor	NOUN
biomedich-267	162	16	in	in	ADP
biomedich-267	162	17	minimizing	minimize	VERB
biomedich-267	162	18	the	the	DET
biomedich-267	162	19	disease	disease	NOUN
biomedich-267	162	20	burden	burden	NOUN
biomedich-267	162	21	,	,	PUNCT
biomedich-267	162	22	even	even	ADV
biomedich-267	162	23	though	though	SCONJ
biomedich-267	162	24	it	it	PRON
biomedich-267	162	25	does	do	AUX
biomedich-267	162	26	not	not	PART
biomedich-267	162	27	impact	impact	VERB
biomedich-267	162	28	the	the	DET
biomedich-267	162	29	vulnerability	vulnerability	NOUN
biomedich-267	162	30	to	to	ADP
biomedich-267	162	31	sars	sar	NOUN
biomedich-267	162	32	-	-	PUNCT
biomedich-267	162	33	cov-2	cov-2	PART
biomedich-267	162	34	viral	viral	ADJ
biomedich-267	162	35	infection	infection	NOUN
biomedich-267	162	36	(	(	PUNCT
biomedich-267	162	37	schiffrin	schiffrin	NOUN
biomedich-267	162	38	et	et	PROPN
biomedich-267	162	39	al	al	PROPN
biomedich-267	162	40	.	.	PROPN
biomedich-267	162	41	,	,	PUNCT
biomedich-267	162	42	2020	2020	NUM
biomedich-267	162	43	)	)	PUNCT
biomedich-267	162	44	.	.	PUNCT
biomedich-267	163	1	hypertension	hypertension	NOUN
biomedich-267	163	2	adversely	adversely	ADV
biomedich-267	163	3	impacts	impact	VERB
biomedich-267	163	4	the	the	DET
biomedich-267	163	5	health	health	NOUN
biomedich-267	163	6	status	status	NOUN
biomedich-267	163	7	of	of	ADP
biomedich-267	163	8	patients	patient	NOUN
biomedich-267	163	9	with	with	ADP
biomedich-267	163	10	covid-19	covid-19	PROPN
biomedich-267	163	11	.	.	PUNCT
biomedich-267	164	1	however	however	ADV
biomedich-267	164	2	,	,	PUNCT
biomedich-267	164	3	broad	broad	ADJ
biomedich-267	164	4	prevalence	prevalence	NOUN
biomedich-267	164	5	studies	study	NOUN
biomedich-267	164	6	showing	show	VERB
biomedich-267	164	7	the	the	DET
biomedich-267	164	8	effects	effect	NOUN
biomedich-267	164	9	of	of	ADP
biomedich-267	164	10	comorbid	comorbid	NOUN
biomedich-267	164	11	diabetes	diabetes	NOUN
biomedich-267	164	12	and	and	CCONJ
biomedich-267	164	13	hypertension	hypertension	NOUN
biomedich-267	164	14	are	be	AUX
biomedich-267	164	15	urgently	urgently	ADV
biomedich-267	164	16	needed	need	VERB
biomedich-267	164	17	(	(	PUNCT
biomedich-267	164	18	parveen	parveen	PROPN
biomedich-267	164	19	et	et	PROPN
biomedich-267	164	20	al	al	PROPN
biomedich-267	164	21	.	.	PROPN
biomedich-267	164	22	,	,	PUNCT
biomedich-267	164	23	2020	2020	NUM
biomedich-267	164	24	)	)	PUNCT
biomedich-267	164	25	.	.	PUNCT
biomedich-267	165	1	however	however	ADV
biomedich-267	165	2	,	,	PUNCT
biomedich-267	165	3	the	the	DET
biomedich-267	165	4	outbreak	outbreak	NOUN
biomedich-267	165	5	of	of	ADP
biomedich-267	165	6	covid-19	covid-19	PROPN
biomedich-267	165	7	may	may	AUX
biomedich-267	165	8	also	also	ADV
biomedich-267	165	9	be	be	AUX
biomedich-267	165	10	a	a	DET
biomedich-267	165	11	specific	specific	ADJ
biomedich-267	165	12	moment	moment	NOUN
biomedich-267	165	13	when	when	SCONJ
biomedich-267	165	14	specialists	specialist	NOUN
biomedich-267	165	15	in	in	ADP
biomedich-267	165	16	pulmonary	pulmonary	ADJ
biomedich-267	165	17	hypertension	hypertension	NOUN
biomedich-267	165	18	have	have	VERB
biomedich-267	165	19	to	to	PART
biomedich-267	165	20	balance	balance	VERB
biomedich-267	165	21	the	the	DET
biomedich-267	165	22	costs	cost	NOUN
biomedich-267	165	23	and	and	CCONJ
biomedich-267	165	24	benefits	benefit	NOUN
biomedich-267	165	25	of	of	ADP
biomedich-267	165	26	diagnostic	diagnostic	ADJ
biomedich-267	165	27	work	work	NOUN
biomedich-267	165	28	-	-	PUNCT
biomedich-267	165	29	up	up	NOUN
biomedich-267	165	30	,	,	PUNCT
biomedich-267	165	31	including	include	VERB
biomedich-267	165	32	possible	possible	ADJ
biomedich-267	165	33	exposure	exposure	NOUN
biomedich-267	165	34	to	to	ADP
biomedich-267	165	35	covid-19	covid-19	PROPN
biomedich-267	165	36	versus	versus	ADP
biomedich-267	165	37	the	the	DET
biomedich-267	165	38	initiation	initiation	NOUN
biomedich-267	165	39	of	of	ADP
biomedich-267	165	40	targeted	target	VERB
biomedich-267	165	41	pulmonary	pulmonary	ADJ
biomedich-267	165	42	arterial	arterial	NOUN
biomedich-267	165	43	hypertension	hypertension	NOUN
biomedich-267	165	44	therapy	therapy	NOUN
biomedich-267	165	45	in	in	ADP
biomedich-267	165	46	a	a	DET
biomedich-267	165	47	select	select	ADJ
biomedich-267	165	48	high	high	ADJ
biomedich-267	165	49	-	-	PUNCT
biomedich-267	165	50	risk	risk	NOUN
biomedich-267	165	51	,	,	PUNCT
biomedich-267	165	52	high	high	ADJ
biomedich-267	165	53	probability	probability	NOUN
biomedich-267	165	54	world	world	NOUN
biomedich-267	165	55	symposium	symposium	NOUN
biomedich-267	165	56	pulmonary	pulmonary	ADJ
biomedich-267	165	57	hypertension	hypertension	NOUN
biomedich-267	165	58	group	group	NOUN
biomedich-267	165	59	1	1	NUM
biomedich-267	165	60	patient	patient	NOUN
biomedich-267	165	61	with	with	ADP
biomedich-267	165	62	pulmonary	pulmonary	ADJ
biomedich-267	165	63	arterial	arterial	NOUN
biomedich-267	165	64	hypertension	hypertension	NOUN
biomedich-267	165	65	(	(	PUNCT
biomedich-267	165	66	rayan	rayan	PROPN
biomedich-267	165	67	et	et	PROPN
biomedich-267	165	68	al	al	PROPN
biomedich-267	165	69	.	.	PROPN
biomedich-267	165	70	,	,	PUNCT
biomedich-267	165	71	2020	2020	NUM
biomedich-267	165	72	)	)	PUNCT
biomedich-267	165	73	.	.	PUNCT
biomedich-267	166	1	a	a	DET
biomedich-267	166	2	severe	severe	ADJ
biomedich-267	166	3	and	and	CCONJ
biomedich-267	166	4	possibly	possibly	ADV
biomedich-267	166	5	fatal	fatal	ADJ
biomedich-267	166	6	manifestation	manifestation	NOUN
biomedich-267	166	7	of	of	ADP
biomedich-267	166	8	covid-19	covid-19	PROPN
biomedich-267	166	9	is	be	AUX
biomedich-267	166	10	cardiac	cardiac	ADJ
biomedich-267	166	11	involvement	involvement	NOUN
biomedich-267	166	12	and	and	CCONJ
biomedich-267	166	13	sars	sar	NOUN
biomedich-267	166	14	-	-	PUNCT
biomedich-267	166	15	cov-2	cov-2	ADV
biomedich-267	166	16	-	-	PUNCT
biomedich-267	166	17	associated	associate	VERB
biomedich-267	166	18	myocarditis	myocarditis	PROPN
biomedich-267	166	19	.	.	PUNCT
biomedich-267	167	1	hypertension	hypertension	NOUN
biomedich-267	167	2	treatment	treatment	NOUN
biomedich-267	167	3	with	with	ADP
biomedich-267	167	4	a	a	DET
biomedich-267	167	5	drug	drug	NOUN
biomedich-267	167	6	that	that	PRON
biomedich-267	167	7	can	can	AUX
biomedich-267	167	8	minimize	minimize	VERB
biomedich-267	167	9	inflammation	inflammation	NOUN
biomedich-267	167	10	in	in	ADP
biomedich-267	167	11	viral	viral	ADJ
biomedich-267	167	12	myocarditis	myocarditis	NOUN
biomedich-267	167	13	and	and	CCONJ
biomedich-267	167	14	does	do	AUX
biomedich-267	167	15	not	not	PART
biomedich-267	167	16	pose	pose	VERB
biomedich-267	167	17	a	a	DET
biomedich-267	167	18	theoretical	theoretical	ADJ
biomedich-267	167	19	risk	risk	NOUN
biomedich-267	167	20	of	of	ADP
biomedich-267	167	21	encouraging	encourage	VERB
biomedich-267	167	22	the	the	DET
biomedich-267	167	23	proliferation	proliferation	NOUN
biomedich-267	167	24	of	of	ADP
biomedich-267	167	25	covid-19	covid-19	PROPN
biomedich-267	167	26	would	would	AUX
biomedich-267	167	27	appear	appear	VERB
biomedich-267	167	28	to	to	PART
biomedich-267	167	29	be	be	AUX
biomedich-267	167	30	a	a	DET
biomedich-267	167	31	sensible	sensible	ADJ
biomedich-267	167	32	strategy	strategy	NOUN
biomedich-267	167	33	for	for	ADP
biomedich-267	167	34	improving	improve	VERB
biomedich-267	167	35	patient	patient	ADJ
biomedich-267	167	36	outcomes	outcome	NOUN
biomedich-267	167	37	(	(	PUNCT
biomedich-267	167	38	antwi	antwi	ADJ
biomedich-267	167	39	-	-	PUNCT
biomedich-267	167	40	amoabeng	amoabeng	NOUN
biomedich-267	167	41	et	et	PROPN
biomedich-267	167	42	al	al	PROPN
biomedich-267	167	43	.	.	PROPN
biomedich-267	167	44	,	,	PUNCT
biomedich-267	167	45	2020	2020	NUM
biomedich-267	167	46	)	)	PUNCT
biomedich-267	167	47	.	.	PUNCT
biomedich-267	168	1	recent	recent	ADJ
biomedich-267	168	2	studies	study	NOUN
biomedich-267	168	3	have	have	AUX
biomedich-267	168	4	shown	show	VERB
biomedich-267	168	5	that	that	SCONJ
biomedich-267	168	6	among	among	ADP
biomedich-267	168	7	patients	patient	NOUN
biomedich-267	168	8	with	with	ADP
biomedich-267	168	9	covid-19	covid-19	PROPN
biomedich-267	168	10	,	,	PUNCT
biomedich-267	168	11	arterial	arterial	ADJ
biomedich-267	168	12	hypertension	hypertension	NOUN
biomedich-267	168	13	,	,	PUNCT
biomedich-267	168	14	diabetes	diabetes	NOUN
biomedich-267	168	15	,	,	PUNCT
biomedich-267	168	16	cardiovascular	cardiovascular	ADJ
biomedich-267	168	17	disorders	disorder	NOUN
biomedich-267	168	18	,	,	PUNCT
biomedich-267	168	19	and	and	CCONJ
biomedich-267	168	20	chronic	chronic	ADJ
biomedich-267	168	21	obstructive	obstructive	ADJ
biomedich-267	168	22	pulmonary	pulmonary	ADJ
biomedich-267	168	23	disease	disease	NOUN
biomedich-267	168	24	are	be	AUX
biomedich-267	168	25	prevalent	prevalent	ADJ
biomedich-267	168	26	.	.	PUNCT
biomedich-267	169	1	research	research	NOUN
biomedich-267	169	2	on	on	ADP
biomedich-267	169	3	the	the	DET
biomedich-267	169	4	outcome	outcome	NOUN
biomedich-267	169	5	of	of	ADP
biomedich-267	169	6	these	these	DET
biomedich-267	169	7	patients	patient	NOUN
biomedich-267	169	8	is	be	AUX
biomedich-267	169	9	scarce	scarce	ADJ
biomedich-267	169	10	,	,	PUNCT
biomedich-267	169	11	and	and	CCONJ
biomedich-267	169	12	there	there	PRON
biomedich-267	169	13	is	be	VERB
biomedich-267	169	14	very	very	ADV
biomedich-267	169	15	little	little	ADJ
biomedich-267	169	16	evidence	evidence	NOUN
biomedich-267	169	17	.	.	PUNCT
biomedich-267	170	1	nevertheless	nevertheless	ADV
biomedich-267	170	2	,	,	PUNCT
biomedich-267	170	3	hypertension	hypertension	NOUN
biomedich-267	170	4	is	be	AUX
biomedich-267	170	5	one	one	NUM
biomedich-267	170	6	of	of	ADP
biomedich-267	170	7	covid-19	covid-19	PROPN
biomedich-267	170	8	's	's	PART
biomedich-267	170	9	most	most	ADV
biomedich-267	170	10	important	important	ADJ
biomedich-267	170	11	risk	risk	NOUN
biomedich-267	170	12	factors	factor	NOUN
biomedich-267	170	13	.	.	PUNCT
biomedich-267	171	1	the	the	DET
biomedich-267	171	2	relationship	relationship	NOUN
biomedich-267	171	3	between	between	ADP
biomedich-267	171	4	hypertension	hypertension	NOUN
biomedich-267	171	5	and	and	CCONJ
biomedich-267	171	6	negative	negative	ADJ
biomedich-267	171	7	outcomes	outcome	NOUN
biomedich-267	171	8	is	be	AUX
biomedich-267	171	9	still	still	ADV
biomedich-267	171	10	questionable	questionable	ADJ
biomedich-267	171	11	(	(	PUNCT
biomedich-267	171	12	tadic	tadic	ADJ
biomedich-267	171	13	et	et	PROPN
biomedich-267	171	14	al	al	PROPN
biomedich-267	171	15	.	.	PROPN
biomedich-267	171	16	,	,	PUNCT
biomedich-267	171	17	2020	2020	NUM
biomedich-267	171	18	)	)	PUNCT
biomedich-267	171	19	.	.	PUNCT
biomedich-267	172	1	renin	renin	ADJ
biomedich-267	172	2	-	-	PUNCT
biomedich-267	172	3	angiotensin	angiotensin	NOUN
biomedich-267	172	4	system	system	NOUN
biomedich-267	172	5	(	(	PUNCT
biomedich-267	172	6	ras	ras	NOUN
biomedich-267	172	7	)	)	PUNCT
biomedich-267	172	8	dysfunction	dysfunction	NOUN
biomedich-267	172	9	has	have	AUX
biomedich-267	172	10	been	be	AUX
biomedich-267	172	11	identified	identify	VERB
biomedich-267	172	12	in	in	ADP
biomedich-267	172	13	patients	patient	NOUN
biomedich-267	172	14	with	with	ADP
biomedich-267	172	15	coronavirus	coronavirus	NOUN
biomedich-267	172	16	infection	infection	NOUN
biomedich-267	172	17	(	(	PUNCT
biomedich-267	172	18	covid-19	covid-19	PROPN
biomedich-267	172	19	)	)	PUNCT
biomedich-267	172	20	.	.	PUNCT
biomedich-267	173	1	still	still	ADV
biomedich-267	173	2	,	,	PUNCT
biomedich-267	173	3	it	it	PRON
biomedich-267	173	4	remains	remain	VERB
biomedich-267	173	5	unclear	unclear	ADJ
biomedich-267	173	6	whether	whether	SCONJ
biomedich-267	173	7	ras	ra	NOUN
biomedich-267	173	8	inhibitors	inhibitor	NOUN
biomedich-267	173	9	,	,	PUNCT
biomedich-267	173	10	such	such	ADJ
biomedich-267	173	11	as	as	ADP
biomedich-267	173	12	angiotensin	angiotensin	NOUN
biomedich-267	173	13	-	-	PUNCT
biomedich-267	173	14	converting	convert	VERB
biomedich-267	173	15	enzyme	enzyme	NOUN
biomedich-267	173	16	inhibitors	inhibitor	NOUN
biomedich-267	173	17	(	(	PUNCT
biomedich-267	173	18	aceis	aceis	NOUN
biomedich-267	173	19	)	)	PUNCT
biomedich-267	173	20	and	and	CCONJ
biomedich-267	173	21	type	type	VERB
biomedich-267	173	22	one	one	NUM
biomedich-267	173	23	receptor	receptor	NOUN
biomedich-267	173	24	blockers	blocker	NOUN
biomedich-267	173	25	(	(	PUNCT
biomedich-267	173	26	arbs	arb	NOUN
biomedich-267	173	27	)	)	PUNCT
biomedich-267	173	28	of	of	ADP
biomedich-267	173	29	angiotensin	angiotensin	PROPN
biomedich-267	173	30	ii	ii	PROPN
biomedich-267	173	31	,	,	PUNCT
biomedich-267	173	32	are	be	AUX
biomedich-267	173	33	associated	associate	VERB
biomedich-267	173	34	with	with	ADP
biomedich-267	173	35	clinical	clinical	ADJ
biomedich-267	173	36	outcomes	outcome	NOUN
biomedich-267	173	37	.	.	PUNCT
biomedich-267	174	1	covid-19	covid-19	PROPN
biomedich-267	174	2	hypertensive	hypertensive	ADJ
biomedich-267	174	3	patients	patient	NOUN
biomedich-267	174	4	have	have	AUX
biomedich-267	174	5	been	be	AUX
biomedich-267	174	6	enrolled	enrol	VERB
biomedich-267	174	7	to	to	PART
biomedich-267	174	8	test	test	VERB
biomedich-267	174	9	the	the	DET
biomedich-267	174	10	impact	impact	NOUN
biomedich-267	174	11	of	of	ADP
biomedich-267	174	12	ras	ras	PROPN
biomedich-267	174	13	inhibitors	inhibitor	NOUN
biomedich-267	174	14	(	(	PUNCT
biomedich-267	174	15	meng	meng	PROPN
biomedich-267	174	16	et	et	PROPN
biomedich-267	174	17	al	al	PROPN
biomedich-267	174	18	.	.	PROPN
biomedich-267	174	19	,	,	PUNCT
biomedich-267	174	20	2020	2020	NUM
biomedich-267	174	21	)	)	PUNCT
biomedich-267	174	22	.	.	PUNCT
biomedich-267	175	1	protein	protein	NOUN
biomedich-267	175	2	for	for	ADP
biomedich-267	175	3	ace2	ace2	NOUN
biomedich-267	175	4	-	-	PUNCT
biomedich-267	175	5	expressing	express	VERB
biomedich-267	175	6	cells	cell	NOUN
biomedich-267	175	7	to	to	PART
biomedich-267	175	8	join	join	VERB
biomedich-267	175	9	.	.	PUNCT
biomedich-267	176	1	ace-2	ace-2	PUNCT
biomedich-267	176	2	is	be	AUX
biomedich-267	176	3	a	a	DET
biomedich-267	176	4	part	part	NOUN
biomedich-267	176	5	of	of	ADP
biomedich-267	176	6	activating	activate	VERB
biomedich-267	176	7	the	the	DET
biomedich-267	176	8	renin	renin	ADJ
biomedich-267	176	9	-	-	PUNCT
biomedich-267	176	10	angiotensin	angiotensin	NOUN
biomedich-267	176	11	(	(	PUNCT
biomedich-267	176	12	ras	ras	NOUN
biomedich-267	176	13	)	)	PUNCT
biomedich-267	176	14	system	system	NOUN
biomedich-267	176	15	that	that	PRON
biomedich-267	176	16	plays	play	VERB
biomedich-267	176	17	an	an	DET
biomedich-267	176	18	important	important	ADJ
biomedich-267	176	19	role	role	NOUN
biomedich-267	176	20	in	in	ADP
biomedich-267	176	21	hypertension	hypertension	NOUN
biomedich-267	176	22	.	.	PUNCT
biomedich-267	177	1	this	this	DET
biomedich-267	177	2	connection	connection	NOUN
biomedich-267	177	3	between	between	ADP
biomedich-267	177	4	ace2	ace2	PROPN
biomedich-267	177	5	and	and	CCONJ
biomedich-267	177	6	sars	sars	PROPN
biomedich-267	177	7	-	-	PUNCT
biomedich-267	177	8	cov-2	cov-2	NOUN
biomedich-267	177	9	sparked	spark	VERB
biomedich-267	177	10	interest	interest	NOUN
biomedich-267	177	11	in	in	ADP
biomedich-267	177	12	investigating	investigate	VERB
biomedich-267	177	13	the	the	DET
biomedich-267	177	14	relationship	relationship	NOUN
biomedich-267	177	15	between	between	ADP
biomedich-267	177	16	inhibitors	inhibitor	NOUN
biomedich-267	177	17	of	of	ADP
biomedich-267	177	18	ras	ra	NOUN
biomedich-267	177	19	and	and	CCONJ
biomedich-267	177	20	infection	infection	NOUN
biomedich-267	177	21	with	with	ADP
biomedich-267	177	22	covid-19	covid-19	PROPN
biomedich-267	177	23	(	(	PUNCT
biomedich-267	177	24	salah	salah	PROPN
biomedich-267	177	25	et	et	PROPN
biomedich-267	177	26	al	al	PROPN
biomedich-267	177	27	.	.	PROPN
biomedich-267	177	28	,	,	PUNCT
biomedich-267	177	29	2021	2021	NUM
biomedich-267	177	30	)	)	PUNCT
biomedich-267	177	31	.	.	PUNCT
biomedich-267	178	1	hypertension	hypertension	NOUN
biomedich-267	178	2	was	be	AUX
biomedich-267	178	3	associated	associate	VERB
biomedich-267	178	4	with	with	ADP
biomedich-267	178	5	increased	increase	VERB
biomedich-267	178	6	poor	poor	ADJ
biomedich-267	178	7	composite	composite	ADJ
biomedich-267	178	8	outcomes	outcome	NOUN
biomedich-267	178	9	in	in	ADP
biomedich-267	178	10	patients	patient	NOUN
biomedich-267	178	11	with	with	ADP
biomedich-267	178	12	covid-19	covid-19	PROPN
biomedich-267	178	13	,	,	PUNCT
biomedich-267	178	14	including	include	VERB
biomedich-267	178	15	mortality	mortality	NOUN
biomedich-267	178	16	,	,	PUNCT
biomedich-267	178	17	extreme	extreme	ADJ
biomedich-267	178	18	covid-19	covid-19	PROPN
biomedich-267	178	19	,	,	PUNCT
biomedich-267	178	20	ards	ard	NOUN
biomedich-267	178	21	,	,	PUNCT
biomedich-267	178	22	need	need	VERB
biomedich-267	178	23	for	for	ADP
biomedich-267	178	24	icu	icu	PROPN
biomedich-267	178	25	treatment	treatment	NOUN
biomedich-267	178	26	,	,	PUNCT
biomedich-267	178	27	and	and	CCONJ
biomedich-267	178	28	disease	disease	NOUN
biomedich-267	178	29	progression	progression	NOUN
biomedich-267	178	30	(	(	PUNCT
biomedich-267	178	31	pranata	pranata	PROPN
biomedich-267	178	32	et	et	PROPN
biomedich-267	178	33	al	al	PROPN
biomedich-267	178	34	.	.	PROPN
biomedich-267	178	35	,	,	PUNCT
biomedich-267	178	36	2020	2020	NUM
biomedich-267	178	37	)	)	PUNCT
biomedich-267	178	38	thyroid	thyroid	NOUN
biomedich-267	178	39	and	and	CCONJ
biomedich-267	178	40	covid-19	covid-19	PROPN
biomedich-267	178	41	the	the	DET
biomedich-267	178	42	immune	immune	ADJ
biomedich-267	178	43	system	system	NOUN
biomedich-267	178	44	,	,	PUNCT
biomedich-267	178	45	especially	especially	ADV
biomedich-267	178	46	cellular	cellular	ADJ
biomedich-267	178	47	immunity	immunity	NOUN
biomedich-267	178	48	,	,	PUNCT
biomedich-267	178	49	is	be	AUX
biomedich-267	178	50	modulated	modulate	VERB
biomedich-267	178	51	by	by	ADP
biomedich-267	178	52	thyroid	thyroid	NOUN
biomedich-267	178	53	hormones	hormone	NOUN
biomedich-267	178	54	.	.	PUNCT
biomedich-267	179	1	the	the	DET
biomedich-267	179	2	dysregulation	dysregulation	NOUN
biomedich-267	179	3	of	of	ADP
biomedich-267	179	4	the	the	DET
biomedich-267	179	5	immune	immune	ADJ
biomedich-267	179	6	system	system	NOUN
biomedich-267	179	7	in	in	ADP
biomedich-267	179	8	hypothyroidism	hypothyroidism	NOUN
biomedich-267	179	9	might	might	AUX
biomedich-267	179	10	increase	increase	VERB
biomedich-267	179	11	the	the	DET
biomedich-267	179	12	risk	risk	NOUN
biomedich-267	179	13	of	of	ADP
biomedich-267	179	14	infection	infection	NOUN
biomedich-267	179	15	.	.	PUNCT
biomedich-267	180	1	however	however	ADV
biomedich-267	180	2	,	,	PUNCT
biomedich-267	180	3	the	the	DET
biomedich-267	180	4	immune	immune	ADJ
biomedich-267	180	5	system	system	NOUN
biomedich-267	180	6	recovers	recover	VERB
biomedich-267	180	7	its	its	PRON
biomedich-267	180	8	normal	normal	ADJ
biomedich-267	180	9	function	function	NOUN
biomedich-267	180	10	after	after	ADP
biomedich-267	180	11	proper	proper	ADJ
biomedich-267	180	12	hormone	hormone	NOUN
biomedich-267	180	13	replacement	replacement	NOUN
biomedich-267	180	14	therapy	therapy	NOUN
biomedich-267	180	15	(	(	PUNCT
biomedich-267	180	16	mitrou	mitrou	PROPN
biomedich-267	180	17	et	et	PROPN
biomedich-267	180	18	al	al	PROPN
biomedich-267	180	19	.	.	PROPN
biomedich-267	180	20	,	,	PUNCT
biomedich-267	180	21	2011	2011	NUM
biomedich-267	180	22	)	)	PUNCT
biomedich-267	180	23	.	.	PUNCT
biomedich-267	181	1	the	the	DET
biomedich-267	181	2	influence	influence	NOUN
biomedich-267	181	3	of	of	ADP
biomedich-267	181	4	pre	pre	ADJ
biomedich-267	181	5	-	-	ADJ
biomedich-267	181	6	existing	existing	ADJ
biomedich-267	181	7	hypothyroidism	hypothyroidism	NOUN
biomedich-267	181	8	on	on	ADP
biomedich-267	181	9	the	the	DET
biomedich-267	181	10	effects	effect	NOUN
biomedich-267	181	11	of	of	ADP
biomedich-267	181	12	covid-19	covid-19	PROPN
biomedich-267	181	13	is	be	AUX
biomedich-267	181	14	unclear	unclear	ADJ
biomedich-267	181	15	(	(	PUNCT
biomedich-267	181	16	van	van	PROPN
biomedich-267	181	17	gerwen	gerwen	PROPN
biomedich-267	181	18	et	et	PROPN
biomedich-267	181	19	al	al	PROPN
biomedich-267	181	20	.	.	PROPN
biomedich-267	181	21	,	,	PUNCT
biomedich-267	181	22	2020	2020	NUM
biomedich-267	181	23	)	)	PUNCT
biomedich-267	181	24	.	.	PUNCT
biomedich-267	182	1	effects	effect	NOUN
biomedich-267	182	2	of	of	ADP
biomedich-267	182	3	covid-19	covid-19	PROPN
biomedich-267	182	4	on	on	ADP
biomedich-267	182	5	the	the	DET
biomedich-267	182	6	hypothalamic	hypothalamic	ADJ
biomedich-267	182	7	-	-	PUNCT
biomedich-267	182	8	pituitary	pituitary	ADJ
biomedich-267	182	9	-	-	PUNCT
biomedich-267	182	10	thyroid	thyroid	NOUN
biomedich-267	182	11	axis	axis	NOUN
biomedich-267	182	12	:	:	PUNCT
biomedich-267	182	13	it	it	PRON
biomedich-267	182	14	is	be	AUX
biomedich-267	182	15	known	know	VERB
biomedich-267	182	16	that	that	SCONJ
biomedich-267	182	17	systemic	systemic	ADJ
biomedich-267	182	18	disorders	disorder	NOUN
biomedich-267	182	19	are	be	AUX
biomedich-267	182	20	associated	associate	VERB
biomedich-267	182	21	with	with	ADP
biomedich-267	182	22	low	low	ADJ
biomedich-267	182	23	-	-	PUNCT
biomedich-267	182	24	t3	t3	NOUN
biomedich-267	182	25	or	or	CCONJ
biomedich-267	182	26	non	non	ADJ
biomedich-267	182	27	-	-	ADJ
biomedich-267	182	28	thyroidal	thyroidal	ADJ
biomedich-267	182	29	syndrome	syndrome	NOUN
biomedich-267	182	30	.	.	PUNCT
biomedich-267	183	1	severe	severe	ADJ
biomedich-267	183	2	covid-19	covid-19	PROPN
biomedich-267	183	3	is	be	AUX
biomedich-267	183	4	expected	expect	VERB
biomedich-267	183	5	to	to	PART
biomedich-267	183	6	cause	cause	VERB
biomedich-267	183	7	such	such	DET
biomedich-267	183	8	a	a	DET
biomedich-267	183	9	disease	disease	NOUN
biomedich-267	183	10	,	,	PUNCT
biomedich-267	183	11	especially	especially	ADV
biomedich-267	183	12	when	when	SCONJ
biomedich-267	183	13	the	the	DET
biomedich-267	183	14	infection	infection	NOUN
biomedich-267	183	15	is	be	AUX
biomedich-267	183	16	associated	associate	VERB
biomedich-267	183	17	with	with	ADP
biomedich-267	183	18	fever	fever	NOUN
biomedich-267	183	19	and	and	CCONJ
biomedich-267	183	20	lower	low	ADJ
biomedich-267	183	21	respiratory	respiratory	ADJ
biomedich-267	183	22	tract	tract	NOUN
biomedich-267	183	23	involvement	involvement	NOUN
biomedich-267	183	24	.	.	PUNCT
biomedich-267	184	1	in	in	ADP
biomedich-267	184	2	addition	addition	NOUN
biomedich-267	184	3	,	,	PUNCT
biomedich-267	184	4	sars	sar	NOUN
biomedich-267	184	5	-	-	PUNCT
biomedich-267	184	6	cov-2	cov-2	PART
biomedich-267	184	7	infection	infection	NOUN
biomedich-267	184	8	has	have	AUX
biomedich-267	184	9	been	be	AUX
biomedich-267	184	10	reported	report	VERB
biomedich-267	184	11	to	to	PART
biomedich-267	184	12	influence	influence	VERB
biomedich-267	184	13	the	the	DET
biomedich-267	184	14	nervous	nervous	ADJ
biomedich-267	184	15	system	system	NOUN
biomedich-267	184	16	,	,	PUNCT
biomedich-267	184	17	typically	typically	ADV
biomedich-267	184	18	affecting	affect	VERB
biomedich-267	184	19	smell	smell	NOUN
biomedich-267	184	20	and	and	CCONJ
biomedich-267	184	21	taste	taste	VERB
biomedich-267	184	22	with	with	ADP
biomedich-267	184	23	the	the	DET
biomedich-267	184	24	involvement	involvement	NOUN
biomedich-267	184	25	of	of	ADP
biomedich-267	184	26	cranial	cranial	ADJ
biomedich-267	184	27	nerves	nerve	NOUN
biomedich-267	184	28	(	(	PUNCT
biomedich-267	184	29	boelaert	boelaert	NOUN
biomedich-267	184	30	et	et	PROPN
biomedich-267	184	31	al	al	PROPN
biomedich-267	184	32	.	.	PROPN
biomedich-267	184	33	,	,	PUNCT
biomedich-267	184	34	2020	2020	NUM
biomedich-267	184	35	)	)	PUNCT
biomedich-267	184	36	.	.	PUNCT
biomedich-267	185	1	follicular	follicular	ADJ
biomedich-267	185	2	cell	cell	NOUN
biomedich-267	185	3	death	death	NOUN
biomedich-267	185	4	would	would	AUX
biomedich-267	185	5	manifest	manifest	VERB
biomedich-267	185	6	as	as	ADP
biomedich-267	185	7	low	low	ADJ
biomedich-267	185	8	t3	t3	PROPN
biomedich-267	185	9	and	and	CCONJ
biomedich-267	185	10	t4	t4	PROPN
biomedich-267	185	11	;	;	PUNCT
biomedich-267	185	12	damage	damage	NOUN
biomedich-267	185	13	to	to	ADP
biomedich-267	185	14	parafollicular	parafollicular	ADJ
biomedich-267	185	15	cells	cell	NOUN
biomedich-267	185	16	would	would	AUX
biomedich-267	185	17	potentially	potentially	ADV
biomedich-267	185	18	result	result	VERB
biomedich-267	185	19	in	in	ADP
biomedich-267	185	20	low	low	ADJ
biomedich-267	185	21	serum	serum	NOUN
biomedich-267	185	22	calcitonin	calcitonin	ADJ
biomedich-267	185	23	levels	level	NOUN
biomedich-267	185	24	.	.	PUNCT
biomedich-267	186	1	this	this	PRON
biomedich-267	186	2	has	have	AUX
biomedich-267	186	3	been	be	AUX
biomedich-267	186	4	suggested	suggest	VERB
biomedich-267	186	5	as	as	ADP
biomedich-267	186	6	a	a	DET
biomedich-267	186	7	possible	possible	ADJ
biomedich-267	186	8	femoral	femoral	ADJ
biomedich-267	186	9	head	head	NOUN
biomedich-267	186	10	osteonecrosis	osteonecrosis	NOUN
biomedich-267	186	11	mechanism	mechanism	NOUN
biomedich-267	186	12	in	in	ADP
biomedich-267	186	13	recovered	recovered	ADJ
biomedich-267	186	14	sars	sars	PROPN
biomedich-267	186	15	patients	patient	NOUN
biomedich-267	186	16	;	;	PUNCT
biomedich-267	186	17	calcitonin	calcitonin	ADJ
biomedich-267	186	18	deficiency	deficiency	NOUN
biomedich-267	186	19	contributes	contribute	VERB
biomedich-267	186	20	to	to	ADP
biomedich-267	186	21	osteoclast	osteoclast	ADJ
biomedich-267	186	22	disinhibition	disinhibition	NOUN
biomedich-267	186	23	leading	lead	VERB
biomedich-267	186	24	to	to	PART
biomedich-267	186	25	osteonecrosis	osteonecrosis	VERB
biomedich-267	186	26	(	(	PUNCT
biomedich-267	186	27	kaiser	kaiser	PROPN
biomedich-267	186	28	et	et	PROPN
biomedich-267	186	29	al	al	PROPN
biomedich-267	186	30	.	.	PROPN
biomedich-267	186	31	,	,	PUNCT
biomedich-267	186	32	2020	2020	NUM
biomedich-267	186	33	)	)	PUNCT
biomedich-267	186	34	.	.	PUNCT
biomedich-267	187	1	data	datum	NOUN
biomedich-267	187	2	on	on	ADP
biomedich-267	187	3	thyroid	thyroid	NOUN
biomedich-267	187	4	function	function	NOUN
biomedich-267	187	5	or	or	CCONJ
biomedich-267	187	6	thyroid	thyroid	NOUN
biomedich-267	187	7	pathology	pathology	NOUN
biomedich-267	187	8	in	in	ADP
biomedich-267	187	9	covid-19	covid-19	PROPN
biomedich-267	187	10	is	be	AUX
biomedich-267	187	11	not	not	PART
biomedich-267	187	12	yet	yet	ADV
biomedich-267	187	13	available	available	ADJ
biomedich-267	187	14	.	.	PUNCT
biomedich-267	188	1	a	a	DET
biomedich-267	188	2	consensus	consensus	NOUN
biomedich-267	188	3	statement	statement	NOUN
biomedich-267	188	4	concerning	concern	VERB
biomedich-267	188	5	problems	problem	NOUN
biomedich-267	188	6	related	relate	VERB
biomedich-267	188	7	to	to	PART
biomedich-267	188	8	thyroid	thyroid	VERB
biomedich-267	188	9	dysfunction	dysfunction	NOUN
biomedich-267	188	10	during	during	ADP
biomedich-267	188	11	the	the	DET
biomedich-267	188	12	covid-19	covid-19	PROPN
biomedich-267	188	13	pandemic	pandemic	NOUN
biomedich-267	188	14	has	have	AUX
biomedich-267	188	15	been	be	AUX
biomedich-267	188	16	released	release	VERB
biomedich-267	188	17	by	by	ADP
biomedich-267	188	18	the	the	DET
biomedich-267	188	19	british	british	PROPN
biomedich-267	188	20	thyroid	thyroid	PROPN
biomedich-267	188	21	association	association	PROPN
biomedich-267	188	22	and	and	CCONJ
biomedich-267	188	23	the	the	DET
biomedich-267	188	24	society	society	NOUN
biomedich-267	188	25	for	for	ADP
biomedich-267	188	26	endocrinology	endocrinology	NOUN
biomedich-267	188	27	(	(	PUNCT
biomedich-267	188	28	bta	bta	PROPN
biomedich-267	188	29	/	/	SYM
biomedich-267	188	30	sfe	sfe	PROPN
biomedich-267	188	31	)	)	PUNCT
biomedich-267	188	32	.	.	PUNCT
biomedich-267	189	1	patients	patient	NOUN
biomedich-267	189	2	with	with	ADP
biomedich-267	189	3	underlying	underlie	VERB
biomedich-267	189	4	hypothyroidism	hypothyroidism	NOUN
biomedich-267	189	5	or	or	CCONJ
biomedich-267	189	6	hyperthyroidism	hyperthyroidism	NOUN
biomedich-267	189	7	are	be	AUX
biomedich-267	189	8	recommended	recommend	VERB
biomedich-267	189	9	to	to	PART
biomedich-267	189	10	continue	continue	VERB
biomedich-267	189	11	their	their	PRON
biomedich-267	189	12	prescription	prescription	NOUN
biomedich-267	189	13	drugs	drug	NOUN
biomedich-267	189	14	as	as	ADP
biomedich-267	189	15	normal	normal	ADJ
biomedich-267	189	16	(	(	PUNCT
biomedich-267	189	17	pal	pal	NOUN
biomedich-267	189	18	et	et	PROPN
biomedich-267	189	19	al	al	PROPN
biomedich-267	189	20	.	.	PROPN
biomedich-267	189	21	,2020	,2020	PROPN
biomedich-267	189	22	)	)	PUNCT
biomedich-267	189	23	.	.	PUNCT
biomedich-267	190	1	hyperthyroidism	hyperthyroidism	NOUN
biomedich-267	190	2	is	be	AUX
biomedich-267	190	3	an	an	DET
biomedich-267	190	4	endocrine	endocrine	ADJ
biomedich-267	190	5	condition	condition	NOUN
biomedich-267	190	6	characterized	characterize	VERB
biomedich-267	190	7	by	by	ADP
biomedich-267	190	8	the	the	DET
biomedich-267	190	9	thyroid	thyroid	NOUN
biomedich-267	190	10	gland	gland	NOUN
biomedich-267	190	11	's	's	PART
biomedich-267	190	12	inappropriately	inappropriately	ADV
biomedich-267	190	13	high	high	ADJ
biomedich-267	190	14	thyroid	thyroid	NOUN
biomedich-267	190	15	hormone	hormone	NOUN
biomedich-267	190	16	output	output	NOUN
biomedich-267	190	17	.	.	PUNCT
biomedich-267	191	1	it	it	PRON
biomedich-267	191	2	is	be	AUX
biomedich-267	191	3	usually	usually	ADV
biomedich-267	191	4	caused	cause	VERB
biomedich-267	191	5	by	by	ADP
biomedich-267	191	6	thyroid	thyroid	NOUN
biomedich-267	191	7	gland	gland	NOUN
biomedich-267	191	8	autoimmune	autoimmune	ADJ
biomedich-267	191	9	dysfunction	dysfunction	NOUN
biomedich-267	191	10	and	and	CCONJ
biomedich-267	191	11	has	have	VERB
biomedich-267	191	12	a	a	DET
biomedich-267	191	13	population	population	NOUN
biomedich-267	191	14	prevalence	prevalence	NOUN
biomedich-267	191	15	of	of	ADP
biomedich-267	191	16	1%-15	1%-15	NUM
biomedich-267	191	17	%	%	NOUN
biomedich-267	191	18	(	(	PUNCT
biomedich-267	191	19	kaur	kaur	PROPN
biomedich-267	191	20	et	et	PROPN
biomedich-267	191	21	al	al	PROPN
biomedich-267	191	22	.	.	PROPN
biomedich-267	191	23	,	,	PUNCT
biomedich-267	191	24	2020	2020	NUM
biomedich-267	191	25	)	)	PUNCT
biomedich-267	191	26	.	.	PUNCT
biomedich-267	192	1	in	in	ADP
biomedich-267	192	2	addition	addition	NOUN
biomedich-267	192	3	to	to	ADP
biomedich-267	192	4	clear	clear	ADJ
biomedich-267	192	5	ultrasonographic	ultrasonographic	ADJ
biomedich-267	192	6	evidence	evidence	NOUN
biomedich-267	192	7	indicating	indicate	VERB
biomedich-267	192	8	subacute	subacute	ADJ
biomedich-267	192	9	thyroiditis	thyroiditis	NOUN
biomedich-267	192	10	,	,	PUNCT
biomedich-267	192	11	the	the	DET
biomedich-267	192	12	patient	patient	NOUN
biomedich-267	192	13	presented	present	VERB
biomedich-267	192	14	with	with	ADP
biomedich-267	192	15	tachycardia	tachycardia	NOUN
biomedich-267	192	16	,	,	PUNCT
biomedich-267	192	17	anterior	anterior	ADJ
biomedich-267	192	18	neck	neck	NOUN
biomedich-267	192	19	pain	pain	NOUN
biomedich-267	192	20	,	,	PUNCT
biomedich-267	192	21	and	and	CCONJ
biomedich-267	192	22	thyroid	thyroid	NOUN
biomedich-267	192	23	function	function	NOUN
biomedich-267	192	24	tests	test	NOUN
biomedich-267	192	25	showing	show	VERB
biomedich-267	192	26	hyperthyroidism	hyperthyroidism	NOUN
biomedich-267	192	27	.	.	PUNCT
biomedich-267	193	1	corticosteroid	corticosteroid	ADJ
biomedich-267	193	2	therapy	therapy	NOUN
biomedich-267	193	3	resulted	result	VERB
biomedich-267	193	4	in	in	ADP
biomedich-267	193	5	a	a	DET
biomedich-267	193	6	fast	fast	ADJ
biomedich-267	193	7	clinical	clinical	ADJ
biomedich-267	193	8	resolution	resolution	NOUN
biomedich-267	193	9	.	.	PUNCT
biomedich-267	194	1	the	the	DET
biomedich-267	194	2	case	case	NOUN
biomedich-267	194	3	shows	show	VERB
biomedich-267	194	4	that	that	SCONJ
biomedich-267	194	5	virus	virus	NOUN
biomedich-267	194	6	-	-	PUNCT
biomedich-267	194	7	related	relate	VERB
biomedich-267	194	8	subacute	subacute	NOUN
biomedich-267	194	9	thyroiditis	thyroiditis	NOUN
biomedich-267	194	10	such	such	ADJ
biomedich-267	194	11	as	as	ADP
biomedich-267	194	12	sars	sar	NOUN
biomedich-267	194	13	-	-	PUNCT
biomedich-267	194	14	cov-2	cov-2	NUM
biomedich-267	194	15	should	should	AUX
biomedich-267	194	16	be	be	AUX
biomedich-267	194	17	regarded	regard	VERB
biomedich-267	194	18	as	as	ADP
biomedich-267	194	19	a	a	DET
biomedich-267	194	20	complication	complication	NOUN
biomedich-267	194	21	of	of	ADP
biomedich-267	194	22	covid-19	covid-19	PROPN
biomedich-267	194	23	and	and	CCONJ
biomedich-267	194	24	treated	treat	VERB
biomedich-267	194	25	as	as	ADP
biomedich-267	194	26	a	a	DET
biomedich-267	194	27	differential	differential	ADJ
biomedich-267	194	28	diagnosis	diagnosis	NOUN
biomedich-267	194	29	in	in	ADP
biomedich-267	194	30	infected	infected	ADJ
biomedich-267	194	31	patients	patient	NOUN
biomedich-267	194	32	with	with	ADP
biomedich-267	194	33	tachycardia	tachycardia	NOUN
biomedich-267	194	34	without	without	ADP
biomedich-267	194	35	evidence	evidence	NOUN
biomedich-267	194	36	of	of	ADP
biomedich-267	194	37	developing	develop	VERB
biomedich-267	194	38	covid-19	covid-19	PROPN
biomedich-267	194	39	disease	disease	NOUN
biomedich-267	194	40	(	(	PUNCT
biomedich-267	194	41	mattar	mattar	PROPN
biomedich-267	194	42	et	et	PROPN
biomedich-267	194	43	al	al	PROPN
biomedich-267	194	44	.	.	PROPN
biomedich-267	194	45	,	,	PUNCT
biomedich-267	194	46	2020	2020	NUM
biomedich-267	194	47	)	)	PUNCT
biomedich-267	194	48	.	.	PUNCT
biomedich-267	195	1	smail	smail	NOUN
biomedich-267	195	2	–	–	PUNCT
biomedich-267	195	3	the	the	DET
biomedich-267	195	4	association	association	NOUN
biomedich-267	195	5	between	between	ADP
biomedich-267	195	6	some	some	DET
biomedich-267	195	7	endocrine	endocrine	NOUN
biomedich-267	195	8	conditions	condition	NOUN
biomedich-267	195	9	and	and	CCONJ
biomedich-267	195	10	covid-19	covid-19	PROPN
biomedich-267	195	11	:	:	PUNCT
biomedich-267	195	12	a	a	DET
biomedich-267	195	13	review	review	NOUN
biomedich-267	195	14	51	51	NUM
biomedich-267	195	15	conclusions	conclusion	NOUN
biomedich-267	195	16	i	i	PRON
biomedich-267	195	17	reached	reach	VERB
biomedich-267	195	18	several	several	ADJ
biomedich-267	195	19	important	important	ADJ
biomedich-267	195	20	points	point	NOUN
biomedich-267	195	21	from	from	ADP
biomedich-267	195	22	this	this	DET
biomedich-267	195	23	review	review	NOUN
biomedich-267	195	24	.	.	PUNCT
biomedich-267	196	1	first	first	ADV
biomedich-267	196	2	,	,	PUNCT
biomedich-267	196	3	patients	patient	NOUN
biomedich-267	196	4	with	with	ADP
biomedich-267	196	5	endocrine	endocrine	ADJ
biomedich-267	196	6	disorders	disorder	NOUN
biomedich-267	196	7	such	such	ADJ
biomedich-267	196	8	as	as	ADP
biomedich-267	196	9	diabetes	diabetes	NOUN
biomedich-267	196	10	,	,	PUNCT
biomedich-267	196	11	obesity	obesity	NOUN
biomedich-267	196	12	,	,	PUNCT
biomedich-267	196	13	hypertension	hypertension	NOUN
biomedich-267	196	14	,	,	PUNCT
biomedich-267	196	15	and	and	CCONJ
biomedich-267	196	16	thyroid	thyroid	NOUN
biomedich-267	196	17	may	may	AUX
biomedich-267	196	18	be	be	AUX
biomedich-267	196	19	more	more	ADV
biomedich-267	196	20	likely	likely	ADJ
biomedich-267	196	21	to	to	PART
biomedich-267	196	22	affect	affect	VERB
biomedich-267	196	23	by	by	ADP
biomedich-267	196	24	covid-19	covid-19	PROPN
biomedich-267	196	25	,	,	PUNCT
biomedich-267	196	26	but	but	CCONJ
biomedich-267	196	27	still	still	ADV
biomedich-267	196	28	controversial	controversial	ADJ
biomedich-267	196	29	from	from	ADP
biomedich-267	196	30	one	one	NUM
biomedich-267	196	31	study	study	NOUN
biomedich-267	196	32	to	to	PART
biomedich-267	196	33	study	study	VERB
biomedich-267	196	34	.	.	PUNCT
biomedich-267	197	1	more	more	ADJ
biomedich-267	197	2	data	datum	NOUN
biomedich-267	197	3	should	should	AUX
biomedich-267	197	4	be	be	AUX
biomedich-267	197	5	gathered	gather	VERB
biomedich-267	197	6	to	to	PART
biomedich-267	197	7	establish	establish	VERB
biomedich-267	197	8	these	these	DET
biomedich-267	197	9	associations	association	NOUN
biomedich-267	197	10	.	.	PUNCT
biomedich-267	198	1	conflict	conflict	NOUN
biomedich-267	198	2	of	of	ADP
biomedich-267	198	3	interest	interest	NOUN
biomedich-267	198	4	:	:	PUNCT
biomedich-267	198	5	author	author	NOUN
biomedich-267	198	6	declare	declare	VERB
biomedich-267	198	7	that	that	SCONJ
biomedich-267	198	8	there	there	PRON
biomedich-267	198	9	is	be	VERB
biomedich-267	198	10	no	no	DET
biomedich-267	198	11	conflict	conflict	NOUN
biomedich-267	198	12	of	of	ADP
biomedich-267	198	13	interest	interest	NOUN
biomedich-267	198	14	.	.	PUNCT
biomedich-267	199	1	references	reference	NOUN
biomedich-267	199	2	albashir	albashir	PROPN
biomedich-267	199	3	,	,	PUNCT
biomedich-267	199	4	a.	a.	PROPN
biomedich-267	199	5	a.	a.	PROPN
biomedich-267	199	6	d.	d.	PROPN
biomedich-267	199	7	(	(	PUNCT
biomedich-267	199	8	2020	2020	NUM
biomedich-267	199	9	)	)	PUNCT
biomedich-267	199	10	.	.	PUNCT
biomedich-267	200	1	the	the	DET
biomedich-267	200	2	potential	potential	ADJ
biomedich-267	200	3	impacts	impact	NOUN
biomedich-267	200	4	of	of	ADP
biomedich-267	200	5	obesity	obesity	NOUN
biomedich-267	200	6	on	on	ADP
biomedich-267	200	7	covid-19	covid-19	PROPN
biomedich-267	200	8	.	.	PUNCT
biomedich-267	200	9	clinical	clinical	ADJ
biomedich-267	200	10	medicine	medicine	NOUN
biomedich-267	200	11	,	,	PUNCT
biomedich-267	200	12	20(4	20(4	NOUN
biomedich-267	200	13	)	)	PUNCT
biomedich-267	200	14	,	,	PUNCT
biomedich-267	200	15	e109	e109	PROPN
biomedich-267	200	16	.	.	PUNCT
biomedich-267	200	17	angelidi	angelidi	PROPN
biomedich-267	200	18	,	,	PUNCT
biomedich-267	200	19	a.	a.	NOUN
biomedich-267	200	20	m.	m.	NOUN
biomedich-267	200	21	,	,	PUNCT
biomedich-267	200	22	belanger	belanger	PROPN
biomedich-267	200	23	,	,	PUNCT
biomedich-267	200	24	m.	m.	NOUN
biomedich-267	200	25	j.	j.	PROPN
biomedich-267	200	26	,	,	PUNCT
biomedich-267	200	27	&	&	CCONJ
biomedich-267	200	28	mantzoros	mantzoros	PROPN
biomedich-267	200	29	,	,	PUNCT
biomedich-267	200	30	c.	c.	PROPN
biomedich-267	200	31	s.	s.	PROPN
biomedich-267	200	32	(	(	PUNCT
biomedich-267	200	33	2020	2020	NUM
biomedich-267	200	34	)	)	PUNCT
biomedich-267	200	35	.	.	PUNCT
biomedich-267	201	1	commentary	commentary	NOUN
biomedich-267	201	2	:	:	PUNCT
biomedich-267	201	3	covid-19	covid-19	PROPN
biomedich-267	201	4	and	and	CCONJ
biomedich-267	201	5	diabetes	diabete	VERB
biomedich-267	201	6	mellitus	mellitus	NOUN
biomedich-267	201	7	:	:	PUNCT
biomedich-267	201	8	what	what	PRON
biomedich-267	201	9	we	we	PRON
biomedich-267	201	10	know	know	VERB
biomedich-267	201	11	,	,	PUNCT
biomedich-267	201	12	how	how	SCONJ
biomedich-267	201	13	our	our	PRON
biomedich-267	201	14	patients	patient	NOUN
biomedich-267	201	15	should	should	AUX
biomedich-267	201	16	be	be	AUX
biomedich-267	201	17	treated	treat	VERB
biomedich-267	201	18	now	now	ADV
biomedich-267	201	19	,	,	PUNCT
biomedich-267	201	20	and	and	CCONJ
biomedich-267	201	21	what	what	PRON
biomedich-267	201	22	should	should	AUX
biomedich-267	201	23	happen	happen	VERB
biomedich-267	201	24	next	next	ADV
biomedich-267	201	25	.	.	PUNCT
biomedich-267	202	1	metabolism	metabolism	NOUN
biomedich-267	202	2	,	,	PUNCT
biomedich-267	202	3	107	107	NUM
biomedich-267	202	4	,	,	PUNCT
biomedich-267	202	5	154245	154245	NUM
biomedich-267	202	6	.	.	PUNCT
biomedich-267	203	1	antwi	antwi	PROPN
biomedich-267	203	2	-	-	PUNCT
biomedich-267	203	3	amoabeng	amoabeng	PROPN
biomedich-267	203	4	,	,	PUNCT
biomedich-267	203	5	d.	d.	PROPN
biomedich-267	203	6	,	,	PUNCT
biomedich-267	203	7	beutler	beutler	NOUN
biomedich-267	203	8	,	,	PUNCT
biomedich-267	203	9	b.	b.	PROPN
biomedich-267	203	10	d.	d.	PROPN
biomedich-267	203	11	,	,	PUNCT
biomedich-267	203	12	moody	moody	PROPN
biomedich-267	203	13	,	,	PUNCT
biomedich-267	203	14	a.	a.	PROPN
biomedich-267	203	15	e.	e.	PROPN
biomedich-267	203	16	,	,	PUNCT
biomedich-267	203	17	kanji	kanji	PROPN
biomedich-267	203	18	,	,	PUNCT
biomedich-267	203	19	z.	z.	PROPN
biomedich-267	203	20	,	,	PUNCT
biomedich-267	203	21	gullapalli	gullapalli	PROPN
biomedich-267	203	22	,	,	PUNCT
biomedich-267	203	23	n.	n.	NOUN
biomedich-267	203	24	,	,	PUNCT
biomedich-267	203	25	&	&	CCONJ
biomedich-267	203	26	rowan	rowan	PROPN
biomedich-267	203	27	,	,	PUNCT
biomedich-267	203	28	c.	c.	PROPN
biomedich-267	203	29	j.	j.	PROPN
biomedich-267	203	30	(	(	PUNCT
biomedich-267	203	31	2020	2020	NUM
biomedich-267	203	32	)	)	PUNCT
biomedich-267	203	33	.	.	PUNCT
biomedich-267	204	1	management	management	NOUN
biomedich-267	204	2	of	of	ADP
biomedich-267	204	3	hypertension	hypertension	NOUN
biomedich-267	204	4	in	in	ADP
biomedich-267	204	5	covid-19	covid-19	PROPN
biomedich-267	204	6	.	.	PUNCT
biomedich-267	204	7	world	world	PROPN
biomedich-267	204	8	journal	journal	PROPN
biomedich-267	204	9	of	of	ADP
biomedich-267	204	10	cardiology	cardiology	NOUN
biomedich-267	204	11	,	,	PUNCT
biomedich-267	204	12	12(5	12(5	NUM
biomedich-267	204	13	)	)	PUNCT
biomedich-267	204	14	,	,	PUNCT
biomedich-267	204	15	228	228	NUM
biomedich-267	204	16	.	.	PUNCT
biomedich-267	204	17	azar	azar	PROPN
biomedich-267	204	18	,	,	PUNCT
biomedich-267	204	19	w.	w.	PROPN
biomedich-267	204	20	s.	s.	PROPN
biomedich-267	204	21	,	,	PUNCT
biomedich-267	204	22	njeim	njeim	PROPN
biomedich-267	204	23	,	,	PUNCT
biomedich-267	204	24	r.	r.	PROPN
biomedich-267	204	25	,	,	PUNCT
biomedich-267	204	26	fares	fare	NOUN
biomedich-267	204	27	,	,	PUNCT
biomedich-267	204	28	a.	a.	PROPN
biomedich-267	204	29	h.	h.	PROPN
biomedich-267	204	30	,	,	PUNCT
biomedich-267	204	31	azar	azar	PROPN
biomedich-267	204	32	,	,	PUNCT
biomedich-267	204	33	n.	n.	PROPN
biomedich-267	204	34	s.	s.	PROPN
biomedich-267	204	35	,	,	PUNCT
biomedich-267	204	36	azar	azar	PROPN
biomedich-267	204	37	,	,	PUNCT
biomedich-267	204	38	s.	s.	PROPN
biomedich-267	204	39	t.	t.	PROPN
biomedich-267	204	40	,	,	PUNCT
biomedich-267	204	41	el	el	PROPN
biomedich-267	204	42	sayed	say	VERB
biomedich-267	204	43	,	,	PUNCT
biomedich-267	204	44	m.	m.	NOUN
biomedich-267	204	45	,	,	PUNCT
biomedich-267	204	46	&	&	CCONJ
biomedich-267	204	47	eid	eid	PROPN
biomedich-267	204	48	,	,	PUNCT
biomedich-267	204	49	a.	a.	NOUN
biomedich-267	204	50	a.	a.	NOUN
biomedich-267	204	51	(	(	PUNCT
biomedich-267	204	52	2020	2020	NUM
biomedich-267	204	53	)	)	PUNCT
biomedich-267	204	54	.	.	PUNCT
biomedich-267	205	1	covid-19	covid-19	PROPN
biomedich-267	205	2	and	and	CCONJ
biomedich-267	205	3	diabetes	diabetes	NOUN
biomedich-267	205	4	mellitus	mellitus	NOUN
biomedich-267	205	5	:	:	PUNCT
biomedich-267	205	6	how	how	SCONJ
biomedich-267	205	7	one	one	NUM
biomedich-267	205	8	pandemic	pandemic	ADJ
biomedich-267	205	9	worsens	worsen	VERB
biomedich-267	205	10	the	the	DET
biomedich-267	205	11	other	other	ADJ
biomedich-267	205	12	.	.	PUNCT
biomedich-267	206	1	reviews	review	NOUN
biomedich-267	206	2	in	in	ADP
biomedich-267	206	3	endocrine	endocrine	NOUN
biomedich-267	206	4	and	and	CCONJ
biomedich-267	206	5	metabolic	metabolic	NOUN
biomedich-267	206	6	disorders	disorder	NOUN
biomedich-267	206	7	,	,	PUNCT
biomedich-267	206	8	21(4	21(4	NUM
biomedich-267	206	9	)	)	PUNCT
biomedich-267	206	10	,	,	PUNCT
biomedich-267	206	11	451	451	NUM
biomedich-267	206	12	-	-	SYM
biomedich-267	206	13	463	463	NUM
biomedich-267	206	14	.	.	PUNCT
biomedich-267	207	1	azzolino	azzolino	PROPN
biomedich-267	207	2	,	,	PUNCT
biomedich-267	207	3	d.	d.	PROPN
biomedich-267	207	4	,	,	PUNCT
biomedich-267	207	5	&	&	CCONJ
biomedich-267	207	6	cesari	cesari	PROPN
biomedich-267	207	7	,	,	PUNCT
biomedich-267	207	8	m.	m.	NOUN
biomedich-267	207	9	(	(	PUNCT
biomedich-267	207	10	2020	2020	NUM
biomedich-267	207	11	)	)	PUNCT
biomedich-267	207	12	.	.	PUNCT
biomedich-267	208	1	obesity	obesity	NOUN
biomedich-267	208	2	and	and	CCONJ
biomedich-267	208	3	covid-19	covid-19	PROPN
biomedich-267	208	4	.	.	PUNCT
biomedich-267	208	5	frontiers	frontier	NOUN
biomedich-267	208	6	in	in	ADP
biomedich-267	208	7	endocrinology	endocrinology	NOUN
biomedich-267	208	8	,	,	PUNCT
biomedich-267	208	9	11	11	NUM
biomedich-267	208	10	,	,	PUNCT
biomedich-267	208	11	757	757	PROPN
biomedich-267	208	12	.	.	PUNCT
biomedich-267	209	1	bansal	bansal	NOUN
biomedich-267	209	2	,	,	PUNCT
biomedich-267	209	3	r.	r.	PROPN
biomedich-267	209	4	,	,	PUNCT
biomedich-267	209	5	gubbi	gubbi	NOUN
biomedich-267	209	6	,	,	PUNCT
biomedich-267	209	7	s.	s.	PROPN
biomedich-267	209	8	,	,	PUNCT
biomedich-267	209	9	&	&	CCONJ
biomedich-267	209	10	muniyappa	muniyappa	PROPN
biomedich-267	209	11	,	,	PUNCT
biomedich-267	209	12	r.	r.	PROPN
biomedich-267	209	13	(	(	PUNCT
biomedich-267	209	14	2020	2020	NUM
biomedich-267	209	15	)	)	PUNCT
biomedich-267	209	16	.	.	PUNCT
biomedich-267	210	1	metabolic	metabolic	NOUN
biomedich-267	210	2	syndrome	syndrome	PROPN
biomedich-267	210	3	and	and	CCONJ
biomedich-267	210	4	covid	covid	PROPN
biomedich-267	210	5	19	19	NUM
biomedich-267	210	6	:	:	PUNCT
biomedich-267	210	7	endocrine	endocrine	NOUN
biomedich-267	210	8	-	-	PUNCT
biomedich-267	210	9	immune	immune	NOUN
biomedich-267	210	10	-	-	PUNCT
biomedich-267	210	11	vascular	vascular	NOUN
biomedich-267	210	12	interactions	interaction	NOUN
biomedich-267	210	13	shapes	shape	VERB
biomedich-267	210	14	clinical	clinical	ADJ
biomedich-267	210	15	course	course	NOUN
biomedich-267	210	16	.	.	PUNCT
biomedich-267	211	1	endocrinology	endocrinology	NOUN
biomedich-267	211	2	,	,	PUNCT
biomedich-267	211	3	161(10	161(10	NUM
biomedich-267	211	4	)	)	PUNCT
biomedich-267	211	5	,	,	PUNCT
biomedich-267	211	6	bqaa112	bqaa112	PROPN
biomedich-267	211	7	.	.	PROPN
biomedich-267	211	8	boelaert	boelaert	PROPN
biomedich-267	211	9	,	,	PUNCT
biomedich-267	211	10	k.	k.	PROPN
biomedich-267	211	11	,	,	PUNCT
biomedich-267	211	12	visser	visser	PROPN
biomedich-267	211	13	,	,	PUNCT
biomedich-267	211	14	w.	w.	PROPN
biomedich-267	211	15	e.	e.	PROPN
biomedich-267	211	16	,	,	PUNCT
biomedich-267	211	17	taylor	taylor	PROPN
biomedich-267	211	18	,	,	PUNCT
biomedich-267	211	19	p.	p.	PROPN
biomedich-267	211	20	n.	n.	PROPN
biomedich-267	211	21	,	,	PUNCT
biomedich-267	211	22	moran	moran	PROPN
biomedich-267	211	23	,	,	PUNCT
biomedich-267	211	24	c.	c.	PROPN
biomedich-267	211	25	,	,	PUNCT
biomedich-267	211	26	leger	leger	PROPN
biomedich-267	211	27	,	,	PUNCT
biomedich-267	211	28	j.	j.	PROPN
biomedich-267	211	29	,	,	PUNCT
biomedich-267	211	30	&	&	CCONJ
biomedich-267	211	31	persani	persani	PROPN
biomedich-267	211	32	,	,	PUNCT
biomedich-267	211	33	l.	l.	PROPN
biomedich-267	211	34	(	(	PUNCT
biomedich-267	211	35	2020	2020	NUM
biomedich-267	211	36	)	)	PUNCT
biomedich-267	211	37	.	.	PUNCT
biomedich-267	212	1	endocrinology	endocrinology	NOUN
biomedich-267	212	2	in	in	ADP
biomedich-267	212	3	the	the	DET
biomedich-267	212	4	time	time	NOUN
biomedich-267	212	5	of	of	ADP
biomedich-267	212	6	covid-19	covid-19	PROPN
biomedich-267	212	7	:	:	PUNCT
biomedich-267	212	8	management	management	NOUN
biomedich-267	212	9	of	of	ADP
biomedich-267	212	10	hyper	hyper	ADJ
biomedich-267	212	11	-	-	ADJ
biomedich-267	212	12	and	and	CCONJ
biomedich-267	212	13	hypo	hypo	ADJ
biomedich-267	212	14	-	-	PUNCT
biomedich-267	212	15	thyroidism	thyroidism	NOUN
biomedich-267	212	16	.	.	PUNCT
biomedich-267	213	1	european	european	PROPN
biomedich-267	213	2	journal	journal	PROPN
biomedich-267	213	3	of	of	ADP
biomedich-267	213	4	endocrinology	endocrinology	NOUN
biomedich-267	213	5	,	,	PUNCT
biomedich-267	213	6	1(aop	1(aop	NUM
biomedich-267	213	7	)	)	PUNCT
biomedich-267	213	8	.	.	PUNCT
biomedich-267	214	1	bonora	bonora	PROPN
biomedich-267	214	2	,	,	PUNCT
biomedich-267	214	3	e.	e.	PROPN
biomedich-267	214	4	,	,	PUNCT
biomedich-267	214	5	&	&	CCONJ
biomedich-267	214	6	defronzo	defronzo	PROPN
biomedich-267	214	7	,	,	PUNCT
biomedich-267	214	8	r.	r.	PROPN
biomedich-267	214	9	a.	a.	PROPN
biomedich-267	214	10	(	(	PUNCT
biomedich-267	214	11	eds	eds	PROPN
biomedich-267	214	12	.	.	PUNCT
biomedich-267	214	13	)	)	PUNCT
biomedich-267	214	14	.	.	PUNCT
biomedich-267	215	1	(	(	PUNCT
biomedich-267	215	2	2018	2018	NUM
biomedich-267	215	3	)	)	PUNCT
biomedich-267	215	4	.	.	PUNCT
biomedich-267	216	1	diabetes	diabetes	NOUN
biomedich-267	216	2	complications	complication	NOUN
biomedich-267	216	3	,	,	PUNCT
biomedich-267	216	4	comorbidities	comorbiditie	NOUN
biomedich-267	216	5	and	and	CCONJ
biomedich-267	216	6	related	related	ADJ
biomedich-267	216	7	disorders	disorder	NOUN
biomedich-267	216	8	.	.	PUNCT
biomedich-267	217	1	springer	springer	NOUN
biomedich-267	217	2	.	.	PUNCT
biomedich-267	218	1	caci	caci	PROPN
biomedich-267	218	2	,	,	PUNCT
biomedich-267	218	3	g.	g.	PROPN
biomedich-267	218	4	,	,	PUNCT
biomedich-267	218	5	albini	albini	PROPN
biomedich-267	218	6	,	,	PUNCT
biomedich-267	218	7	a.	a.	NOUN
biomedich-267	218	8	,	,	PUNCT
biomedich-267	218	9	malerba	malerba	PROPN
biomedich-267	218	10	,	,	PUNCT
biomedich-267	218	11	m.	m.	NOUN
biomedich-267	218	12	,	,	PUNCT
biomedich-267	218	13	noonan	noonan	PROPN
biomedich-267	218	14	,	,	PUNCT
biomedich-267	218	15	d.	d.	PROPN
biomedich-267	218	16	m.	m.	PROPN
biomedich-267	218	17	,	,	PUNCT
biomedich-267	218	18	pochetti	pochetti	NOUN
biomedich-267	218	19	,	,	PUNCT
biomedich-267	218	20	p.	p.	PROPN
biomedich-267	218	21	,	,	PUNCT
biomedich-267	218	22	&	&	CCONJ
biomedich-267	218	23	polosa	polosa	PROPN
biomedich-267	218	24	,	,	PUNCT
biomedich-267	218	25	r.	r.	PROPN
biomedich-267	218	26	(	(	PUNCT
biomedich-267	218	27	2020	2020	NUM
biomedich-267	218	28	)	)	PUNCT
biomedich-267	218	29	.	.	PUNCT
biomedich-267	219	1	covid-19	covid-19	PROPN
biomedich-267	219	2	and	and	CCONJ
biomedich-267	219	3	obesity	obesity	NOUN
biomedich-267	219	4	:	:	PUNCT
biomedich-267	219	5	dangerous	dangerous	ADJ
biomedich-267	219	6	liaisons	liaison	NOUN
biomedich-267	219	7	.	.	PUNCT
biomedich-267	220	1	journal	journal	NOUN
biomedich-267	220	2	of	of	ADP
biomedich-267	220	3	clinical	clinical	ADJ
biomedich-267	220	4	medicine	medicine	NOUN
biomedich-267	220	5	,	,	PUNCT
biomedich-267	220	6	9(8	9(8	NUM
biomedich-267	220	7	)	)	PUNCT
biomedich-267	220	8	,	,	PUNCT
biomedich-267	220	9	2511	2511	NUM
biomedich-267	220	10	.	.	PUNCT
biomedich-267	221	1	cai	cai	PROPN
biomedich-267	221	2	,	,	PUNCT
biomedich-267	221	3	q.	q.	PROPN
biomedich-267	221	4	,	,	PUNCT
biomedich-267	221	5	chen	chen	PROPN
biomedich-267	221	6	,	,	PUNCT
biomedich-267	221	7	f.	f.	PROPN
biomedich-267	221	8	,	,	PUNCT
biomedich-267	221	9	wang	wang	PROPN
biomedich-267	221	10	,	,	PUNCT
biomedich-267	221	11	t.	t.	PROPN
biomedich-267	221	12	,	,	PUNCT
biomedich-267	221	13	luo	luo	PROPN
biomedich-267	221	14	,	,	PUNCT
biomedich-267	221	15	f.	f.	PROPN
biomedich-267	221	16	,	,	PUNCT
biomedich-267	221	17	liu	liu	PROPN
biomedich-267	221	18	,	,	PUNCT
biomedich-267	221	19	x.	x.	PROPN
biomedich-267	221	20	,	,	PUNCT
biomedich-267	221	21	wu	wu	PROPN
biomedich-267	221	22	,	,	PUNCT
biomedich-267	221	23	q.	q.	PROPN
biomedich-267	221	24	,	,	PUNCT
biomedich-267	221	25	...	...	PUNCT
biomedich-267	221	26	&	&	CCONJ
biomedich-267	221	27	chen	chen	PROPN
biomedich-267	221	28	,	,	PUNCT
biomedich-267	221	29	j.	j.	PROPN
biomedich-267	221	30	(	(	PUNCT
biomedich-267	221	31	2020	2020	NUM
biomedich-267	221	32	)	)	PUNCT
biomedich-267	221	33	.	.	PUNCT
biomedich-267	222	1	obesity	obesity	NOUN
biomedich-267	222	2	and	and	CCONJ
biomedich-267	222	3	covid-19	covid-19	PROPN
biomedich-267	222	4	severity	severity	NOUN
biomedich-267	222	5	in	in	ADP
biomedich-267	222	6	a	a	DET
biomedich-267	222	7	designated	designate	VERB
biomedich-267	222	8	hospital	hospital	NOUN
biomedich-267	222	9	in	in	ADP
biomedich-267	222	10	shenzhen	shenzhen	PROPN
biomedich-267	222	11	,	,	PUNCT
biomedich-267	222	12	china	china	PROPN
biomedich-267	222	13	.	.	PUNCT
biomedich-267	223	1	diabetes	diabetes	NOUN
biomedich-267	223	2	care	care	NOUN
biomedich-267	223	3	,	,	PUNCT
biomedich-267	223	4	43(7	43(7	NUM
biomedich-267	223	5	)	)	PUNCT
biomedich-267	223	6	,	,	PUNCT
biomedich-267	223	7	1392	1392	NUM
biomedich-267	223	8	-	-	SYM
biomedich-267	223	9	1398	1398	NUM
biomedich-267	223	10	.	.	PUNCT
biomedich-267	224	1	cai	cai	PROPN
biomedich-267	224	2	,	,	PUNCT
biomedich-267	224	3	q.	q.	PROPN
biomedich-267	224	4	,	,	PUNCT
biomedich-267	224	5	chen	chen	PROPN
biomedich-267	224	6	,	,	PUNCT
biomedich-267	224	7	f.	f.	PROPN
biomedich-267	224	8	,	,	PUNCT
biomedich-267	224	9	wang	wang	PROPN
biomedich-267	224	10	,	,	PUNCT
biomedich-267	224	11	t.	t.	PROPN
biomedich-267	224	12	,	,	PUNCT
biomedich-267	224	13	luo	luo	PROPN
biomedich-267	224	14	,	,	PUNCT
biomedich-267	224	15	f.	f.	PROPN
biomedich-267	224	16	,	,	PUNCT
biomedich-267	224	17	liu	liu	PROPN
biomedich-267	224	18	,	,	PUNCT
biomedich-267	224	19	x.	x.	PROPN
biomedich-267	224	20	,	,	PUNCT
biomedich-267	224	21	wu	wu	PROPN
biomedich-267	224	22	,	,	PUNCT
biomedich-267	224	23	q.	q.	PROPN
biomedich-267	224	24	,	,	PUNCT
biomedich-267	224	25	...	...	PUNCT
biomedich-267	224	26	&	&	CCONJ
biomedich-267	224	27	chen	chen	PROPN
biomedich-267	224	28	,	,	PUNCT
biomedich-267	224	29	j.	j.	PROPN
biomedich-267	224	30	(	(	PUNCT
biomedich-267	224	31	2020	2020	NUM
biomedich-267	224	32	)	)	PUNCT
biomedich-267	224	33	.	.	PUNCT
biomedich-267	225	1	obesity	obesity	NOUN
biomedich-267	225	2	and	and	CCONJ
biomedich-267	225	3	covid-19	covid-19	PROPN
biomedich-267	225	4	severity	severity	NOUN
biomedich-267	225	5	in	in	ADP
biomedich-267	225	6	a	a	DET
biomedich-267	225	7	designated	designate	VERB
biomedich-267	225	8	hospital	hospital	NOUN
biomedich-267	225	9	in	in	ADP
biomedich-267	225	10	shenzhen	shenzhen	PROPN
biomedich-267	225	11	,	,	PUNCT
biomedich-267	225	12	china	china	PROPN
biomedich-267	225	13	.	.	PUNCT
biomedich-267	226	1	diabetes	diabetes	NOUN
biomedich-267	226	2	care	care	NOUN
biomedich-267	226	3	.	.	PUNCT
biomedich-267	227	1	chen	chen	PROPN
biomedich-267	227	2	,	,	PUNCT
biomedich-267	227	3	y.	y.	PROPN
biomedich-267	227	4	,	,	PUNCT
biomedich-267	227	5	gong	gong	PROPN
biomedich-267	227	6	,	,	PUNCT
biomedich-267	227	7	x.	x.	PROPN
biomedich-267	227	8	,	,	PUNCT
biomedich-267	227	9	wang	wang	PROPN
biomedich-267	227	10	,	,	PUNCT
biomedich-267	227	11	l.	l.	PROPN
biomedich-267	227	12	,	,	PUNCT
biomedich-267	227	13	&	&	CCONJ
biomedich-267	227	14	guo	guo	PROPN
biomedich-267	227	15	,	,	PUNCT
biomedich-267	227	16	j.	j.	PROPN
biomedich-267	227	17	(	(	PUNCT
biomedich-267	227	18	2020	2020	NUM
biomedich-267	227	19	)	)	PUNCT
biomedich-267	227	20	.	.	PUNCT
biomedich-267	228	1	effects	effect	NOUN
biomedich-267	228	2	of	of	ADP
biomedich-267	228	3	hypertension	hypertension	NOUN
biomedich-267	228	4	,	,	PUNCT
biomedich-267	228	5	diabetes	diabetes	NOUN
biomedich-267	228	6	and	and	CCONJ
biomedich-267	228	7	coronary	coronary	ADJ
biomedich-267	228	8	heart	heart	NOUN
biomedich-267	228	9	disease	disease	NOUN
biomedich-267	228	10	on	on	ADP
biomedich-267	228	11	covid19	covid19	NOUN
biomedich-267	228	12	diseases	disease	NOUN
biomedich-267	228	13	severity	severity	NOUN
biomedich-267	228	14	:	:	PUNCT
biomedich-267	228	15	a	a	DET
biomedich-267	228	16	systematic	systematic	ADJ
biomedich-267	228	17	review	review	NOUN
biomedich-267	228	18	and	and	CCONJ
biomedich-267	228	19	metaanalysis	metaanalysis	NOUN
biomedich-267	228	20	.	.	PUNCT
biomedich-267	229	1	medrxiv	medrxiv	PROPN
biomedich-267	229	2	.	.	PUNCT
biomedich-267	229	3	deng	deng	PROPN
biomedich-267	229	4	,	,	PUNCT
biomedich-267	229	5	m.	m.	NOUN
biomedich-267	229	6	,	,	PUNCT
biomedich-267	229	7	qi	qi	PROPN
biomedich-267	229	8	,	,	PUNCT
biomedich-267	229	9	y.	y.	PROPN
biomedich-267	229	10	,	,	PUNCT
biomedich-267	229	11	deng	deng	PROPN
biomedich-267	229	12	,	,	PUNCT
biomedich-267	229	13	l.	l.	PROPN
biomedich-267	229	14	,	,	PUNCT
biomedich-267	229	15	wang	wang	PROPN
biomedich-267	229	16	,	,	PUNCT
biomedich-267	229	17	h.	h.	PROPN
biomedich-267	229	18	,	,	PUNCT
biomedich-267	229	19	xu	xu	PROPN
biomedich-267	229	20	,	,	PUNCT
biomedich-267	229	21	y.	y.	PROPN
biomedich-267	229	22	,	,	PUNCT
biomedich-267	229	23	li	li	PROPN
biomedich-267	229	24	,	,	PUNCT
biomedich-267	229	25	z.	z.	PROPN
biomedich-267	229	26	,	,	PUNCT
biomedich-267	229	27	...	...	PUNCT
biomedich-267	229	28	&	&	CCONJ
biomedich-267	229	29	dai	dai	PROPN
biomedich-267	229	30	,	,	PUNCT
biomedich-267	229	31	z.	z.	PROPN
biomedich-267	229	32	(	(	PUNCT
biomedich-267	229	33	2020	2020	NUM
biomedich-267	229	34	)	)	PUNCT
biomedich-267	229	35	.	.	PUNCT
biomedich-267	230	1	obesity	obesity	NOUN
biomedich-267	230	2	as	as	ADP
biomedich-267	230	3	a	a	DET
biomedich-267	230	4	potential	potential	ADJ
biomedich-267	230	5	predictor	predictor	NOUN
biomedich-267	230	6	of	of	ADP
biomedich-267	230	7	disease	disease	NOUN
biomedich-267	230	8	severity	severity	NOUN
biomedich-267	230	9	in	in	ADP
biomedich-267	230	10	young	young	ADJ
biomedich-267	230	11	covid‐19	covid‐19	PROPN
biomedich-267	230	12	patients	patient	NOUN
biomedich-267	230	13	:	:	PUNCT
biomedich-267	230	14	a	a	DET
biomedich-267	230	15	retrospective	retrospective	ADJ
biomedich-267	230	16	study	study	NOUN
biomedich-267	230	17	.	.	PUNCT
biomedich-267	231	1	obesity	obesity	NOUN
biomedich-267	231	2	,	,	PUNCT
biomedich-267	231	3	28(10	28(10	NUM
biomedich-267	231	4	)	)	PUNCT
biomedich-267	231	5	,	,	PUNCT
biomedich-267	231	6	1815	1815	NUM
biomedich-267	231	7	-	-	SYM
biomedich-267	231	8	1825	1825	NUM
biomedich-267	231	9	.	.	PUNCT
biomedich-267	232	1	di	di	PROPN
biomedich-267	232	2	carlo	carlo	PROPN
biomedich-267	232	3	,	,	PUNCT
biomedich-267	232	4	d.	d.	PROPN
biomedich-267	232	5	t.	t.	PROPN
biomedich-267	232	6	,	,	PUNCT
biomedich-267	232	7	montemurro	montemurro	PROPN
biomedich-267	232	8	,	,	PUNCT
biomedich-267	232	9	n.	n.	NOUN
biomedich-267	232	10	,	,	PUNCT
biomedich-267	232	11	petrella	petrella	NOUN
biomedich-267	232	12	,	,	PUNCT
biomedich-267	232	13	g.	g.	PROPN
biomedich-267	232	14	,	,	PUNCT
biomedich-267	232	15	siciliano	siciliano	PROPN
biomedich-267	232	16	,	,	PUNCT
biomedich-267	232	17	g.	g.	PROPN
biomedich-267	232	18	,	,	PUNCT
biomedich-267	232	19	ceravolo	ceravolo	PROPN
biomedich-267	232	20	,	,	PUNCT
biomedich-267	232	21	r.	r.	PROPN
biomedich-267	232	22	,	,	PUNCT
biomedich-267	232	23	&	&	CCONJ
biomedich-267	232	24	perrini	perrini	PROPN
biomedich-267	232	25	,	,	PUNCT
biomedich-267	232	26	p.	p.	NOUN
biomedich-267	232	27	(	(	PUNCT
biomedich-267	232	28	2020	2020	NUM
biomedich-267	232	29	)	)	PUNCT
biomedich-267	232	30	.	.	PUNCT
biomedich-267	233	1	exploring	explore	VERB
biomedich-267	233	2	the	the	DET
biomedich-267	233	3	clinical	clinical	ADJ
biomedich-267	233	4	association	association	NOUN
biomedich-267	233	5	between	between	ADP
biomedich-267	233	6	neurological	neurological	ADJ
biomedich-267	233	7	symptoms	symptom	NOUN
biomedich-267	233	8	and	and	CCONJ
biomedich-267	233	9	covid-19	covid-19	PROPN
biomedich-267	233	10	pandemic	pandemic	ADJ
biomedich-267	233	11	outbreak	outbreak	NOUN
biomedich-267	233	12	:	:	PUNCT
biomedich-267	233	13	a	a	DET
biomedich-267	233	14	systematic	systematic	ADJ
biomedich-267	233	15	review	review	NOUN
biomedich-267	233	16	of	of	ADP
biomedich-267	233	17	current	current	ADJ
biomedich-267	233	18	literature	literature	NOUN
biomedich-267	233	19	.	.	PUNCT
biomedich-267	234	1	journal	journal	PROPN
biomedich-267	234	2	of	of	ADP
biomedich-267	234	3	neurology	neurology	NOUN
biomedich-267	234	4	,	,	PUNCT
biomedich-267	234	5	1	1	NUM
biomedich-267	234	6	-	-	SYM
biomedich-267	234	7	9	9	NUM
biomedich-267	234	8	.	.	PUNCT
biomedich-267	235	1	dicker	dicker	PROPN
biomedich-267	235	2	,	,	PUNCT
biomedich-267	235	3	d.	d.	PROPN
biomedich-267	235	4	,	,	PUNCT
biomedich-267	235	5	bettini	bettini	PROPN
biomedich-267	235	6	,	,	PUNCT
biomedich-267	235	7	s.	s.	PROPN
biomedich-267	235	8	,	,	PUNCT
biomedich-267	235	9	farpour	farpour	PROPN
biomedich-267	235	10	-	-	PUNCT
biomedich-267	235	11	lambert	lambert	NOUN
biomedich-267	235	12	,	,	PUNCT
biomedich-267	235	13	n.	n.	NOUN
biomedich-267	235	14	,	,	PUNCT
biomedich-267	235	15	frühbeck	frühbeck	NOUN
biomedich-267	235	16	,	,	PUNCT
biomedich-267	235	17	g.	g.	PROPN
biomedich-267	235	18	,	,	PUNCT
biomedich-267	235	19	golan	golan	PROPN
biomedich-267	235	20	,	,	PUNCT
biomedich-267	235	21	r.	r.	PROPN
biomedich-267	235	22	,	,	PUNCT
biomedich-267	235	23	goossens	goossens	PROPN
biomedich-267	235	24	,	,	PUNCT
biomedich-267	235	25	g.	g.	PROPN
biomedich-267	235	26	,	,	PUNCT
biomedich-267	235	27	...	...	PUNCT
biomedich-267	235	28	&	&	CCONJ
biomedich-267	235	29	hassapiou	hassapiou	NOUN
biomedich-267	235	30	,	,	PUNCT
biomedich-267	235	31	m.	m.	NOUN
biomedich-267	235	32	n.	n.	NOUN
biomedich-267	235	33	(	(	PUNCT
biomedich-267	235	34	2020	2020	NUM
biomedich-267	235	35	)	)	PUNCT
biomedich-267	235	36	.	.	PUNCT
biomedich-267	236	1	obesity	obesity	NOUN
biomedich-267	236	2	and	and	CCONJ
biomedich-267	236	3	covid-19	covid-19	PROPN
biomedich-267	236	4	:	:	PUNCT
biomedich-267	236	5	the	the	DET
biomedich-267	236	6	two	two	NUM
biomedich-267	236	7	sides	side	NOUN
biomedich-267	236	8	of	of	ADP
biomedich-267	236	9	the	the	DET
biomedich-267	236	10	coin	coin	NOUN
biomedich-267	236	11	.	.	PUNCT
biomedich-267	237	1	obesity	obesity	NOUN
biomedich-267	237	2	facts	fact	NOUN
biomedich-267	237	3	,	,	PUNCT
biomedich-267	237	4	13(4	13(4	NUM
biomedich-267	237	5	)	)	PUNCT
biomedich-267	237	6	,	,	PUNCT
biomedich-267	237	7	430	430	NUM
biomedich-267	237	8	-	-	SYM
biomedich-267	237	9	438	438	NUM
biomedich-267	237	10	.	.	PUNCT
biomedich-267	238	1	dietz	dietz	PROPN
biomedich-267	238	2	,	,	PUNCT
biomedich-267	238	3	w.	w.	PROPN
biomedich-267	238	4	,	,	PUNCT
biomedich-267	238	5	&	&	CCONJ
biomedich-267	238	6	santos‐burgoa	santos‐burgoa	NOUN
biomedich-267	238	7	,	,	PUNCT
biomedich-267	238	8	c.	c.	PROPN
biomedich-267	238	9	(	(	PUNCT
biomedich-267	238	10	2020	2020	NUM
biomedich-267	238	11	)	)	PUNCT
biomedich-267	238	12	.	.	PUNCT
biomedich-267	239	1	obesity	obesity	NOUN
biomedich-267	239	2	and	and	CCONJ
biomedich-267	239	3	its	its	PRON
biomedich-267	239	4	implications	implication	NOUN
biomedich-267	239	5	for	for	ADP
biomedich-267	239	6	covid‐19	covid‐19	PROPN
biomedich-267	239	7	mortality	mortality	NOUN
biomedich-267	239	8	.	.	PUNCT
biomedich-267	240	1	obesity	obesity	NOUN
biomedich-267	240	2	,	,	PUNCT
biomedich-267	240	3	28(6	28(6	NUM
biomedich-267	240	4	)	)	PUNCT
biomedich-267	240	5	,	,	PUNCT
biomedich-267	240	6	10051005	10051005	NUM
biomedich-267	240	7	.	.	PUNCT
biomedich-267	241	1	drucker	drucker	PROPN
biomedich-267	241	2	,	,	PUNCT
biomedich-267	241	3	d.	d.	PROPN
biomedich-267	241	4	j.	j.	PROPN
biomedich-267	241	5	(	(	PUNCT
biomedich-267	241	6	2020	2020	NUM
biomedich-267	241	7	)	)	PUNCT
biomedich-267	241	8	.	.	PUNCT
biomedich-267	242	1	coronavirus	coronavirus	NOUN
biomedich-267	242	2	infections	infection	NOUN
biomedich-267	242	3	and	and	CCONJ
biomedich-267	242	4	type	type	NOUN
biomedich-267	242	5	2	2	NUM
biomedich-267	242	6	diabetes	diabetes	NOUN
biomedich-267	242	7	—	—	PUNCT
biomedich-267	242	8	shared	share	VERB
biomedich-267	242	9	pathways	pathway	NOUN
biomedich-267	242	10	with	with	ADP
biomedich-267	242	11	therapeutic	therapeutic	ADJ
biomedich-267	242	12	implications	implication	NOUN
biomedich-267	242	13	.	.	PUNCT
biomedich-267	243	1	endocrine	endocrine	ADJ
biomedich-267	243	2	reviews	review	NOUN
biomedich-267	243	3	,	,	PUNCT
biomedich-267	243	4	41(3	41(3	NUM
biomedich-267	243	5	)	)	PUNCT
biomedich-267	243	6	,	,	PUNCT
biomedich-267	243	7	bnaa011	bnaa011	PROPN
biomedich-267	243	8	.	.	PUNCT
biomedich-267	244	1	finer	finer	PROPN
biomedich-267	244	2	,	,	PUNCT
biomedich-267	244	3	n.	n.	PROPN
biomedich-267	244	4	,	,	PUNCT
biomedich-267	244	5	garnett	garnett	PROPN
biomedich-267	244	6	,	,	PUNCT
biomedich-267	244	7	s.	s.	PROPN
biomedich-267	244	8	p.	p.	PROPN
biomedich-267	244	9	,	,	PUNCT
biomedich-267	244	10	&	&	CCONJ
biomedich-267	244	11	bruun	bruun	PROPN
biomedich-267	244	12	,	,	PUNCT
biomedich-267	244	13	j.	j.	PROPN
biomedich-267	244	14	m.	m.	PROPN
biomedich-267	244	15	(	(	PUNCT
biomedich-267	244	16	2020	2020	NUM
biomedich-267	244	17	)	)	PUNCT
biomedich-267	244	18	.	.	PUNCT
biomedich-267	245	1	covid‐19	covid‐19	PROPN
biomedich-267	245	2	and	and	CCONJ
biomedich-267	245	3	obesity	obesity	NOUN
biomedich-267	245	4	.	.	PUNCT
biomedich-267	246	1	clinical	clinical	ADJ
biomedich-267	246	2	obesity	obesity	NOUN
biomedich-267	246	3	,	,	PUNCT
biomedich-267	246	4	10(3	10(3	NUM
biomedich-267	246	5	)	)	PUNCT
biomedich-267	246	6	.	.	PUNCT
biomedich-267	247	1	goyal	goyal	PROPN
biomedich-267	247	2	,	,	PUNCT
biomedich-267	247	3	p.	p.	NOUN
biomedich-267	247	4	,	,	PUNCT
biomedich-267	247	5	ringel	ringel	NOUN
biomedich-267	247	6	,	,	PUNCT
biomedich-267	247	7	j.	j.	PROPN
biomedich-267	247	8	b.	b.	PROPN
biomedich-267	247	9	,	,	PUNCT
biomedich-267	247	10	rajan	rajan	PROPN
biomedich-267	247	11	,	,	PUNCT
biomedich-267	247	12	m.	m.	NOUN
biomedich-267	247	13	,	,	PUNCT
biomedich-267	247	14	choi	choi	NOUN
biomedich-267	247	15	,	,	PUNCT
biomedich-267	247	16	j.	j.	PROPN
biomedich-267	247	17	j.	j.	PROPN
biomedich-267	247	18	,	,	PUNCT
biomedich-267	247	19	pinheiro	pinheiro	PROPN
biomedich-267	247	20	,	,	PUNCT
biomedich-267	247	21	l.	l.	PROPN
biomedich-267	247	22	c.	c.	PROPN
biomedich-267	247	23	,	,	PUNCT
biomedich-267	247	24	li	li	PROPN
biomedich-267	247	25	,	,	PUNCT
biomedich-267	247	26	h.	h.	PROPN
biomedich-267	247	27	a.	a.	PROPN
biomedich-267	247	28	,	,	PUNCT
biomedich-267	247	29	...	...	PUNCT
biomedich-267	247	30	&	&	CCONJ
biomedich-267	247	31	chen	chen	PROPN
biomedich-267	247	32	,	,	PUNCT
biomedich-267	247	33	r.	r.	PROPN
biomedich-267	247	34	(	(	PUNCT
biomedich-267	247	35	2020	2020	NUM
biomedich-267	247	36	)	)	PUNCT
biomedich-267	247	37	.	.	PUNCT
biomedich-267	248	1	obesity	obesity	NOUN
biomedich-267	248	2	and	and	CCONJ
biomedich-267	248	3	covid-19	covid-19	PROPN
biomedich-267	248	4	in	in	ADP
biomedich-267	248	5	new	new	PROPN
biomedich-267	248	6	york	york	PROPN
biomedich-267	248	7	city	city	PROPN
biomedich-267	248	8	:	:	PUNCT
biomedich-267	248	9	a	a	DET
biomedich-267	248	10	retrospective	retrospective	ADJ
biomedich-267	248	11	cohort	cohort	NOUN
biomedich-267	248	12	study	study	NOUN
biomedich-267	248	13	.	.	PUNCT
biomedich-267	249	1	annals	annal	NOUN
biomedich-267	249	2	of	of	ADP
biomedich-267	249	3	internal	internal	ADJ
biomedich-267	249	4	medicine	medicine	NOUN
biomedich-267	249	5	,	,	PUNCT
biomedich-267	249	6	173(10	173(10	NUM
biomedich-267	249	7	)	)	PUNCT
biomedich-267	249	8	,	,	PUNCT
biomedich-267	249	9	855	855	NUM
biomedich-267	249	10	-	-	SYM
biomedich-267	249	11	858	858	NUM
biomedich-267	249	12	.	.	PUNCT
biomedich-267	250	1	guan	guan	PROPN
biomedich-267	250	2	,	,	PUNCT
biomedich-267	250	3	w.	w.	PROPN
biomedich-267	250	4	j.	j.	PROPN
biomedich-267	250	5	,	,	PUNCT
biomedich-267	250	6	ni	ni	PROPN
biomedich-267	250	7	,	,	PUNCT
biomedich-267	250	8	z.	z.	PROPN
biomedich-267	250	9	y.	y.	PROPN
biomedich-267	250	10	,	,	PUNCT
biomedich-267	250	11	hu	hu	PROPN
biomedich-267	250	12	,	,	PUNCT
biomedich-267	250	13	y.	y.	PROPN
biomedich-267	250	14	,	,	PUNCT
biomedich-267	250	15	liang	liang	PROPN
biomedich-267	250	16	,	,	PUNCT
biomedich-267	250	17	w.	w.	PROPN
biomedich-267	250	18	h.	h.	PROPN
biomedich-267	250	19	,	,	PUNCT
biomedich-267	250	20	ou	ou	PROPN
biomedich-267	250	21	,	,	PUNCT
biomedich-267	250	22	c.	c.	PROPN
biomedich-267	250	23	q.	q.	PROPN
biomedich-267	250	24	,	,	PUNCT
biomedich-267	250	25	he	he	PRON
biomedich-267	250	26	,	,	PUNCT
biomedich-267	250	27	j.	j.	PROPN
biomedich-267	250	28	x.	x.	PROPN
biomedich-267	250	29	,	,	PUNCT
biomedich-267	250	30	...	...	PUNCT
biomedich-267	250	31	&	&	CCONJ
biomedich-267	250	32	du	du	PROPN
biomedich-267	250	33	,	,	PUNCT
biomedich-267	250	34	b.	b.	PROPN
biomedich-267	250	35	(	(	PUNCT
biomedich-267	250	36	2020	2020	NUM
biomedich-267	250	37	)	)	PUNCT
biomedich-267	250	38	.	.	PUNCT
biomedich-267	251	1	clinical	clinical	ADJ
biomedich-267	251	2	characteristics	characteristic	NOUN
biomedich-267	251	3	of	of	ADP
biomedich-267	251	4	coronavirus	coronavirus	NOUN
biomedich-267	251	5	disease	disease	NOUN
biomedich-267	251	6	2019	2019	NUM
biomedich-267	251	7	in	in	ADP
biomedich-267	251	8	china	china	PROPN
biomedich-267	251	9	.	.	PUNCT
biomedich-267	252	1	new	new	PROPN
biomedich-267	252	2	england	england	PROPN
biomedich-267	252	3	journal	journal	PROPN
biomedich-267	252	4	of	of	ADP
biomedich-267	252	5	medicine	medicine	NOUN
biomedich-267	252	6	,	,	PUNCT
biomedich-267	252	7	382(18	382(18	NUM
biomedich-267	252	8	)	)	PUNCT
biomedich-267	252	9	,	,	PUNCT
biomedich-267	252	10	1708	1708	NUM
biomedich-267	252	11	-	-	SYM
biomedich-267	252	12	1720	1720	NUM
biomedich-267	252	13	.	.	PUNCT
biomedich-267	253	1	hales	hales	PROPN
biomedich-267	253	2	,	,	PUNCT
biomedich-267	253	3	c.	c.	PROPN
biomedich-267	253	4	m.	m.	PROPN
biomedich-267	253	5	,	,	PUNCT
biomedich-267	253	6	carroll	carroll	PROPN
biomedich-267	253	7	,	,	PUNCT
biomedich-267	253	8	m.	m.	NOUN
biomedich-267	253	9	d.	d.	PROPN
biomedich-267	253	10	,	,	PUNCT
biomedich-267	253	11	fryar	fryar	PROPN
biomedich-267	253	12	,	,	PUNCT
biomedich-267	253	13	c.	c.	PROPN
biomedich-267	253	14	d.	d.	PROPN
biomedich-267	253	15	,	,	PUNCT
biomedich-267	253	16	&	&	CCONJ
biomedich-267	253	17	ogden	ogden	PROPN
biomedich-267	253	18	,	,	PUNCT
biomedich-267	253	19	c.	c.	PROPN
biomedich-267	253	20	l.	l.	PROPN
biomedich-267	253	21	(	(	PUNCT
biomedich-267	253	22	2020	2020	NUM
biomedich-267	253	23	)	)	PUNCT
biomedich-267	253	24	.	.	PUNCT
biomedich-267	254	1	prevalence	prevalence	NOUN
biomedich-267	254	2	of	of	ADP
biomedich-267	254	3	obesity	obesity	NOUN
biomedich-267	254	4	and	and	CCONJ
biomedich-267	254	5	severe	severe	ADJ
biomedich-267	254	6	obesity	obesity	NOUN
biomedich-267	254	7	among	among	ADP
biomedich-267	254	8	adults	adult	NOUN
biomedich-267	254	9	:	:	PUNCT
biomedich-267	254	10	united	united	PROPN
biomedich-267	254	11	states	states	PROPN
biomedich-267	254	12	,	,	PUNCT
biomedich-267	254	13	2017–2018	2017–2018	NUM
biomedich-267	254	14	.	.	PUNCT
biomedich-267	255	1	hamer	hamer	NOUN
biomedich-267	255	2	,	,	PUNCT
biomedich-267	255	3	m.	m.	NOUN
biomedich-267	255	4	,	,	PUNCT
biomedich-267	255	5	gale	gale	NOUN
biomedich-267	255	6	,	,	PUNCT
biomedich-267	255	7	c.	c.	PROPN
biomedich-267	255	8	r.	r.	PROPN
biomedich-267	255	9	,	,	PUNCT
biomedich-267	255	10	kivimäki	kivimäki	PROPN
biomedich-267	255	11	,	,	PUNCT
biomedich-267	255	12	m.	m.	NOUN
biomedich-267	255	13	,	,	PUNCT
biomedich-267	255	14	&	&	CCONJ
biomedich-267	255	15	batty	batty	PROPN
biomedich-267	255	16	,	,	PUNCT
biomedich-267	255	17	g.	g.	PROPN
biomedich-267	255	18	d.	d.	PROPN
biomedich-267	255	19	(	(	PUNCT
biomedich-267	255	20	2020	2020	NUM
biomedich-267	255	21	)	)	PUNCT
biomedich-267	255	22	.	.	PUNCT
biomedich-267	256	1	overweight	overweight	ADJ
biomedich-267	256	2	,	,	PUNCT
biomedich-267	256	3	obesity	obesity	NOUN
biomedich-267	256	4	,	,	PUNCT
biomedich-267	256	5	and	and	CCONJ
biomedich-267	256	6	risk	risk	NOUN
biomedich-267	256	7	of	of	ADP
biomedich-267	256	8	hospitalization	hospitalization	NOUN
biomedich-267	256	9	for	for	ADP
biomedich-267	256	10	covid19	covid19	NOUN
biomedich-267	256	11	:	:	PUNCT
biomedich-267	256	12	a	a	DET
biomedich-267	256	13	community	community	NOUN
biomedich-267	256	14	-	-	PUNCT
biomedich-267	256	15	based	base	VERB
biomedich-267	256	16	cohort	cohort	NOUN
biomedich-267	256	17	study	study	NOUN
biomedich-267	256	18	of	of	ADP
biomedich-267	256	19	adults	adult	NOUN
biomedich-267	256	20	in	in	ADP
biomedich-267	256	21	the	the	DET
biomedich-267	256	22	united	united	ADJ
biomedich-267	256	23	kingdom	kingdom	PROPN
biomedich-267	256	24	.	.	PUNCT
biomedich-267	257	1	proceedings	proceeding	NOUN
biomedich-267	257	2	of	of	ADP
biomedich-267	257	3	the	the	DET
biomedich-267	257	4	national	national	PROPN
biomedich-267	257	5	academy	academy	PROPN
biomedich-267	257	6	of	of	ADP
biomedich-267	257	7	sciences	sciences	PROPN
biomedich-267	257	8	,	,	PUNCT
biomedich-267	257	9	117(35	117(35	NUM
biomedich-267	257	10	)	)	PUNCT
biomedich-267	257	11	,	,	PUNCT
biomedich-267	257	12	21011	21011	NUM
biomedich-267	257	13	-	-	SYM
biomedich-267	257	14	21013	21013	NUM
biomedich-267	257	15	.	.	PUNCT
biomedich-267	258	1	hartmann	hartmann	PROPN
biomedich-267	258	2	-	-	PUNCT
biomedich-267	258	3	boyce	boyce	PROPN
biomedich-267	258	4	,	,	PUNCT
biomedich-267	258	5	j.	j.	PROPN
biomedich-267	258	6	,	,	PUNCT
biomedich-267	258	7	morris	morris	PROPN
biomedich-267	258	8	,	,	PUNCT
biomedich-267	258	9	e.	e.	PROPN
biomedich-267	258	10	,	,	PUNCT
biomedich-267	258	11	goyder	goyder	PROPN
biomedich-267	258	12	,	,	PUNCT
biomedich-267	258	13	c.	c.	PROPN
biomedich-267	258	14	,	,	PUNCT
biomedich-267	258	15	kinton	kinton	PROPN
biomedich-267	258	16	,	,	PUNCT
biomedich-267	258	17	j.	j.	PROPN
biomedich-267	258	18	,	,	PUNCT
biomedich-267	258	19	perring	perring	PROPN
biomedich-267	258	20	,	,	PUNCT
biomedich-267	258	21	j.	j.	PROPN
biomedich-267	258	22	,	,	PUNCT
biomedich-267	258	23	nunan	nunan	PROPN
biomedich-267	258	24	,	,	PUNCT
biomedich-267	258	25	d.	d.	PROPN
biomedich-267	258	26	,	,	PUNCT
biomedich-267	258	27	...	...	PUNCT
biomedich-267	258	28	&	&	CCONJ
biomedich-267	258	29	roussel	roussel	PROPN
biomedich-267	258	30	,	,	PUNCT
biomedich-267	258	31	r.	r.	PROPN
biomedich-267	258	32	(	(	PUNCT
biomedich-267	258	33	2020	2020	NUM
biomedich-267	258	34	)	)	PUNCT
biomedich-267	258	35	.	.	PUNCT
biomedich-267	259	1	diabetes	diabetes	NOUN
biomedich-267	259	2	and	and	CCONJ
biomedich-267	259	3	covid19	covid19	NOUN
biomedich-267	259	4	:	:	PUNCT
biomedich-267	259	5	risks	risk	NOUN
biomedich-267	259	6	,	,	PUNCT
biomedich-267	259	7	management	management	NOUN
biomedich-267	259	8	,	,	PUNCT
biomedich-267	259	9	and	and	CCONJ
biomedich-267	259	10	learnings	learning	NOUN
biomedich-267	259	11	from	from	ADP
biomedich-267	259	12	other	other	ADJ
biomedich-267	259	13	national	national	ADJ
biomedich-267	259	14	disasters	disaster	NOUN
biomedich-267	259	15	.	.	PUNCT
biomedich-267	260	1	diabetes	diabetes	NOUN
biomedich-267	260	2	care	care	NOUN
biomedich-267	260	3	,	,	PUNCT
biomedich-267	260	4	43(8	43(8	NOUN
biomedich-267	260	5	)	)	PUNCT
biomedich-267	260	6	,	,	PUNCT
biomedich-267	260	7	1695	1695	NUM
biomedich-267	260	8	-	-	SYM
biomedich-267	260	9	1703	1703	NUM
biomedich-267	260	10	.	.	PUNCT
biomedich-267	261	1	huang	huang	PROPN
biomedich-267	261	2	,	,	PUNCT
biomedich-267	261	3	i.	i.	PROPN
biomedich-267	261	4	,	,	PUNCT
biomedich-267	261	5	lim	lim	PROPN
biomedich-267	261	6	,	,	PUNCT
biomedich-267	261	7	m.	m.	NOUN
biomedich-267	261	8	a.	a.	PROPN
biomedich-267	261	9	,	,	PUNCT
biomedich-267	261	10	&	&	CCONJ
biomedich-267	261	11	pranata	pranata	PROPN
biomedich-267	261	12	,	,	PUNCT
biomedich-267	261	13	r.	r.	PROPN
biomedich-267	261	14	(	(	PUNCT
biomedich-267	261	15	2020	2020	NUM
biomedich-267	261	16	)	)	PUNCT
biomedich-267	261	17	.	.	PUNCT
biomedich-267	262	1	diabetes	diabetes	NOUN
biomedich-267	262	2	mellitus	mellitus	NOUN
biomedich-267	262	3	is	be	AUX
biomedich-267	262	4	associated	associate	VERB
biomedich-267	262	5	with	with	ADP
biomedich-267	262	6	increased	increase	VERB
biomedich-267	262	7	mortality	mortality	NOUN
biomedich-267	262	8	and	and	CCONJ
biomedich-267	262	9	severity	severity	NOUN
biomedich-267	262	10	of	of	ADP
biomedich-267	262	11	disease	disease	NOUN
biomedich-267	262	12	in	in	ADP
biomedich-267	262	13	covid-19	covid-19	PROPN
biomedich-267	262	14	pneumonia	pneumonia	NOUN
biomedich-267	262	15	–	–	PUNCT
biomedich-267	262	16	a	a	DET
biomedich-267	262	17	systematic	systematic	ADJ
biomedich-267	262	18	review	review	NOUN
biomedich-267	262	19	,	,	PUNCT
biomedich-267	262	20	meta	meta	ADJ
biomedich-267	262	21	-	-	PUNCT
biomedich-267	262	22	analysis	analysis	NOUN
biomedich-267	262	23	,	,	PUNCT
biomedich-267	262	24	and	and	CCONJ
biomedich-267	262	25	meta	meta	ADJ
biomedich-267	262	26	-	-	PUNCT
biomedich-267	262	27	regression	regression	NOUN
biomedich-267	262	28	.	.	PUNCT
biomedich-267	263	1	diabetes	diabetes	NOUN
biomedich-267	263	2	&	&	CCONJ
biomedich-267	263	3	metabolic	metabolic	PROPN
biomedich-267	263	4	syndrome	syndrome	PROPN
biomedich-267	263	5	:	:	PUNCT
biomedich-267	263	6	clinical	clinical	ADJ
biomedich-267	263	7	research	research	NOUN
biomedich-267	263	8	&	&	CCONJ
biomedich-267	263	9	reviews	review	NOUN
biomedich-267	263	10	.	.	PUNCT
biomedich-267	264	1	hussain	hussain	PROPN
biomedich-267	264	2	,	,	PUNCT
biomedich-267	264	3	a.	a.	NOUN
biomedich-267	264	4	,	,	PUNCT
biomedich-267	264	5	bhowmik	bhowmik	ADJ
biomedich-267	264	6	,	,	PUNCT
biomedich-267	264	7	b.	b.	PROPN
biomedich-267	264	8	,	,	PUNCT
biomedich-267	264	9	&	&	CCONJ
biomedich-267	264	10	do	do	VERB
biomedich-267	264	11	vale	vale	PROPN
biomedich-267	264	12	moreira	moreira	PROPN
biomedich-267	264	13	,	,	PUNCT
biomedich-267	264	14	n.	n.	PROPN
biomedich-267	264	15	c.	c.	PROPN
biomedich-267	264	16	(	(	PUNCT
biomedich-267	264	17	2020	2020	NUM
biomedich-267	264	18	)	)	PUNCT
biomedich-267	264	19	.	.	PUNCT
biomedich-267	265	1	covid-19	covid-19	PROPN
biomedich-267	265	2	and	and	CCONJ
biomedich-267	265	3	diabetes	diabetes	NOUN
biomedich-267	265	4	:	:	PUNCT
biomedich-267	265	5	knowledge	knowledge	NOUN
biomedich-267	265	6	in	in	ADP
biomedich-267	265	7	progress	progress	NOUN
biomedich-267	265	8	.	.	PUNCT
biomedich-267	266	1	diabetes	diabetes	NOUN
biomedich-267	266	2	research	research	NOUN
biomedich-267	266	3	and	and	CCONJ
biomedich-267	266	4	clinical	clinical	ADJ
biomedich-267	266	5	practice	practice	NOUN
biomedich-267	266	6	,	,	PUNCT
biomedich-267	266	7	108142	108142	NUM
biomedich-267	266	8	.	.	PUNCT
biomedich-267	267	1	hussain	hussain	PROPN
biomedich-267	267	2	,	,	PUNCT
biomedich-267	267	3	a.	a.	PROPN
biomedich-267	267	4	,	,	PUNCT
biomedich-267	267	5	mahawar	mahawar	PROPN
biomedich-267	267	6	,	,	PUNCT
biomedich-267	267	7	k.	k.	PROPN
biomedich-267	267	8	,	,	PUNCT
biomedich-267	267	9	xia	xia	PROPN
biomedich-267	267	10	,	,	PUNCT
biomedich-267	267	11	z.	z.	PROPN
biomedich-267	267	12	,	,	PUNCT
biomedich-267	267	13	yang	yang	PROPN
biomedich-267	267	14	,	,	PUNCT
biomedich-267	267	15	w.	w.	PROPN
biomedich-267	267	16	,	,	PUNCT
biomedich-267	267	17	&	&	CCONJ
biomedich-267	267	18	shamsi	shamsi	PROPN
biomedich-267	267	19	,	,	PUNCT
biomedich-267	267	20	e.	e.	PROPN
biomedich-267	267	21	h.	h.	PROPN
biomedich-267	267	22	(	(	PUNCT
biomedich-267	267	23	2020	2020	NUM
biomedich-267	267	24	)	)	PUNCT
biomedich-267	267	25	.	.	PUNCT
biomedich-267	268	1	obesity	obesity	NOUN
biomedich-267	268	2	and	and	CCONJ
biomedich-267	268	3	mortality	mortality	NOUN
biomedich-267	268	4	of	of	ADP
biomedich-267	268	5	covid-19	covid-19	PROPN
biomedich-267	268	6	.	.	PUNCT
biomedich-267	269	1	meta	meta	ADJ
biomedich-267	269	2	-	-	PUNCT
biomedich-267	269	3	analysis	analysis	NOUN
biomedich-267	269	4	.	.	PUNCT
biomedich-267	270	1	obesity	obesity	NOUN
biomedich-267	270	2	research	research	NOUN
biomedich-267	270	3	&	&	CCONJ
biomedich-267	270	4	clinical	clinical	ADJ
biomedich-267	270	5	practice	practice	NOUN
biomedich-267	270	6	.	.	PUNCT
biomedich-267	271	1	hussain	hussain	PROPN
biomedich-267	271	2	,	,	PUNCT
biomedich-267	271	3	s.	s.	PROPN
biomedich-267	271	4	,	,	PUNCT
biomedich-267	271	5	baxi	baxi	PROPN
biomedich-267	271	6	,	,	PUNCT
biomedich-267	271	7	h.	h.	PROPN
biomedich-267	271	8	,	,	PUNCT
biomedich-267	271	9	jamali	jamali	PROPN
biomedich-267	271	10	,	,	PUNCT
biomedich-267	271	11	m.	m.	PROPN
biomedich-267	271	12	c.	c.	PROPN
biomedich-267	271	13	,	,	PUNCT
biomedich-267	271	14	nisar	nisar	PROPN
biomedich-267	271	15	,	,	PUNCT
biomedich-267	271	16	n.	n.	NOUN
biomedich-267	271	17	,	,	PUNCT
biomedich-267	271	18	&	&	CCONJ
biomedich-267	271	19	hussain	hussain	PROPN
biomedich-267	271	20	,	,	PUNCT
biomedich-267	271	21	m.	m.	NOUN
biomedich-267	271	22	s.	s.	PROPN
biomedich-267	271	23	(	(	PUNCT
biomedich-267	271	24	2020	2020	NUM
biomedich-267	271	25	)	)	PUNCT
biomedich-267	271	26	.	.	PUNCT
biomedich-267	272	1	burden	burden	NOUN
biomedich-267	272	2	of	of	ADP
biomedich-267	272	3	diabetes	diabetes	NOUN
biomedich-267	272	4	mellitus	mellitus	NOUN
biomedich-267	272	5	and	and	CCONJ
biomedich-267	272	6	its	its	PRON
biomedich-267	272	7	impact	impact	NOUN
biomedich-267	272	8	on	on	ADP
biomedich-267	272	9	covid-19	covid-19	PROPN
biomedich-267	272	10	patients	patient	NOUN
biomedich-267	272	11	:	:	PUNCT
biomedich-267	272	12	a	a	DET
biomedich-267	272	13	meta	meta	ADJ
biomedich-267	272	14	-	-	PUNCT
biomedich-267	272	15	analysis	analysis	NOUN
biomedich-267	272	16	of	of	ADP
biomedich-267	272	17	real	real	ADJ
biomedich-267	272	18	-	-	PUNCT
biomedich-267	272	19	world	world	NOUN
biomedich-267	272	20	evidence	evidence	NOUN
biomedich-267	272	21	.	.	PUNCT
biomedich-267	273	1	diabetes	diabetes	NOUN
biomedich-267	273	2	&	&	CCONJ
biomedich-267	273	3	metabolic	metabolic	PROPN
biomedich-267	273	4	syndrome	syndrome	PROPN
biomedich-267	273	5	:	:	PUNCT
biomedich-267	273	6	clinical	clinical	ADJ
biomedich-267	273	7	research	research	NOUN
biomedich-267	273	8	&	&	CCONJ
biomedich-267	273	9	reviews	review	NOUN
biomedich-267	273	10	,	,	PUNCT
biomedich-267	273	11	14(6	14(6	NOUN
biomedich-267	273	12	)	)	PUNCT
biomedich-267	273	13	,	,	PUNCT
biomedich-267	273	14	1595	1595	NUM
biomedich-267	273	15	-	-	SYM
biomedich-267	273	16	1602	1602	NUM
biomedich-267	273	17	.	.	PUNCT
biomedich-267	274	1	kaiser	kaiser	PROPN
biomedich-267	274	2	,	,	PUNCT
biomedich-267	274	3	u.	u.	PROPN
biomedich-267	274	4	b.	b.	PROPN
biomedich-267	274	5	,	,	PUNCT
biomedich-267	274	6	mirmira	mirmira	PROPN
biomedich-267	274	7	,	,	PUNCT
biomedich-267	274	8	r.	r.	PROPN
biomedich-267	274	9	g.	g.	PROPN
biomedich-267	274	10	,	,	PUNCT
biomedich-267	274	11	&	&	CCONJ
biomedich-267	274	12	stewart	stewart	PROPN
biomedich-267	274	13	,	,	PUNCT
biomedich-267	274	14	p.	p.	NOUN
biomedich-267	274	15	m.	m.	NOUN
biomedich-267	274	16	(	(	PUNCT
biomedich-267	274	17	2020	2020	NUM
biomedich-267	274	18	)	)	PUNCT
biomedich-267	274	19	.	.	PUNCT
biomedich-267	275	1	our	our	PRON
biomedich-267	275	2	response	response	NOUN
biomedich-267	275	3	to	to	ADP
biomedich-267	275	4	covid-19	covid-19	PROPN
biomedich-267	275	5	as	as	ADP
biomedich-267	275	6	endocrinologists	endocrinologist	NOUN
biomedich-267	275	7	and	and	CCONJ
biomedich-267	275	8	diabetologists	diabetologist	NOUN
biomedich-267	275	9	.	.	PUNCT
biomedich-267	276	1	kang	kang	PROPN
biomedich-267	276	2	,	,	PUNCT
biomedich-267	276	3	z.	z.	PROPN
biomedich-267	276	4	,	,	PUNCT
biomedich-267	276	5	luo	luo	PROPN
biomedich-267	276	6	,	,	PUNCT
biomedich-267	276	7	s.	s.	PROPN
biomedich-267	276	8	,	,	PUNCT
biomedich-267	276	9	gui	gui	PROPN
biomedich-267	276	10	,	,	PUNCT
biomedich-267	276	11	y.	y.	PROPN
biomedich-267	276	12	,	,	PUNCT
biomedich-267	276	13	zhou	zhou	PROPN
biomedich-267	276	14	,	,	PUNCT
biomedich-267	276	15	h.	h.	PROPN
biomedich-267	276	16	,	,	PUNCT
biomedich-267	276	17	zhang	zhang	PROPN
biomedich-267	276	18	,	,	PUNCT
biomedich-267	276	19	z.	z.	PROPN
biomedich-267	276	20	,	,	PUNCT
biomedich-267	276	21	tian	tian	PROPN
biomedich-267	276	22	,	,	PUNCT
biomedich-267	276	23	c.	c.	PROPN
biomedich-267	276	24	,	,	PUNCT
biomedich-267	276	25	...	...	PUNCT
biomedich-267	276	26	&	&	CCONJ
biomedich-267	276	27	hu	hu	PROPN
biomedich-267	276	28	,	,	PUNCT
biomedich-267	276	29	d.	d.	PROPN
biomedich-267	276	30	(	(	PUNCT
biomedich-267	276	31	2020	2020	NUM
biomedich-267	276	32	)	)	PUNCT
biomedich-267	276	33	.	.	PUNCT
biomedich-267	277	1	obesity	obesity	NOUN
biomedich-267	277	2	is	be	AUX
biomedich-267	277	3	a	a	DET
biomedich-267	277	4	potential	potential	ADJ
biomedich-267	277	5	risk	risk	NOUN
biomedich-267	277	6	factor	factor	NOUN
biomedich-267	277	7	contributing	contribute	VERB
biomedich-267	277	8	to	to	ADP
biomedich-267	277	9	clinical	clinical	ADJ
biomedich-267	277	10	manifestations	manifestation	NOUN
biomedich-267	277	11	of	of	ADP
biomedich-267	277	12	covid-19	covid-19	PROPN
biomedich-267	277	13	.	.	PUNCT
biomedich-267	278	1	international	international	PROPN
biomedich-267	278	2	journal	journal	PROPN
biomedich-267	278	3	of	of	ADP
biomedich-267	278	4	obesity	obesity	NOUN
biomedich-267	278	5	,	,	PUNCT
biomedich-267	278	6	44(12	44(12	NUM
biomedich-267	278	7	)	)	PUNCT
biomedich-267	278	8	,	,	PUNCT
biomedich-267	278	9	2479	2479	NUM
biomedich-267	278	10	-	-	SYM
biomedich-267	278	11	2485	2485	NUM
biomedich-267	278	12	.	.	PUNCT
biomedich-267	279	1	kassir	kassir	PROPN
biomedich-267	279	2	,	,	PUNCT
biomedich-267	279	3	r.	r.	PROPN
biomedich-267	279	4	(	(	PUNCT
biomedich-267	279	5	2020	2020	NUM
biomedich-267	279	6	)	)	PUNCT
biomedich-267	279	7	.	.	PUNCT
biomedich-267	280	1	risk	risk	NOUN
biomedich-267	280	2	of	of	ADP
biomedich-267	280	3	covid‐19	covid‐19	PROPN
biomedich-267	280	4	for	for	ADP
biomedich-267	280	5	patients	patient	NOUN
biomedich-267	280	6	with	with	ADP
biomedich-267	280	7	obesity	obesity	NOUN
biomedich-267	280	8	.	.	PUNCT
biomedich-267	281	1	obesity	obesity	NOUN
biomedich-267	281	2	reviews	review	NOUN
biomedich-267	281	3	,	,	PUNCT
biomedich-267	281	4	21(6	21(6	NUM
biomedich-267	281	5	)	)	PUNCT
biomedich-267	281	6	.	.	PUNCT
biomedich-267	282	1	kaur	kaur	PROPN
biomedich-267	282	2	,	,	PUNCT
biomedich-267	282	3	d.	d.	PROPN
biomedich-267	282	4	,	,	PUNCT
biomedich-267	282	5	galloway	galloway	PROPN
biomedich-267	282	6	,	,	PUNCT
biomedich-267	282	7	g.	g.	PROPN
biomedich-267	282	8	k.	k.	PROPN
biomedich-267	282	9	,	,	PUNCT
biomedich-267	282	10	&	&	CCONJ
biomedich-267	282	11	oyibo	oyibo	PROPN
biomedich-267	282	12	,	,	PUNCT
biomedich-267	282	13	s.	s.	PROPN
biomedich-267	282	14	o.	o.	PROPN
biomedich-267	282	15	(	(	PUNCT
biomedich-267	282	16	2020	2020	NUM
biomedich-267	282	17	)	)	PUNCT
biomedich-267	282	18	.	.	PUNCT
biomedich-267	283	1	patient	patient	ADJ
biomedich-267	283	2	satisfaction	satisfaction	NOUN
biomedich-267	283	3	with	with	ADP
biomedich-267	283	4	the	the	DET
biomedich-267	283	5	use	use	NOUN
biomedich-267	283	6	of	of	ADP
biomedich-267	283	7	telemedicine	telemedicine	NOUN
biomedich-267	283	8	in	in	ADP
biomedich-267	283	9	the	the	DET
biomedich-267	283	10	management	management	NOUN
biomedich-267	283	11	of	of	ADP
biomedich-267	283	12	hyperthyroidism	hyperthyroidism	NOUN
biomedich-267	283	13	.	.	PUNCT
biomedich-267	284	1	cureus	cureus	NOUN
biomedich-267	284	2	,	,	PUNCT
biomedich-267	284	3	12(8	12(8	NUM
biomedich-267	284	4	)	)	PUNCT
biomedich-267	284	5	.	.	PUNCT
biomedich-267	285	1	52	52	NUM
biomedich-267	285	2	biology	biology	NOUN
biomedich-267	285	3	,	,	PUNCT
biomedich-267	285	4	medicine	medicine	NOUN
biomedich-267	285	5	,	,	PUNCT
biomedich-267	285	6	&	&	CCONJ
biomedich-267	285	7	natural	natural	ADJ
biomedich-267	285	8	product	product	NOUN
biomedich-267	285	9	chemistry	chemistry	NOUN
biomedich-267	285	10	12	12	NUM
biomedich-267	285	11	(	(	PUNCT
biomedich-267	285	12	1	1	NUM
biomedich-267	285	13	)	)	PUNCT
biomedich-267	285	14	,	,	PUNCT
biomedich-267	285	15	2023	2023	NUM
biomedich-267	285	16	:	:	PUNCT
biomedich-267	285	17	45	45	NUM
biomedich-267	285	18	-	-	SYM
biomedich-267	285	19	53	53	NUM
biomedich-267	285	20	koliaki	koliaki	ADJ
biomedich-267	285	21	,	,	PUNCT
biomedich-267	285	22	c.	c.	PROPN
biomedich-267	285	23	,	,	PUNCT
biomedich-267	285	24	tentolouris	tentolouris	PROPN
biomedich-267	285	25	,	,	PUNCT
biomedich-267	285	26	a.	a.	NOUN
biomedich-267	285	27	,	,	PUNCT
biomedich-267	285	28	eleftheriadou	eleftheriadou	NOUN
biomedich-267	285	29	,	,	PUNCT
biomedich-267	285	30	i.	i.	PROPN
biomedich-267	285	31	,	,	PUNCT
biomedich-267	285	32	melidonis	melidonis	PROPN
biomedich-267	285	33	,	,	PUNCT
biomedich-267	285	34	a.	a.	NOUN
biomedich-267	285	35	,	,	PUNCT
biomedich-267	285	36	dimitriadis	dimitriadis	VERB
biomedich-267	285	37	,	,	PUNCT
biomedich-267	285	38	g.	g.	PROPN
biomedich-267	285	39	,	,	PUNCT
biomedich-267	285	40	&	&	CCONJ
biomedich-267	285	41	tentolouris	tentolouris	PROPN
biomedich-267	285	42	,	,	PUNCT
biomedich-267	285	43	n.	n.	PROPN
biomedich-267	285	44	(	(	PUNCT
biomedich-267	285	45	2020	2020	NUM
biomedich-267	285	46	)	)	PUNCT
biomedich-267	285	47	.	.	PUNCT
biomedich-267	286	1	clinical	clinical	ADJ
biomedich-267	286	2	management	management	NOUN
biomedich-267	286	3	of	of	ADP
biomedich-267	286	4	diabetes	diabetes	NOUN
biomedich-267	286	5	mellitus	mellitus	NOUN
biomedich-267	286	6	in	in	ADP
biomedich-267	286	7	the	the	DET
biomedich-267	286	8	era	era	NOUN
biomedich-267	286	9	of	of	ADP
biomedich-267	286	10	covid-19	covid-19	PROPN
biomedich-267	286	11	:	:	PUNCT
biomedich-267	286	12	practical	practical	ADJ
biomedich-267	286	13	issues	issue	NOUN
biomedich-267	286	14	,	,	PUNCT
biomedich-267	286	15	peculiarities	peculiarity	NOUN
biomedich-267	286	16	and	and	CCONJ
biomedich-267	286	17	concerns	concern	NOUN
biomedich-267	286	18	.	.	PUNCT
biomedich-267	287	1	journal	journal	NOUN
biomedich-267	287	2	of	of	ADP
biomedich-267	287	3	clinical	clinical	ADJ
biomedich-267	287	4	medicine	medicine	NOUN
biomedich-267	287	5	,	,	PUNCT
biomedich-267	287	6	9(7	9(7	NUM
biomedich-267	287	7	)	)	PUNCT
biomedich-267	287	8	,	,	PUNCT
biomedich-267	287	9	2288	2288	NUM
biomedich-267	287	10	.	.	PUNCT
biomedich-267	288	1	kreutz	kreutz	PROPN
biomedich-267	288	2	,	,	PUNCT
biomedich-267	288	3	r.	r.	PROPN
biomedich-267	288	4	,	,	PUNCT
biomedich-267	288	5	algharably	algharably	ADV
biomedich-267	288	6	,	,	PUNCT
biomedich-267	288	7	e.	e.	PROPN
biomedich-267	288	8	a.	a.	PROPN
biomedich-267	288	9	e.	e.	PROPN
biomedich-267	288	10	h.	h.	PROPN
biomedich-267	288	11	,	,	PUNCT
biomedich-267	288	12	azizi	azizi	PROPN
biomedich-267	288	13	,	,	PUNCT
biomedich-267	288	14	m.	m.	NOUN
biomedich-267	288	15	,	,	PUNCT
biomedich-267	288	16	dobrowolski	dobrowolski	ADJ
biomedich-267	288	17	,	,	PUNCT
biomedich-267	288	18	p.	p.	NOUN
biomedich-267	288	19	,	,	PUNCT
biomedich-267	288	20	guzik	guzik	NOUN
biomedich-267	288	21	,	,	PUNCT
biomedich-267	288	22	t.	t.	PROPN
biomedich-267	288	23	,	,	PUNCT
biomedich-267	288	24	januszewicz	januszewicz	PROPN
biomedich-267	288	25	,	,	PUNCT
biomedich-267	288	26	a.	a.	NOUN
biomedich-267	288	27	,	,	PUNCT
biomedich-267	288	28	...	...	PUNCT
biomedich-267	288	29	&	&	CCONJ
biomedich-267	288	30	burnier	burnier	NOUN
biomedich-267	288	31	,	,	PUNCT
biomedich-267	288	32	m.	m.	NOUN
biomedich-267	288	33	(	(	PUNCT
biomedich-267	288	34	2020	2020	NUM
biomedich-267	288	35	)	)	PUNCT
biomedich-267	288	36	.	.	PUNCT
biomedich-267	289	1	hypertension	hypertension	NOUN
biomedich-267	289	2	,	,	PUNCT
biomedich-267	289	3	the	the	DET
biomedich-267	289	4	renin	renin	ADJ
biomedich-267	289	5	–	–	PUNCT
biomedich-267	289	6	angiotensin	angiotensin	NOUN
biomedich-267	289	7	system	system	NOUN
biomedich-267	289	8	,	,	PUNCT
biomedich-267	289	9	and	and	CCONJ
biomedich-267	289	10	the	the	DET
biomedich-267	289	11	risk	risk	NOUN
biomedich-267	289	12	of	of	ADP
biomedich-267	289	13	lower	low	ADJ
biomedich-267	289	14	respiratory	respiratory	ADJ
biomedich-267	289	15	tract	tract	NOUN
biomedich-267	289	16	infections	infection	NOUN
biomedich-267	289	17	and	and	CCONJ
biomedich-267	289	18	lung	lung	NOUN
biomedich-267	289	19	injury	injury	NOUN
biomedich-267	289	20	:	:	PUNCT
biomedich-267	289	21	implications	implication	NOUN
biomedich-267	289	22	for	for	ADP
biomedich-267	289	23	covid-19european	covid-19european	PROPN
biomedich-267	289	24	society	society	NOUN
biomedich-267	289	25	of	of	ADP
biomedich-267	289	26	hypertension	hypertension	NOUN
biomedich-267	289	27	covid-19	covid-19	PROPN
biomedich-267	289	28	task	task	PROPN
biomedich-267	289	29	force	force	NOUN
biomedich-267	289	30	review	review	NOUN
biomedich-267	289	31	of	of	ADP
biomedich-267	289	32	evidence	evidence	NOUN
biomedich-267	289	33	.	.	PUNCT
biomedich-267	290	1	cardiovascular	cardiovascular	ADJ
biomedich-267	290	2	research	research	NOUN
biomedich-267	290	3	.	.	PUNCT
biomedich-267	291	1	kumar	kumar	PROPN
biomedich-267	291	2	,	,	PUNCT
biomedich-267	291	3	a.	a.	PROPN
biomedich-267	291	4	,	,	PUNCT
biomedich-267	291	5	arora	arora	PROPN
biomedich-267	291	6	,	,	PUNCT
biomedich-267	291	7	a.	a.	PROPN
biomedich-267	291	8	,	,	PUNCT
biomedich-267	291	9	sharma	sharma	PROPN
biomedich-267	291	10	,	,	PUNCT
biomedich-267	291	11	p.	p.	PROPN
biomedich-267	291	12	,	,	PUNCT
biomedich-267	291	13	anikhindi	anikhindi	PROPN
biomedich-267	291	14	,	,	PUNCT
biomedich-267	291	15	s.	s.	PROPN
biomedich-267	291	16	a.	a.	PROPN
biomedich-267	291	17	,	,	PUNCT
biomedich-267	291	18	bansal	bansal	NOUN
biomedich-267	291	19	,	,	PUNCT
biomedich-267	291	20	n.	n.	NOUN
biomedich-267	291	21	,	,	PUNCT
biomedich-267	291	22	singla	singla	PRON
biomedich-267	291	23	,	,	PUNCT
biomedich-267	291	24	v.	v.	ADV
biomedich-267	291	25	,	,	PUNCT
biomedich-267	291	26	...	...	PUNCT
biomedich-267	291	27	&	&	CCONJ
biomedich-267	291	28	srivastava	srivastava	PROPN
biomedich-267	291	29	,	,	PUNCT
biomedich-267	291	30	a.	a.	NOUN
biomedich-267	291	31	(	(	PUNCT
biomedich-267	291	32	2020	2020	NUM
biomedich-267	291	33	)	)	PUNCT
biomedich-267	291	34	.	.	PUNCT
biomedich-267	291	35	is	be	AUX
biomedich-267	291	36	diabetes	diabetes	NOUN
biomedich-267	291	37	mellitus	mellitus	NOUN
biomedich-267	291	38	associated	associate	VERB
biomedich-267	291	39	with	with	ADP
biomedich-267	291	40	mortality	mortality	NOUN
biomedich-267	291	41	and	and	CCONJ
biomedich-267	291	42	severity	severity	NOUN
biomedich-267	291	43	of	of	ADP
biomedich-267	291	44	covid-19	covid-19	PROPN
biomedich-267	291	45	?	?	PUNCT
biomedich-267	292	1	a	a	DET
biomedich-267	292	2	metaanalysis	metaanalysis	NOUN
biomedich-267	292	3	.	.	PUNCT
biomedich-267	293	1	diabetes	diabetes	NOUN
biomedich-267	293	2	&	&	CCONJ
biomedich-267	293	3	metabolic	metabolic	PROPN
biomedich-267	293	4	syndrome	syndrome	PROPN
biomedich-267	293	5	:	:	PUNCT
biomedich-267	293	6	clinical	clinical	ADJ
biomedich-267	293	7	research	research	NOUN
biomedich-267	293	8	&	&	CCONJ
biomedich-267	293	9	reviews	review	NOUN
biomedich-267	293	10	.	.	PUNCT
biomedich-267	294	1	kwok	kwok	PROPN
biomedich-267	294	2	,	,	PUNCT
biomedich-267	294	3	s.	s.	PROPN
biomedich-267	294	4	,	,	PUNCT
biomedich-267	294	5	adam	adam	PROPN
biomedich-267	294	6	,	,	PUNCT
biomedich-267	294	7	s.	s.	PROPN
biomedich-267	294	8	,	,	PUNCT
biomedich-267	294	9	ho	ho	PROPN
biomedich-267	294	10	,	,	PUNCT
biomedich-267	294	11	j.	j.	PROPN
biomedich-267	294	12	h.	h.	PROPN
biomedich-267	294	13	,	,	PUNCT
biomedich-267	294	14	iqbal	iqbal	PROPN
biomedich-267	294	15	,	,	PUNCT
biomedich-267	294	16	z.	z.	PROPN
biomedich-267	294	17	,	,	PUNCT
biomedich-267	294	18	turkington	turkington	PROPN
biomedich-267	294	19	,	,	PUNCT
biomedich-267	294	20	p.	p.	PROPN
biomedich-267	294	21	,	,	PUNCT
biomedich-267	294	22	razvi	razvi	VERB
biomedich-267	294	23	,	,	PUNCT
biomedich-267	294	24	s.	s.	PROPN
biomedich-267	294	25	,	,	PUNCT
biomedich-267	294	26	...	...	PUNCT
biomedich-267	294	27	&	&	CCONJ
biomedich-267	294	28	syed	syed	ADJ
biomedich-267	294	29	,	,	PUNCT
biomedich-267	294	30	a.	a.	NOUN
biomedich-267	294	31	a.	a.	NOUN
biomedich-267	294	32	(	(	PUNCT
biomedich-267	294	33	2020	2020	NUM
biomedich-267	294	34	)	)	PUNCT
biomedich-267	294	35	.	.	PUNCT
biomedich-267	295	1	obesity	obesity	NOUN
biomedich-267	295	2	:	:	PUNCT
biomedich-267	295	3	a	a	DET
biomedich-267	295	4	critical	critical	ADJ
biomedich-267	295	5	risk	risk	NOUN
biomedich-267	295	6	factor	factor	NOUN
biomedich-267	295	7	in	in	ADP
biomedich-267	295	8	the	the	DET
biomedich-267	295	9	covid‐19	covid‐19	PROPN
biomedich-267	295	10	pandemic	pandemic	NOUN
biomedich-267	295	11	.	.	PUNCT
biomedich-267	296	1	clinical	clinical	ADJ
biomedich-267	296	2	obesity	obesity	NOUN
biomedich-267	296	3	,	,	PUNCT
biomedich-267	296	4	10(6	10(6	NOUN
biomedich-267	296	5	)	)	PUNCT
biomedich-267	296	6	,	,	PUNCT
biomedich-267	296	7	e12403	e12403	PROPN
biomedich-267	296	8	.	.	PUNCT
biomedich-267	296	9	liang	liang	PROPN
biomedich-267	296	10	,	,	PUNCT
biomedich-267	296	11	j.	j.	PROPN
biomedich-267	296	12	j.	j.	PROPN
biomedich-267	296	13	,	,	PUNCT
biomedich-267	296	14	liu	liu	PROPN
biomedich-267	296	15	,	,	PUNCT
biomedich-267	296	16	j.	j.	PROPN
biomedich-267	296	17	,	,	PUNCT
biomedich-267	296	18	chen	chen	PROPN
biomedich-267	296	19	,	,	PUNCT
biomedich-267	296	20	y.	y.	PROPN
biomedich-267	296	21	,	,	PUNCT
biomedich-267	296	22	ye	ye	PROPN
biomedich-267	296	23	,	,	PUNCT
biomedich-267	296	24	b.	b.	PROPN
biomedich-267	296	25	,	,	PUNCT
biomedich-267	296	26	li	li	PROPN
biomedich-267	296	27	,	,	PUNCT
biomedich-267	296	28	n.	n.	PROPN
biomedich-267	296	29	,	,	PUNCT
biomedich-267	296	30	wang	wang	PROPN
biomedich-267	296	31	,	,	PUNCT
biomedich-267	296	32	x.	x.	PROPN
biomedich-267	296	33	,	,	PUNCT
biomedich-267	296	34	...	...	PUNCT
biomedich-267	296	35	&	&	CCONJ
biomedich-267	296	36	shao	shao	PROPN
biomedich-267	296	37	,	,	PUNCT
biomedich-267	296	38	j.	j.	PROPN
biomedich-267	296	39	(	(	PUNCT
biomedich-267	296	40	2020	2020	NUM
biomedich-267	296	41	)	)	PUNCT
biomedich-267	296	42	.	.	PUNCT
biomedich-267	297	1	characteristics	characteristic	NOUN
biomedich-267	297	2	of	of	ADP
biomedich-267	297	3	laboratory	laboratory	NOUN
biomedich-267	297	4	findings	finding	NOUN
biomedich-267	297	5	of	of	ADP
biomedich-267	297	6	covid-19	covid-19	PROPN
biomedich-267	297	7	patients	patient	NOUN
biomedich-267	297	8	with	with	ADP
biomedich-267	297	9	comorbid	comorbid	NOUN
biomedich-267	297	10	diabetes	diabetes	NOUN
biomedich-267	297	11	mellitus	mellitus	NOUN
biomedich-267	297	12	.	.	PUNCT
biomedich-267	298	1	diabetes	diabetes	NOUN
biomedich-267	298	2	research	research	NOUN
biomedich-267	298	3	and	and	CCONJ
biomedich-267	298	4	clinical	clinical	ADJ
biomedich-267	298	5	practice	practice	NOUN
biomedich-267	298	6	,	,	PUNCT
biomedich-267	298	7	167	167	NUM
biomedich-267	298	8	,	,	PUNCT
biomedich-267	298	9	108351	108351	NUM
biomedich-267	298	10	.	.	PUNCT
biomedich-267	299	1	lim	lim	PROPN
biomedich-267	299	2	,	,	PUNCT
biomedich-267	299	3	s.	s.	PROPN
biomedich-267	299	4	,	,	PUNCT
biomedich-267	299	5	bae	bae	PROPN
biomedich-267	299	6	,	,	PUNCT
biomedich-267	299	7	j.	j.	PROPN
biomedich-267	299	8	h.	h.	PROPN
biomedich-267	299	9	,	,	PUNCT
biomedich-267	299	10	kwon	kwon	PROPN
biomedich-267	299	11	,	,	PUNCT
biomedich-267	299	12	h.	h.	PROPN
biomedich-267	299	13	s.	s.	PROPN
biomedich-267	299	14	,	,	PUNCT
biomedich-267	299	15	&	&	CCONJ
biomedich-267	299	16	nauck	nauck	PROPN
biomedich-267	299	17	,	,	PUNCT
biomedich-267	299	18	m.	m.	NOUN
biomedich-267	299	19	a.	a.	NOUN
biomedich-267	299	20	(	(	PUNCT
biomedich-267	299	21	2020	2020	NUM
biomedich-267	299	22	)	)	PUNCT
biomedich-267	299	23	.	.	PUNCT
biomedich-267	300	1	covid-19	covid-19	PROPN
biomedich-267	300	2	and	and	CCONJ
biomedich-267	300	3	diabetes	diabetes	NOUN
biomedich-267	300	4	mellitus	mellitus	NOUN
biomedich-267	300	5	:	:	PUNCT
biomedich-267	300	6	from	from	ADP
biomedich-267	300	7	pathophysiology	pathophysiology	NOUN
biomedich-267	300	8	to	to	ADP
biomedich-267	300	9	clinical	clinical	ADJ
biomedich-267	300	10	management	management	NOUN
biomedich-267	300	11	.	.	PUNCT
biomedich-267	301	1	nature	nature	NOUN
biomedich-267	301	2	reviews	review	VERB
biomedich-267	301	3	endocrinology	endocrinology	NOUN
biomedich-267	301	4	,	,	PUNCT
biomedich-267	301	5	1	1	NUM
biomedich-267	301	6	-	-	SYM
biomedich-267	301	7	20	20	NUM
biomedich-267	301	8	.	.	PUNCT
biomedich-267	302	1	lim	lim	PROPN
biomedich-267	302	2	,	,	PUNCT
biomedich-267	302	3	s.	s.	PROPN
biomedich-267	302	4	,	,	PUNCT
biomedich-267	302	5	shin	shin	PROPN
biomedich-267	302	6	,	,	PUNCT
biomedich-267	302	7	s.	s.	PROPN
biomedich-267	302	8	m.	m.	PROPN
biomedich-267	302	9	,	,	PUNCT
biomedich-267	302	10	nam	nam	PROPN
biomedich-267	302	11	,	,	PUNCT
biomedich-267	302	12	g.	g.	PROPN
biomedich-267	302	13	e.	e.	PROPN
biomedich-267	302	14	,	,	PUNCT
biomedich-267	302	15	jung	jung	PROPN
biomedich-267	302	16	,	,	PUNCT
biomedich-267	302	17	c.	c.	PROPN
biomedich-267	302	18	h.	h.	PROPN
biomedich-267	302	19	,	,	PUNCT
biomedich-267	302	20	&	&	CCONJ
biomedich-267	302	21	koo	koo	PROPN
biomedich-267	302	22	,	,	PUNCT
biomedich-267	302	23	b.	b.	PROPN
biomedich-267	302	24	k.	k.	PROPN
biomedich-267	302	25	(	(	PUNCT
biomedich-267	302	26	2020	2020	NUM
biomedich-267	302	27	)	)	PUNCT
biomedich-267	302	28	.	.	PUNCT
biomedich-267	303	1	proper	proper	ADJ
biomedich-267	303	2	management	management	NOUN
biomedich-267	303	3	of	of	ADP
biomedich-267	303	4	people	people	NOUN
biomedich-267	303	5	with	with	ADP
biomedich-267	303	6	obesity	obesity	NOUN
biomedich-267	303	7	during	during	ADP
biomedich-267	303	8	the	the	DET
biomedich-267	303	9	covid-19	covid-19	PROPN
biomedich-267	303	10	pandemic	pandemic	NOUN
biomedich-267	303	11	.	.	PUNCT
biomedich-267	304	1	journal	journal	NOUN
biomedich-267	304	2	of	of	ADP
biomedich-267	304	3	obesity	obesity	NOUN
biomedich-267	304	4	&	&	CCONJ
biomedich-267	304	5	metabolic	metabolic	PROPN
biomedich-267	304	6	syndrome	syndrome	PROPN
biomedich-267	304	7	,	,	PUNCT
biomedich-267	304	8	29(2	29(2	NUM
biomedich-267	304	9	)	)	PUNCT
biomedich-267	304	10	,	,	PUNCT
biomedich-267	304	11	84	84	NUM
biomedich-267	304	12	.	.	PUNCT
biomedich-267	305	1	lockhart	lockhart	PROPN
biomedich-267	305	2	,	,	PUNCT
biomedich-267	305	3	s.	s.	PROPN
biomedich-267	305	4	m.	m.	PROPN
biomedich-267	305	5	,	,	PUNCT
biomedich-267	305	6	&	&	CCONJ
biomedich-267	305	7	o’rahilly	o’rahilly	ADV
biomedich-267	305	8	,	,	PUNCT
biomedich-267	305	9	s.	s.	PROPN
biomedich-267	305	10	(	(	PUNCT
biomedich-267	305	11	2020	2020	NUM
biomedich-267	305	12	)	)	PUNCT
biomedich-267	305	13	.	.	PUNCT
biomedich-267	306	1	when	when	SCONJ
biomedich-267	306	2	two	two	NUM
biomedich-267	306	3	pandemics	pandemic	NOUN
biomedich-267	306	4	meet	meet	VERB
biomedich-267	306	5	:	:	PUNCT
biomedich-267	306	6	why	why	SCONJ
biomedich-267	306	7	is	be	AUX
biomedich-267	306	8	obesity	obesity	NOUN
biomedich-267	306	9	associated	associate	VERB
biomedich-267	306	10	with	with	ADP
biomedich-267	306	11	increased	increase	VERB
biomedich-267	306	12	covid-19	covid-19	PROPN
biomedich-267	306	13	mortality	mortality	NOUN
biomedich-267	306	14	?	?	PUNCT
biomedich-267	306	15	.	.	PUNCT
biomedich-267	307	1	med	med	PROPN
biomedich-267	307	2	.	.	PUNCT
biomedich-267	307	3	maddaloni	maddaloni	NOUN
biomedich-267	307	4	,	,	PUNCT
biomedich-267	307	5	e.	e.	PROPN
biomedich-267	307	6	,	,	PUNCT
biomedich-267	307	7	&	&	CCONJ
biomedich-267	307	8	buzzetti	buzzetti	PROPN
biomedich-267	307	9	,	,	PUNCT
biomedich-267	307	10	r.	r.	PROPN
biomedich-267	307	11	(	(	PUNCT
biomedich-267	307	12	2020	2020	NUM
biomedich-267	307	13	)	)	PUNCT
biomedich-267	307	14	.	.	PUNCT
biomedich-267	308	1	covid‐19	covid‐19	PROPN
biomedich-267	308	2	and	and	CCONJ
biomedich-267	308	3	diabetes	diabetes	NOUN
biomedich-267	308	4	mellitus	mellitus	NOUN
biomedich-267	308	5	:	:	PUNCT
biomedich-267	308	6	unveiling	unveil	VERB
biomedich-267	308	7	the	the	DET
biomedich-267	308	8	interaction	interaction	NOUN
biomedich-267	308	9	of	of	ADP
biomedich-267	308	10	two	two	NUM
biomedich-267	308	11	pandemics	pandemic	NOUN
biomedich-267	308	12	.	.	PUNCT
biomedich-267	309	1	diabetes	diabetes	NOUN
biomedich-267	309	2	/	/	SYM
biomedich-267	309	3	metabolism	metabolism	NOUN
biomedich-267	309	4	research	research	NOUN
biomedich-267	309	5	and	and	CCONJ
biomedich-267	309	6	reviews	review	NOUN
biomedich-267	309	7	,	,	PUNCT
biomedich-267	309	8	e33213321	e33213321	NOUN
biomedich-267	309	9	.	.	PUNCT
biomedich-267	310	1	marazuela	marazuela	PROPN
biomedich-267	310	2	,	,	PUNCT
biomedich-267	310	3	m.	m.	NOUN
biomedich-267	310	4	,	,	PUNCT
biomedich-267	310	5	giustina	giustina	PROPN
biomedich-267	310	6	,	,	PUNCT
biomedich-267	310	7	a.	a.	PROPN
biomedich-267	310	8	,	,	PUNCT
biomedich-267	310	9	&	&	CCONJ
biomedich-267	310	10	puig	puig	PROPN
biomedich-267	310	11	-	-	PUNCT
biomedich-267	310	12	domingo	domingo	PROPN
biomedich-267	310	13	,	,	PUNCT
biomedich-267	310	14	m.	m.	NOUN
biomedich-267	310	15	(	(	PUNCT
biomedich-267	310	16	2020	2020	NUM
biomedich-267	310	17	)	)	PUNCT
biomedich-267	310	18	.	.	PUNCT
biomedich-267	311	1	endocrine	endocrine	NOUN
biomedich-267	311	2	and	and	CCONJ
biomedich-267	311	3	metabolic	metabolic	NOUN
biomedich-267	311	4	aspects	aspect	NOUN
biomedich-267	311	5	of	of	ADP
biomedich-267	311	6	the	the	DET
biomedich-267	311	7	covid-19	covid-19	PROPN
biomedich-267	311	8	pandemic	pandemic	NOUN
biomedich-267	311	9	.	.	PUNCT
biomedich-267	312	1	reviews	review	NOUN
biomedich-267	312	2	in	in	ADP
biomedich-267	312	3	endocrine	endocrine	NOUN
biomedich-267	312	4	and	and	CCONJ
biomedich-267	312	5	metabolic	metabolic	NOUN
biomedich-267	312	6	disorders	disorder	NOUN
biomedich-267	312	7	,	,	PUNCT
biomedich-267	312	8	21(4	21(4	NUM
biomedich-267	312	9	)	)	PUNCT
biomedich-267	312	10	,	,	PUNCT
biomedich-267	312	11	495507	495507	NUM
biomedich-267	312	12	.	.	PUNCT
biomedich-267	313	1	mathew	mathew	PROPN
biomedich-267	313	2	,	,	PUNCT
biomedich-267	313	3	d.	d.	PROPN
biomedich-267	313	4	,	,	PUNCT
biomedich-267	313	5	giles	giles	PROPN
biomedich-267	313	6	,	,	PUNCT
biomedich-267	313	7	j.	j.	PROPN
biomedich-267	313	8	r.	r.	PROPN
biomedich-267	313	9	,	,	PUNCT
biomedich-267	313	10	baxter	baxter	PROPN
biomedich-267	313	11	,	,	PUNCT
biomedich-267	313	12	a.	a.	PROPN
biomedich-267	313	13	e.	e.	PROPN
biomedich-267	313	14	,	,	PUNCT
biomedich-267	313	15	oldridge	oldridge	PROPN
biomedich-267	313	16	,	,	PUNCT
biomedich-267	313	17	d.	d.	PROPN
biomedich-267	313	18	a.	a.	PROPN
biomedich-267	313	19	,	,	PUNCT
biomedich-267	313	20	greenplate	greenplate	VERB
biomedich-267	313	21	,	,	PUNCT
biomedich-267	313	22	a.	a.	PROPN
biomedich-267	313	23	r.	r.	PROPN
biomedich-267	313	24	,	,	PUNCT
biomedich-267	313	25	wu	wu	PROPN
biomedich-267	313	26	,	,	PUNCT
biomedich-267	313	27	j.	j.	PROPN
biomedich-267	313	28	e.	e.	PROPN
biomedich-267	313	29	,	,	PUNCT
biomedich-267	313	30	...	...	PUNCT
biomedich-267	313	31	&	&	CCONJ
biomedich-267	313	32	manne	manne	PROPN
biomedich-267	313	33	,	,	PUNCT
biomedich-267	313	34	s.	s.	PROPN
biomedich-267	313	35	(	(	PUNCT
biomedich-267	313	36	2020	2020	NUM
biomedich-267	313	37	)	)	PUNCT
biomedich-267	313	38	.	.	PUNCT
biomedich-267	314	1	deep	deep	ADJ
biomedich-267	314	2	immune	immune	ADJ
biomedich-267	314	3	profiling	profiling	NOUN
biomedich-267	314	4	of	of	ADP
biomedich-267	314	5	covid-19	covid-19	PROPN
biomedich-267	314	6	patients	patient	NOUN
biomedich-267	314	7	reveals	reveal	VERB
biomedich-267	314	8	distinct	distinct	ADJ
biomedich-267	314	9	immunotypes	immunotype	NOUN
biomedich-267	314	10	with	with	ADP
biomedich-267	314	11	therapeutic	therapeutic	ADJ
biomedich-267	314	12	implications	implication	NOUN
biomedich-267	314	13	.	.	PUNCT
biomedich-267	315	1	science	science	NOUN
biomedich-267	315	2	,	,	PUNCT
biomedich-267	315	3	369(6508	369(6508	NUM
biomedich-267	315	4	)	)	PUNCT
biomedich-267	315	5	.	.	PUNCT
biomedich-267	316	1	mattar	mattar	PROPN
biomedich-267	316	2	,	,	PUNCT
biomedich-267	316	3	s.	s.	PROPN
biomedich-267	316	4	a.	a.	PROPN
biomedich-267	316	5	m.	m.	PROPN
biomedich-267	316	6	,	,	PUNCT
biomedich-267	316	7	koh	koh	PROPN
biomedich-267	316	8	,	,	PUNCT
biomedich-267	316	9	s.	s.	PROPN
biomedich-267	316	10	j.	j.	PROPN
biomedich-267	316	11	q.	q.	PROPN
biomedich-267	316	12	,	,	PUNCT
biomedich-267	316	13	chandran	chandran	PROPN
biomedich-267	316	14	,	,	PUNCT
biomedich-267	316	15	s.	s.	PROPN
biomedich-267	316	16	r.	r.	PROPN
biomedich-267	316	17	,	,	PUNCT
biomedich-267	316	18	&	&	CCONJ
biomedich-267	316	19	cherng	cherng	PROPN
biomedich-267	316	20	,	,	PUNCT
biomedich-267	316	21	b.	b.	PROPN
biomedich-267	317	1	p.	p.	PROPN
biomedich-267	317	2	z.	z.	PROPN
biomedich-267	318	1	(	(	PUNCT
biomedich-267	318	2	2020	2020	NUM
biomedich-267	318	3	)	)	PUNCT
biomedich-267	318	4	.	.	PUNCT
biomedich-267	319	1	subacute	subacute	VERB
biomedich-267	319	2	thyroiditis	thyroiditis	NOUN
biomedich-267	319	3	associated	associate	VERB
biomedich-267	319	4	with	with	ADP
biomedich-267	319	5	covid-19	covid-19	PROPN
biomedich-267	319	6	.	.	PUNCT
biomedich-267	320	1	bmj	bmj	PROPN
biomedich-267	320	2	case	case	NOUN
biomedich-267	320	3	reports	report	VERB
biomedich-267	320	4	cp	cp	NOUN
biomedich-267	320	5	,	,	PUNCT
biomedich-267	320	6	13(8	13(8	NUM
biomedich-267	320	7	)	)	PUNCT
biomedich-267	320	8	,	,	PUNCT
biomedich-267	320	9	e237336	e237336	PROPN
biomedich-267	320	10	.	.	PUNCT
biomedich-267	320	11	mcsharry	mcsharry	PROPN
biomedich-267	320	12	,	,	PUNCT
biomedich-267	320	13	d.	d.	PROPN
biomedich-267	320	14	,	,	PUNCT
biomedich-267	320	15	&	&	CCONJ
biomedich-267	320	16	malhotra	malhotra	PROPN
biomedich-267	320	17	,	,	PUNCT
biomedich-267	320	18	a.	a.	NOUN
biomedich-267	320	19	(	(	PUNCT
biomedich-267	320	20	2020	2020	NUM
biomedich-267	320	21	)	)	PUNCT
biomedich-267	320	22	.	.	PUNCT
biomedich-267	321	1	potential	potential	ADJ
biomedich-267	321	2	influences	influence	NOUN
biomedich-267	321	3	of	of	ADP
biomedich-267	321	4	obstructive	obstructive	ADJ
biomedich-267	321	5	sleep	sleep	NOUN
biomedich-267	321	6	apnea	apnea	NOUN
biomedich-267	321	7	and	and	CCONJ
biomedich-267	321	8	obesity	obesity	NOUN
biomedich-267	321	9	on	on	ADP
biomedich-267	321	10	covid-19	covid-19	PROPN
biomedich-267	321	11	severity	severity	NOUN
biomedich-267	321	12	.	.	PUNCT
biomedich-267	322	1	journal	journal	NOUN
biomedich-267	322	2	of	of	ADP
biomedich-267	322	3	clinical	clinical	ADJ
biomedich-267	322	4	sleep	sleep	NOUN
biomedich-267	322	5	medicine	medicine	NOUN
biomedich-267	322	6	,	,	PUNCT
biomedich-267	322	7	16(9	16(9	NUM
biomedich-267	322	8	)	)	PUNCT
biomedich-267	322	9	,	,	PUNCT
biomedich-267	322	10	1645	1645	NUM
biomedich-267	322	11	-	-	SYM
biomedich-267	322	12	1645	1645	NUM
biomedich-267	322	13	.	.	PUNCT
biomedich-267	323	1	meng	meng	PROPN
biomedich-267	323	2	,	,	PUNCT
biomedich-267	323	3	j.	j.	PROPN
biomedich-267	323	4	,	,	PUNCT
biomedich-267	323	5	xiao	xiao	PROPN
biomedich-267	323	6	,	,	PUNCT
biomedich-267	323	7	g.	g.	PROPN
biomedich-267	323	8	,	,	PUNCT
biomedich-267	323	9	zhang	zhang	PROPN
biomedich-267	323	10	,	,	PUNCT
biomedich-267	323	11	j.	j.	PROPN
biomedich-267	323	12	,	,	PUNCT
biomedich-267	323	13	he	he	PRON
biomedich-267	323	14	,	,	PUNCT
biomedich-267	323	15	x.	x.	NOUN
biomedich-267	323	16	,	,	PUNCT
biomedich-267	323	17	ou	ou	PROPN
biomedich-267	323	18	,	,	PUNCT
biomedich-267	323	19	m.	m.	NOUN
biomedich-267	323	20	,	,	PUNCT
biomedich-267	323	21	bi	bi	PROPN
biomedich-267	323	22	,	,	PUNCT
biomedich-267	323	23	j.	j.	PROPN
biomedich-267	323	24	,	,	PUNCT
biomedich-267	323	25	...	...	PUNCT
biomedich-267	323	26	&	&	CCONJ
biomedich-267	323	27	gao	gao	PROPN
biomedich-267	323	28	,	,	PUNCT
biomedich-267	323	29	h.	h.	PROPN
biomedich-267	323	30	(	(	PUNCT
biomedich-267	323	31	2020	2020	NUM
biomedich-267	323	32	)	)	PUNCT
biomedich-267	323	33	.	.	PUNCT
biomedich-267	324	1	renin	renin	ADJ
biomedich-267	324	2	-	-	PUNCT
biomedich-267	324	3	angiotensin	angiotensin	NOUN
biomedich-267	324	4	system	system	NOUN
biomedich-267	324	5	inhibitors	inhibitor	NOUN
biomedich-267	324	6	improve	improve	VERB
biomedich-267	324	7	the	the	DET
biomedich-267	324	8	clinical	clinical	ADJ
biomedich-267	324	9	outcomes	outcome	NOUN
biomedich-267	324	10	of	of	ADP
biomedich-267	324	11	covid-19	covid-19	PROPN
biomedich-267	324	12	patients	patient	NOUN
biomedich-267	324	13	with	with	ADP
biomedich-267	324	14	hypertension	hypertension	NOUN
biomedich-267	324	15	.	.	PUNCT
biomedich-267	325	1	emerging	emerge	VERB
biomedich-267	325	2	microbes	microbe	NOUN
biomedich-267	325	3	&	&	CCONJ
biomedich-267	325	4	infections	infection	NOUN
biomedich-267	325	5	,	,	PUNCT
biomedich-267	325	6	9(1	9(1	NUM
biomedich-267	325	7	)	)	PUNCT
biomedich-267	325	8	,	,	PUNCT
biomedich-267	325	9	757	757	PROPN
biomedich-267	325	10	-	-	SYM
biomedich-267	325	11	760	760	NUM
biomedich-267	325	12	.	.	PUNCT
biomedich-267	325	13	metzger	metzger	PROPN
biomedich-267	325	14	,	,	PUNCT
biomedich-267	325	15	b.	b.	PROPN
biomedich-267	325	16	e.	e.	PROPN
biomedich-267	325	17	,	,	PUNCT
biomedich-267	325	18	contreras	contreras	PROPN
biomedich-267	325	19	,	,	PUNCT
biomedich-267	325	20	m.	m.	NOUN
biomedich-267	325	21	,	,	PUNCT
biomedich-267	325	22	sacks	sack	NOUN
biomedich-267	325	23	,	,	PUNCT
biomedich-267	325	24	d.	d.	PROPN
biomedich-267	325	25	a.	a.	PROPN
biomedich-267	325	26	,	,	PUNCT
biomedich-267	325	27	watson	watson	PROPN
biomedich-267	325	28	,	,	PUNCT
biomedich-267	325	29	w.	w.	PROPN
biomedich-267	325	30	,	,	PUNCT
biomedich-267	325	31	dooley	dooley	PROPN
biomedich-267	325	32	,	,	PUNCT
biomedich-267	325	33	s.	s.	PROPN
biomedich-267	325	34	l.	l.	PROPN
biomedich-267	325	35	,	,	PUNCT
biomedich-267	325	36	foderaro	foderaro	NOUN
biomedich-267	325	37	,	,	PUNCT
biomedich-267	325	38	m.	m.	NOUN
biomedich-267	325	39	,	,	PUNCT
biomedich-267	325	40	...	...	PUNCT
biomedich-267	325	41	&	&	CCONJ
biomedich-267	325	42	fox	fox	PROPN
biomedich-267	325	43	,	,	PUNCT
biomedich-267	325	44	s.	s.	PROPN
biomedich-267	325	45	(	(	PUNCT
biomedich-267	325	46	2008	2008	NUM
biomedich-267	325	47	)	)	PUNCT
biomedich-267	325	48	.	.	PUNCT
biomedich-267	326	1	hyperglycemia	hyperglycemia	NOUN
biomedich-267	326	2	and	and	CCONJ
biomedich-267	326	3	adverse	adverse	ADJ
biomedich-267	326	4	pregnancy	pregnancy	NOUN
biomedich-267	326	5	outcomes	outcome	NOUN
biomedich-267	326	6	.	.	PUNCT
biomedich-267	327	1	new	new	PROPN
biomedich-267	327	2	england	england	PROPN
biomedich-267	327	3	journal	journal	PROPN
biomedich-267	327	4	of	of	ADP
biomedich-267	327	5	medicine	medicine	NOUN
biomedich-267	327	6	,	,	PUNCT
biomedich-267	327	7	358(19	358(19	NUM
biomedich-267	327	8	)	)	PUNCT
biomedich-267	327	9	,	,	PUNCT
biomedich-267	327	10	1991	1991	NUM
biomedich-267	327	11	-	-	SYM
biomedich-267	327	12	2002	2002	NUM
biomedich-267	327	13	.	.	PUNCT
biomedich-267	328	1	miller	miller	PROPN
biomedich-267	328	2	,	,	PUNCT
biomedich-267	328	3	l.	l.	PROPN
biomedich-267	328	4	e.	e.	PROPN
biomedich-267	328	5	,	,	PUNCT
biomedich-267	328	6	bhattacharyya	bhattacharyya	PROPN
biomedich-267	328	7	,	,	PUNCT
biomedich-267	328	8	r.	r.	PROPN
biomedich-267	328	9	,	,	PUNCT
biomedich-267	328	10	&	&	CCONJ
biomedich-267	328	11	miller	miller	PROPN
biomedich-267	328	12	,	,	PUNCT
biomedich-267	328	13	a.	a.	PROPN
biomedich-267	328	14	l.	l.	PROPN
biomedich-267	328	15	(	(	PUNCT
biomedich-267	328	16	2020	2020	NUM
biomedich-267	328	17	)	)	PUNCT
biomedich-267	328	18	.	.	PUNCT
biomedich-267	329	1	diabetes	diabetes	NOUN
biomedich-267	329	2	mellitus	mellitus	NOUN
biomedich-267	329	3	increases	increase	VERB
biomedich-267	329	4	the	the	DET
biomedich-267	329	5	risk	risk	NOUN
biomedich-267	329	6	of	of	ADP
biomedich-267	329	7	hospital	hospital	NOUN
biomedich-267	329	8	mortality	mortality	NOUN
biomedich-267	329	9	in	in	ADP
biomedich-267	329	10	patients	patient	NOUN
biomedich-267	329	11	with	with	ADP
biomedich-267	329	12	covid-19	covid-19	PROPN
biomedich-267	329	13	:	:	PUNCT
biomedich-267	329	14	systematic	systematic	ADJ
biomedich-267	329	15	review	review	NOUN
biomedich-267	329	16	with	with	ADP
biomedich-267	329	17	meta	meta	ADJ
biomedich-267	329	18	-	-	PUNCT
biomedich-267	329	19	analysis	analysis	NOUN
biomedich-267	329	20	.	.	PUNCT
biomedich-267	330	1	medicine	medicine	NOUN
biomedich-267	330	2	,	,	PUNCT
biomedich-267	330	3	99(40	99(40	NUM
biomedich-267	330	4	)	)	PUNCT
biomedich-267	330	5	.	.	PUNCT
biomedich-267	331	1	mitrou	mitrou	PROPN
biomedich-267	331	2	,	,	PUNCT
biomedich-267	331	3	p.	p.	PROPN
biomedich-267	331	4	,	,	PUNCT
biomedich-267	331	5	raptis	raptis	PROPN
biomedich-267	331	6	,	,	PUNCT
biomedich-267	331	7	s.	s.	PROPN
biomedich-267	331	8	a.	a.	PROPN
biomedich-267	331	9	,	,	PUNCT
biomedich-267	331	10	&	&	CCONJ
biomedich-267	331	11	dimitriadis	dimitriadis	PROPN
biomedich-267	331	12	,	,	PUNCT
biomedich-267	331	13	g.	g.	PROPN
biomedich-267	331	14	(	(	PUNCT
biomedich-267	331	15	2011	2011	NUM
biomedich-267	331	16	)	)	PUNCT
biomedich-267	331	17	.	.	PUNCT
biomedich-267	332	1	thyroid	thyroid	NOUN
biomedich-267	332	2	disease	disease	NOUN
biomedich-267	332	3	in	in	ADP
biomedich-267	332	4	older	old	ADJ
biomedich-267	332	5	people	people	NOUN
biomedich-267	332	6	.	.	PUNCT
biomedich-267	333	1	maturitas	maturita	NOUN
biomedich-267	333	2	,	,	PUNCT
biomedich-267	333	3	70(1	70(1	NOUN
biomedich-267	333	4	)	)	PUNCT
biomedich-267	333	5	,	,	PUNCT
biomedich-267	333	6	5	5	NUM
biomedich-267	333	7	-	-	SYM
biomedich-267	333	8	9	9	NUM
biomedich-267	333	9	.	.	PUNCT
biomedich-267	333	10	mukona	mukona	PROPN
biomedich-267	333	11	,	,	PUNCT
biomedich-267	333	12	d.	d.	PROPN
biomedich-267	333	13	m.	m.	PROPN
biomedich-267	333	14	,	,	PUNCT
biomedich-267	333	15	&	&	CCONJ
biomedich-267	333	16	zvinavashe	zvinavashe	PROPN
biomedich-267	333	17	,	,	PUNCT
biomedich-267	333	18	m.	m.	NOUN
biomedich-267	333	19	(	(	PUNCT
biomedich-267	333	20	2020	2020	NUM
biomedich-267	333	21	)	)	PUNCT
biomedich-267	333	22	.	.	PUNCT
biomedich-267	334	1	self	self	NOUN
biomedich-267	334	2	-	-	PUNCT
biomedich-267	334	3	management	management	NOUN
biomedich-267	334	4	of	of	ADP
biomedich-267	334	5	diabetes	diabetes	NOUN
biomedich-267	334	6	mellitus	mellitus	NOUN
biomedich-267	334	7	during	during	ADP
biomedich-267	334	8	the	the	DET
biomedich-267	334	9	covid-19	covid-19	PROPN
biomedich-267	334	10	pandemic	pandemic	NOUN
biomedich-267	334	11	:	:	PUNCT
biomedich-267	334	12	recommendations	recommendation	NOUN
biomedich-267	334	13	for	for	ADP
biomedich-267	334	14	a	a	DET
biomedich-267	334	15	resource	resource	NOUN
biomedich-267	334	16	limited	limited	ADJ
biomedich-267	334	17	setting	setting	NOUN
biomedich-267	334	18	.	.	PUNCT
biomedich-267	335	1	diabetes	diabetes	NOUN
biomedich-267	335	2	&	&	CCONJ
biomedich-267	335	3	metabolic	metabolic	PROPN
biomedich-267	335	4	syndrome	syndrome	PROPN
biomedich-267	335	5	:	:	PUNCT
biomedich-267	335	6	clinical	clinical	ADJ
biomedich-267	335	7	research	research	NOUN
biomedich-267	335	8	&	&	CCONJ
biomedich-267	335	9	reviews	review	NOUN
biomedich-267	335	10	.	.	PUNCT
biomedich-267	336	1	nakeshbandi	nakeshbandi	PROPN
biomedich-267	336	2	,	,	PUNCT
biomedich-267	336	3	m.	m.	NOUN
biomedich-267	336	4	,	,	PUNCT
biomedich-267	336	5	maini	maini	PROPN
biomedich-267	336	6	,	,	PUNCT
biomedich-267	336	7	r.	r.	PROPN
biomedich-267	336	8	,	,	PUNCT
biomedich-267	336	9	daniel	daniel	PROPN
biomedich-267	336	10	,	,	PUNCT
biomedich-267	336	11	p.	p.	PROPN
biomedich-267	336	12	,	,	PUNCT
biomedich-267	336	13	rosengarten	rosengarten	PROPN
biomedich-267	336	14	,	,	PUNCT
biomedich-267	336	15	s.	s.	PROPN
biomedich-267	336	16	,	,	PUNCT
biomedich-267	336	17	parmar	parmar	PROPN
biomedich-267	336	18	,	,	PUNCT
biomedich-267	336	19	p.	p.	PROPN
biomedich-267	336	20	,	,	PUNCT
biomedich-267	336	21	wilson	wilson	PROPN
biomedich-267	336	22	,	,	PUNCT
biomedich-267	336	23	c.	c.	PROPN
biomedich-267	336	24	,	,	PUNCT
biomedich-267	336	25	...	...	PUNCT
biomedich-267	336	26	&	&	CCONJ
biomedich-267	336	27	joseph	joseph	PROPN
biomedich-267	336	28	,	,	PUNCT
biomedich-267	336	29	m.	m.	NOUN
biomedich-267	336	30	a.	a.	NOUN
biomedich-267	336	31	(	(	PUNCT
biomedich-267	336	32	2020	2020	NUM
biomedich-267	336	33	)	)	PUNCT
biomedich-267	336	34	.	.	PUNCT
biomedich-267	337	1	the	the	DET
biomedich-267	337	2	impact	impact	NOUN
biomedich-267	337	3	of	of	ADP
biomedich-267	337	4	obesity	obesity	NOUN
biomedich-267	337	5	on	on	ADP
biomedich-267	337	6	covid-19	covid-19	PROPN
biomedich-267	337	7	complications	complication	NOUN
biomedich-267	337	8	:	:	PUNCT
biomedich-267	337	9	a	a	DET
biomedich-267	337	10	retrospective	retrospective	ADJ
biomedich-267	337	11	cohort	cohort	NOUN
biomedich-267	337	12	study	study	NOUN
biomedich-267	337	13	.	.	PUNCT
biomedich-267	338	1	international	international	ADJ
biomedich-267	338	2	journal	journal	PROPN
biomedich-267	338	3	of	of	ADP
biomedich-267	338	4	obesity	obesity	NOUN
biomedich-267	338	5	,	,	PUNCT
biomedich-267	338	6	44(9	44(9	NOUN
biomedich-267	338	7	)	)	PUNCT
biomedich-267	338	8	,	,	PUNCT
biomedich-267	338	9	1832	1832	NUM
biomedich-267	338	10	-	-	SYM
biomedich-267	338	11	1837	1837	NUM
biomedich-267	338	12	.	.	PUNCT
biomedich-267	339	1	onder	onder	PROPN
biomedich-267	339	2	,	,	PUNCT
biomedich-267	339	3	g.	g.	PROPN
biomedich-267	339	4	,	,	PUNCT
biomedich-267	339	5	rezza	rezza	NOUN
biomedich-267	339	6	,	,	PUNCT
biomedich-267	339	7	g.	g.	PROPN
biomedich-267	339	8	,	,	PUNCT
biomedich-267	339	9	&	&	CCONJ
biomedich-267	339	10	brusaferro	brusaferro	PROPN
biomedich-267	339	11	,	,	PUNCT
biomedich-267	339	12	s.	s.	PROPN
biomedich-267	339	13	(	(	PUNCT
biomedich-267	339	14	2020	2020	NUM
biomedich-267	339	15	)	)	PUNCT
biomedich-267	339	16	.	.	PUNCT
biomedich-267	340	1	case	case	NOUN
biomedich-267	340	2	-	-	PUNCT
biomedich-267	340	3	fatality	fatality	NOUN
biomedich-267	340	4	rate	rate	NOUN
biomedich-267	340	5	and	and	CCONJ
biomedich-267	340	6	characteristics	characteristic	NOUN
biomedich-267	340	7	of	of	ADP
biomedich-267	340	8	patients	patient	NOUN
biomedich-267	340	9	dying	die	VERB
biomedich-267	340	10	in	in	ADP
biomedich-267	340	11	relation	relation	NOUN
biomedich-267	340	12	to	to	ADP
biomedich-267	340	13	covid-19	covid-19	PROPN
biomedich-267	340	14	in	in	ADP
biomedich-267	340	15	italy	italy	PROPN
biomedich-267	340	16	.	.	PUNCT
biomedich-267	341	1	jama	jama	PROPN
biomedich-267	341	2	,	,	PUNCT
biomedich-267	341	3	323(18	323(18	NUM
biomedich-267	341	4	)	)	PUNCT
biomedich-267	341	5	,	,	PUNCT
biomedich-267	341	6	1775	1775	NUM
biomedich-267	341	7	-	-	SYM
biomedich-267	341	8	1776	1776	NUM
biomedich-267	341	9	.	.	PUNCT
biomedich-267	342	1	pal	pal	PROPN
biomedich-267	342	2	,	,	PUNCT
biomedich-267	342	3	r.	r.	PROPN
biomedich-267	342	4	,	,	PUNCT
biomedich-267	342	5	&	&	CCONJ
biomedich-267	342	6	banerjee	banerjee	PROPN
biomedich-267	342	7	,	,	PUNCT
biomedich-267	342	8	m.	m.	NOUN
biomedich-267	342	9	(	(	PUNCT
biomedich-267	342	10	2020	2020	NUM
biomedich-267	342	11	)	)	PUNCT
biomedich-267	342	12	.	.	PUNCT
biomedich-267	343	1	covid-19	covid-19	PROPN
biomedich-267	343	2	and	and	CCONJ
biomedich-267	343	3	the	the	DET
biomedich-267	343	4	endocrine	endocrine	NOUN
biomedich-267	343	5	system	system	NOUN
biomedich-267	343	6	:	:	PUNCT
biomedich-267	343	7	exploring	explore	VERB
biomedich-267	343	8	the	the	DET
biomedich-267	343	9	unexplored	unexplored	ADJ
biomedich-267	343	10	.	.	PUNCT
biomedich-267	344	1	journal	journal	PROPN
biomedich-267	344	2	of	of	ADP
biomedich-267	344	3	endocrinological	endocrinological	ADJ
biomedich-267	344	4	investigation	investigation	NOUN
biomedich-267	344	5	,	,	PUNCT
biomedich-267	344	6	43(7	43(7	NUM
biomedich-267	344	7	)	)	PUNCT
biomedich-267	344	8	,	,	PUNCT
biomedich-267	344	9	1027	1027	NUM
biomedich-267	344	10	-	-	SYM
biomedich-267	344	11	1031	1031	NUM
biomedich-267	344	12	.	.	PUNCT
biomedich-267	345	1	pal	pal	PROPN
biomedich-267	345	2	,	,	PUNCT
biomedich-267	345	3	r.	r.	PROPN
biomedich-267	345	4	,	,	PUNCT
biomedich-267	345	5	&	&	CCONJ
biomedich-267	345	6	bhadada	bhadada	PROPN
biomedich-267	345	7	,	,	PUNCT
biomedich-267	345	8	s.	s.	PROPN
biomedich-267	345	9	k.	k.	PROPN
biomedich-267	345	10	(	(	PUNCT
biomedich-267	345	11	2020	2020	NUM
biomedich-267	345	12	)	)	PUNCT
biomedich-267	345	13	.	.	PUNCT
biomedich-267	346	1	covid-19	covid-19	PROPN
biomedich-267	346	2	and	and	CCONJ
biomedich-267	346	3	diabetes	diabetes	NOUN
biomedich-267	346	4	mellitus	mellitus	NOUN
biomedich-267	346	5	:	:	PUNCT
biomedich-267	346	6	an	an	DET
biomedich-267	346	7	unholy	unholy	ADJ
biomedich-267	346	8	interaction	interaction	NOUN
biomedich-267	346	9	of	of	ADP
biomedich-267	346	10	two	two	NUM
biomedich-267	346	11	pandemics	pandemic	NOUN
biomedich-267	346	12	.	.	PUNCT
biomedich-267	347	1	diabetes	diabetes	NOUN
biomedich-267	347	2	&	&	CCONJ
biomedich-267	347	3	metabolic	metabolic	PROPN
biomedich-267	347	4	syndrome	syndrome	PROPN
biomedich-267	347	5	:	:	PUNCT
biomedich-267	347	6	clinical	clinical	ADJ
biomedich-267	347	7	research	research	NOUN
biomedich-267	347	8	&	&	CCONJ
biomedich-267	347	9	reviews	review	NOUN
biomedich-267	347	10	.	.	PUNCT
biomedich-267	348	1	pal	pal	PROPN
biomedich-267	348	2	,	,	PUNCT
biomedich-267	348	3	r.	r.	PROPN
biomedich-267	348	4	,	,	PUNCT
biomedich-267	348	5	&	&	CCONJ
biomedich-267	348	6	bhadada	bhadada	PROPN
biomedich-267	348	7	,	,	PUNCT
biomedich-267	348	8	s.	s.	PROPN
biomedich-267	348	9	k.	k.	PROPN
biomedich-267	348	10	(	(	PUNCT
biomedich-267	348	11	2020	2020	NUM
biomedich-267	348	12	)	)	PUNCT
biomedich-267	348	13	.	.	PUNCT
biomedich-267	349	1	should	should	AUX
biomedich-267	349	2	anti	anti	ADJ
biomedich-267	349	3	-	-	ADJ
biomedich-267	349	4	diabetic	diabetic	ADJ
biomedich-267	349	5	medications	medication	NOUN
biomedich-267	349	6	be	be	AUX
biomedich-267	349	7	reconsidered	reconsider	VERB
biomedich-267	349	8	amid	amid	ADP
biomedich-267	349	9	covid-19	covid-19	PROPN
biomedich-267	349	10	pandemic	pandemic	NOUN
biomedich-267	349	11	?	?	PUNCT
biomedich-267	349	12	.	.	PUNCT
biomedich-267	350	1	diabetes	diabetes	NOUN
biomedich-267	350	2	research	research	NOUN
biomedich-267	350	3	and	and	CCONJ
biomedich-267	350	4	clinical	clinical	ADJ
biomedich-267	350	5	practice	practice	NOUN
biomedich-267	350	6	,	,	PUNCT
biomedich-267	350	7	163	163	NUM
biomedich-267	350	8	.	.	PUNCT
biomedich-267	351	1	parveen	parveen	PROPN
biomedich-267	351	2	,	,	PUNCT
biomedich-267	351	3	r.	r.	PROPN
biomedich-267	351	4	,	,	PUNCT
biomedich-267	351	5	sehar	sehar	ADJ
biomedich-267	351	6	,	,	PUNCT
biomedich-267	351	7	n.	n.	NOUN
biomedich-267	351	8	,	,	PUNCT
biomedich-267	351	9	bajpai	bajpai	PROPN
biomedich-267	351	10	,	,	PUNCT
biomedich-267	351	11	r.	r.	PROPN
biomedich-267	351	12	,	,	PUNCT
biomedich-267	351	13	&	&	CCONJ
biomedich-267	351	14	agarwal	agarwal	PROPN
biomedich-267	351	15	,	,	PUNCT
biomedich-267	351	16	n.	n.	PROPN
biomedich-267	351	17	b.	b.	PROPN
biomedich-267	351	18	(	(	PUNCT
biomedich-267	351	19	2020	2020	NUM
biomedich-267	351	20	)	)	PUNCT
biomedich-267	351	21	.	.	PUNCT
biomedich-267	352	1	association	association	NOUN
biomedich-267	352	2	of	of	ADP
biomedich-267	352	3	diabetes	diabetes	NOUN
biomedich-267	352	4	and	and	CCONJ
biomedich-267	352	5	hypertension	hypertension	NOUN
biomedich-267	352	6	with	with	ADP
biomedich-267	352	7	disease	disease	NOUN
biomedich-267	352	8	severity	severity	NOUN
biomedich-267	352	9	in	in	ADP
biomedich-267	352	10	covid-19	covid-19	PROPN
biomedich-267	352	11	patients	patient	NOUN
biomedich-267	352	12	:	:	PUNCT
biomedich-267	352	13	a	a	DET
biomedich-267	352	14	systematic	systematic	ADJ
biomedich-267	352	15	literature	literature	NOUN
biomedich-267	352	16	review	review	NOUN
biomedich-267	352	17	and	and	CCONJ
biomedich-267	352	18	exploratory	exploratory	ADJ
biomedich-267	352	19	meta	meta	ADJ
biomedich-267	352	20	-	-	PUNCT
biomedich-267	352	21	analysis	analysis	NOUN
biomedich-267	352	22	.	.	PUNCT
biomedich-267	353	1	diabetes	diabetes	NOUN
biomedich-267	353	2	research	research	NOUN
biomedich-267	353	3	and	and	CCONJ
biomedich-267	353	4	clinical	clinical	ADJ
biomedich-267	353	5	practice	practice	NOUN
biomedich-267	353	6	,	,	PUNCT
biomedich-267	353	7	166	166	NUM
biomedich-267	353	8	,	,	PUNCT
biomedich-267	353	9	108295	108295	NUM
biomedich-267	353	10	.	.	PUNCT
biomedich-267	354	1	popkin	popkin	PROPN
biomedich-267	354	2	,	,	PUNCT
biomedich-267	354	3	b.	b.	PROPN
biomedich-267	354	4	m.	m.	PROPN
biomedich-267	354	5	,	,	PUNCT
biomedich-267	354	6	du	du	PROPN
biomedich-267	354	7	,	,	PUNCT
biomedich-267	354	8	s.	s.	PROPN
biomedich-267	354	9	,	,	PUNCT
biomedich-267	354	10	green	green	PROPN
biomedich-267	354	11	,	,	PUNCT
biomedich-267	354	12	w.	w.	PROPN
biomedich-267	354	13	d.	d.	PROPN
biomedich-267	354	14	,	,	PUNCT
biomedich-267	354	15	beck	beck	PROPN
biomedich-267	354	16	,	,	PUNCT
biomedich-267	354	17	m.	m.	NOUN
biomedich-267	354	18	a.	a.	PROPN
biomedich-267	354	19	,	,	PUNCT
biomedich-267	354	20	algaith	algaith	NOUN
biomedich-267	354	21	,	,	PUNCT
biomedich-267	354	22	t.	t.	PROPN
biomedich-267	354	23	,	,	PUNCT
biomedich-267	354	24	herbst	herbst	PROPN
biomedich-267	354	25	,	,	PUNCT
biomedich-267	354	26	c.	c.	PROPN
biomedich-267	354	27	h.	h.	PROPN
biomedich-267	354	28	,	,	PUNCT
biomedich-267	354	29	...	...	PUNCT
biomedich-267	354	30	&	&	CCONJ
biomedich-267	354	31	shekar	shekar	PROPN
biomedich-267	354	32	,	,	PUNCT
biomedich-267	354	33	m.	m.	NOUN
biomedich-267	354	34	(	(	PUNCT
biomedich-267	354	35	2020	2020	NUM
biomedich-267	354	36	)	)	PUNCT
biomedich-267	354	37	.	.	PUNCT
biomedich-267	355	1	individuals	individual	NOUN
biomedich-267	355	2	with	with	ADP
biomedich-267	355	3	obesity	obesity	NOUN
biomedich-267	355	4	and	and	CCONJ
biomedich-267	355	5	covid‐19	covid‐19	PROPN
biomedich-267	355	6	:	:	PUNCT
biomedich-267	355	7	a	a	DET
biomedich-267	355	8	global	global	ADJ
biomedich-267	355	9	perspective	perspective	NOUN
biomedich-267	355	10	on	on	ADP
biomedich-267	355	11	the	the	DET
biomedich-267	355	12	epidemiology	epidemiology	NOUN
biomedich-267	355	13	and	and	CCONJ
biomedich-267	355	14	biological	biological	ADJ
biomedich-267	355	15	relationships	relationship	NOUN
biomedich-267	355	16	.	.	PUNCT
biomedich-267	356	1	obesity	obesity	NOUN
biomedich-267	356	2	reviews	review	NOUN
biomedich-267	356	3	,	,	PUNCT
biomedich-267	356	4	21(11	21(11	NUM
biomedich-267	356	5	)	)	PUNCT
biomedich-267	356	6	,	,	PUNCT
biomedich-267	356	7	e13128	e13128	NOUN
biomedich-267	356	8	.	.	PROPN
biomedich-267	356	9	pranata	pranata	PROPN
biomedich-267	356	10	,	,	PUNCT
biomedich-267	356	11	r.	r.	PROPN
biomedich-267	356	12	,	,	PUNCT
biomedich-267	356	13	lim	lim	PROPN
biomedich-267	356	14	,	,	PUNCT
biomedich-267	356	15	m.	m.	NOUN
biomedich-267	356	16	a.	a.	PROPN
biomedich-267	356	17	,	,	PUNCT
biomedich-267	356	18	huang	huang	PROPN
biomedich-267	356	19	,	,	PUNCT
biomedich-267	356	20	i.	i.	PROPN
biomedich-267	356	21	,	,	PUNCT
biomedich-267	356	22	raharjo	raharjo	PROPN
biomedich-267	356	23	,	,	PUNCT
biomedich-267	356	24	s.	s.	PROPN
biomedich-267	356	25	b.	b.	PROPN
biomedich-267	356	26	,	,	PUNCT
biomedich-267	356	27	&	&	CCONJ
biomedich-267	356	28	lukito	lukito	PROPN
biomedich-267	356	29	,	,	PUNCT
biomedich-267	356	30	a.	a.	NOUN
biomedich-267	356	31	a.	a.	NOUN
biomedich-267	356	32	(	(	PUNCT
biomedich-267	356	33	2020	2020	NUM
biomedich-267	356	34	)	)	PUNCT
biomedich-267	356	35	.	.	PUNCT
biomedich-267	357	1	hypertension	hypertension	NOUN
biomedich-267	357	2	is	be	AUX
biomedich-267	357	3	associated	associate	VERB
biomedich-267	357	4	with	with	ADP
biomedich-267	357	5	increased	increase	VERB
biomedich-267	357	6	mortality	mortality	NOUN
biomedich-267	357	7	and	and	CCONJ
biomedich-267	357	8	severity	severity	NOUN
biomedich-267	357	9	of	of	ADP
biomedich-267	357	10	disease	disease	NOUN
biomedich-267	357	11	in	in	ADP
biomedich-267	357	12	covid-19	covid-19	PROPN
biomedich-267	357	13	pneumonia	pneumonia	NOUN
biomedich-267	357	14	:	:	PUNCT
biomedich-267	357	15	a	a	DET
biomedich-267	357	16	systematic	systematic	ADJ
biomedich-267	357	17	review	review	NOUN
biomedich-267	357	18	,	,	PUNCT
biomedich-267	357	19	meta	meta	ADJ
biomedich-267	357	20	-	-	PUNCT
biomedich-267	357	21	analysis	analysis	NOUN
biomedich-267	357	22	and	and	CCONJ
biomedich-267	357	23	meta	meta	NOUN
biomedich-267	357	24	-	-	PUNCT
biomedich-267	357	25	regression	regression	NOUN
biomedich-267	357	26	.	.	PUNCT
biomedich-267	358	1	journal	journal	NOUN
biomedich-267	358	2	of	of	ADP
biomedich-267	358	3	the	the	DET
biomedich-267	358	4	renin	renin	ADJ
biomedich-267	358	5	-	-	PUNCT
biomedich-267	358	6	angiotensin	angiotensin	NOUN
biomedich-267	358	7	-	-	PUNCT
biomedich-267	358	8	aldosterone	aldosterone	NOUN
biomedich-267	358	9	system	system	NOUN
biomedich-267	358	10	:	:	PUNCT
biomedich-267	358	11	jraas	jraas	ADJ
biomedich-267	358	12	,	,	PUNCT
biomedich-267	358	13	21(2	21(2	NUM
biomedich-267	358	14	)	)	PUNCT
biomedich-267	358	15	.	.	PUNCT
biomedich-267	359	1	pugliese	pugliese	PROPN
biomedich-267	359	2	,	,	PUNCT
biomedich-267	359	3	g.	g.	PROPN
biomedich-267	359	4	,	,	PUNCT
biomedich-267	359	5	vitale	vitale	PROPN
biomedich-267	359	6	,	,	PUNCT
biomedich-267	359	7	m.	m.	NOUN
biomedich-267	359	8	,	,	PUNCT
biomedich-267	359	9	resi	resi	PROPN
biomedich-267	359	10	,	,	PUNCT
biomedich-267	359	11	v.	v.	PROPN
biomedich-267	359	12	,	,	PUNCT
biomedich-267	359	13	&	&	CCONJ
biomedich-267	359	14	orsi	orsi	PROPN
biomedich-267	359	15	,	,	PUNCT
biomedich-267	359	16	e.	e.	PROPN
biomedich-267	359	17	(	(	PUNCT
biomedich-267	359	18	2020	2020	NUM
biomedich-267	359	19	)	)	PUNCT
biomedich-267	359	20	.	.	PUNCT
biomedich-267	359	21	is	be	AUX
biomedich-267	359	22	diabetes	diabetes	NOUN
biomedich-267	359	23	mellitus	mellitus	NOUN
biomedich-267	359	24	a	a	DET
biomedich-267	359	25	risk	risk	NOUN
biomedich-267	359	26	factor	factor	NOUN
biomedich-267	359	27	for	for	ADP
biomedich-267	359	28	coronavirus	coronavirus	NOUN
biomedich-267	359	29	disease	disease	NOUN
biomedich-267	359	30	19	19	NUM
biomedich-267	359	31	(	(	PUNCT
biomedich-267	359	32	covid19	covid19	NOUN
biomedich-267	359	33	)	)	PUNCT
biomedich-267	359	34	?	?	PUNCT
biomedich-267	359	35	.	.	PUNCT
biomedich-267	360	1	acta	acta	PROPN
biomedich-267	360	2	diabetologica	diabetologica	PROPN
biomedich-267	360	3	,	,	PUNCT
biomedich-267	360	4	1	1	NUM
biomedich-267	360	5	-	-	SYM
biomedich-267	360	6	11	11	NUM
biomedich-267	360	7	.	.	PUNCT
biomedich-267	361	1	puig	puig	PROPN
biomedich-267	361	2	-	-	PUNCT
biomedich-267	361	3	domingo	domingo	PROPN
biomedich-267	361	4	,	,	PUNCT
biomedich-267	361	5	m.	m.	NOUN
biomedich-267	361	6	,	,	PUNCT
biomedich-267	361	7	marazuela	marazuela	PROPN
biomedich-267	361	8	,	,	PUNCT
biomedich-267	361	9	m.	m.	NOUN
biomedich-267	361	10	,	,	PUNCT
biomedich-267	361	11	&	&	CCONJ
biomedich-267	361	12	giustina	giustina	PROPN
biomedich-267	361	13	,	,	PUNCT
biomedich-267	361	14	a.	a.	NOUN
biomedich-267	361	15	(	(	PUNCT
biomedich-267	361	16	2020	2020	NUM
biomedich-267	361	17	)	)	PUNCT
biomedich-267	361	18	.	.	PUNCT
biomedich-267	362	1	covid-19	covid-19	PROPN
biomedich-267	362	2	and	and	CCONJ
biomedich-267	362	3	endocrine	endocrine	NOUN
biomedich-267	362	4	diseases	disease	NOUN
biomedich-267	362	5	.	.	PUNCT
biomedich-267	363	1	a	a	DET
biomedich-267	363	2	statement	statement	NOUN
biomedich-267	363	3	from	from	ADP
biomedich-267	363	4	the	the	DET
biomedich-267	363	5	european	european	PROPN
biomedich-267	363	6	society	society	NOUN
biomedich-267	363	7	of	of	ADP
biomedich-267	363	8	endocrinology	endocrinology	NOUN
biomedich-267	363	9	.	.	PUNCT
biomedich-267	364	1	endocrine	endocrine	PROPN
biomedich-267	364	2	,	,	PUNCT
biomedich-267	364	3	68(1	68(1	NOUN
biomedich-267	364	4	)	)	PUNCT
biomedich-267	364	5	,	,	PUNCT
biomedich-267	364	6	2	2	NUM
biomedich-267	364	7	-	-	SYM
biomedich-267	364	8	5	5	NUM
biomedich-267	364	9	.	.	PUNCT
biomedich-267	365	1	radzikowska	radzikowska	PROPN
biomedich-267	365	2	,	,	PUNCT
biomedich-267	365	3	u.	u.	NOUN
biomedich-267	365	4	,	,	PUNCT
biomedich-267	365	5	ding	ding	NOUN
biomedich-267	365	6	,	,	PUNCT
biomedich-267	365	7	m.	m.	NOUN
biomedich-267	365	8	,	,	PUNCT
biomedich-267	365	9	tan	tan	PROPN
biomedich-267	365	10	,	,	PUNCT
biomedich-267	365	11	g.	g.	PROPN
biomedich-267	365	12	,	,	PUNCT
biomedich-267	365	13	zhakparov	zhakparov	PROPN
biomedich-267	365	14	,	,	PUNCT
biomedich-267	365	15	d.	d.	PROPN
biomedich-267	365	16	,	,	PUNCT
biomedich-267	365	17	peng	peng	PROPN
biomedich-267	365	18	,	,	PUNCT
biomedich-267	365	19	y.	y.	PROPN
biomedich-267	365	20	,	,	PUNCT
biomedich-267	365	21	wawrzyniak	wawrzyniak	PROPN
biomedich-267	365	22	,	,	PUNCT
biomedich-267	365	23	p.	p.	PROPN
biomedich-267	365	24	,	,	PUNCT
biomedich-267	365	25	...	...	PUNCT
biomedich-267	365	26	&	&	CCONJ
biomedich-267	365	27	reiger	reiger	NOUN
biomedich-267	365	28	,	,	PUNCT
biomedich-267	365	29	m.	m.	NOUN
biomedich-267	365	30	(	(	PUNCT
biomedich-267	365	31	2020	2020	NUM
biomedich-267	365	32	)	)	PUNCT
biomedich-267	365	33	.	.	PUNCT
biomedich-267	366	1	distribution	distribution	NOUN
biomedich-267	366	2	of	of	ADP
biomedich-267	366	3	ace2	ace2	PROPN
biomedich-267	366	4	,	,	PUNCT
biomedich-267	366	5	cd147	cd147	PROPN
biomedich-267	366	6	,	,	PUNCT
biomedich-267	366	7	cd26	cd26	PROPN
biomedich-267	366	8	and	and	CCONJ
biomedich-267	366	9	other	other	ADJ
biomedich-267	366	10	sars‐cov‐2	sars‐cov‐2	PROPN
biomedich-267	366	11	associated	associate	VERB
biomedich-267	366	12	molecules	molecule	NOUN
biomedich-267	366	13	in	in	ADP
biomedich-267	366	14	tissues	tissue	NOUN
biomedich-267	366	15	and	and	CCONJ
biomedich-267	366	16	immune	immune	ADJ
biomedich-267	366	17	cells	cell	NOUN
biomedich-267	366	18	in	in	ADP
biomedich-267	366	19	health	health	NOUN
biomedich-267	366	20	and	and	CCONJ
biomedich-267	366	21	in	in	ADP
biomedich-267	366	22	asthma	asthma	NOUN
biomedich-267	366	23	,	,	PUNCT
biomedich-267	366	24	copd	copd	NOUN
biomedich-267	366	25	,	,	PUNCT
biomedich-267	366	26	obesity	obesity	NOUN
biomedich-267	366	27	,	,	PUNCT
biomedich-267	366	28	hypertension	hypertension	NOUN
biomedich-267	366	29	,	,	PUNCT
biomedich-267	366	30	and	and	CCONJ
biomedich-267	366	31	covid‐19	covid‐19	PROPN
biomedich-267	366	32	risk	risk	NOUN
biomedich-267	366	33	factors	factor	NOUN
biomedich-267	366	34	.	.	PUNCT
biomedich-267	367	1	allergy	allergy	NOUN
biomedich-267	367	2	.	.	PUNCT
biomedich-267	368	1	rostam	rostam	NOUN
biomedich-267	368	2	,	,	PUNCT
biomedich-267	368	3	s.	s.	PROPN
biomedich-267	368	4	r.	r.	PROPN
biomedich-267	368	5	k.	k.	PROPN
biomedich-267	368	6	,	,	PUNCT
biomedich-267	368	7	shekhany	shekhany	PROPN
biomedich-267	368	8	,	,	PUNCT
biomedich-267	368	9	k.	k.	PROPN
biomedich-267	368	10	a.	a.	PROPN
biomedich-267	368	11	m.	m.	PROPN
biomedich-267	368	12	,	,	PUNCT
biomedich-267	368	13	&	&	CCONJ
biomedich-267	368	14	smail	smail	PROPN
biomedich-267	368	15	,	,	PUNCT
biomedich-267	368	16	h.	h.	PROPN
biomedich-267	368	17	o.	o.	PROPN
biomedich-267	368	18	(	(	PUNCT
biomedich-267	368	19	2020	2020	NUM
biomedich-267	368	20	)	)	PUNCT
biomedich-267	368	21	.	.	PUNCT
biomedich-267	369	1	comparative	comparative	ADJ
biomedich-267	369	2	study	study	NOUN
biomedich-267	369	3	of	of	ADP
biomedich-267	369	4	some	some	DET
biomedich-267	369	5	biochemical	biochemical	ADJ
biomedich-267	369	6	parameters	parameter	NOUN
biomedich-267	369	7	among	among	ADP
biomedich-267	369	8	of	of	ADP
biomedich-267	369	9	covid-19	covid-19	PROPN
biomedich-267	369	10	symptoms	symptom	NOUN
biomedich-267	369	11	and	and	CCONJ
biomedich-267	369	12	non	non	ADJ
biomedich-267	369	13	covid-19	covid-19	PROPN
biomedich-267	369	14	symptoms	symptom	VERB
biomedich-267	369	15	individuals	individual	NOUN
biomedich-267	369	16	.	.	PUNCT
biomedich-267	370	1	biovalentia	biovalentia	PROPN
biomedich-267	370	2	:	:	PUNCT
biomedich-267	370	3	biological	biological	ADJ
biomedich-267	370	4	research	research	NOUN
biomedich-267	370	5	journal	journal	NOUN
biomedich-267	370	6	,	,	PUNCT
biomedich-267	370	7	6(2	6(2	NUM
biomedich-267	370	8	)	)	PUNCT
biomedich-267	370	9	.	.	PUNCT
biomedich-267	371	1	rubino	rubino	PROPN
biomedich-267	371	2	,	,	PUNCT
biomedich-267	371	3	f.	f.	PROPN
biomedich-267	371	4	,	,	PUNCT
biomedich-267	371	5	amiel	amiel	PROPN
biomedich-267	371	6	,	,	PUNCT
biomedich-267	371	7	s.	s.	PROPN
biomedich-267	371	8	a.	a.	PROPN
biomedich-267	371	9	,	,	PUNCT
biomedich-267	371	10	zimmet	zimmet	NOUN
biomedich-267	371	11	,	,	PUNCT
biomedich-267	371	12	p.	p.	NOUN
biomedich-267	371	13	,	,	PUNCT
biomedich-267	371	14	alberti	alberti	PROPN
biomedich-267	371	15	,	,	PUNCT
biomedich-267	371	16	g.	g.	PROPN
biomedich-267	371	17	,	,	PUNCT
biomedich-267	371	18	bornstein	bornstein	PROPN
biomedich-267	371	19	,	,	PUNCT
biomedich-267	371	20	s.	s.	PROPN
biomedich-267	371	21	,	,	PUNCT
biomedich-267	371	22	eckel	eckel	PROPN
biomedich-267	371	23	,	,	PUNCT
biomedich-267	371	24	r.	r.	PROPN
biomedich-267	371	25	h.	h.	PROPN
biomedich-267	371	26	,	,	PUNCT
biomedich-267	371	27	...	...	PUNCT
biomedich-267	371	28	&	&	CCONJ
biomedich-267	371	29	del	del	PROPN
biomedich-267	371	30	prato	prato	PROPN
biomedich-267	371	31	,	,	PUNCT
biomedich-267	371	32	s.	s.	PROPN
biomedich-267	371	33	(	(	PUNCT
biomedich-267	371	34	2020	2020	NUM
biomedich-267	371	35	)	)	PUNCT
biomedich-267	371	36	.	.	PUNCT
biomedich-267	372	1	new	new	ADJ
biomedich-267	372	2	-	-	PUNCT
biomedich-267	372	3	onset	onset	NOUN
biomedich-267	372	4	diabetes	diabetes	NOUN
biomedich-267	372	5	in	in	ADP
biomedich-267	372	6	covid-19	covid-19	PROPN
biomedich-267	372	7	.	.	PUNCT
biomedich-267	373	1	new	new	PROPN
biomedich-267	373	2	england	england	PROPN
biomedich-267	373	3	journal	journal	PROPN
biomedich-267	373	4	of	of	ADP
biomedich-267	373	5	medicine	medicine	NOUN
biomedich-267	373	6	.	.	PUNCT
biomedich-267	374	1	ryan	ryan	PROPN
biomedich-267	374	2	,	,	PUNCT
biomedich-267	374	3	j.	j.	PROPN
biomedich-267	374	4	j.	j.	PROPN
biomedich-267	374	5	,	,	PUNCT
biomedich-267	374	6	melendres	melendre	NOUN
biomedich-267	374	7	-	-	PUNCT
biomedich-267	374	8	groves	grove	NOUN
biomedich-267	374	9	,	,	PUNCT
biomedich-267	374	10	l.	l.	PROPN
biomedich-267	374	11	,	,	PUNCT
biomedich-267	374	12	zamanian	zamanian	PROPN
biomedich-267	374	13	,	,	PUNCT
biomedich-267	374	14	r.	r.	PROPN
biomedich-267	374	15	t.	t.	PROPN
biomedich-267	374	16	,	,	PUNCT
biomedich-267	374	17	oudiz	oudiz	PROPN
biomedich-267	374	18	,	,	PUNCT
biomedich-267	374	19	r.	r.	PROPN
biomedich-267	374	20	j.	j.	PROPN
biomedich-267	374	21	,	,	PUNCT
biomedich-267	374	22	chakinala	chakinala	NOUN
biomedich-267	374	23	,	,	PUNCT
biomedich-267	374	24	m.	m.	NOUN
biomedich-267	374	25	,	,	PUNCT
biomedich-267	374	26	rosenzweig	rosenzweig	PROPN
biomedich-267	374	27	,	,	PUNCT
biomedich-267	374	28	e.	e.	PROPN
biomedich-267	374	29	b.	b.	PROPN
biomedich-267	374	30	,	,	PUNCT
biomedich-267	374	31	&	&	CCONJ
biomedich-267	374	32	gomberg	gomberg	PROPN
biomedich-267	374	33	-	-	PUNCT
biomedich-267	374	34	maitland	maitland	PROPN
biomedich-267	374	35	,	,	PUNCT
biomedich-267	374	36	m.	m.	NOUN
biomedich-267	374	37	(	(	PUNCT
biomedich-267	374	38	2020	2020	NUM
biomedich-267	374	39	)	)	PUNCT
biomedich-267	374	40	.	.	PUNCT
biomedich-267	375	1	care	care	NOUN
biomedich-267	375	2	of	of	ADP
biomedich-267	375	3	patients	patient	NOUN
biomedich-267	375	4	with	with	ADP
biomedich-267	375	5	pulmonary	pulmonary	ADJ
biomedich-267	375	6	arterial	arterial	ADJ
biomedich-267	375	7	hypertension	hypertension	NOUN
biomedich-267	375	8	during	during	ADP
biomedich-267	375	9	the	the	DET
biomedich-267	375	10	coronavirus	coronavirus	NOUN
biomedich-267	375	11	(	(	PUNCT
biomedich-267	375	12	covid-19	covid-19	PROPN
biomedich-267	375	13	)	)	PUNCT
biomedich-267	375	14	pandemic	pandemic	ADJ
biomedich-267	375	15	.	.	PUNCT
biomedich-267	376	1	pulmonary	pulmonary	ADJ
biomedich-267	376	2	circulation	circulation	NOUN
biomedich-267	376	3	,	,	PUNCT
biomedich-267	376	4	10(2	10(2	NUM
biomedich-267	376	5	)	)	PUNCT
biomedich-267	376	6	,	,	PUNCT
biomedich-267	376	7	2045894020920153	2045894020920153	NUM
biomedich-267	376	8	.	.	PUNCT
biomedich-267	377	1	smail	smail	NOUN
biomedich-267	377	2	–	–	PUNCT
biomedich-267	377	3	the	the	DET
biomedich-267	377	4	association	association	NOUN
biomedich-267	377	5	between	between	ADP
biomedich-267	377	6	some	some	DET
biomedich-267	377	7	endocrine	endocrine	NOUN
biomedich-267	377	8	conditions	condition	NOUN
biomedich-267	377	9	and	and	CCONJ
biomedich-267	377	10	covid-19	covid-19	PROPN
biomedich-267	377	11	:	:	PUNCT
biomedich-267	377	12	a	a	DET
biomedich-267	377	13	review	review	NOUN
biomedich-267	377	14	53	53	NUM
biomedich-267	377	15	rychter	rychter	NOUN
biomedich-267	377	16	,	,	PUNCT
biomedich-267	377	17	a.	a.	NOUN
biomedich-267	377	18	m.	m.	NOUN
biomedich-267	377	19	,	,	PUNCT
biomedich-267	377	20	zawada	zawada	PROPN
biomedich-267	377	21	,	,	PUNCT
biomedich-267	377	22	a.	a.	NOUN
biomedich-267	377	23	,	,	PUNCT
biomedich-267	377	24	ratajczak	ratajczak	PROPN
biomedich-267	377	25	,	,	PUNCT
biomedich-267	377	26	a.	a.	PROPN
biomedich-267	377	27	e.	e.	PROPN
biomedich-267	377	28	,	,	PUNCT
biomedich-267	377	29	dobrowolska	dobrowolska	PROPN
biomedich-267	377	30	,	,	PUNCT
biomedich-267	377	31	a.	a.	NOUN
biomedich-267	377	32	,	,	PUNCT
biomedich-267	377	33	&	&	CCONJ
biomedich-267	377	34	krela‐kaźmierczak	krela‐kaźmierczak	PROPN
biomedich-267	377	35	,	,	PUNCT
biomedich-267	377	36	i.	i.	PROPN
biomedich-267	377	37	(	(	PUNCT
biomedich-267	377	38	2020	2020	NUM
biomedich-267	377	39	)	)	PUNCT
biomedich-267	377	40	.	.	PUNCT
biomedich-267	378	1	should	should	AUX
biomedich-267	378	2	patients	patient	NOUN
biomedich-267	378	3	with	with	ADP
biomedich-267	378	4	obesity	obesity	NOUN
biomedich-267	378	5	be	be	VERB
biomedich-267	378	6	more	more	ADV
biomedich-267	378	7	afraid	afraid	ADJ
biomedich-267	378	8	of	of	ADP
biomedich-267	378	9	covid‐19	covid‐19	PROPN
biomedich-267	378	10	?	?	PUNCT
biomedich-267	378	11	.	.	PUNCT
biomedich-267	379	1	obesity	obesity	NOUN
biomedich-267	379	2	reviews	review	NOUN
biomedich-267	379	3	,	,	PUNCT
biomedich-267	379	4	21(9	21(9	NOUN
biomedich-267	379	5	)	)	PUNCT
biomedich-267	379	6	,	,	PUNCT
biomedich-267	379	7	e13083	e13083	PROPN
biomedich-267	379	8	.	.	PUNCT
biomedich-267	380	1	salah	salah	PROPN
biomedich-267	380	2	,	,	PUNCT
biomedich-267	380	3	h.	h.	PROPN
biomedich-267	380	4	m.	m.	PROPN
biomedich-267	380	5	,	,	PUNCT
biomedich-267	380	6	calcaterra	calcaterra	PROPN
biomedich-267	380	7	,	,	PUNCT
biomedich-267	380	8	g.	g.	PROPN
biomedich-267	380	9	,	,	PUNCT
biomedich-267	380	10	&	&	CCONJ
biomedich-267	380	11	mehta	mehta	PROPN
biomedich-267	380	12	,	,	PUNCT
biomedich-267	380	13	j.	j.	PROPN
biomedich-267	380	14	l.	l.	PROPN
biomedich-267	380	15	(	(	PUNCT
biomedich-267	380	16	2020	2020	NUM
biomedich-267	380	17	)	)	PUNCT
biomedich-267	380	18	.	.	PUNCT
biomedich-267	381	1	reninangiotensin	reninangiotensin	NOUN
biomedich-267	381	2	system	system	NOUN
biomedich-267	381	3	blockade	blockade	NOUN
biomedich-267	381	4	and	and	CCONJ
biomedich-267	381	5	mortality	mortality	NOUN
biomedich-267	381	6	in	in	ADP
biomedich-267	381	7	patients	patient	NOUN
biomedich-267	381	8	with	with	ADP
biomedich-267	381	9	hypertension	hypertension	NOUN
biomedich-267	381	10	and	and	CCONJ
biomedich-267	381	11	covid-19	covid-19	PROPN
biomedich-267	381	12	infection	infection	NOUN
biomedich-267	381	13	.	.	PUNCT
biomedich-267	382	1	journal	journal	NOUN
biomedich-267	382	2	of	of	ADP
biomedich-267	382	3	cardiovascular	cardiovascular	ADJ
biomedich-267	382	4	pharmacology	pharmacology	NOUN
biomedich-267	382	5	and	and	CCONJ
biomedich-267	382	6	therapeutics	therapeutic	NOUN
biomedich-267	382	7	,	,	PUNCT
biomedich-267	382	8	25(6	25(6	NOUN
biomedich-267	382	9	)	)	PUNCT
biomedich-267	382	10	,	,	PUNCT
biomedich-267	382	11	503507	503507	NUM
biomedich-267	382	12	.	.	PUNCT
biomedich-267	383	1	sattar	sattar	PROPN
biomedich-267	383	2	,	,	PUNCT
biomedich-267	383	3	n.	n.	PROPN
biomedich-267	383	4	,	,	PUNCT
biomedich-267	383	5	mcinnes	mcinnes	PROPN
biomedich-267	383	6	,	,	PUNCT
biomedich-267	383	7	i.	i.	PROPN
biomedich-267	383	8	b.	b.	PROPN
biomedich-267	383	9	,	,	PUNCT
biomedich-267	383	10	&	&	CCONJ
biomedich-267	383	11	mcmurray	mcmurray	PROPN
biomedich-267	383	12	,	,	PUNCT
biomedich-267	383	13	j.	j.	PROPN
biomedich-267	383	14	j.	j.	PROPN
biomedich-267	383	15	(	(	PUNCT
biomedich-267	383	16	2020	2020	NUM
biomedich-267	383	17	)	)	PUNCT
biomedich-267	383	18	.	.	PUNCT
biomedich-267	384	1	obesity	obesity	NOUN
biomedich-267	384	2	a	a	DET
biomedich-267	384	3	risk	risk	NOUN
biomedich-267	384	4	factor	factor	NOUN
biomedich-267	384	5	for	for	ADP
biomedich-267	384	6	severe	severe	ADJ
biomedich-267	384	7	covid-19	covid-19	PROPN
biomedich-267	384	8	infection	infection	NOUN
biomedich-267	384	9	:	:	PUNCT
biomedich-267	384	10	multiple	multiple	ADJ
biomedich-267	384	11	potential	potential	ADJ
biomedich-267	384	12	mechanisms	mechanism	NOUN
biomedich-267	384	13	.	.	PUNCT
biomedich-267	385	1	circulation	circulation	NOUN
biomedich-267	385	2	.	.	PUNCT
biomedich-267	386	1	schiffrin	schiffrin	NOUN
biomedich-267	386	2	,	,	PUNCT
biomedich-267	386	3	e.	e.	PROPN
biomedich-267	386	4	l.	l.	PROPN
biomedich-267	386	5	,	,	PUNCT
biomedich-267	386	6	flack	flack	NOUN
biomedich-267	386	7	,	,	PUNCT
biomedich-267	386	8	j.	j.	PROPN
biomedich-267	386	9	m.	m.	PROPN
biomedich-267	386	10	,	,	PUNCT
biomedich-267	386	11	ito	ito	PROPN
biomedich-267	386	12	,	,	PUNCT
biomedich-267	386	13	s.	s.	PROPN
biomedich-267	386	14	,	,	PUNCT
biomedich-267	386	15	muntner	muntner	NOUN
biomedich-267	386	16	,	,	PUNCT
biomedich-267	386	17	p.	p.	NOUN
biomedich-267	386	18	,	,	PUNCT
biomedich-267	386	19	&	&	CCONJ
biomedich-267	386	20	webb	webb	PROPN
biomedich-267	386	21	,	,	PUNCT
biomedich-267	386	22	r.	r.	PROPN
biomedich-267	386	23	c.	c.	PROPN
biomedich-267	386	24	(	(	PUNCT
biomedich-267	386	25	2020	2020	NUM
biomedich-267	386	26	)	)	PUNCT
biomedich-267	386	27	.	.	PUNCT
biomedich-267	387	1	hypertension	hypertension	NOUN
biomedich-267	387	2	and	and	CCONJ
biomedich-267	387	3	covid-19	covid-19	PROPN
biomedich-267	387	4	.	.	PROPN
biomedich-267	387	5	shang	shang	PROPN
biomedich-267	387	6	,	,	PUNCT
biomedich-267	387	7	j.	j.	PROPN
biomedich-267	387	8	,	,	PUNCT
biomedich-267	387	9	wang	wang	PROPN
biomedich-267	387	10	,	,	PUNCT
biomedich-267	387	11	q.	q.	PROPN
biomedich-267	387	12	,	,	PUNCT
biomedich-267	387	13	zhang	zhang	PROPN
biomedich-267	387	14	,	,	PUNCT
biomedich-267	387	15	h.	h.	PROPN
biomedich-267	387	16	,	,	PUNCT
biomedich-267	387	17	wang	wang	PROPN
biomedich-267	387	18	,	,	PUNCT
biomedich-267	387	19	x.	x.	PROPN
biomedich-267	387	20	,	,	PUNCT
biomedich-267	387	21	wan	wan	PROPN
biomedich-267	387	22	,	,	PUNCT
biomedich-267	387	23	j.	j.	PROPN
biomedich-267	387	24	,	,	PUNCT
biomedich-267	387	25	yan	yan	PROPN
biomedich-267	387	26	,	,	PUNCT
biomedich-267	387	27	y.	y.	PROPN
biomedich-267	387	28	,	,	PUNCT
biomedich-267	387	29	...	...	PUNCT
biomedich-267	387	30	&	&	CCONJ
biomedich-267	387	31	lin	lin	PROPN
biomedich-267	387	32	,	,	PUNCT
biomedich-267	387	33	j.	j.	PROPN
biomedich-267	387	34	(	(	PUNCT
biomedich-267	387	35	2020	2020	NUM
biomedich-267	387	36	)	)	PUNCT
biomedich-267	387	37	.	.	PUNCT
biomedich-267	388	1	the	the	DET
biomedich-267	388	2	relationship	relationship	NOUN
biomedich-267	388	3	between	between	ADP
biomedich-267	388	4	diabetes	diabetes	NOUN
biomedich-267	388	5	mellitus	mellitus	NOUN
biomedich-267	388	6	and	and	CCONJ
biomedich-267	388	7	covid-19	covid-19	PROPN
biomedich-267	388	8	prognosis	prognosis	NOUN
biomedich-267	388	9	:	:	PUNCT
biomedich-267	388	10	a	a	DET
biomedich-267	388	11	retrospective	retrospective	ADJ
biomedich-267	388	12	cohort	cohort	NOUN
biomedich-267	388	13	study	study	NOUN
biomedich-267	388	14	in	in	ADP
biomedich-267	388	15	wuhan	wuhan	PROPN
biomedich-267	388	16	,	,	PUNCT
biomedich-267	388	17	china	china	PROPN
biomedich-267	388	18	.	.	PUNCT
biomedich-267	389	1	the	the	DET
biomedich-267	389	2	american	american	PROPN
biomedich-267	389	3	journal	journal	PROPN
biomedich-267	389	4	of	of	ADP
biomedich-267	389	5	medicine	medicine	NOUN
biomedich-267	389	6	,	,	PUNCT
biomedich-267	389	7	134(1	134(1	NUM
biomedich-267	389	8	)	)	PUNCT
biomedich-267	389	9	,	,	PUNCT
biomedich-267	389	10	e6	e6	PROPN
biomedich-267	389	11	-	-	PUNCT
biomedich-267	389	12	e14	e14	NOUN
biomedich-267	389	13	.	.	PUNCT
biomedich-267	390	1	shekhar	shekhar	PROPN
biomedich-267	390	2	,	,	PUNCT
biomedich-267	390	3	s.	s.	PROPN
biomedich-267	390	4	,	,	PUNCT
biomedich-267	390	5	wurth	wurth	PROPN
biomedich-267	390	6	,	,	PUNCT
biomedich-267	390	7	r.	r.	PROPN
biomedich-267	390	8	,	,	PUNCT
biomedich-267	390	9	kamilaris	kamilaris	PROPN
biomedich-267	390	10	,	,	PUNCT
biomedich-267	390	11	c.	c.	PROPN
biomedich-267	390	12	d.	d.	PROPN
biomedich-267	390	13	,	,	PUNCT
biomedich-267	390	14	eisenhofer	eisenhofer	NOUN
biomedich-267	390	15	,	,	PUNCT
biomedich-267	390	16	g.	g.	PROPN
biomedich-267	390	17	,	,	PUNCT
biomedich-267	390	18	barrera	barrera	PROPN
biomedich-267	390	19	,	,	PUNCT
biomedich-267	390	20	f.	f.	PROPN
biomedich-267	390	21	j.	j.	PROPN
biomedich-267	390	22	,	,	PUNCT
biomedich-267	390	23	hajdenberg	hajdenberg	PROPN
biomedich-267	390	24	,	,	PUNCT
biomedich-267	390	25	m.	m.	NOUN
biomedich-267	390	26	,	,	PUNCT
biomedich-267	390	27	...	...	PUNCT
biomedich-267	390	28	&	&	CCONJ
biomedich-267	390	29	stratakis	stratakis	PROPN
biomedich-267	390	30	,	,	PUNCT
biomedich-267	390	31	c.	c.	PROPN
biomedich-267	390	32	a.	a.	PROPN
biomedich-267	390	33	(	(	PUNCT
biomedich-267	390	34	2020	2020	NUM
biomedich-267	390	35	)	)	PUNCT
biomedich-267	390	36	.	.	PUNCT
biomedich-267	391	1	endocrine	endocrine	ADJ
biomedich-267	391	2	conditions	condition	NOUN
biomedich-267	391	3	and	and	CCONJ
biomedich-267	391	4	covid-19	covid-19	PROPN
biomedich-267	391	5	.	.	PROPN
biomedich-267	391	6	hormone	hormone	PROPN
biomedich-267	391	7	and	and	CCONJ
biomedich-267	391	8	metabolic	metabolic	NOUN
biomedich-267	391	9	research	research	NOUN
biomedich-267	391	10	,	,	PUNCT
biomedich-267	391	11	52(7	52(7	NUM
biomedich-267	391	12	)	)	PUNCT
biomedich-267	391	13	,	,	PUNCT
biomedich-267	391	14	471	471	NUM
biomedich-267	391	15	.	.	PUNCT
biomedich-267	392	1	singh	singh	PROPN
biomedich-267	392	2	,	,	PUNCT
biomedich-267	392	3	a.	a.	PROPN
biomedich-267	392	4	k.	k.	PROPN
biomedich-267	392	5	,	,	PUNCT
biomedich-267	392	6	gupta	gupta	PROPN
biomedich-267	392	7	,	,	PUNCT
biomedich-267	392	8	r.	r.	PROPN
biomedich-267	392	9	,	,	PUNCT
biomedich-267	392	10	ghosh	ghosh	PROPN
biomedich-267	392	11	,	,	PUNCT
biomedich-267	392	12	a.	a.	PROPN
biomedich-267	392	13	,	,	PUNCT
biomedich-267	392	14	&	&	CCONJ
biomedich-267	392	15	misra	misra	PROPN
biomedich-267	392	16	,	,	PUNCT
biomedich-267	392	17	a.	a.	NOUN
biomedich-267	392	18	(	(	PUNCT
biomedich-267	392	19	2020	2020	NUM
biomedich-267	392	20	)	)	PUNCT
biomedich-267	392	21	.	.	PUNCT
biomedich-267	393	1	diabetes	diabetes	NOUN
biomedich-267	393	2	in	in	ADP
biomedich-267	393	3	covid-19	covid-19	PROPN
biomedich-267	393	4	:	:	PUNCT
biomedich-267	393	5	prevalence	prevalence	NOUN
biomedich-267	393	6	,	,	PUNCT
biomedich-267	393	7	pathophysiology	pathophysiology	NOUN
biomedich-267	393	8	,	,	PUNCT
biomedich-267	393	9	prognosis	prognosis	NOUN
biomedich-267	393	10	and	and	CCONJ
biomedich-267	393	11	practical	practical	ADJ
biomedich-267	393	12	considerations	consideration	NOUN
biomedich-267	393	13	.	.	PUNCT
biomedich-267	394	1	diabetes	diabetes	NOUN
biomedich-267	394	2	&	&	CCONJ
biomedich-267	394	3	metabolic	metabolic	PROPN
biomedich-267	394	4	syndrome	syndrome	PROPN
biomedich-267	394	5	:	:	PUNCT
biomedich-267	394	6	clinical	clinical	ADJ
biomedich-267	394	7	research	research	NOUN
biomedich-267	394	8	&	&	CCONJ
biomedich-267	394	9	reviews	review	NOUN
biomedich-267	394	10	.	.	PUNCT
biomedich-267	395	1	singhai	singhai	PROPN
biomedich-267	395	2	,	,	PUNCT
biomedich-267	395	3	k.	k.	PROPN
biomedich-267	395	4	,	,	PUNCT
biomedich-267	395	5	swami	swami	PROPN
biomedich-267	395	6	,	,	PUNCT
biomedich-267	395	7	m.	m.	NOUN
biomedich-267	395	8	k.	k.	PROPN
biomedich-267	395	9	,	,	PUNCT
biomedich-267	395	10	nebhinani	nebhinani	PROPN
biomedich-267	395	11	,	,	PUNCT
biomedich-267	395	12	n.	n.	NOUN
biomedich-267	395	13	,	,	PUNCT
biomedich-267	395	14	rastogi	rastogi	PROPN
biomedich-267	395	15	,	,	PUNCT
biomedich-267	395	16	a.	a.	NOUN
biomedich-267	395	17	,	,	PUNCT
biomedich-267	395	18	&	&	CCONJ
biomedich-267	395	19	jude	jude	PROPN
biomedich-267	395	20	,	,	PUNCT
biomedich-267	395	21	e.	e.	PROPN
biomedich-267	395	22	(	(	PUNCT
biomedich-267	395	23	2020	2020	NUM
biomedich-267	395	24	)	)	PUNCT
biomedich-267	395	25	.	.	PUNCT
biomedich-267	396	1	psychological	psychological	ADJ
biomedich-267	396	2	adaptive	adaptive	ADJ
biomedich-267	396	3	difficulties	difficulty	NOUN
biomedich-267	396	4	and	and	CCONJ
biomedich-267	396	5	their	their	PRON
biomedich-267	396	6	management	management	NOUN
biomedich-267	396	7	during	during	ADP
biomedich-267	396	8	covid-19	covid-19	PROPN
biomedich-267	396	9	pandemic	pandemic	ADJ
biomedich-267	396	10	in	in	ADP
biomedich-267	396	11	people	people	NOUN
biomedich-267	396	12	with	with	ADP
biomedich-267	396	13	diabetes	diabetes	NOUN
biomedich-267	396	14	mellitus	mellitus	NOUN
biomedich-267	396	15	.	.	PUNCT
biomedich-267	397	1	diabetes	diabetes	NOUN
biomedich-267	397	2	&	&	CCONJ
biomedich-267	397	3	metabolic	metabolic	PROPN
biomedich-267	397	4	syndrome	syndrome	PROPN
biomedich-267	397	5	:	:	PUNCT
biomedich-267	397	6	clinical	clinical	ADJ
biomedich-267	397	7	research	research	NOUN
biomedich-267	397	8	&	&	CCONJ
biomedich-267	397	9	reviews	review	NOUN
biomedich-267	397	10	,	,	PUNCT
biomedich-267	397	11	14(6	14(6	NOUN
biomedich-267	397	12	)	)	PUNCT
biomedich-267	397	13	,	,	PUNCT
biomedich-267	397	14	1603	1603	NUM
biomedich-267	397	15	-	-	SYM
biomedich-267	397	16	1605	1605	NUM
biomedich-267	397	17	.	.	PUNCT
biomedich-267	398	1	smail	smail	NOUN
biomedich-267	398	2	,	,	PUNCT
biomedich-267	398	3	h.	h.	PROPN
biomedich-267	398	4	o.	o.	PROPN
biomedich-267	398	5	(	(	PUNCT
biomedich-267	398	6	2019	2019	NUM
biomedich-267	398	7	)	)	PUNCT
biomedich-267	398	8	.	.	PUNCT
biomedich-267	399	1	the	the	DET
biomedich-267	399	2	epigenetics	epigenetic	NOUN
biomedich-267	399	3	of	of	ADP
biomedich-267	399	4	diabetes	diabetes	NOUN
biomedich-267	399	5	,	,	PUNCT
biomedich-267	399	6	obesity	obesity	NOUN
biomedich-267	399	7	,	,	PUNCT
biomedich-267	399	8	overweight	overweight	ADJ
biomedich-267	399	9	and	and	CCONJ
biomedich-267	399	10	cardiovascular	cardiovascular	ADJ
biomedich-267	399	11	disease	disease	NOUN
biomedich-267	399	12	.	.	PUNCT
biomedich-267	400	1	aims	aim	VERB
biomedich-267	400	2	genetics	genetic	NOUN
biomedich-267	400	3	,	,	PUNCT
biomedich-267	400	4	6(3	6(3	NUM
biomedich-267	400	5	)	)	PUNCT
biomedich-267	400	6	,	,	PUNCT
biomedich-267	400	7	36	36	NUM
biomedich-267	400	8	.	.	PUNCT
biomedich-267	401	1	smail	smail	NOUN
biomedich-267	401	2	,	,	PUNCT
biomedich-267	401	3	h.	h.	PROPN
biomedich-267	401	4	o.	o.	PROPN
biomedich-267	401	5	,	,	PUNCT
biomedich-267	401	6	&	&	CCONJ
biomedich-267	401	7	mohamad	mohamad	PROPN
biomedich-267	401	8	,	,	PUNCT
biomedich-267	401	9	d.	d.	PROPN
biomedich-267	401	10	a.	a.	PROPN
biomedich-267	401	11	(	(	PUNCT
biomedich-267	401	12	2022	2022	NUM
biomedich-267	401	13	)	)	PUNCT
biomedich-267	401	14	.	.	PUNCT
biomedich-267	402	1	identification	identification	NOUN
biomedich-267	402	2	dna	dna	PROPN
biomedich-267	402	3	methylation	methylation	NOUN
biomedich-267	402	4	change	change	NOUN
biomedich-267	402	5	of	of	ADP
biomedich-267	402	6	abcc8	abcc8	ADJ
biomedich-267	402	7	gene	gene	NOUN
biomedich-267	402	8	in	in	ADP
biomedich-267	402	9	type	type	NOUN
biomedich-267	402	10	2	2	NUM
biomedich-267	402	11	diabetes	diabetes	NOUN
biomedich-267	402	12	mellitus	mellitus	NOUN
biomedich-267	402	13	as	as	ADP
biomedich-267	402	14	predictive	predictive	ADJ
biomedich-267	402	15	biomarkers	biomarker	NOUN
biomedich-267	402	16	.	.	PUNCT
biomedich-267	403	1	aro	aro	NOUN
biomedich-267	403	2	-	-	PUNCT
biomedich-267	403	3	the	the	DET
biomedich-267	403	4	scientific	scientific	ADJ
biomedich-267	403	5	journal	journal	NOUN
biomedich-267	403	6	of	of	ADP
biomedich-267	403	7	koya	koya	PROPN
biomedich-267	403	8	university	university	PROPN
biomedich-267	403	9	,	,	PUNCT
biomedich-267	403	10	10(1	10(1	NUM
biomedich-267	403	11	)	)	PUNCT
biomedich-267	403	12	,	,	PUNCT
biomedich-267	403	13	63	63	NUM
biomedich-267	403	14	-	-	SYM
biomedich-267	403	15	67	67	NUM
biomedich-267	403	16	.	.	PUNCT
biomedich-267	404	1	https://doi.org/10.14500/aro.10947	https://doi.org/10.14500/aro.10947	PROPN
biomedich-267	404	2	smail	smail	PROPN
biomedich-267	404	3	,	,	PUNCT
biomedich-267	404	4	h.	h.	PROPN
biomedich-267	404	5	,	,	PUNCT
biomedich-267	404	6	smail	smail	NOUN
biomedich-267	404	7	,	,	PUNCT
biomedich-267	404	8	k.	k.	PROPN
biomedich-267	404	9	,	,	PUNCT
biomedich-267	404	10	&	&	CCONJ
biomedich-267	404	11	amin	amin	PROPN
biomedich-267	404	12	,	,	PUNCT
biomedich-267	404	13	s.	s.	PROPN
biomedich-267	404	14	o.	o.	PROPN
biomedich-267	404	15	(	(	PUNCT
biomedich-267	404	16	2021	2021	NUM
biomedich-267	404	17	)	)	PUNCT
biomedich-267	404	18	.	.	PUNCT
biomedich-267	405	1	relationship	relationship	NOUN
biomedich-267	405	2	between	between	ADP
biomedich-267	405	3	pattern	pattern	NOUN
biomedich-267	405	4	of	of	ADP
biomedich-267	405	5	fingerprints	fingerprint	NOUN
biomedich-267	405	6	and	and	CCONJ
biomedich-267	405	7	obesity	obesity	NOUN
biomedich-267	405	8	.	.	PUNCT
biomedich-267	406	1	journal	journal	NOUN
biomedich-267	406	2	of	of	ADP
biomedich-267	406	3	experimental	experimental	ADJ
biomedich-267	406	4	and	and	CCONJ
biomedich-267	406	5	molecular	molecular	ADJ
biomedich-267	406	6	biology	biology	NOUN
biomedich-267	406	7	,	,	PUNCT
biomedich-267	406	8	21(1	21(1	NUM
biomedich-267	406	9	)	)	PUNCT
biomedich-267	406	10	,	,	PUNCT
biomedich-267	406	11	27	27	NUM
biomedich-267	406	12	-	-	SYM
biomedich-267	406	13	33	33	NUM
biomedich-267	406	14	.	.	PUNCT
biomedich-267	407	1	retrieved	retrieve	VERB
biomedich-267	407	2	from	from	ADP
biomedich-267	407	3	http://www.jemb.bio.uaic.ro/index.php/jemb/article/view/47	http://www.jemb.bio.uaic.ro/index.php/jemb/article/view/47	PROPN
biomedich-267	407	4	stefan	stefan	PROPN
biomedich-267	407	5	,	,	PUNCT
biomedich-267	407	6	n.	n.	PROPN
biomedich-267	407	7	,	,	PUNCT
biomedich-267	407	8	birkenfeld	birkenfeld	ADJ
biomedich-267	407	9	,	,	PUNCT
biomedich-267	407	10	a.	a.	PROPN
biomedich-267	407	11	l.	l.	PROPN
biomedich-267	407	12	,	,	PUNCT
biomedich-267	407	13	schulze	schulze	NOUN
biomedich-267	407	14	,	,	PUNCT
biomedich-267	407	15	m.	m.	PROPN
biomedich-267	407	16	b.	b.	PROPN
biomedich-267	407	17	,	,	PUNCT
biomedich-267	407	18	&	&	CCONJ
biomedich-267	407	19	ludwig	ludwig	PROPN
biomedich-267	407	20	,	,	PUNCT
biomedich-267	407	21	d.	d.	PROPN
biomedich-267	407	22	s.	s.	PROPN
biomedich-267	407	23	(	(	PUNCT
biomedich-267	407	24	2020	2020	NUM
biomedich-267	407	25	)	)	PUNCT
biomedich-267	407	26	.	.	PUNCT
biomedich-267	408	1	obesity	obesity	NOUN
biomedich-267	408	2	and	and	CCONJ
biomedich-267	408	3	impaired	impaired	ADJ
biomedich-267	408	4	metabolic	metabolic	NOUN
biomedich-267	408	5	health	health	NOUN
biomedich-267	408	6	in	in	ADP
biomedich-267	408	7	patients	patient	NOUN
biomedich-267	408	8	with	with	ADP
biomedich-267	408	9	covid-19	covid-19	PROPN
biomedich-267	408	10	.	.	PUNCT
biomedich-267	408	11	nature	nature	PROPN
biomedich-267	408	12	reviews	review	VERB
biomedich-267	408	13	endocrinology	endocrinology	NOUN
biomedich-267	408	14	,	,	PUNCT
biomedich-267	408	15	1	1	NUM
biomedich-267	408	16	-	-	SYM
biomedich-267	408	17	2	2	NUM
biomedich-267	408	18	.	.	PUNCT
biomedich-267	408	19	tadic	tadic	ADJ
biomedich-267	408	20	,	,	PUNCT
biomedich-267	408	21	m.	m.	NOUN
biomedich-267	408	22	,	,	PUNCT
biomedich-267	408	23	cuspidi	cuspidi	PROPN
biomedich-267	408	24	,	,	PUNCT
biomedich-267	408	25	c.	c.	PROPN
biomedich-267	408	26	,	,	PUNCT
biomedich-267	408	27	grassi	grassi	PROPN
biomedich-267	408	28	,	,	PUNCT
biomedich-267	408	29	g.	g.	PROPN
biomedich-267	408	30	,	,	PUNCT
biomedich-267	408	31	&	&	CCONJ
biomedich-267	408	32	mancia	mancia	PROPN
biomedich-267	408	33	,	,	PUNCT
biomedich-267	408	34	g.	g.	PROPN
biomedich-267	408	35	(	(	PUNCT
biomedich-267	408	36	2020	2020	NUM
biomedich-267	408	37	)	)	PUNCT
biomedich-267	408	38	.	.	PUNCT
biomedich-267	409	1	covid‐19	covid‐19	PROPN
biomedich-267	409	2	and	and	CCONJ
biomedich-267	409	3	arterial	arterial	ADJ
biomedich-267	409	4	hypertension	hypertension	NOUN
biomedich-267	409	5	:	:	PUNCT
biomedich-267	409	6	hypothesis	hypothesis	NOUN
biomedich-267	409	7	or	or	CCONJ
biomedich-267	409	8	evidence	evidence	NOUN
biomedich-267	409	9	?	?	PUNCT
biomedich-267	409	10	.	.	PUNCT
biomedich-267	410	1	the	the	DET
biomedich-267	410	2	journal	journal	NOUN
biomedich-267	410	3	of	of	ADP
biomedich-267	410	4	clinical	clinical	ADJ
biomedich-267	410	5	hypertension	hypertension	NOUN
biomedich-267	410	6	,	,	PUNCT
biomedich-267	410	7	22(7	22(7	NUM
biomedich-267	410	8	)	)	PUNCT
biomedich-267	410	9	,	,	PUNCT
biomedich-267	410	10	11201126	11201126	NUM
biomedich-267	410	11	.	.	PUNCT
biomedich-267	411	1	tartof	tartof	PROPN
biomedich-267	411	2	,	,	PUNCT
biomedich-267	411	3	s.	s.	PROPN
biomedich-267	411	4	y.	y.	PROPN
biomedich-267	411	5	,	,	PUNCT
biomedich-267	411	6	qian	qian	PROPN
biomedich-267	411	7	,	,	PUNCT
biomedich-267	411	8	l.	l.	PROPN
biomedich-267	411	9	,	,	PUNCT
biomedich-267	411	10	hong	hong	PROPN
biomedich-267	411	11	,	,	PUNCT
biomedich-267	411	12	v.	v.	PROPN
biomedich-267	411	13	,	,	PUNCT
biomedich-267	411	14	wei	wei	PROPN
biomedich-267	411	15	,	,	PUNCT
biomedich-267	411	16	r.	r.	PROPN
biomedich-267	411	17	,	,	PUNCT
biomedich-267	411	18	nadjafi	nadjafi	PROPN
biomedich-267	411	19	,	,	PUNCT
biomedich-267	411	20	r.	r.	PROPN
biomedich-267	411	21	f.	f.	PROPN
biomedich-267	411	22	,	,	PUNCT
biomedich-267	411	23	fischer	fischer	PROPN
biomedich-267	411	24	,	,	PUNCT
biomedich-267	411	25	h.	h.	PROPN
biomedich-267	411	26	,	,	PUNCT
biomedich-267	411	27	...	...	PUNCT
biomedich-267	411	28	&	&	CCONJ
biomedich-267	411	29	saxena	saxena	PROPN
biomedich-267	411	30	,	,	PUNCT
biomedich-267	411	31	t.	t.	PROPN
biomedich-267	411	32	(	(	PUNCT
biomedich-267	411	33	2020	2020	NUM
biomedich-267	411	34	)	)	PUNCT
biomedich-267	411	35	.	.	PUNCT
biomedich-267	412	1	obesity	obesity	NOUN
biomedich-267	412	2	and	and	CCONJ
biomedich-267	412	3	mortality	mortality	NOUN
biomedich-267	412	4	among	among	ADP
biomedich-267	412	5	patients	patient	NOUN
biomedich-267	412	6	diagnosed	diagnose	VERB
biomedich-267	412	7	with	with	ADP
biomedich-267	412	8	covid-19	covid-19	PROPN
biomedich-267	412	9	:	:	PUNCT
biomedich-267	412	10	results	result	NOUN
biomedich-267	412	11	from	from	ADP
biomedich-267	412	12	an	an	DET
biomedich-267	412	13	integrated	integrate	VERB
biomedich-267	412	14	health	health	NOUN
biomedich-267	412	15	care	care	NOUN
biomedich-267	412	16	organization	organization	NOUN
biomedich-267	412	17	.	.	PUNCT
biomedich-267	413	1	annals	annal	NOUN
biomedich-267	413	2	of	of	ADP
biomedich-267	413	3	internal	internal	ADJ
biomedich-267	413	4	medicine	medicine	NOUN
biomedich-267	413	5	,	,	PUNCT
biomedich-267	413	6	173(10	173(10	NUM
biomedich-267	413	7	)	)	PUNCT
biomedich-267	413	8	,	,	PUNCT
biomedich-267	413	9	773	773	NUM
biomedich-267	413	10	-	-	SYM
biomedich-267	413	11	781	781	NUM
biomedich-267	413	12	.	.	PUNCT
biomedich-267	414	1	van	van	PROPN
biomedich-267	414	2	gemert	gemert	NOUN
biomedich-267	414	3	,	,	PUNCT
biomedich-267	414	4	t.	t.	PROPN
biomedich-267	414	5	e.	e.	PROPN
biomedich-267	414	6	,	,	PUNCT
biomedich-267	414	7	moses	moses	PROPN
biomedich-267	414	8	,	,	PUNCT
biomedich-267	414	9	r.	r.	PROPN
biomedich-267	414	10	g.	g.	PROPN
biomedich-267	414	11	,	,	PUNCT
biomedich-267	414	12	pape	pape	NOUN
biomedich-267	414	13	,	,	PUNCT
biomedich-267	414	14	a.	a.	NOUN
biomedich-267	414	15	v.	v.	PROPN
biomedich-267	414	16	,	,	PUNCT
biomedich-267	414	17	&	&	CCONJ
biomedich-267	414	18	morris	morris	PROPN
biomedich-267	414	19	,	,	PUNCT
biomedich-267	414	20	g.	g.	PROPN
biomedich-267	414	21	j.	j.	PROPN
biomedich-267	414	22	(	(	PUNCT
biomedich-267	414	23	2020	2020	NUM
biomedich-267	414	24	)	)	PUNCT
biomedich-267	414	25	.	.	PUNCT
biomedich-267	415	1	gestational	gestational	ADJ
biomedich-267	415	2	diabetes	diabetes	NOUN
biomedich-267	415	3	mellitus	mellitus	NOUN
biomedich-267	415	4	testing	testing	NOUN
biomedich-267	415	5	in	in	ADP
biomedich-267	415	6	the	the	DET
biomedich-267	415	7	covid‐19	covid‐19	PROPN
biomedich-267	415	8	pandemic	pandemic	NOUN
biomedich-267	415	9	:	:	PUNCT
biomedich-267	415	10	the	the	DET
biomedich-267	415	11	problems	problem	NOUN
biomedich-267	415	12	with	with	ADP
biomedich-267	415	13	simplifying	simplify	VERB
biomedich-267	415	14	the	the	DET
biomedich-267	415	15	diagnostic	diagnostic	ADJ
biomedich-267	415	16	process	process	NOUN
biomedich-267	415	17	.	.	PUNCT
biomedich-267	416	1	australian	australian	ADJ
biomedich-267	416	2	and	and	CCONJ
biomedich-267	416	3	new	new	PROPN
biomedich-267	416	4	zealand	zealand	PROPN
biomedich-267	416	5	journal	journal	NOUN
biomedich-267	416	6	of	of	ADP
biomedich-267	416	7	obstetrics	obstetric	NOUN
biomedich-267	416	8	and	and	CCONJ
biomedich-267	416	9	gynaecology	gynaecology	NOUN
biomedich-267	416	10	,	,	PUNCT
biomedich-267	416	11	60(5	60(5	NOUN
biomedich-267	416	12	)	)	PUNCT
biomedich-267	416	13	,	,	PUNCT
biomedich-267	416	14	671	671	NUM
biomedich-267	416	15	-	-	SYM
biomedich-267	416	16	674	674	NUM
biomedich-267	416	17	.	.	PUNCT
biomedich-267	417	1	van	van	PROPN
biomedich-267	417	2	gerwen	gerwen	PROPN
biomedich-267	417	3	,	,	PUNCT
biomedich-267	417	4	m.	m.	NOUN
biomedich-267	417	5	,	,	PUNCT
biomedich-267	417	6	alsen	alsen	NOUN
biomedich-267	417	7	,	,	PUNCT
biomedich-267	417	8	m.	m.	NOUN
biomedich-267	417	9	,	,	PUNCT
biomedich-267	417	10	little	little	ADJ
biomedich-267	417	11	,	,	PUNCT
biomedich-267	417	12	c.	c.	NOUN
biomedich-267	417	13	,	,	PUNCT
biomedich-267	417	14	barlow	barlow	PROPN
biomedich-267	417	15	,	,	PUNCT
biomedich-267	417	16	j.	j.	PROPN
biomedich-267	417	17	,	,	PUNCT
biomedich-267	417	18	naymagon	naymagon	PROPN
biomedich-267	417	19	,	,	PUNCT
biomedich-267	417	20	l.	l.	PROPN
biomedich-267	417	21	,	,	PUNCT
biomedich-267	417	22	tremblay	tremblay	NOUN
biomedich-267	417	23	,	,	PUNCT
biomedich-267	417	24	d.	d.	PROPN
biomedich-267	417	25	,	,	PUNCT
biomedich-267	417	26	...	...	PUNCT
biomedich-267	417	27	&	&	CCONJ
biomedich-267	417	28	genden	genden	PROPN
biomedich-267	417	29	,	,	PUNCT
biomedich-267	417	30	e.	e.	PROPN
biomedich-267	417	31	(	(	PUNCT
biomedich-267	417	32	2020	2020	NUM
biomedich-267	417	33	)	)	PUNCT
biomedich-267	417	34	.	.	PUNCT
biomedich-267	418	1	outcomes	outcome	NOUN
biomedich-267	418	2	of	of	ADP
biomedich-267	418	3	patients	patient	NOUN
biomedich-267	418	4	with	with	ADP
biomedich-267	418	5	hypothyroidism	hypothyroidism	NOUN
biomedich-267	418	6	and	and	CCONJ
biomedich-267	418	7	covid-19	covid-19	PROPN
biomedich-267	418	8	:	:	PUNCT
biomedich-267	418	9	a	a	DET
biomedich-267	418	10	retrospective	retrospective	ADJ
biomedich-267	418	11	cohort	cohort	NOUN
biomedich-267	418	12	study	study	NOUN
biomedich-267	418	13	.	.	PUNCT
biomedich-267	419	1	frontiers	frontier	NOUN
biomedich-267	419	2	in	in	ADP
biomedich-267	419	3	endocrinology	endocrinology	NOUN
biomedich-267	419	4	,	,	PUNCT
biomedich-267	419	5	11	11	NUM
biomedich-267	419	6	,	,	PUNCT
biomedich-267	419	7	565	565	NUM
biomedich-267	419	8	.	.	PUNCT
biomedich-267	420	1	vas	vas	X
biomedich-267	420	2	,	,	PUNCT
biomedich-267	420	3	p.	p.	NOUN
biomedich-267	420	4	,	,	PUNCT
biomedich-267	420	5	hopkins	hopkins	PROPN
biomedich-267	420	6	,	,	PUNCT
biomedich-267	420	7	d.	d.	PROPN
biomedich-267	420	8	,	,	PUNCT
biomedich-267	420	9	feher	feher	ADJ
biomedich-267	420	10	,	,	PUNCT
biomedich-267	420	11	m.	m.	NOUN
biomedich-267	420	12	,	,	PUNCT
biomedich-267	420	13	rubino	rubino	PROPN
biomedich-267	420	14	,	,	PUNCT
biomedich-267	420	15	f.	f.	PROPN
biomedich-267	420	16	,	,	PUNCT
biomedich-267	420	17	&	&	CCONJ
biomedich-267	420	18	b	b	PROPN
biomedich-267	420	19	whyte	whyte	PROPN
biomedich-267	420	20	,	,	PUNCT
biomedich-267	420	21	m.	m.	NOUN
biomedich-267	420	22	(	(	PUNCT
biomedich-267	420	23	2020	2020	NUM
biomedich-267	420	24	)	)	PUNCT
biomedich-267	420	25	.	.	PUNCT
biomedich-267	421	1	diabetes	diabetes	NOUN
biomedich-267	421	2	,	,	PUNCT
biomedich-267	421	3	obesity	obesity	NOUN
biomedich-267	421	4	and	and	CCONJ
biomedich-267	421	5	covid‐19	covid‐19	PROPN
biomedich-267	421	6	:	:	PUNCT
biomedich-267	421	7	a	a	DET
biomedich-267	421	8	complex	complex	ADJ
biomedich-267	421	9	interplay	interplay	NOUN
biomedich-267	421	10	.	.	PUNCT
biomedich-267	422	1	diabetes	diabetes	NOUN
biomedich-267	422	2	,	,	PUNCT
biomedich-267	422	3	obesity	obesity	NOUN
biomedich-267	422	4	and	and	CCONJ
biomedich-267	422	5	metabolism	metabolism	NOUN
biomedich-267	422	6	,	,	PUNCT
biomedich-267	422	7	22(10	22(10	NUM
biomedich-267	422	8	)	)	PUNCT
biomedich-267	422	9	,	,	PUNCT
biomedich-267	422	10	18921896	18921896	NUM
biomedich-267	422	11	.	.	PUNCT
biomedich-267	423	1	yang	yang	PROPN
biomedich-267	423	2	,	,	PUNCT
biomedich-267	423	3	j.	j.	PROPN
biomedich-267	423	4	,	,	PUNCT
biomedich-267	423	5	tian	tian	PROPN
biomedich-267	423	6	,	,	PUNCT
biomedich-267	423	7	c.	c.	PROPN
biomedich-267	423	8	,	,	PUNCT
biomedich-267	423	9	chen	chen	PROPN
biomedich-267	423	10	,	,	PUNCT
biomedich-267	423	11	y.	y.	PROPN
biomedich-267	423	12	,	,	PUNCT
biomedich-267	423	13	zhu	zhu	PROPN
biomedich-267	423	14	,	,	PUNCT
biomedich-267	423	15	c.	c.	PROPN
biomedich-267	423	16	,	,	PUNCT
biomedich-267	423	17	chi	chi	PROPN
biomedich-267	423	18	,	,	PUNCT
biomedich-267	423	19	h.	h.	PROPN
biomedich-267	423	20	,	,	PUNCT
biomedich-267	423	21	&	&	CCONJ
biomedich-267	423	22	li	li	PROPN
biomedich-267	423	23	,	,	PUNCT
biomedich-267	423	24	j.	j.	PROPN
biomedich-267	423	25	(	(	PUNCT
biomedich-267	423	26	2020	2020	NUM
biomedich-267	423	27	)	)	PUNCT
biomedich-267	423	28	.	.	PUNCT
biomedich-267	424	1	obesity	obesity	NOUN
biomedich-267	424	2	aggravates	aggravate	VERB
biomedich-267	424	3	covid‐19	covid‐19	PROPN
biomedich-267	424	4	:	:	PUNCT
biomedich-267	424	5	an	an	DET
biomedich-267	424	6	updated	update	VERB
biomedich-267	424	7	systematic	systematic	ADJ
biomedich-267	424	8	review	review	NOUN
biomedich-267	424	9	and	and	CCONJ
biomedich-267	424	10	meta‐analysis	meta‐analysis	NOUN
biomedich-267	424	11	.	.	PROPN
biomedich-267	424	12	journal	journal	PROPN
biomedich-267	424	13	of	of	ADP
biomedich-267	424	14	medical	medical	ADJ
biomedich-267	424	15	virology	virology	NOUN
biomedich-267	424	16	.	.	PUNCT
biomedich-267	425	1	yang	yang	PROPN
biomedich-267	425	2	,	,	PUNCT
biomedich-267	425	3	j.	j.	PROPN
biomedich-267	425	4	,	,	PUNCT
biomedich-267	425	5	zheng	zheng	PROPN
biomedich-267	425	6	,	,	PUNCT
biomedich-267	425	7	y.	y.	PROPN
biomedich-267	425	8	,	,	PUNCT
biomedich-267	425	9	gou	gou	PROPN
biomedich-267	425	10	,	,	PUNCT
biomedich-267	425	11	x.	x.	NOUN
biomedich-267	425	12	,	,	PUNCT
biomedich-267	425	13	pu	pu	PROPN
biomedich-267	425	14	,	,	PUNCT
biomedich-267	425	15	k.	k.	PROPN
biomedich-267	425	16	,	,	PUNCT
biomedich-267	425	17	chen	chen	PROPN
biomedich-267	425	18	,	,	PUNCT
biomedich-267	425	19	z.	z.	PROPN
biomedich-267	425	20	,	,	PUNCT
biomedich-267	425	21	guo	guo	PROPN
biomedich-267	425	22	,	,	PUNCT
biomedich-267	425	23	q.	q.	PROPN
biomedich-267	425	24	,	,	PUNCT
biomedich-267	425	25	...	...	PUNCT
biomedich-267	425	26	&	&	CCONJ
biomedich-267	425	27	zhou	zhou	PROPN
biomedich-267	425	28	,	,	PUNCT
biomedich-267	425	29	y.	y.	PROPN
biomedich-267	425	30	(	(	PUNCT
biomedich-267	425	31	2020	2020	NUM
biomedich-267	425	32	)	)	PUNCT
biomedich-267	425	33	.	.	PUNCT
biomedich-267	426	1	prevalence	prevalence	NOUN
biomedich-267	426	2	of	of	ADP
biomedich-267	426	3	comorbidities	comorbiditie	NOUN
biomedich-267	426	4	and	and	CCONJ
biomedich-267	426	5	its	its	PRON
biomedich-267	426	6	effects	effect	NOUN
biomedich-267	426	7	in	in	ADP
biomedich-267	426	8	coronavirus	coronavirus	NOUN
biomedich-267	426	9	disease	disease	NOUN
biomedich-267	426	10	2019	2019	NUM
biomedich-267	426	11	patient	patient	NOUN
biomedich-267	426	12	:	:	PUNCT
biomedich-267	426	13	a	a	DET
biomedich-267	426	14	systematic	systematic	ADJ
biomedich-267	426	15	review	review	NOUN
biomedich-267	426	16	and	and	CCONJ
biomedich-267	426	17	meta	meta	ADJ
biomedich-267	426	18	-	-	PUNCT
biomedich-267	426	19	analysis	analysis	NOUN
biomedich-267	426	20	.	.	PUNCT
biomedich-267	427	1	international	international	ADJ
biomedich-267	427	2	journal	journal	NOUN
biomedich-267	427	3	of	of	ADP
biomedich-267	427	4	infectious	infectious	ADJ
biomedich-267	427	5	diseases	disease	NOUN
biomedich-267	427	6	,	,	PUNCT
biomedich-267	427	7	94	94	NUM
biomedich-267	427	8	,	,	PUNCT
biomedich-267	427	9	91	91	NUM
biomedich-267	427	10	-	-	SYM
biomedich-267	427	11	95	95	NUM
biomedich-267	427	12	.	.	PUNCT
biomedich-267	428	1	zaki	zaki	PROPN
biomedich-267	428	2	,	,	PUNCT
biomedich-267	428	3	n.	n.	NOUN
biomedich-267	428	4	,	,	PUNCT
biomedich-267	428	5	alashwal	alashwal	NOUN
biomedich-267	428	6	,	,	PUNCT
biomedich-267	428	7	h.	h.	PROPN
biomedich-267	428	8	,	,	PUNCT
biomedich-267	428	9	&	&	CCONJ
biomedich-267	428	10	ibrahim	ibrahim	PROPN
biomedich-267	428	11	,	,	PUNCT
biomedich-267	428	12	s.	s.	PROPN
biomedich-267	428	13	(	(	PUNCT
biomedich-267	428	14	2020	2020	NUM
biomedich-267	428	15	)	)	PUNCT
biomedich-267	428	16	.	.	PUNCT
biomedich-267	429	1	association	association	NOUN
biomedich-267	429	2	of	of	ADP
biomedich-267	429	3	hypertension	hypertension	NOUN
biomedich-267	429	4	,	,	PUNCT
biomedich-267	429	5	diabetes	diabetes	NOUN
biomedich-267	429	6	,	,	PUNCT
biomedich-267	429	7	stroke	stroke	NOUN
biomedich-267	429	8	,	,	PUNCT
biomedich-267	429	9	cancer	cancer	NOUN
biomedich-267	429	10	,	,	PUNCT
biomedich-267	429	11	kidney	kidney	NOUN
biomedich-267	429	12	disease	disease	NOUN
biomedich-267	429	13	,	,	PUNCT
biomedich-267	429	14	and	and	CCONJ
biomedich-267	429	15	high	high	ADJ
biomedich-267	429	16	-	-	PUNCT
biomedich-267	429	17	cholesterol	cholesterol	NOUN
biomedich-267	429	18	with	with	ADP
biomedich-267	429	19	covid-19	covid-19	PROPN
biomedich-267	429	20	disease	disease	NOUN
biomedich-267	429	21	severity	severity	NOUN
biomedich-267	429	22	and	and	CCONJ
biomedich-267	429	23	fatality	fatality	NOUN
biomedich-267	429	24	:	:	PUNCT
biomedich-267	429	25	a	a	DET
biomedich-267	429	26	systematic	systematic	ADJ
biomedich-267	429	27	review	review	NOUN
biomedich-267	429	28	.	.	PUNCT
biomedich-267	430	1	diabetes	diabetes	NOUN
biomedich-267	430	2	&	&	CCONJ
biomedich-267	430	3	metabolic	metabolic	PROPN
biomedich-267	430	4	syndrome	syndrome	PROPN
biomedich-267	430	5	:	:	PUNCT
biomedich-267	430	6	clinical	clinical	ADJ
biomedich-267	430	7	research	research	NOUN
biomedich-267	430	8	&	&	CCONJ
biomedich-267	430	9	reviews	review	NOUN
biomedich-267	430	10	,	,	PUNCT
biomedich-267	430	11	14(5	14(5	NUM
biomedich-267	430	12	)	)	PUNCT
biomedich-267	430	13	,	,	PUNCT
biomedich-267	430	14	1133	1133	NUM
biomedich-267	430	15	-	-	SYM
biomedich-267	430	16	1142	1142	NUM
biomedich-267	430	17	.	.	PUNCT
biomedich-267	431	1	zhou	zhou	PROPN
biomedich-267	431	2	,	,	PUNCT
biomedich-267	431	3	f.	f.	PROPN
biomedich-267	431	4	,	,	PUNCT
biomedich-267	431	5	yu	yu	PROPN
biomedich-267	431	6	,	,	PUNCT
biomedich-267	431	7	t.	t.	PROPN
biomedich-267	431	8	,	,	PUNCT
biomedich-267	431	9	du	du	PROPN
biomedich-267	431	10	,	,	PUNCT
biomedich-267	431	11	r.	r.	PROPN
biomedich-267	431	12	,	,	PUNCT
biomedich-267	431	13	fan	fan	PROPN
biomedich-267	431	14	,	,	PUNCT
biomedich-267	431	15	g.	g.	PROPN
biomedich-267	431	16	,	,	PUNCT
biomedich-267	431	17	liu	liu	PROPN
biomedich-267	431	18	,	,	PUNCT
biomedich-267	431	19	y.	y.	PROPN
biomedich-267	431	20	,	,	PUNCT
biomedich-267	431	21	liu	liu	PROPN
biomedich-267	431	22	,	,	PUNCT
biomedich-267	431	23	z.	z.	PROPN
biomedich-267	431	24	,	,	PUNCT
biomedich-267	431	25	...	...	PUNCT
biomedich-267	431	26	&	&	CCONJ
biomedich-267	431	27	guan	guan	PROPN
biomedich-267	431	28	,	,	PUNCT
biomedich-267	431	29	l.	l.	PROPN
biomedich-267	431	30	(	(	PUNCT
biomedich-267	431	31	2020	2020	NUM
biomedich-267	431	32	)	)	PUNCT
biomedich-267	431	33	.	.	PUNCT
biomedich-267	432	1	clinical	clinical	ADJ
biomedich-267	432	2	course	course	NOUN
biomedich-267	432	3	and	and	CCONJ
biomedich-267	432	4	risk	risk	NOUN
biomedich-267	432	5	factors	factor	NOUN
biomedich-267	432	6	for	for	ADP
biomedich-267	432	7	mortality	mortality	NOUN
biomedich-267	432	8	of	of	ADP
biomedich-267	432	9	adult	adult	NOUN
biomedich-267	432	10	inpatients	inpatient	NOUN
biomedich-267	432	11	with	with	ADP
biomedich-267	432	12	covid-19	covid-19	PROPN
biomedich-267	432	13	in	in	ADP
biomedich-267	432	14	wuhan	wuhan	PROPN
biomedich-267	432	15	,	,	PUNCT
biomedich-267	432	16	china	china	PROPN
biomedich-267	432	17	:	:	PUNCT
biomedich-267	432	18	a	a	DET
biomedich-267	432	19	retrospective	retrospective	ADJ
biomedich-267	432	20	cohort	cohort	NOUN
biomedich-267	432	21	study	study	NOUN
biomedich-267	432	22	.	.	PUNCT
biomedich-267	433	1	the	the	DET
biomedich-267	433	2	lancet	lancet	PROPN
biomedich-267	433	3	.	.	PUNCT
biomedich-267	434	1	this	this	DET
biomedich-267	434	2	page	page	NOUN
biomedich-267	434	3	intentionally	intentionally	ADV
biomedich-267	434	4	left	leave	VERB
biomedich-267	434	5	blank	blank	ADV